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This thesis reports contributions to three branches of organoboron chemistry: boron 
incorporation, boron homologation, and boron functionalization. 
Firstly, a decarboxylative borylation reaction has been developed. Carboxylic acids, pre-
activated as their corresponding N-hydroxyphthalimide esters, have been found to undergo a 
decarboxylative borylation process in the presence of bis(catecholato)diboron in 
N,N-dimethylacetamide solvent under blue LED irradiation to deliver, after transesterification 
with pinacol, stable and isolable pinacol boronic esters. These simple conditions extended to a 
wide range of functional group-bearing and structurally diverse carboxylic acids to give the 
corresponding boronic esters in mostly good to excellent yields. Mechanistic studies have 
revealed that a single electron transfer between the activated ester and bis(catecholato)diboron, 
which form a light-absorbing EDA complex, is responsible for initiating the transformation, 
and that the ability of the solvent to stabilize boryl radicals is critical to successful reaction. 
Secondly, the Aggarwal lithiation−borylation methodology has been expanded to enable the 
synthesis of 1,3-diols, which were previously inaccessible due to -elimination of the 
intermediate boronate complexes. 1,2-Bis(boronic esters) were discovered to undergo stereo- 
and regioselective homologation using enantioenriched lithium carbenoids in the presence of 
bulky diamines, such as sparteine. The resultant 1,3-bis(boronic esters) were oxidized to deliver 
a wide range of structurally diverse secondary-secondary and secondary-tertiary 1,3-diols in 
good to excellent yields and perfect diastereoisomeric ratios, the latter of which is especially 
noteworthy since these substrates have not previously been accessible with such generality and 
high diastereoselectivity. 
Finally, we have developed a novel, strained bicyclobutyl boronate complex that has enabled, 
for the first time, the reaction of C−C -bonds of boronate complexes with electrophiles. We 
have invented a linchpin reagent, a bicyclobutyl sulfoxide, that enables the facile generation of 
bicyclobutyl lithium on demand, which then reacts with a boronic ester to form the bicyclobutyl 
boronate complex. These highly reactive intermediates have been reacted with electrophiles to 
produce a set of pharmaceutically-relevant 1,1,3-trisubstituted borylated cyclobutanes with 
excellent diastereoselectivity. Of note, electrophilic palladium(II)-aryl complexes were found 
to be excellent electrophiles and have enabled the addition of two modular units, a boronic ester 
and an aryl triflate, across a C−C -bond. This reaction constitutes the first report of a C−C 
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1. Boron in organic chemistry 
1.1 The boron atom 
Boron-containing organic compounds, most commonly, but not limited to, boranes, boronic 
acids, and boronic esters (collectively referred to as ‘boron’ throughout this chapter) possess a 
trivalent structure where the boron atom is bound to three substituents. For boranes, these three 
substituents are carbon-based (C−B bonds), but boronic acids and boronic esters, the latter of 
which will be the focus of this report, have a single carbon-based substituent and two 
hydroxy/alkoxy/aryloxy groups (B−O bonds) (Scheme 1A). Due to possessing only three 
bonding electron pairs, the boron center has only six valence electrons. Therefore, boron is 
sp2-hybridised and adopts a trigonal planar configuration with a vacant p-orbital projecting 
orthogonally to its three substituents. It is predominantly this vacant p-orbital that engenders 
boron-containing organic compounds with their diverse reactivity profiles, and indeed enables 
the reactivity discussed throughout this chapter and the whole of this report.1 
 
Scheme 1. The boron atom in organic chemistry: (A) General structure of boranes, boronic acids, and boronic esters. (B) 
Formation of a boronate complex. (C) 1,2-Metalate rearrangement with expulsion of an -leaving group. 
Being electron-deficient, boron centers are Lewis acidic and can therefore reversibly coordinate 
with internal or external nucleophiles. The result is an eight electron, tetrahedral boronate 
complex, such as 1 (Scheme 1B). One of the substituents on a boronate complex can undergo 
a 1,2-migration, with the overall process being termed a 1,2-metalate rearrangement, if there is 
a suitably electron-deficient center  to the boron atom, with this typically being an adjacent 
carbon atom bearing a leaving group, to give an organoboron product. Stereoelectronic 
requirements of the 1,2-metalate rearrangement dictate an antiperiplanar alignment of the 
migrating substituent and the leaving group (Scheme 1C). In a concerted mechanism, a boron 
substituent migrates into the C−LG * orbital whilst the C−LG bond breaks, explaining why 
the overall transformation is completely stereospecific; the migrating substituent retains its 
original stereochemistry and the stereochemistry at the migratory terminus atom in inverted. 
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Exploitation of this fundamental mechanistic pathway has led to the development of a plethora 
of synthetically useful reactions involving organoboron compounds, most of which can be 
grouped into three distinct categories. 
1.2 The three-stage approach to organoboron chemistry 
Broadly, organoboron chemistry consists of three fundamental stages (Figure 1): first, 
incorporation of the boron atom into the desired substrate, often using a pre-installed functional 
group as a synthetic handle; which is followed by boron homologation, where the boron-bearing 
hydrocarbon chain is grown by the (typically stereoselective) insertion of modular units into 
the C−B bond; and finally, boron functionalization, where the boron atom is transformed into 
another functional group, usually with loss of the boron atom itself. 
 
Figure 1. A generic representation of the three-stage approach to organoboron chemistry: boron incorporation, boron 
homologation, then boron functionalization. 
This approach is highly versatile and enables the rapid, iterative synthesis of complex organic 
molecules. A prime example of this three-stage concept in operation is Aggarwal’s 2015 total 
synthesis of kalkitoxin (Scheme 2).2 The initial boronic ester is prepared from the 
corresponding alkyl chloride − 4-methoxybenzyl chloride (2) − which is a cheap, commercially 
available starting material, using Miyaura borylation conditions.3 Here, 2 is treated with 
Pd(PPh3)4, bis(pinacolato)diboron (B2pin2), and potassium carbonate to displace the chloride 
and incorporate a pinacol boronic ester to give 3 in excellent yield. Next, the hydrocarbon chain 
is homologated in an iterative fashion to provide the elongated boronic ester 4: from 3, six 
homologations, using a combination of three lithium carbenoid building blocks, (R)-5, (S)-54 
and 6, install six carbon atoms, three of which are asymmetric centers, to deliver boronic ester 
4. This entire sequence is performed without intermediate purification, where the crude product 
is entered directly into the proceeding reaction, whilst maintaining excellent stereofidelity and 
yield per step. Boronic ester 4 is next subjected to a boron functionalization reaction. Here, 
lithium methoxy amide reacts with the boronic ester to convert it into the corresponding primary 
amine, which is immediately coupled with a carboxylic acid. At this stage, thorough purification 
finally occurs to deliver amide 7 in 52 % yield, and as a single diastereoisomer, from starting 
boronic ester 3. Through use of this three-stage approach, a range of organoboron chemistries 
have enabled the transformation of a simple, cheap starting material into a complex natural 
product precursor bearing three stereocenters (not counting the one from the carboxylic acid) 
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in just 8 steps, and only two purifications. Due to the efficiency of this route, it meets a number 
of criteria used to judge synthetic ideality.5 
 
Scheme 2. The total synthesis of kalkitoxin using the three-stage organoboron chemistry approach. 
Since this thesis will describe contributions to boron incorporation, boron homologation, and 
boron functionalization, each of these stages will be briefly introduced in the upcoming sections 
to provide a broad oversight of the field. The discussion will focus on state of the art or 
particularly instructive methods, and those that will help put the research detailed later in this 
thesis into context. 
1.2.1 Boron incorporation 
Boronic esters are highly versatile functional groups (see chapter 1.2.3), so any novel method 
for their incorporation into organic substrates is inherently valuable, especially if it utilizes 
previously unexploited feedstock molecules. Innumerable methods have thus been devised to 
introduce boron into a wide range of substrates using previously installed functional handles.1 
 
Scheme 3. Brown hydroboration chemistry: (A) General hydroboration−oxidation process; (B) mechanism; and (C) 
hydroboration of 1-methylcyclopentene to give the trans product as a single diastereoisomer. 
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Perhaps the most well-known example of a boron incorporation reaction is the hydroboration 
of alkenes, wherein a boron and a hydrogen atom are added across a C−C -bond to yield an 
alkyl organoboron product. This classic reaction was first discovered in 1957 by Brown and 
was the genesis of organoboron chemistry as a whole.6 Its significance was eventually 
recognized by Brown being awarded a Nobel prize in Chemistry in 1979. In its most simple 
form, the B−H bond of diborane is added across the C−C -bond of an olefin to deliver a 
primary alkyl borane 8 (Scheme 3A). This intermediate can then add its remaining B−H bonds 
across two further olefins to ultimately result in tri-alkyl borane 9, which, after oxidation, 
provides three equivalents of the corresponding primary alcohol 10.  
The hydroboration reaction proceeds via four-membered transition state 11 (Scheme 3B), 
which ultimately causes it to be both regio- and stereoselective: the boron and hydrogen atoms 
are added simultaneously onto the same face of the C−C -bond; and, in the transition state, the 
build up of partial positive charge is preferentially located on the more substituted carbon atom, 
and the bulkier boron atom is placed on the less hindered carbon atom (Anti-Markovnikov 
addition). In practical terms, this means, for example, that 1-methylcyclopentene is converted 
to trans-2-methylcyclopentanol after a hydroboration−oxidation sequence (Scheme 3C). 
Whilst the classic Brown hydroboration is still widely used for the incorporation of boron into 
organic molecules (albeit not always in the exact manner described above), it has since been 
largely superseded by a plethora of modern methods. A review of this variegated field, 
unfortunately, falls out of the scope of this thesis and there are many excellent reviews already 
present in the literature that provide a broad oversight of these modern methods.1,7 
1.2.2 Boron homologation 
Metal carbenoids,8 which exhibit both nucleophilic and electrophilic properties, have been 
frequently used for boron homologation. The metal carbenoid acts as a nucleophile, attacking 
the vacant p-orbital of a boron center, to generate a boronate complex. This is followed by a 
substituent on the boron atom migrating to the electrophilic carbon center of the carbenoid, 
expelling a leaving group. To render this rearrangement enantioselective, two general methods 
have emerged: substrate control, and reagent control. 
In substrate-controlled homologation, a boronic ester bearing a chiral diol is reacted with a 
prochiral metal carbenoid, containing two identical leaving groups, to form a boronate complex. 
The chirality of the diol on the boron atom subsequently determines which diastereotopic 
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leaving group is expelled upon 1,2-metalate rearrangement, and so also determines which 
diastereomeric organoboron product is formed.9 
 
Scheme 4. Matteson’s substrate-controlled homologation of boronic esters. 
Matteson10 found that when an enantiopure boronic ester of type 12, which bears a chiral diol 
ligand, was reacted with dichloromethyl lithium, it formed boronate complex 13 (Scheme 4). 
In the presence of zinc chloride, which was found to be key to achieving high yield and 
diastereoselectivity,11 stereospecific 1,2-metalate rearrangement to form α-chloroboronic ester 
14 occurs. Matteson proposed that binding of zinc chloride to the less hindered oxygen atom of 
the diol ligand and a chloride of the dichloromethyl moiety stabilizes transition state 15 relative 
to 16,12 which favors 1,2-metalate rearrangement to form 14. Treatment of 14 with an 
organolithium or Grignard reagent displaces the remaining chloride, in a similar process, to 
result in the formation of alkylated boronic ester 17 with exceptional diastereoselectivity 
(typically >95:5 diastereoisomeric ratio (d.r.) or better). 
The power of this approach has been demonstrated by the total synthesis of several natural 
products, including japonilure,13 (2R,3R,1’R)-stegobinone,14 serricorin15 and 
(−)-microcarpalide.16 Owing to the substrate-controlled nature of the Matteson process, it is 
necessary to change the configuration of the diol ligand between steps in an iterative 
homologation sequence if the opposite stereochemistry is required. This is a major drawback 
because three concession steps are necessary for such an exchange. 
In the reagent-controlled variant of boronic ester homologation, an enantioenriched metal 
carbenoid is reacted with an organoboron species to form a boronate complex. Because the 
stereochemical information of the metal carbenoid is retained upon boronate complex 
formation, there is only one possible stereochemical outcome: the boronate complex undergoes 
stereospecific 1,2-metalate rearrangement to expel the single leaving group with inversion of 
- 6 - 
 
the accepting carbon center. This translates the chirality of the metal carbenoid into the 
organoboron product. 
In 1990, Hoppe17 devised a (−)-sparteine (18, (−)-sp)-mediated asymmetric deprotonation of 
O-alkyl carbamates 19 at low temperature with sec-butyl lithium (sec-BuLi) to give 
configurationally stable organolithium (−)-sp-Li-19, which could be trapped with a variety of 
electrophiles with retention of stereochemistry (Scheme 5). A major limitation of this 
methodology at the time was that (+)-sparteine was not commercially available. Notably, 
several carbamates 19, after 18-mediated lithiation with sec-butyl lithium, were trapped with 
triisopropyl borate, and then transesterified with pinacol, to yield α-boryl carbamates 20. After 
their isolation, these were shown to react with Grignard reagents to form boronate complexes 
that, after heating to induce 1,2-metalate rearrangement and then oxidizing with a NaOH/H2O2 
mixture, produced secondary alcohols 21 in good yield and excellent enantiomeric excess 
(e.e.)18 
 
Scheme 5. Hoppe’s sparteine-mediated lithiation of carbamates and subsequent trapping with electrophiles. 
In 2006, Kocienski19 first performed a boronic ester homologation with a lithiated carbamate 
in a ‘one-pot’ operation (Scheme 6). During a total synthesis of (S)-(−)-N-acetylcolchinol, 
carbamate 22 was deprotonated with sec-butyl lithium/(−)-sparteine and trapped with aryl 
boronic ester 23, which contains an aryl substituent capable of undergoing 1,2-migration. The 
subsequent boronate complex underwent 1,2-metalate rearrangement, and the resultant boronic 
ester oxidized, to give secondary alcohol 24 in good yield and with an excellent enantiomeric 
ratio (e.r.) of 98:2. 
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Scheme 6. Kocienski’s total synthesis of (S)-(−)-N-acetylcolchinol via a ‘one-pot’ Hoppe-type boronic ester homologation 
using a lithiated carbamate. 
Aggarwal20 has since explored this chemistry more thoroughly and termed the process 
‘lithiation−borylation’. In an analogous procedure to that described by Kocienski, a number of 
primary O-alkyl carbamates 19 were subjected to (−)-sparteine (18) and (+)-sparteine 
surrogate21 25 – a readily synthesized replacement for the commercially unavailable 
(+)-sparteine – mediated lithiation with sec-butyl lithium and then trapped with a number of 
boranes and boronic esters (Scheme 7). After 1,2-metalate rearrangement and oxidation, the 
corresponding secondary alcohols 21 were obtained in high yield and e.r. across all examples. 
An impressive iterative process was also described, where the intermediate boronic ester 26 
was isolated and submitted to a further homologation reaction. This process was used to 
synthesize all four possible stereoisomers of alcohol 27 in excellent yields and with excellent 
levels of enantio- and diastereocontrol.22 
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Scheme 7. (A) Aggarwal’s homologation of boronic esters and boranes using lithiated carbamates. (B) Aggarwal’s iterative 
homologation of boronic esters with lithiated carbamates. 
2,4,6-Triisopropyl benzoates (TIB esters) 28, originally developed by Beak,23 have also been 
shown by Aggarwal to be effective homologating reagents for boronic esters.24 In an analogous 
procedure to that described in Scheme 7, TIB esters 28 can be submitted to a (−)-sparteine-
mediated lithiation at low temperature with sec-butyl lithium to generate configurationally 
stable lithiated benzoate (−)-sp-Li-28 in high e.r. (Scheme 8). Reaction with a boronic ester, 
then 1,2-metalate rearrangement and oxidation, yields the homologated alcohol 21. TIB esters 
were found to be particularly effective when using challenging migrating groups, such as 
methyl and phenyl, or substituents containing esters or nitriles, because the benzoate is a better 
leaving group than the previously used carbamates. 
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Scheme 8. Aggarwal’s lithiation−borylation using lithiated TIB esters. 
Aggarwal has recently pushed the boundaries of this iterative lithiation−borylation process, 
now named ‘Assembly-Line Synthesis’, through the synthesis of compound 29 (Scheme 9).4 
Using highly enantioenriched lithiated species (R)-5 and (S)-5, derived from the corresponding 
trimethyl stannanes, it was possible to perform nine consecutive homologations of a simple 
boronic ester starting material, with only simple aqueous work-ups every third homologation, 
to synthesize 29 in excellent purity, and enantio- and diastereoselectivity. 
 
Scheme 9. Aggarwal’s iterative homologation of boronic esters – named ‘Assembly-Line Synthesis’. 
1.2.3 Boron functionalization 
Boron can be easily converted into a wide range of other functional groups,25 and the 
development of new functionalizations and improvement of current methods are still 
intensively researched. This is arguably why borylation reactions are intrinsically more 
valuable than many other functional group incorporation reactions. They essentially enable 
access to any other functional group, albeit in a two step sequence, using a general borylation 
reaction followed by a well-developed boron functionalization. This sequence avoids the time 
and resource intensive endeavours of developing novel reactions to incorporate every other 
desired functional group. This makes late-stage borylations particularly powerful since 
advanced scaffolds can be borylated and then easily derivatized without the requirement of 
designing several independent de novo syntheses of the final desired functionalized compounds. 
A summary of selected boron functionalizations is included in Figure 2. 
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Figure 2. Selected boron functionalizations. 
The archetypal boron functionalization reaction is its oxidation to the corresponding alcohol, 
which was first developed by Brown, using organoboranes.26 Here, a mixture of sodium 
hydroxide and hydrogen peroxide generates a peroxide anion, which adds to the vacant p-orbital 
of the boron atom to form an intermediate boronate complex. One of the boron substituents 
undergoes a stereospecific 1,2-migration, with expulsion of hydroxide, to give the oxidized 
product, which, after aqueous hydrolysis, reveals the corresponding alcohol and removes the 
boron atom, whose ultimate fate is as a water-soluble boric acid derivative (Scheme 10). 
 
Scheme 10. Oxidation of boron using a mixture of sodium hydroxide and hydrogen peroxide. 
Similar transformations, that proceed via analogous mechanisms, are boron amination,27 
sulfuration, and phosphination, however the last two are only scantily described using 
organoboranes in a single report from 1970.28 
Some of the most versatile boron transformations proceed via intermediate vinyl or aryl 
boronate complexes,29 and all operate on similar mechanistic principles. The Zweifel reaction 
is the most basic of these transformations and had its genesis in 1967.30 In its most simple form, 
and using a modernized method as an example,31 unsubstituted vinylmagnesium chloride or 
vinyl lithium can add to a boronic ester to form a vinyl boronate complex 30 (Scheme 11). The 
C−C -bond of the vinyl group then reacts with iodine to form an intermediate iodonium 
species. This then undergoes a stereospecific 1,2-metalate rearrangement, which results in the 
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net addition of iodide and the migrating carbon substituent across the C−C -bond of the vinyl 
group. Sodium methoxide is then added to effect elimination of the boron atom and the iodide, 
which proceeds via a transient boronate complex, to reform the C−C -bond. The overall 
transformation thus converts a boronic ester into the corresponding olefin 31 with complete 
retention of the stereochemistry of the original boronic ester. This concept has been proven to 
be enabling for the general conversion of boron into unsaturated functional groups, which now 
also include both E- and Z-polysubstituted olefins using the same starting materials,32 ketones,33 
alkynes,34 and allenes.35 
 
Scheme 11. Zweifel reaction mechanism. *e.s. = enantiospecificity, d.s. = diastereospecificity. 
An inventive twist on this reactivity was reported by Aggarwal in 2014.36 Here, electron-rich 
aryl lithiums, using furyl lithium as a representative example, are reacted with boronic esters to 
form the corresponding aryl boronate complexes 32 (Scheme 12). Next, an electrophile, 
N-bromosuccinimide, reacts with the electron-rich -system of the aryl ring through an 
electrophilic aromatic substitution mechanism to eventually induce 1,2-metalate rearrangement 
and give dearomatized intermediate 33. Much like in the previous Zweifel reaction, a base, 
most likely the succinimide anion in this case, forms a transient boronate complex with 33 to 
eliminate both the boron center and bromide to restore aromaticity. The overall transformation 
thus converts a boronic ester into an aryl ring, such as a furan 34 or, more generally, electron-
rich aryl rings 35. As before, the process is entirely stereospecific with complete retention of 
stereochemical information. The process was not limited to furan and extended to a wide range 
of substituted electron-rich aromatic rings. 
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Scheme 12. Coupling of a boronic ester with electron-rich aryl lithium reagents using Zweifel-type conditions. 
Aggarwal has since devised numerous similar transformations to convert boronic esters into 
pyridines and quinolines,37 phenylacetylenes,38 ortho-subtituted benzylic boronic esters,39 and 
phenols,40 amongst other miscellaneous examples.41 
The most recently reported fundamental method of transforming boron into another functional 
groups is via a ‘nucleophilic boronate complex’. In all previous reactions involving boronate 
complexes, nucleophilic C−B bonds have displaced adjacent leaving groups, however this was 
always in the context of intramolecular 1,2-metalate rearrangements. In 2011, Aggarwal42 
showed that boronate complexes 36, formed from organoboronic esters and an aryl lithium, 
could behave as organometallic-type nucleophiles and react directly with external electrophiles 
through the nucleophilic C−B bond (Scheme 13). A small set of secondary dialkyl pinacol 
boronic esters were converted to the corresponding boronate complexes, using either para-
methoxyphenyl or 3,5-di(trifluoromethyl)phenyl lithium, and then reacted directly with a range 
of interesting electrophiles to form the functionalized products 37 in generally good yields and 
good to excellent enantiospecificities. This chemistry has recently been extended to 
fluorination, which also achieved good yields and enantiospecificities across a range of 
secondary dialkyl boronic ester substrates.43  
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Scheme 13. Aggarwal’s nucleophilic boronate complex chemistry. 
Mechanistically, these reactions proceed via SE2inv pathways, where the electrophile approaches 
the backside of the nucleophilic C−B bond and, upon reaction, results in inversion of the 
stereocenter originally bearing the boronic ester. In most examples, good enantiospecificity is 
obtained. However, for some electrophiles, a notable decrease in, or even absence of, 
enantiospecificity is observed. This has been shown, using radical clock experiments, to result 
from a competing single electron transfer pathway, which gives an intermediate alkyl radical 
that leads to loss of stereochemical information.43   
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2. Photoinduced decarboxylative borylation 
2.1 Why decarboxylative borylation? 
2.1.1 The importance of boron 
Carboxylic acids are among the most prevalent and structurally variegated organic building 
blocks present in nature. Furthermore, they are typically widely available, inexpensive, 
chemically stable, and non-toxic. They therefore represent attractive precursors to almost every 
other functional group, including the boronic ester. 
In stark contrast, organoboron compounds are scarcely found in nature and are thus almost 
invariably produced via chemical synthesis. Yet, as presented in chapter 1, boron-containing 
compounds are often linchpin molecules due to their ability to be engaged in iterative chain-
growth processes20 or transformed in a single step into a wide range of other functional groups.25 
Additionally, boron is increasingly becoming an important end-point in and of itself, 
specifically in the arena of medicinal chemistry, where some boron-containing compounds have 
been found to possess anticancer, antibacterial and antiviral activities, amongst others.44 Indeed, 
there are several boron-containing drugs with current FDA approval (Figure 3), some examples 
include: tavaborole (38), a topical antifungal for treatment of onychomycosis; bortezomib (39), 
a protease inhibitor used for the treatment of myeloma and lymphoma; ixazomib (40), also a 
protease inhibitor used for the treatment of myeloma; and vaborbactam (41), a non -lactam 
-lactamase inhibitor used in conjunction with meropenem to treat bacterial infections.45 It 
should be noted that the majority of boron-containing drugs, including three of those just 
described, are chiral -amino boronic acids.46 
 
Figure 3. Current FDA-approved boron-containing drugs. 
As discussed in section 1.1, boron owes a lot of its reactivity to its vacant p-orbital, which 
enables it to react with nucleophiles to form anionic tetrahedral boronate complexes. 
Unsurprisingly, it is primarily this chemistry that endows some boron-containing compounds 
with potent biological activities. Boron-containing drugs chiefly act as inhibitors of proteases,44 
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which are enzymes that are responsible for the cleavage of peptidic bonds. These enzymes 
operate (Figure 4A), taking serine protease as a typical example, by binding the substrate in 
such a fashion that orientates the carbonyl of the scissile amide bond near the hydroxyl group 
of an active-site serine residue. This undergoes base-catalyzed nucleophilic attack into the 
amide carbonyl to result in a tetrahedral intermediate 42, which subsequently collapses to 
extrude the amine component and thus form the acylated serine residue. Finally, attack by a 
water molecule generates a second tetrahedral intermediate, which can then break down to 
release the carboxyl fragment of the cleaved peptide. Boron-containing compounds can 
sometimes act as so-called ‘transition state analogues’ to inhibit these hydrolytic enzymes by 
mimicking the tetrahedral intermediates, such as 42: the serine undergoes nucleophilic attack 
into the empty p-orbital of the boron atom to form a stable tetrahedral boronate complex, such 
as 43 (Figure 4B). Whilst formation of these boronate complexes is reversible, if the active site 
excludes water then the reverse process will be slow and thus the enzyme will be efficiently 
inhibited. 
 
Figure 4. (A) Simplified depiction of the mechanism of peptidic bond cleavage by proteases. (B) How boron-containing drugs 
can act as ‘transition state analogues’ to inhibit proteases.  
Thus, devising a method for the generalized introduction of boron using carboxylic acid starting 
materials is a particularly worthy goal, since it enables the merging of the best qualities of 
carboxylic acids and boron: the diverse abundance of carboxylic acids, and the broad chemistry 
of organoboron compounds. It will also enable the late-stage conversion of carboxylic acids, 
including those embedded within bioactive molecules, to their boron-containing congeners 
without the need to design a de novo synthesis of the boron-containing analogue. More 
specifically, the ability to convert any naturally-sourced carboxylic acid into its corresponding 
boron-containing analogue will serve as a platform for the preparation of a diverse set of 
molecules using a two step sequence, where the first step, the decarboxylative borylation itself, 
is common, and the second is any desired boron functionalization reaction, which are already 
well-developed.25 This new reaction will thus enable access to any decarboxylative 
transformation product without the time-consuming endeavour of developing a host of novel 
reactions to incorporate each desired functional group.  
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2.1.2 General overview of radical-based decarboxylative functionalizations 
Due to the benefits of using carboxylic acids as synthetic precursors, described in section 2.1.1, 
generalized approaches to radical-based decarboxylative functionalizations have become 
increasingly researched over the past 15 years. They have emerged as highly enabling 
transformations for the incorporation of a host of different functional groups into otherwise 
challenging substrates (see Figure 5 for a brief summary of current transformations). The most 
commonly used fundamental technologies that have encouraged development of this field are 
photoredox chemistry47 and N-hydroxyphthalimide esters (NHPI esters),48 the latter of which 
are isolable activated carboxylic acids conveniently synthesized using robust amide coupling 
chemistry.49 Since these vast fields have been extensively reviewed recently,50 we will only 
discuss two comparable examples here to highlight their complementarity. 
 
Figure 5. Summary of selected decarboxylative functionalizations, either direct from the carboxylic acid or from the 
activated NHPI ester. 
Using the 1,4-addition of alkyl radicals to electrophilic olefins, also known as the Giese 
reaction,51 as a representative example, a report from MacMillan52 in 2014 described the 
generation of alkyl radicals from carboxylic acids, which subsequently underwent 1,4-addition 
to Michael acceptors (Scheme 14). Using visible light-mediated photoredox catalysis, 
carboxylate anions (E1/2
red = +1.16 V vs SCE in acetonitrile)53 could be oxidized by a strongly 
oxidizing photo-excited iridium photocatalyst (E1/2
III*/II = +1.21 V vs SCE in acetonitrile)54 to 
deliver a carboxyl radical, which rapidly decarboxylates. The resulting nucleophilic alkyl 
radical then adds to an electron-deficient olefin to give a stabilized -acyl radical. The iridium 
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photocatalyst finally reduces this radical to yield, after protonation of the subsequent anion, the 
1,4-addition product. The substrate scope of this process was found to be very broad, 
encompassing a wide variety of Michael acceptors and carboxylic acids, the latter of which 
included a range of -amino carboxylic acids. 
 
Scheme 14. MacMillan’s decarboxylative Giese reaction using photoredox catalysis. 
On the other hand, NHPI esters demonstrate complementary reactivity to the unactivated 
carboxylic acids because the carboxyl radical, which is the required precursor to the 
corresponding decarboxylated carbon-centered radical, is revealed through a reductive process, 
rather than an oxidative one. These NHPI esters can be considered analogues of the classical 
thiohydroxyamate esters (‘Barton esters’),55 but ones that are far more stable to isolation and 
insensitive to light. 
In 2012 and 2015, Overman56 reported the generation of tertiary alkyl radicals from the 
corresponding NHPI esters 44 (Scheme 15). Here, an excited state ruthenium(II) photocatalyst 
is reduced by Hantzsch ester to form a strongly reducing ruthenium(I) catalyst, which then 
reduces the NHPI ester 44 to result in radical anion 45. Homolytic cleavage of the N−O bond 
then follows to give a carboxyl radical that rapidly decarboxylates to yield an alkyl radical, 46, 
which undergoes 1,4-addition to the Michael acceptor to provide a stabilized -acyl radical. 
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Reduction and then protonation of this species by the oxidized Hantzsch ester finally yields the 
1,4-addition product. The scope of both reaction partners, NHPI esters and electron-deficient 
olefins, was broad and furnished an interesting range of products in mostly good to excellent 
yields. 
 
Scheme 15. Overman’s decarboxylative Giese reaction using NHPI esters. 
In addition to the two representative examples just described, combining radical-based 
decarboxylation strategies with the fresh fields of photoredox and NHPI ester chemistry has 
achieved the facile transformation of a wide-range of carboxylic acids into a plethora of useful 
functional groups (Figure 5). Once we noticed its power to construct diverse structures from 
simple starting materials, we undertook our own inspection of the field to identify how we could 
combine the novelty of photoredox chemistry with the comparatively well-explored field of 
organoboron chemistry (see chapter 1). We noticed that one decarboxylative functionalization 
was conspicuously absent: the decarboxylative borylation. So, due to the perceived impact it 
would have in the chemical community, and to complement our general interest in the 
homologation and functionalization of organoboron compounds, we sought to devise a new 
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process that could transform carboxylic acids into their boron-containing analogs, preferably 
the most synthetically useful boronic esters. 
2.1.3 Decarbonylative borylations 
Prior to our investigations, there were no reports of decarboxylative borylation reactions, 
however, there were four similar reports of conceptually related decarbonylative borylations. 
Whilst these reports predominantly detail the decarbonylative borylation of aryl carboxylic acid 
derivatives, some do present very limited examples using alkyl carboxylic acid derivatives. 
The first report of a decarbonylative borylation process came in 2016 from Shi (Scheme 16).57 
In this study, N-Boc-activated amides were found to undergo decarbonylative borylation to 
forge new C(sp2)−B bonds: a wide range of aryl N-Boc amides were treated with Ni(OAc)2, an 
N-heterocyclic carbene ligand, bis(neopentylglycolato)diboron (B2neo2), and both NaOtBu and 
K3PO4, to form the corresponding aryl boronic esters 47. Most interestingly, however, two 
examples of benzylic N-Boc amides undergoing decarbonylative borylation to form new 
C(sp3)−B bonds were shown (one being 48), albeit with modest yield. Whilst no further 
examples were given, these do in fact represent the first reactions where alkyl carboxylic acids 
have been formally transformed into their corresponding alkyl boronic esters, albeit via the 
amide. A related decarbonylative borylation of cyclic amides was reported by Rueping in 
2017,58 however only a very small set of substrates was described. 
 
Scheme 16. Shi’s decarbonylative borylation of N-Boc amides. 
Two almost identical reports in late 2016, from Rueping (Scheme 17A)59 and Shi (Scheme 
17B),60 detail nickel-catalyzed decarbonylative borylations of aryl phenol esters. The two sets 
of conditions varied slightly but, in general terms, the phenol esters of aryl carboxylic acids 
were treated with Ni(COD)2, a ligand, a diboron reagent, and base, to effect a decarbonylative 
borylation process to form the corresponding aryl boronic esters 47 and 49. In both cases, broad 
substrate scopes were exhibited. Rueping also described a single example of the transformation 
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of an unactivated alkyl substrate, where a new C(sp3)−B bond is formed, albeit in low yield (50, 
Scheme 17A). 
 
Scheme 17. (A) Rueping and (B) Shi’s decarbonylative borylations of aryl phenol esters. 
All the decarbonylation reactions discussed to this point are proposed to proceed via nickel(0)-
nickel(II) redox cycles (Scheme 18): firstly, the ligated nickel(0) species undergoes oxidative 
addition into the C(acyl)−X bond of the amide or phenol ester to form a nickel(II)-acyl species; 
this is followed by a base-mediated transmetalation61 with the diboron reagent to furnish a 
nickel(II)-acyl-boryl intermediate; decarbonylation (extrusion of carbon monoxide) then occurs 
to give a nickel(II)-aryl-boryl complex; which finally undergoes reductive elimination to yield 
the aryl boronic ester product and regenerate the nickel(0) catalyst. 
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Scheme 18. General mechanism for the decarbonylative borylation reactions under nickel catalysis. 
The final example of a decarbonylative borylation process came from Niwa and Hosoya in 2017 
(Scheme 19).62 This methodology is distinct from the previous in that it utilizes rhodium-
catalysis rather than nickel, though the rest of the additives, including ligand, diboron reagent, 
and base, are similar. Here, aryl thioesters were treated with [Rh(OH)(COD)]2, tri-n-butyl 
phosphine, bis(pinacolato)diboron (B2pin2), and potassium acetate to convert them into their 
corresponding aryl boronic esters 49. As before, a wide range of aryl thioesters were shown to 
be competent substrates. An interesting alkyl thioester was also transformed, albeit in modest 
yield (51), which is a much more challenging substrate than the benzylic examples (48 and 50) 
previously used in nickel-catalyzed decarbonylative borylation processes. Mechanistically, this 
transformation is proposed to begin with the transmetalation of a rhodium(I) species with B2pin2 
to form a rhodium(I)-boryl intermediate, which then undergoes oxidative addition into the 
C(acyl)−S bond of the aryl thioester. The resulting rhodium(III)-boryl-acyl complex next 
decarbonylates, releasing carbon monoxide, to generate a rhodium(III)-boryl-aryl species 
which finally undergoes reductive elimination to yield the aryl boronic ester product 49 and 
regenerate the rhodium(I) catalyst. 
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Scheme 19. Niwa and Hosoya’s decarbonylative borylation of aryl thioesters under rhodium catalysis. 
The described decarbonylative borylation reactions clearly have enormous potential in the 
synthesis of aryl boronic esters, however they are evidently less suitable for the synthesis of the 
more challenging alkyl boronic esters. There is, therefore, an unfulfilled need for a general 
decarboxylative or decarbonylative borylation process that enables the synthesis of alkyl 
boronic esters from the corresponding alkyl carboxylic acids. 
2.2 Project proposal  
 
The data presented in this section has been partially published in: A. Fawcett, J. Pradeilles, Y. 
Wang, T. Mutsuga, E. L. Myers and V. K. Aggarwal, Science 2017, 357, 283−286.63 Where 
indicated (†), the data presented was obtained by one of my co-workers, Johan Pradeilles, Dr 
Yahui Wang or Dr Tatsuya Mustuga, and is included in this thesis to provide a complete picture 
of the work. Unpublished DFT calculations, performed by summer student Harvey Dale, will 
occasionally be mentioned and will be indicated similarly. 
 
- 23 - 
 
From the outset of this project, decarboxylative borylation processes, more specifically the net 
transformation of alkyl carboxylic acids into their corresponding alkyl boronic esters, were 
essentially unprecedented; a few decarbonylative borylation processes, predominantly of aryl 
carboxylic acid derivatives (section 2.1.3), had already been reported. We, therefore, sought a 
new method, complementary to those already disclosed, that would allow the preparation of 
alkyl boronic esters from their corresponding alkyl carboxylic acids. 
We initially identified that a nickel-catalyzed decarboxylative borylation of NHPI ester 
activated carboxylic acids to be most promising, since all expected fundamental steps had been 
previously demonstrated.  
In 2016, Baran64 first described a highly versatile aryl-alkyl cross-coupling process which 
utilized carboxylic acids that had been pre-activated as their corresponding NHPI esters 44, also 
termed ‘redox-active esters’ (Scheme 20). In this initial report, NHPI esters were treated with 
aryl zinc reagents, in the presence of a nickel catalyst and a bipyridine ligand, to perform a net 
decarboxylative cross-coupling of the NHPI ester and organozinc reaction components to form 
alkylated arenes 52. A brief substrate scope was demonstrated, however this work has since 
been vastly expanded upon to encompass a wide variety of organometallic nucleophiles, 
including alkyl,65 alkenyl,66 and alkynyl67 organozincs, and aryl68 and alkynyl Grignards.67 It is 
also possible to perform Barton decarboxylation or Giese reactions,69 under similar conditions 
and using the same NHPI esters as the radical precursors. 
 
Scheme 20. Baran’s seminal decarboxylative cross-coupling of NHPI esters and arylzinc reagents. 
Most relevantly, boronic acids have also been used as the organometallic component (Scheme 
21).70 In a similar fashion, NHPI esters 44 were treated with aryl boronic acids, in the presence 
of nickel(II) chloride hexahydrate, a bipyridine ligand, and a large excess of triethylamine, to 
effect a Suzuki−Miyaura-like cross-coupling between the NHPI ester and the aryl boronic acid 
to form the corresponding alkylated arenes 52. The NHPI ester substrate scope was shown to 
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be broad, which included a range of primary and secondary examples, as was the boronic acid 
substrate scope, which comprised a selection of functionalized aryl groups, as well as 
heterocycles. 
 
Scheme 21. Baran’s decarboxylative cross-coupling of NHPI esters and arylboronic acids. 
The postulated mechanism for all described transformations (Scheme 22), in general terms, 
starts with a bipyridine ligated nickel(I) species, which first undergoes transmetalation with the 
aryl zinc or aryl boronic acid reagent, the latter of which is aided by complexation with a 
hydroxide anion generated by the deprotonation of water by triethylamine. The subsequent 
nickel(I)-aryl complex reduces the NHPI ester 44 to afford a cationic nickel(II)-aryl species and 
radical anion 45, which undergoes homolytic N−O bond cleavage and decarboxylation to 
deliver the corresponding alkyl radical 46. The nickel(II)-aryl complex and alkyl radical 46 
next combine to give a nickel(III)-aryl-alkyl species that, after reductive elimination, finally 
leads to the cross-coupled product 52. 
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Scheme 22. Proposed mechanism of Baran’s decarboxylative cross-coupling reactions. 
With this work in mind we devised the following decarboxylative borylation procedure, which 
combines features from the two methodologies: treat an NHPI ester 44 with a diboron reagent 
in the presence of a nickel catalyst and a bipyridine ligand (Scheme 23A). We considered that 
an external base or even a pre-activated diboron reagent, such as the tert-butyl lithium-B2pin2 
adduct previously described by Bedford,71 would be necessary to achieve efficient 
transmetalation. This proposed reaction should, mechanistically, proceed in an analogous 
manner to Baran’s transformations (Scheme 22) with the only difference being that a nickel(I)-
boryl species, such as 53, rather than a nickel(I)-aryl species, is reducing the NHPI ester and 
that an alkyl boronic ester 54 is formed. Therefore, we initially thought the critical variable 
would be the bipyridine ligand since its substituents could modulate the redox potential of the 
nickel center and encourage single electron transfer. 
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Scheme 23. (A) Initally proposed nickel-catalyzed decarboxylative borylation of NHPI esters. (B) Our unsuccessful attempts 
at realizing this proposal.† 
Using NHPI ester 55 as a model substrate, a combination of a broad range of nickel sources, 
diboron reagents, ligands, bases, solvents, and temperatures were tested, but unfortunately no 
presence of the desired decarboxylative borylation product 56 was ever detected (Scheme 
23B).† 
Alongside these investigations, we envisaged an entirely novel approach whereby an activated 
diboron species, where one boron atom is complexed with a Lewis base, such as 57, acts as a 
single electron reductant72 to reduce an NHPI ester in a manner analogous to the nickel(I) 
catalyst proposed previously. After an identical fragmentation and decarboxylation sequence, 
the resultant alkyl radical 46 will combine with another molecule of the (activated) diboron 
species to provide the decarboxylative borylation product 54 (Scheme 24). 
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Scheme 24. Proposed decarboxylative borylation of NHPI esters. 
We were appreciative of the photochemistry of phthalimides,73 so irradiating our reactions with 
light was a strong consideration. In particular, we noticed that phthalimides, in their ground 
states, are poor oxidants (E1/2 = −1.4 V). However, in a photoexcited state, phthalimides are 
good single electron oxidants (E1/2* = +1.6 V vs SCE) with a long-lived triplet state which is 
known to undergo bimolecular single electron transfer processes. We proposed that this would 
pair well with an activated diboron species which, like other boronate complexes, should be 
easily oxidized.74 
We were intrigued by a report from Fu75 that described a decarboxylative arylthiation of NHPI 
esters under visible-light irradiation without the addition of any photocatalysts. This was 
particularly surprising since most photochemistry associated with phthalimides utilizes UV 
irradiation.73 Their only additive, cesium carbonate, is proposed to form a complex with an 
NHPI ester, suggested to be 58 (Scheme 25) on the basis of 15N NMR experiments, which is 
strongly absorbing in the visible region. It is proposed that it is this species which absorbs light 
to deliver a photoexcited species that is easily reduced by a thiolate anion. 
We thought that we could harness this cesium carbonate−NHPI ester complex in our proposed 
decarboxylative borylation sequence (Scheme 25). If 58 truly does form, then it could 
potentially complex with a diboron molecule to form an NHPI ester-diboron adduct, 59, where 
the diboron species interacts with an oxygen atom of the NHPI ester to give an activated sp2−sp3 
diboron species. If the reaction is under constant visible-light irradiation, the NHPI ester will 
become photoexcited and then oxidize the complexed activated diboron species. The potential 
benefit of exploiting this activation mode is that it locks the two activated redox-active species 
together and thus makes the subsequent single electron transfer process intra-complex, which 
would hopefully make it an even more facile operation. 
- 28 - 
 
 
Scheme 25. Proposed photoinduced decarboxylative borylation of NHPI esters using cesium carbonate as an activator. 
2.3 Results and discussion 
2.3.1 Reaction discovery 
In a first set of experiments, 1.5 equivalents of cesium carbonate was mixed with 1.0 equivalent 
of model NHPI ester 55 in the presence of 1.0 equivalent of a range of boron species in 
N,N-dimethylformamide (DMF) at ambient temperature under irradiation with blue LEDs. If 
the reaction was not expected to directly form the pinacol boronic ester, pinacol and 
triethylamine were added after 14 h to effect transesterification to the more stable pinacol 
boronic ester. We ultimately discovered that out of all the tested diboron species, 
bis(catecholato)diboron (B2cat2) was uniquely effective at promoting the desired reactivity and 
yielded 8 % (by calibrated GC−FID analysis) of decarboxylative borylation product 60 
(Scheme 26). 
 
Scheme 26. Initial discovery of the decarboxylative borylation of NHPI esters. 
2.3.2 Optimization of the decarboxylative borylation 
With this initial discovery in hand, we initiated a campaign to optimize this new transformation. 
The first experiment, removal of the cesium carbonate base, led to a surprising result: a yield 
increase from 8 % to 69 % (Table 1, entries 1 and 2). From here a couple modifications, namely 
a change of solvent from DMF to N,N-dimethylacetamide (DMAc) (entry 3), and a slight 
increase in the equivalents of B2cat2 from 1.00 to 1.25 (entry 8), resulted in our final conditions: 
a 0.10 M DMAc solution containing 1.0 equivalent of NHPI ester 55 and 1.25 equivalents of 
B2cat2 is stirred at ambient temperature under blue LED irradiation for 14 hours, triethylamine 
and pinacol are then added to effect transesterification to the stable and subsequently isolable 
pinacol boronic ester 60 (entry 8). For our model substrate 55, the decarboxylative borylation 
reaction formed the corresponding pinacol boronic ester 60 in 87 % isolated yield (91 % by 
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GC−FID). A range of further experiments demonstrated that a standard household white 
lightbulb (entry 12) was as efficient as blue LEDs, and that degassing the solvent and purging 
the reaction vial headspace with argon or nitrogen was crucial to achieving consistently high 
yields (entry 15), potentially because this removes oxygen which could otherwise react with 
our proposed radical intermediates. A final few experiments confirmed the requirement of 
isolating the NHPI esters (entry 15), and that the tetrachlorophthalimide analogue65 of 55 
performed equally well (entry 16). 
Table 1. Optimization of the decarboxylative borylation using NHPI ester 55 as a model substrate. 
 
Whilst this optimisation process was very rapid and straightforward, we did make several 
revealing observations that had important implications on our understanding of the reaction 
mechanism (discussed later in section 2.4). 1) Amide- and urea-based solvents, including DMF, 
DMAc, 1,3-dimethyl-2-imidazolidinone (DMI), N,N′-dimethylpropyleneurea (DMPU), and 
tetramethylurea (TMU), were uniquely effective at promoting the reaction. All other solvents 
tested (see supplementary materials for full details) either resulted in trace quantities of product 
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or none at all. 2) Control experiments confirmed that the reaction is accelerated by light, since 
a 36 % yield was observed when the reaction was kept in the dark. However, there is evidently 
a slow background reaction which also leads to the decarboxylative borylation product. This is 
supported by an experiment in the dark which showed that increasing the reaction time to 70 h, 
from the normal 14 h, led to 63 % product formation. We do not suspect that this reactivity has 
resulted from small amounts of light, which the reaction mixture is presumably subjected to 
during reaction set-up, inducing an efficient chain reaction because this result was invariant 
across several repeat experiments with varying amounts of light exclusion. Unfortunately, 
simply heating the reaction at 80 °C gave a low yield, which further demonstrates the beneficial 
action of the visible-light irradiation. 
2.3.3 Substrate Scope 
We next explored the substrate scope using our optimized reaction conditions and found it to 
be very broad. Primary carboxylic acids were tested first (61−71) (Scheme 27A) resulting in 
the desired primary pinacol boronic esters in good to excellent yields. Notably, these substrates 
demonstrate that a wide range of functional groups are compatible with our reaction conditions, 
including alkyl bromides (64), alkynes (65), carbamates and -amino acids (66), perfluoroalkyl 
chains (67),† esters (69),† pyridines (70),† and aryl halides (71).† Secondary carboxylic acids 
were next tested (73−82) (Scheme 27B), whilst this sub-section of substrates demonstrates few 
new compatible functional groups, it instead shows the effect of stereogenic centers on the 
diastereoselectivity of the reaction. trans-Phenyl cyclopropyl NHPI ester, the precursor to 74, 
was prepared with a >98:2 d.r., and after subsequent decarboxylative borylation the 
corresponding pinacol boronic ester was isolated with 98:2 d.r.† in good yield. Moving the 
stereocenter further away, however, resulted in almost complete loss of stereochemical 
information; for substrate 76, the starting NHPI ester was prepared as a single diastereoisomer, 
yet the resulting pinacol boronic ester 76 was isolated as a 1:1.3 mixture of diastereoisomers. 
A 1,2-bis(NHPI ester), the precursor to 1,2-bis(boronic ester) 80, was also synthesized as the 
single anti-isomer, yet upon decarboxylative borylation yielded the 1,2-bis(boronic ester) 80 as 
a 90:10 mixture of diastereoisomers. These results are supportive of a radical based mechanism 
(discussed later in section 2.4). Model NHPI ester 55 could also be transformed into the 
corresponding N-methyliminodiacetic acid protected boronic ester (BMIDA)76 72 in good 
yield. Tertiary boronic esters are also good substrates (83−88) (Scheme 27C), albeit only those 
where all three substituents are ‘tied back’ into a ring structure, such as in 1,1-
phenylcyclopropyl pinacol boronic ester 83,† a bicyclo[2.2.2]octyl pinacol boronic ester 85,† 
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and adamantyl pinacol boronic ester 84, the last of which could also be synthesized on gram-
scale using a more concentrated reaction solution with minimal decrease in yield. 
Bicyclo[1.1.1]pentyl (88) and cubanyl (86 and 87) substituted boronic esters could also be 
prepared in good yield. These two substrates are notable for being the first and second/third77 
reports of these borylated scaffolds, respectively. 
Finally, to highlight the ability of our new methodology to diversify natural product scaffolds, 
we prepared a range of natural product-derived NHPI esters and subjected them to our 
optimized reaction conditions (89−99) (Scheme 27D). Stearic acid (89), lithocholic acid (90 
and 91),† arachidonic acid (92),† gibberellic acid (95),† derivatized glutamic acid (96),† succinic 
acid (98)† and pinonic acid (99)† were all successful and yielded the corresponding pinacol 
boronic esters in modest to excellent yields. Two carboxylic acid-containing drugs, fenbufen 
(93)† and indomethacin (94), were also capable substrates. The formation of these products 
further exemplifies the functional group tolerance of our decarboxylative borylation reaction, 
which now includes alkenes (97 and 92), protected and unprotected alcohols (90 and 91), 
ketones (99), amides, and aryl chlorides (94). 
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Scheme 27. Decarboxylative borylation substrate scope. (A) Primary, (B) secondary, (C) tertiary, and (D) natural product- 
and drug-derived boronic esters from the corresponding NHPI esters. 
 
2.3.4 Unsuccessful substrates 
Despite displaying broad functional group tolerance and an ability to borylate a wide variety of 
carbon scaffolds, there are many substrates that do not undergo successful decarboxylative 
borylation under our optimized conditions. A summary of all tested unsuccessful NHPI esters 
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is shown in Figure 6, arranged into categories determined by their structure/substitution that 
potentially explain their failing. Unfortunately, due to time constraints, no studies have yet been 
undertaken to pinpoint the exact reason why these particular substrates were unsuccessful, 
however, through consideration of a variety of factors, a number of potential reasons can be 
proposed.  
 
Figure 6. NHPI esters that did not undergo decarboxylative borylation under our optimized conditions. 
Across all experiments concerned, no identifiable side-products were observed, such as the 
products of hydrodecarboxylation or decarboxylative dimerization, so something else must be 
occurring. Upon decarboxylation of the NHPI esters in Figure 6A, which include flexible 
tertiary, -heteroatom, allylic, and secondary benzylic substrates, a stabilized radical is formed. 
It is possible that this stabilization could confer an inability to react with a diboron compound, 
however, based on some preliminary calculations,† this does not appear to be the case. Instead, 
we propose that the stabilized radical gets oxidized to the stabilized carbocation. The nature of 
the oxidizing species is unknown, though a prime candidate would be the NHPI ester starting 
material. The NHPI esters in Figure 6B, if they underwent successful decarboxylative 
borylation, would deliver boronic ester products that are probably unstable78 and thus would 
not be possible to isolate using our current methods. Finally, aryl and vinyl NHPI esters, 
including those shown in Figure 6C, were probably unsuccessful because the required radical 
intermediate would be more difficult to form due to it being located within an sp2-, rather than 
sp3-, orbital. The increased s-character of the sp2- over the sp3-orbital means that radicals 
located within sp2-orbitals are less stable than those in sp3-orbitals. This could result in a 
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decreased rate of decarboxylation of the intermediate carboxyl radicals leading to sp2-centered 
radicals than those leading to sp3-centered radicals. In the case of phenyl NHPI ester, benzoic 
acid was quantitatively isolated after subjecting it to our optimized decarboxylative borylation 
conditions,† which could suggest that the intermediate carboxyl radical did form, but abstracted 
a hydrogen atom from, potentially, a solvent molecule or was trapped by a B2cat2 molecule, 
rather than undergoing decarboxylation and subsequent borylation. 
2.4 Mechanism and mechanistic investigations 
The reaction conditions of our decarboxylative borylation process are very simple: stir an NHPI 
ester and B2cat2 in DMAc under blue LED irradiation. The mechanism of this process is 
therefore very intriguing – how do these simple components come together to transform the 
activated carboxylic acid into a boronic ester? We will first discuss the evidence, both from our 
own investigations and studies by other groups, followed by our final proposed mechanism, 
where the prior discussion will be put into context. 
2.4.1 What is the light absorbing species? 
Critical to our understanding of the mechanism is determining which species is light absorbing, 
and hence which species is photoexcited to initiate the reaction. We therefore analysed all 
reaction components, in isolation and in combination, by UV-visible spectroscopy (Figure 7). 
It should be noted at this stage that the blue LEDs used throughout all experiments emit in the 
range 425−475 nm, with the maxima at 450 nm. The independent absorbance spectra of both 
the model NHPI ester 55 and B2cat2 in DMAc solutions (at the concentrations used in the 
optimized reaction conditions, 0.1 M for NHPI and 0.125 M for B2cat2) only displayed 
absorbance bands in the ultraviolet region, with maxima at 314 and 303 nm, respectively, 
without any bands in the visible region. In combination, however, an absorbance shoulder is 
observed, on the bathochromic side, which overlaps with the emission region of the blue LEDs. 
This is accompanied by the reaction solution turning a pale yellow color. Solutions of the 
individual components are colorless. 
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Figure 7. UV-visible absorbance spectra of NHPI ester 55, B2cat2, and the two combined, in DMAc at reaction relevant 
concentration. 
A set of experiments where the UV-visible absorbance spectra of DMAc solutions of NHPI 
ester 55 were measured with incrementally increasing equivalents of B2cat2 showed a neat 
trend: a positive, approximately linear dependence of the intensity of the visible-light 
absorbance band upon equivalents of B2cat2. These data provide support for the presence of an 
equilibrium between the two free components and an adduct between the NHPI ester and B2cat2, 
where increased equivalents of B2cat2 relative to NHPI ester lead to an increasing population 
of the adduct and a simultaneous increase in visible absorbance. This does not, however, 
translate into increasing reaction yields (see Table 1), for example when more than 1.5 
equivalents of B2cat2 are used a yield decrease is observed. 
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Figure 8. UV-visible absorbance spectra of NHPI ester 55 in DMAc with incrementally increasing equivalents of B2cat2. 
As a solution in DMAc, B2cat2 seemingly exists in an equilibrium between ‘free’ B2cat2 and a 
B2cat2-DMAc adduct 100 (Scheme 28), where presumably the oxygen of the DMAc carbonyl 
complexes with one boron atom of B2cat2. 
11B NMR spectroscopic analysis shows that in non-
coordinating solvents, such as dichloromethane, free B2cat2 is the only species, as evidenced by 
a single sharp peak at 29.7 ppm (Figure 9A). In DMAc solvent, however, the 11B NMR signal 








Figure 9. 11B NMR data of B2cat2, and B2cat2 and NHPI ester 55, in DCM and DMAc. 
A previously isolated 4-picoline-B2cat2 adduct
79 is reported to exhibit two clear resonances in 
its solid-state 11B NMR spectrum, one at ca. 32 ppm and the other at ca. 13 ppm for the sp2- 
and sp3-boron centers, respectively. If we were quantitatively forming the B2cat2-DMAc adduct 
100 we would expect to observe a similar spectrum, yet we do not (see below for discussion of 
the very sharp peak at 13.8 ppm). We are instead seeing a broad time-averaged NMR signal, 
where it appears that the majority of the B2cat2 is in its free form, but with a considerable 
proportion existing as 100. Indeed, DFT calculations suggest that formation of 100 is slightly 
endergonic (G = +2.2 kcal/mol) and that its fractional abundance in a 0.1 M B2cat2 solution in 
DMAc is approximately 20 % (Scheme 28). 
 
Scheme 28. Equilibrium between free B2cat2 and a DMAc-B2cat2 adduct in DMAc solution. 
Interestingly, a very sharp peak is observed at 13.8 ppm, which is indicative of a highly 
symmetrical boron center. This was confirmed to be [Bcat2]− through independent synthesis,
† 
A B2cat2 in DCM B B2cat2 in DMAc 
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which is an expected product of the decomposition of sp2−sp3 diboron species,80 adding further 
support to the existence of a fleeting B2cat2-DMAc adduct. It is currently unknown, however, 
what the counter ion to this species is and exactly how it forms. 
Adding NHPI ester 55 to these DCM and DMAc solutions of B2cat2 does not significantly 
change the 11B NMR spectra (Figure 9C and D), which implies that no strong NHPI ester-
boron center interactions are occurring, which likely excludes the possibility of complexes 
where a boron atom of B2cat2 coordinates to an amide oxygen of the NHPI ester, such as that 
proposed in Scheme 25.75  
On the basis of the given data, it is most likely that a -stacking electron donor-acceptor (EDA) 
complex,81 formed between the electron-poor aryl ring of the phthalimide unit82 and the 
electron-rich aryl ring of one catechol unit in B2cat2, is responsible for the visible absorptivity 
of the mixture of B2cat2 and NHPI ester 55 in DMAc. It is not certain, however, whether this 
complex is formed of the NHPI ester and free B2cat2, the NHPI ester and a DMAc-B2cat2 adduct 
(100), or both. Methyl NHPI ester 101 and B2cat2 were calculated to form -stacking adduct 
102, which was an exergonic (G = −1.2 kcal/mol) process (Scheme 29), however an adduct 
of 100 and NHPI ester 101 was not considered computationally.† EDA complexes are highly 
sensitive to the dielectric permittivity of the solvent,81 with more polar solvents leading to 
bathochromic shifts, so we set out to find a highly polar solvent that displays no interaction 
with B2cat2, but does show a bathochromic shift in the UV-visible absorbance spectrum when 
NHPI ester 55 and B2cat2 are dissolved together in it. Methanol ( = ) was found to have 
no observable interaction with B2cat2, according to 
11B NMR spectroscopic analysis analysis 
(single peak at  = 30.6 ppm), but does reveal a bathochromic shift in the UV-visible absorbance 
spectrum of a 0.1 M mixture of NHPI ester 55 and B2cat2 (and an accompanying yellow 
solution), which is very similar to that shown in DMAc ( = 37.8). These data could imply that 
it is in fact free B2cat2 that is forming an EDA complex with the NHPI ester, and not 100. The 
decarboxylative borylation reaction does not work in methanol (Table 1 and supplementary 
materials), which demonstrates that an ability to enable the formation of a visible light 
absorbing EDA complex is not the only important criterion when selecting a solvent for this 
reaction. Unfortunately, due to the poor solubility of both NHPI ester 55 and B2cat2 in low 
polarity solvents, a comparable set of UV-visible absorbance spectra could not be obtained in 
a low polarity, non-coordinating solvent such as DCM ( = 8.93). 
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Scheme 29. Calculated equilibrium between NHPI ester 101 and B2cat2 in DMAc solution. 
Regardless of its exact identity, a complex that consists of the NHPI ester and B2cat2 is most 
likely to be the light absorbing species which, upon photoexcitation by the blue LED irradiation, 
initiates the decarboxylative borylation reaction. The true identity of this species will not be 
unambiguously determined without further experimentation and DFT calculation. 
2.4.2 Photoinitiation and single electron transfer 
The photoinitiation and single electron transfer step, where the phthalimide moiety within the 
NHPI is reduced by a B2cat2 molecule (or a DMAc-B2cat2 adduct 100) is the likely next step. 
B2cat2 is the single electron reductant in this reaction since, under our optimized conditions but 
in the absence of B2cat2, starting NHPI ester 55 was found to undergo no reaction and could 
could be quantitatively recovered (97 %). 100 could also be the reductant, however, we shall 
focus on the more probable reduction by free B2cat2, since the fractional abundance of 100 in a 
DMAc solution of B2cat2 is calculated to only be approximately 20 % (Scheme 29). 
A plausible explanation is that NHPI ester-B2cat2 EDA complex 103 absorbs a photon from the 
blue LED irradiation to form an intermediate photoexcited complex 104, or ‘exciplex’ (Scheme 
30A).81 The photoexcited EDA complex 104 then undergoes an intra-complex single electron 
transfer event.83 When considering redox potentials, this single electron transfer step is likely 
to be thermodynamically favourable. In isolation, the photoexcited phthalimide moiety is a 
good oxidant (E1/2* = +1.6 V vs SCE) and has a triplet state with a sufficiently long lifetime to 
undergo bimolecular single electron transfer.73 The redox potential of B2cat2 has not been 
reported, however the structurally similar benzodioxole is a good reductant (E1/2
oxid = +1.45 V 
vs SCE).84 So, after formation of exciplex 104, B2cat2 should release an electron from one of 
its electron-rich catechol rings to the electron-poor phthalimide group to form radical anion 45 
and B2cat2
•+ 105. This radical ion pair then has two potential fates: 1) back electron transfer, 
from the phthalimide radical anion 45 to B2cat2
•+ 105 to reform the neutral complex 103; or 2) 
diffusive separation (Scheme 30B), followed by homolytic cleavage of the N−O bond and 
subsequent rapid decarboxylation to form the corresponding alkyl radical 46. Considering the 
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proximate nature of the two radical components, it is likely that back electron transfer will be 
the dominant pathway, however, since the reaction is under continuous intense irradiation even 
a low quantum yield could be sufficient for successful photoinitiation. 
 
Scheme 30. (A) Photoexcitation of EDA complex to induce single electron transfer. (B) N−O bond homolysis and 
decarboxylation of radical anion 45 to give alkyl radical 46. 
The fate of the oxidized B2cat2 (B2cat2
•+ 105) has not been investigated experimentally or 
computationally. If we assume that when radicals 45 and 105 are in close proximity back 
electron transfer is dominant, the reaction can only proceed if the two radical species escape 
the solvent cage. 105 is most likely to encounter solvent DMAc molecules, which we know can 
interact with B2cat2 via its carbonyl oxygen (Figure 9 and Scheme 28). Therefore, it is possible 
that a DMAc molecule will complex with the B2cat2
•+ species, via the boron atom bearing the 
oxidized catechol moiety, to form boronate complex intermediate 106 (Scheme 31A). Another 
DMAc solvent molecule could then complex to the second boron center and induce B−B bond 
homolysis to form two stabilized species: a DMAc stabilized boryl radical 107 (see section 
2.4.4); and a DMAc-Bcat adduct 108, whose counterion would be the phthalimide anion 
generated upon N−O homolysis of 45. A nice piece of evidence to support this pathway would 
be the detection of 108, most likely by mass spectrometry. We have, unfortunately, never tried 
to detect 108, though it is likely to be very unstable and thus challenging to observe even when 
using mild high-resolution mass techniques. 
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Scheme 31. The potential fates of radical cation 105. 
There is also the possibility that the oxidized Bcat unit of B2cat2
•+ is rapidly trapped by radical 
anion 45 (Scheme 31B). The resultant boronate complex 109 would require the addition of a 
solvent DMAc molecule to the second boron atom to effect B−B bond homolysis and thus 
generate stabilized boryl radical 107 and borylated radical phthalimide 110, which could then 
undergo N−O bond cleavage and decarboxylation. Alternatively, fragmentation and 
decarboxylation of 109 could occur prior to B−B bond cleavage, and then the resultant boronate 
complex 111 would decompose in a similar manner to 109 through complexation with a solvent 
DMAc molecule to give stabilized boryl radical 107 and borylated phthalimide 112. We have 
unsuccessfully attempted to observe 112 by high-resolution mass spectrometry, which could 
suggest that these are not operative pathways, however, 112 is very likely to be unstable and 
thus difficult to detect. 
2.4.3 Proof of radical intermediates 
NHPI esters were first shown to be efficient alkyl radical precursors by Okada in 1988,48 and 
since then numerous other studies have agreed.50 Nevertheless, we still wished to obtain some 
confirmation that we too were operating via the same alkyl radical intermediates. Some 
evidence has already been obtained during our substrate scope. Chiral cyclopentyl NHPI ester 
113, synthesized as a single diastereoisomer, was borylated and the resultant boronic ester 76 
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found to have an eroded diastereopurity (Scheme 32A); the diastereomeric ratio was found to 
be 1.3:1. 
In previous work, methyl cyclopropyl  and 5-hexenyl groups85 have been utilized to probe the 
intermediacy of alkyl radicals since they, after generation of the corresponding carboxyl 
radicals and subsequent decarboxylation, undergo rapid radical ring-opening (rate constant = 
1.3 × 108 s−1) and cyclization reactions (rate constant = 1.0 × 105 s−1), respectively.85 114 and 
115 were prepared and subjected to our optimized decarboxylative borylation conditions. The 
borylation product from 114 was found to be exclusively 68, the ring-opened product, in 56 % 
isolated yield (Scheme 32B). Furthermore, the borylation product of 115 was a 1:1.5 mixture 
of the linear, uncyclized, product 116, and cyclized product 117 (total yield 77 %) (Scheme 
32C). These three experiments and literature precedents suggest the intermediacy of alkyl 
radicals. 
 
Scheme 32. Proof of alkyl radical intermediates: (A) Enantio-destructive decarboxylative borylation. (B) ‘Radical-clock’ 
radical ring-opening experiment. (C) Radical cyclization. 
Alkyl and aryl radicals have been previously proposed to react with diboron species,86 and so 
the trapping of our radical intermediates by B2cat2 is the most likely, and inevitable, next step. 
The cyclisation experiment described above was repeated under a range of different reaction 
concentrations, from as low as 0.01 M, and up to 1.0 M (the optimized conditions are 0.1 M) 
(Scheme 33). Whilst these experiments were not conducted under steady state conditions, due 
to the insolubility of B2cat2 in DMAc at high concentration, a clear trend is observed. A 
decreasing reaction concentration leads to an increase in the proportion of cyclized product 117, 
and a concomitant decrease in the proportion of the linear product 116. This observation is 
consistent with an outer-sphere trapping of the alkyl radical 46 with B2cat2/B2cat2-DMAc 
adduct, where the diboron species responsible for reducing the NHPI ester to induce 
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fragmentation and decarboxylation is not the same as the species that is trapped by the alkyl 
radical to form the decarboxylative borylation product. This result could be suggestive of a 
radical chain process (see section 2.4.4). 
 
Scheme 33. Radical cyclization experiments over a range of reaction concentrations. 
At this stage it is not clear which exact diboron species reacts with the alkyl radical to form the 
borylated product, but, since a bis-ligated diboron species is necessary for B−B bond 
homolysis,87 there are two distinct possibilities that ultimately lead to the same outcome: 1) the 
alkyl radical 46 reacts directly with B2cat2-DMAc 100 (Scheme 34A), to give a bis-adduct that 
undergoes spontaneous B−B bond cleavage to generate product 118 and a DMAc-stabilized 
boryl radical 107; or 2) the alkyl radical reacts with free B2cat2 (Scheme 34B) to generate an 
intermediate mono-adduct 119 that then reacts with a solvent DMAc molecule and 
subsequently undergoes B−B bond cleavage to generate product 118 and a DMAc-stabilized 
boryl radical 107. We have discounted the possibility of any alkyl radical-boryl radical 
couplings72a because both species should be in very low concentration and thus not likely to 
meet. 
 
Scheme 34. Possible pathways of alkyl radical borylation with (A) DMAc-B2cat2 or (B) free B2cat2. 
Whilst we have not obtained any experimental evidence to ascertain which pathway is 
operating, some DFT calculations by ourselves† and Studer88 could shed some light on this 
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issue. Studer calculated (Scheme 35A) that addition of alkyl radical 120 to a boron atom of 
B2cat2 to form adduct 121, where the unpaired electron occupies a -orbital and is delocalised 
over the Bcat moiety,89 had a low energetic barrier (G‡ = +9.2 kcal/mol) and was overall 
slightly endergonic (G = +3.0 kcal/mol). They found that subsequent B−B bond fragmentation 
of 121 to give boronic ester 122, their reaction product, and an unstabilized boryl radical, was 
overall endergonic (G = +8.0 kcal/mol) and had an appreciable energetic barrier (G‡ = +16.0 
kcal/mol). The unstabilized boryl radical 123 was calculated to then react immediately with a 
solvent DMF molecule in a highly exergonic process (G = −31.4 kcal/mol). Considering the 
endothermic B−B bond homolysis of 121 to 122 and the unstabilized boryl radical, adduct 121 
would rather fragment to regenerate its two precursors, radical 120 and B2cat2. A more plausible 
pathway was therefore found where 121 is first trapped with DMF, which reacts with the sp2-
boron center, in a barrier-less and exergonic process (G = −7.3 kcal/mol) to give intermediate 
bis-adduct 124. Interestingly, 124 is best described as having a B−B one-electron -bond.90 
This B−B bond undergoes an exergonic (G = −16.1 kcal/mol) cleavage with a low barrier 
(G‡ = +6.1 kcal/mol) to deliver their product boronic ester 122 and a DMF stabilized boryl 
radical, the latter of which was found to react further in a single electron reduction process with 
trifluoromethyl iodide to turnover their radical cascade cycle. 
 
Scheme 35. Calculated pathways of alkyl radical borylation by (A) Studer and (B) Aggarwal.† 
- 45 - 
 
Our calculations describe a similar picture (Scheme 35B).† Once the alkyl radical, in this 
example methyl radical, is formed it reacts with DMAc-B2cat2 adduct 100 in a barrier-less, 
exergonic (G = −15.3 kcal/mol) process to form bis-adduct 125, from which there are two 
accessible pathways: 1) reversible and endergonic (G = +8.4 kcal/mol) disassociation of 
DMAc; or 2) homolytic B−B bond fragmentation, which is kinetically favoured (G‡ = +5.3 
kcal/mol) and exergonic (G = −15.8 kcal/mol), to deliver the methyl boronic ester product and 
a DMAc-stabilized boryl radical 107. We did not calculate the analogous process whereby an 
alkyl radical reacts with a free B2cat2 molecule. 
These theoretical insights suggest that reaction of an alkyl radical with free B2cat2 or a DMAc-
B2cat2 adduct are both possible. If we take both studies to be comparable, the reaction with the 
DMAc-B2cat2 adduct would be slightly kinetically favoured, however, since only a small 
proportion of the B2cat2 molecules are calculated to exist as the DMAc-B2cat2 adduct 
(approximately 20 %), it is more likely that both pathways are operational. 
2.4.4 The presence and function of boryl radicals 
Both sets of DFT calculations (Scheme 35) invoke the critical involvement of DMAc-stabilized 
boryl radicals; without them there are no propagation steps and no facile B−B bond cleavage. 
Boron-centered radicals, or boryl radicals, have been historically much less explored than 
carbon-, nitrogen-, or oxygen-centered radicals. Boryl radicals (Figure 10) are formed when a 
boron atom is covalently bound to two substituents and leaves its third p-electron unused, which 
is placed in the unused sp2-orbital. Due to the boron atom’s already electron-deficient nature, a 
boryl radical of this type is extremely unstable and highly reactive, however, boryl radicals can 
be stabilized by accepting a lone-pair of electrons from a suitable Lewis base.91 The first 
stabilized boryl radicals to be detailed, by Roberts,92 are the so-called -type boryl radicals, 
where Lewis bases such as amines or phosphines, coordinate to the boron center. This affords 
significant stabilization since the Lewis base donates two electrons to alleviate the electron-
deficient nature of the boron atom, as well as locating the unpaired electron in an sp3-orbital. In 
2009, Curran93 and Lalevée94 introduced boryl radicals stabilized by N-heterocyclic carbenes 
and pyridines, respectively. These so-called -type boryl radicals are more stable than the 
-type because they obtain further stabilization from the unpaired electron being placed in the 
boron atom’s pz-orbital, which allows the spin density to be delocalized across the -system of 
the coordinating Lewis base. Zipse95 has since computationally studied the stability of a range 
of - and -type boryl radicals. Interestingly, and important to our study, certain solvents, 
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including DMF and acetone, were found to be exceptional at stabilizing boryl radicals and about 
as good as pyridine. 
 
Figure 10. Summary of boryl radical stability, including how amide- and urea-based solvents can stabilize boryl radicals. 
A key piece of evidence to support the involvement of boryl radicals in our decarboxylative 
borylation reaction is the unique ability of amide- and urea-based solvents to promote reactivity. 
For example, during our optimization of the decarboxylative borylation of NHPI esters, we 
tested a wide range of solvents and found DMF, DMAc, DMPU, DMI and TMU to be the only 
solvents to deliver detectable quantities of the desired decarboxylative borylation product. As 
just described, DMF (and by extension DMAc and other similar solvents) has been previously 
calculated, by Zipse,95 Studer88 and us,‡ to afford considerable stabilization to boryl radicals. 
Interestingly, Zipse95 also calculated that acetone provides significant stabilization to boryl 
radicals, in fact more than DMF, however acetone did not furnish any decarboxylative 
borylation product during our optimization campaign (Table 1 and supplementary materials). 
Whilst this has not been probed further experimentally or theoretically, there are two potential 
explanations for this observation: acetone possesses too low a dielectric permittivity ( = 20.7, 
cf.  = 37.8 for DMAc) to allow formation of a light absorbing EDA complex (see section 
2.4.2); and/or the oxygen atom of acetone is insufficiently nucleophilic to competently complex 
to the boron atoms of B2cat2 as required during the mechanistic cycle (no broadening of the 
11B 
NMR signal of B2cat2 was observed in acetone, single peak at  = 31.8 ppm). 
To test for the ability of boryl radicals to promote decarboxylative borylation we treated 
standard NHPI ester 55 with B2cat2 in dichloromethane (a non-coordinating solvent that does 
not promote decarboxylative borylation) in the presence of two equivalents of DMAP (Scheme 
36). The reaction was performed separately under blue LED irradiation and in the dark, and in 
both cases gave similar yields of decarboxylative borylation product 60 (10 % under blue LED 
irradiation and 13 % in the dark). Although the yields are very low, this does indicate that even 
without visible light irradiation, boryl radicals, which are formed by the homolytic B−B bond 
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cleavage of a bis DMAP adduct of B2cat2,
87 can reduce NHPI ester 55 to induce fragmentation 
and decarboxylation to form an alkyl radical, which is subsequently trapped with a boron 
reagent (in this particular case it could be B2cat2 or a persistent DMAP-Bcat radical)
72a (please 
see section 2.5 for two contemporaneous decarboxylative borylation reactions that use this 
exact approach). 
 
Scheme 36. Decarboxylative borylation of NHPI ester 55 using DMAP and B2cat2 as a source of boryl radicals. 
These data perhaps also provide an insight into why there is a slow thermal decarboxylative 
borylation under our optimized reaction conditions. If our reaction is performed in the dark for 
14 h, 36 % of product 60 forms, and if the reaction time is extended to 70 h, 63 % of 60 is 
formed. Under these conditions an adduct of two solvent DMAc molecules and one B2cat2 126, 
with one DMAc complexed to each boron center, could form and fragment to deliver two 
DMAc stabilized boryl radicals which can directly reduce an NHPI ester to initiate the 
transformation. DFT calculations have shown,† however, that formation of 126 is very 
endergonic (G = +11.0 kcal/mol) and thus not likely to be highly populated under our reaction 
conditions (Scheme 37). Furthermore, the B−B homolytic bond cleavage was calculated to be 
highly endothermic (G = +33.9 kcal/mol) and thus infeasible at ambient temperature. Whilst 
these calculations do cast some doubt on our hypothesis, the formation of two DMAc stabilized 
boryl radicals from the corresponding bis DMAc adduct of B2cat2 is currently the only 
explanation for why our decarboxylative borylation reaction proceeds slowly in the dark. 
 
Scheme 37. Equilibrium between free B2cat2 and a (DMAc)2-B2cat2 adduct in DMAc solution.† 
We believe the final role of boryl radicals is to propagate a radical chain process. Whilst a 
quantum yield96 has not been measured, a radical chain process is likely based on our evidence 
that suggests our borylation product results from an outer sphere trapping of the alkyl radical 
by a B2cat2 molecule (Scheme 33), rather than trapping with a DMAc-stabilized boryl radical 
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generated within the same solvent cage following initial reduction of the NHPI ester. Studer88 
has calculated that reduction of trifluoromethyl iodide with a DMF-stabilized boryl radical is 
an exergonic process (G = −12.4 kcal/mol). So, it is plausible that boryl radicals are also able 
to reduce NHPI esters in their ground state to form radical anion 45 and DMAc-Bcat adduct 
108 (Scheme 38A).  
 
Scheme 38. Pathways of radical chain propagation by DMAc-stabilized boryl radicals 107: (A) Single electron transfer from 
107 to an NHPI ester; or (B) radical borylation of an NHPI ester by 107. 
It cannot be ruled out at this stage that the DMAc-stabilized boryl radical does not react with 
an NHPI ester via the boron center itself, to perform a borylation, as has been observed in the 
reaction of N-heterocyclic carbene stabilized boryl radicals with xanthates93a (Scheme 38B). 
We have calculated the reaction of DMAc-stabilized boryl radical 107 with methyl NHPI ester 
101 through one amide oxygen atom to be barrier-less and markedly exergonic (G = −18.4 
kcal/mol). The intermediate radical 127 can then undergo what would be a rate-determining, 
but nevertheless facile, homolysis of the N−O bond (G‡ = +10.3 kcal/mol) in an overall 
exergonic process (G = −21.3 kcal/mol) to form a carboxyl radical, which can then undergo 
decarboxylation to deliver the methyl radical.† 
2.4.5 Complete proposed mechanism 
The complete proposed mechanism, that brings together the discussion from sections 2.4.1 to 
2.4.4, is depicted in Scheme 39. 
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Scheme 39. Full proposed mechanism of the photoinduced decarboxylative borylation of NHPI esters. 
In DMAc solution, NHPI ester 44 and a B2cat2 molecule come together to form a visible light 
absorbing -stacking EDA complex 103 (Scheme 39A). Upon photoexcitation of 103 to give 
exciplex 104, an intra-complex single electron transfer event occurs,83 in which an electron is 
transmitted from an electron-rich catechol ring of B2cat2 to the electron-deficient aryl ring of 
the phthalimide moiety, to form a radical ion pair consisting of radical anion 45 and radical 
cation 105. If diffusive separation of 45 and 105 does not occur, back electron transfer will 
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regenerate the original neutral species 44 and B2cat2. If the two components do separate 
(Scheme 39B), radical anion 45 undergoes a facile N−O bond homolysis to deliver a 
phthalimide anion and carboxyl radical, the latter of which rapidly decarboxylates to form alkyl 
radical 46. The B2cat2
•+ species 105 is decomposed through the addition of two solvent DMAc 
molecules, to form a stabilized boryl radical 107 and a DMAc-Bcat adduct 108. Alkyl radical 
46 most likely reacts with a free B2cat2 molecule to form radical adduct 119, which, after 
complexation with a molecule of solvent DMAc, undergoes B−B bond homolysis to form alkyl 
boronic ester product 118 and a molecule of DMAc-stabilized boryl radical 107 (Scheme 39C). 
Boryl radical 107 can induce a radical chain process whereby it transfers an electron to the 
phthalimide portion of the NHPI ester 44, to form radical anion 45 and 108, the former of which 
re-enters the reaction cycle after N−O bond homolysis and decarboxylation to form alkyl radical 
46 (Scheme 39D). 
2.4.6 Borylation using other diboron reagents: some contrary evidence 
There is some difficult-to-explain experimental evidence that could cast doubt on some of our 
mechanistic proposals (Scheme 40). Specifically, whilst B2cat2 is by far the most efficient 
diboron source for this transformation, there is some reactivity when model NHPI ester 55 is 
treated with a range of other diboron reagents under our optimized conditions. B2pin2, B2neo2 
and B2(OH)4 all provided some decarboxylative borylation product 60. Intriguingly, all three 
reagents give similar yields when used under blue LED irradiation, in the dark at ambient 
temperature, or when heated at 80 °C. Addition of catechol to the reactions with B2pin2 or 
B2neo2 do not lead to much improved yields, but the mixture of catechol with B2(OH)4 does 
lead to a dramatic yield increase, potentially because B2cat2, or mixed diboron species 
B2(OH)2(cat), is forming in situ and participating in the proposed mechanistic steps outlined in 
Scheme 39. 
 
Scheme 40. Decarboxylative borylation using alternative diboron reagents under a variety of conditions. 
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These results imply that when using these diboron sources, the decarboxylative borylation 
reaction is a purely thermal process and thus not accelerated by visible-light irradiation. 
Considering the full mechanism proposed in Scheme 39, the most notable step that would 
clearly not work well using these alternative diboron reagents, and could explain why light is 
not an important factor, is that B2pin2, B2neo2 and B2(OH)4 do not have electron-rich aryl rings, 
so the -stacking EDA complex simply cannot form using these three reagents. Furthermore, 
since electron-rich aryl rings are absent, there is no electron-donor to reduce the NHPI ester to 
initiate the decarboxylative transformation. Indeed, upon analysis of the UV-visible absorbance 
spectrum of a mixture of NHPI ester 55 and B2pin2 (0.1 M for each component in DMAc) we 
do not observe any absorbance bands in the visible region (Figure 11). It appears that there is 
some interaction between 55 and B2pin2, as shown by the hump observed at approximately 
350 nm, however the effect is less pronounced than that observed when using B2cat2 and does 
not lead to any visible absorbance.  
Wavelength (nm)

















NHPI ester 55 and B2pin2
 
Figure 11. UV-visible absorbance spectra for B2pin2, NHPI ester 55, and B2pin2 and 55 in DMAc. 
If this is a purely thermal process, how is the reaction being initiated? Something must be 
reducing the NHPI ester to form the corresponding radical anion, which ultimately leads to 
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decarboxylation, however this species is difficult to identify. The NHPI ester cannot be reacting 
in its highly oxidizing (E1/2* = +1.6 V vs SCE) photoexcited triplet state, and so must be reacting 
in its much less oxidizing ground state (E1/2 = −1.4 V),
73 since there is no visible light radiation 
to achieve the photoexcitation (and indeed the NHPI ester does not absorb in the appropriate 
visible region). There is also little to no interaction between DMAc and B2pin2, B2neo2 or 
B2(OH)4, as judged by 
11B NMR spectroscopic analysis (Figure 12), so any potentially 
reducing sp2−sp3 DMAc-diboron adducts72 are either not forming or are forming in vanishingly 
low proportions. B2cat2 is vastly more Lewis acidic than these three alternative reagents,
97 so, 
considering that in a 0.1 M solution of B2cat2 in DMAc approximately only 20 % is calculated 
to be in the DMAc-B2cat2 adduct and none as the DMAc2-B2cat2 adduct, it is doubtful that any 
of the other DMAc-diboron adducts are forming at all in solution. Ultimately, the solution to 




Figure 12. 11B NMR spectra of (A) B2pin2, (B) B2neo2, (C) B2(OH)4 and (D) B2cat2 in DMAc at 0.1 M. 
The remainder of the mechanistic cycle, namely the trapping of the alkyl radicals by a diboron 
reagent and the reduction of the NHPI ester with a boryl radical, appear to remain plausible 
since similar steps have been proposed in related radical-based borylation chemistries.86 It is 
A B2pin2 in DMAc 
29.9 ppm 
B B2neo2 in DMAc 
27.2 ppm 







C B2(OH)4 in DMAc 
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possible, however, that Bcat radicals are more stable than Bpin, Bneo or B(OH)2 radicals due 
to increased delocalization of the unpaired electron across the catechol ring,89 which might also 
lead to increased yields. 
2.5 Contemporaneous decarboxylative borylations 
After submission of the manuscript detailing the work outlined in this chapter (and mostly 
whilst our manuscript describing this work was undergoing review), a flurry of reports was 
published which described similar decarboxylative borylation processes.98 
The first report, from Baran,99 described a nickel-catalyzed decarboxylative borylation process 
(Scheme 41), under conditions similar to those we initially investigated (Scheme 23). Here, in 
general terms, pre-isolated or in situ-generated NHPI esters 44 are treated with NiCl2 
hexahydrate, a bipyridine ligand, magnesium bromide, and B2pin2 pre-complexed with methyl 
lithium, in a mixture of THF and DMF. This method was effective for the decarboxylative 
borylation of a range of carboxylic acid substrates, including the important -amino carboxylic 
acids, to form the corresponding boronic esters and -amino boronic esters 128 in mostly 
moderate to good yields. Impressively, it was possible to convert carboxylic acids embedded 
within a few structurally complex polypeptides, including the iconic vancomycin, to the 
corresponding -amino boronic esters with high substrate-controlled diastereoselectivity. Its 
presumed mechanism is exactly as that proposed in Scheme 23A. 
 
Scheme 41. Baran’s nickel-catalyzed decarboxylative borylation of NHPI esters. 
Whilst this method is evidently very useful for the synthesis of structurally complex boronic 
esters and exhibits a prolific substrate scope, which includes the coveted -amino boronic 
esters, it suffers in comparison to our methodology in terms of its practicability. Our method is 
strikingly easy:100 stir two solids, the NHPI ester and B2cat2, in DMAc under blue LED 
irradiation overnight. Baran’s, however, requires an inhomogeneous solution of nickel catalyst 
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and bipyridine ligand in DMF, that has been pre-mixed overnight, to be added to a suspension 
of the NHPI ester and magnesium bromide in THF before sonicating to achieve complete 
dissolution. Then, a pre-complexed mixture of B2pin2 and air- and moisture-sensitive methyl 
lithium in THF is added in a single portion before stirring for an hour at 0 °C and then a further 
hour at ambient temperature. 
The second report, from Li,101 is very similar to our method, but with a few notable differences 
(Scheme 42). In this work, the same NHPI esters are treated with an iridium photocatalyst, four 
equivalents of a diboron reagent, B2(OH)4 for secondary and B2pin2 for primary substrates, 
under white light irradiation to yield the desired boronic esters, which, in the case of the 
secondary examples, are isolated as the trifluoroborate salts following treatment with aqueous 
KHF2. The substrate scope of primary and secondary boronic ester products is as broad as our 
and Baran’s methodologies, however Li’s is unsuccessful when applied to tertiary carboxylic 
acids, though it is not clear which substrates were tested. As with our method, Li’s also does 
not transform -amino acids or secondary benzylic carboxylic acids, since it likely suffers from 
the same issues we encountered (see section 2.3.4). In contrast to our and Baran’s procedures, 
however, Li gave one example that showed his process can convert an aryl NHPI ester into the 
corresponding aryl boronic ester, albeit in a low yield and over an extended reaction time. 
 
Scheme 42. Li’s decarboxylative borylation of NHPI esters under photoredox catalysis. 
The authors suggest that their mechanism starts with the photoexcited iridium photocatalyst, 
which reduces the NHPI ester 44 to generate radical anion 45. This undergoes subsequent 
homolytic cleavage of the N−O bond to form phthalimide anion and the carboxylate radical, 
the latter of which rapidly decarboxylates to release carbon dioxide and alkyl radical 46. They 
propose that the phthalimide anion deprotonates a water molecule to generate hydroxide, which 
then complexes with a diboron species to form an activated sp2−sp3 diboron reagent 129. The 
alkyl radical 46 next reacts with 129 to form the final boronic ester product, alongside a boryl 
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radical anion which is oxidized by the photocatalyst to regenerate the active iridium(III) 
photocatalyst (Scheme 43). 
 
Scheme 43. Li’s proposed mechanism for the photoredox catalyzed decarboxylative borylation of NHPI esters. 
Since this methodology is more-or-less identical to ours, it is possible that their mechanism is 
too, which means their additional photocatalyst could be a bystander. We tested this hypothesis 
and found this could be the case. It should be noted that Li performed their process in the 
absence of the iridium photocatalyst and observed ‘no reaction’. We subjected model NHPI 
ester 55 to conditions very similar to Li’s, but with the iridium photocatalyst omitted and with 
a different work-up procedure to aid analysis by GC−FID rather than isolation as the 
trifluoroborate salt. It was found that the desired boronic ester 60 was formed in 82 % yield 
(Scheme 44). Whilst there are some differences between our and Li’s experiments, notably use 
of our blue LEDs, rather than a white 45 W CFL, and conversion to the pinacol boronic ester 
rather than the trifluoroborate salt, these results suggest that their iridium photocatalyst could 
be an unnecessary addition. Boronic ester 60 was formed in 82 % yield, which is identical to 
the yield of the similar boronic ester 130 synthesized by Li. 
 
Scheme 44. Replication of Li’s control experiment with conflicting results. 
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There have also been two similar reports of the decarboxylative borylation of aryl NHPI esters, 
which are complementary to our, Baran and Li’s processes. Firstly, Glorius102 found that 
treating isolated or in situ-activated aryl NHPI esters 131 with B2pin2, pyridine, and cesium 
carbonate in ethyl acetate under purple LED irradiation led to the formation of the 
corresponding decarboxylative borylation products 49 (Scheme 45A). Shang and Fu103 then 
reported a thermal decarboxylative borylation where the same aryl NHPI esters are treated with 
a catalytic quantity of tert-butyl isonicotinate ester, which is a pyridine bearing a tert-butyl ester 
moiety in the para position, and B2pin2 at 110 °C (Scheme 45B). The substrate scope of both 
procedures was found to be very broad, encompassing a wide range of (hetero)aromatics, 
however, they were not applied to the synthesis of alkyl boronic esters. There are unfortunately 
no comments as to whether there is any success with this class of substrates. 
 
Scheme 45. (A) Glorius’s, and (B) Shang and Fu’s decarboxylative borylations of aryl NHPI esters. 
Mechanistically, both are very similar to each other and our own work. Glorius’ (Scheme 46A) 
is proposed to start with the purple LED irradiation exciting NHPI ester 131 to result in a 
photoexcited NHPI ester 131*, which then oxidizes an N-adduct of pyridine and B2pin2 132. 
This results in radical anion 133 and radical cation species 134, the former of which undergoes 
homolytic N−O bond cleavage, extrudes carbon dioxide to form an aryl radical, and then finally 
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reacts with the sp2-hybridized boron center of 134 to yield the aryl boronic ester product 49 
alongside a pyridine-Bcat adduct. Similarly, Shang and Fu (Scheme 46B) propose that a mono 
N-adduct of isonicotinate ester and B2pin2, 135, complexes with an oxygen atom of aryl NHPI 
ester 131. Intra-complex single electron transfer then occurs, which results in a persistent 
isonicotinate stabilized boryl radical 136. An NHPI radical anion also forms, which undergoes 
N−O bond homolysis, followed by decarboxylation, to give an aryl radical. This performs a 
radical-radical coupling with 136 to form the final aryl boronic ester product 49 and regenerate 
the catalytic isonicotinate species. 
 
Scheme 46. (A) Glorius’s, and (B) Shang and Fu’s proposed decarboxylative borylation mechanisms. 
2.6 Decarboxylative borylation of -amino acids 
An important class of substrates that are unsuccessful under our optimized conditions are the 
-amino acids. Since most boron-containing drugs are -amino boronic acids (Figure 3),44 
which could be derived from a decarboxylative borylation of the corresponding -amino acids, 
we sought a second procedure that could transform -amino acids into -amino boronic esters. 
Whilst Baran’s method99 is applicable to the synthesis of these substrates (Scheme 41), there is 
still appreciable need for an experimentally simple procedure that avoids use of toxic transition 
metals and other additives. 
When Boc-proline NHPI ester 137 was subjected to our optimized conditions (Table 2, entry 
1), only 8 % of the corresponding -amino boronic ester 138 was observed by calibrated 
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GC−FID, despite the starting NHPI ester being completely consumed. This translated to only a 
trace amount of impure 138 being isolated, presumably due to instability on silica gel.78 We 
were inspired by the successful decarboxylative borylation of alkyl NHPI ester 55 in the 
presence of two equivalents of DMAP (Scheme 36), and so we tested this additive in the 
reaction, under otherwise identical conditions, and observed a dramatic yield increase from 8 % 
to 22% (entry 2). At this early stage we also discovered that the tetrachlorophthalimide analogue 
of 137 was completely unsuccessful (entry 3); that the yield peaks at about five hours, however 
a 14 hour reaction time (overnight) was retained for convenience (entries 4−8); and that 
increasing the equivalents of B2cat2 to two was detrimental to the yield (entry 9). We next 
embarked on an additive screen: an additive, marginally superior to DMAP, 4-methoxypyridine 
(4MeOPy), was identified and gave 28 % of 138 (entry 10), however all other additives tested 
resulted in either no observed product or a decreased yield (see supplementary materials for full 
list of results). Taking 4MeOPy forward, the next discovery was that adding acetic acid, rather 
than triethylamine, alongside pinacol at the end of the reaction for the transesterification step 
almost doubled the yield of 138 to give 52 % (entry 11). It is not clear why acetic acid is superior 
to triethylamine in this instance, but it is thought that addition of a proton source helps to 
protonate the excess pyridine additive in the reaction mixture, which would prevent it from 
coordinating to the intermediate catechol boronic ester and thus inhibiting the transesterification 
process. Noticing that excess B2cat2 was detrimental in prior experiments, we next tested a 
range of mixtures of B2cat2 and B2(OH)4 (entries 12−16). We were delighted to see that one 
equivalent of B2(OH)4 mixed with 0.5 equivalents of B2cat2 gave an increased yield of 73 % 
(entry 15). A range of solvents were finally tested (entries 17−20), and it was found that across 
the limited selection chosen, all performed similarly, with DME performing slightly better, 
giving 138 in 83 %. In line with our previous discovery that using light was unnecessary when 
using DMAP as an additive in the decarboxylative borylation of alkyl carboxylic acids, light 
was also found to not be necessary in this reaction, yielding 82 % of 138 when the reaction was 
ran in the dark (entry 21). However, heating the reaction to 80 °C resulted in complete 
decomposition (entry 22). 
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Table 2. Optimization of the decarboxylative borylation of -amino acid NHPI ester 137. 
 
Whilst no mechanistic investigations have been undertaken, the presumed mechanism is as 
follows (Scheme 47): a 4MeOPy molecule coordinates to each boron atom of B2cat2 (or 
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B2(OH)4, or B2(OH)2(cat)), which results in homolytic B−B bond cleavage to form two 
persistent pyridine-stabilized boryl radicals 139.72a One of these reacts with the NHPI ester 137, 
in either a single electron transfer or borylation event, to ultimately result in -amino alkyl 
radical 140 and either a borylated phthalimide 112 and unligated pyridine, or a phthalimide 
anion and a pyridine-Bcat adduct 141. The alkyl radical 140 then has two potential fates: 1) it 
reacts directly with a persistent pyridine-stabilized boryl radical 139 to form the boronic ester 
product 138; or 2) reacts with free B2cat2 to form an intermediate adduct, which undergoes B−B 
bond homolysis upon coordination of a pyridine molecule to the second boron atom to form the 
boronic ester product 138 and a pyridine-stabilized radical 139. 
 
Scheme 47. Proposed mechanism of the decarboxylative borylation of -amino carboxylic acids using pyridine. 
Due to time pressure, this work was suspended in favour of finishing the previous project (see 
sections 2.3 and 2.4). It is now under current investigation by another member of the Aggarwal 
group. 
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2.7 Conclusions, Impact and Future work 
2.7.1 Conclusions 
2017 was the year of the decarboxylative borylation:98 in the space of a few months, five 
separate reports detailed the transformation of carboxylic acids into boronic esters. Our 
contribution describes the conversion of N-hydroxyphthalimide activated carboxylic acids into 
their corresponding boronic esters in an operationally simple, broad-based and mechanistically 
distinct process.63 Our reaction conditions are very simple: stir an NHPI ester in the presence 
of B2cat2 in DMAc solvent under blue LED irradiation for 14 h, then pinacol and triethylamine 
are added to effect transesterification of the catechol boronic ester into the stable, isolable 
pinacol boronic ester. These conditions successfully converted a wide range of carboxylic acid 
substrates into the corresponding boronic esters in mostly good to excellent yields, which 
includes primary, secondary, constrained tertiary, and drug- and natural product-derived 
examples, with a wide functional group tolerance. Unfortunately, a number of carboxylic acid 
substrates were unsuccessful, which included -heteroatom, secondary benzylic, non-
constrained tertiary, and allylic carboxylic acids. It is believed these are unsuccessful because 
the intermediate alkyl radicals become oxidized to the corresponding stabilized carbocations. 
The mechanism, whilst not fully understood at this stage, is suspected to be initiated by a 
photoexcited EDA complex of an NHPI ester and B2cat2 undergoing intra-complex single 
electron transfer. Decarboxylation results, which generates an alkyl radical that is trapped by a 
B2cat2 molecule. DMAc solvent is intrinsic to the proposed mechanism, as we believe it is 
responsible for aiding B−B bond cleavage to form the product boronic ester and a DMAc-
stabilized boryl radical, which is a key species in propagating a radical chain process. 
Some steps have been taken to address the key shortcoming of this decarboxylative borylation 
reaction, which is the inability to access -amino boronic esters from the corresponding 
-amino carboxylic acids. To date, a method has been devised that allows transformation of a 
model substrate, Boc-proline NHPI ester, into its corresponding -amino boronic ester in 
excellent yield. 
2.7.2 Unprecedented access to borylated scaffolds 
The described decarboxylative borylation reaction has enabled unprecedented access to a range 
of interesting borylated scaffolds (Figure 13A). In particular, synthesis of bicyclo[1.1.1]pentyl 
boronic ester 88 and cubanyl boronic esters 86 and 87 represent the first and second/third77 
reports, respectively, of these pharmaceutically-relevant structures. It is hoped that these new 
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substrates will provide a platform for the preparation of diversely substituted cubanes and 
bicyclo[1.1.1]pentanes via subsequent boronic ester transformations. Indeed, cubanyl boronic 
ester 87 has already been transformed into the corresponding furan, indole,36 and pyridine37 in 
modest to good yields. 
 
Figure 13. (A) Unprecedented access to borylated scaffolds. (B) Boronic esters now routinely synthesized using our 
decarboxylative borylation. 
Furthermore, even though several of the boronic esters we have reported have been previously 
prepared via other methods, we now use our decarboxylative borylation for the routine synthesis 
of many boronic esters since the method is so practically conveniently (Figure 13B). For 
example, adamantyl boronic ester 84 is now regularly prepared on gram-scale using this 
method. A small range of boronic esters have also been prepared and subsequently utilized as 
substrates in other methodologies currently being developed within the Aggarwal group. 
2.7.3 Radical-based borylation of other functional groups 
Our decarboxylative borylation reaction could provide a platform for the development of further 
radical-based borylation technologies. Conceptually, our decarboxylative borylation is derived 
from the classic Barton decarboxylation,55 and so it would be interesting to investigate whether 
other widely-available functional groups can be replaced by a boronic ester under similar 
conditions. For example, the Barton−McCombie deoxygenation104 is related to the Barton 
decarboxylation, but instead allows the deoxygenation of alcohols to form alkyl radicals, rather 
than using carboxylic acids as the radical precursors. It might, therefore, be possible to design 
an analogous deoxygenative borylation process using the Barton−McCombie reaction as the 
template (Scheme 48). This concept is currently being investigated by another member of the 
Aggarwal group. 
- 63 - 
 
 
Scheme 48. Proposed deoxygenative borylation using our conditions and a ‘Barton-McCombie’ radical precursor.. 
Additionally, Glorius105 and Watson106 have reported the use of alkyl pyridinium salts 
(‘Katritzky salts’)107 as alkyl radical precursors under both nickel-catalyzed and photoredox 
conditions. Alkyl pyridinium salts, which are synthesized from the corresponding alkyl amines 
using a pyrylium salt, have been shown to undergo single electron reduction, followed by a 
deamination, to generate pyridine and an alkyl radical, the latter of which is trapped by either 
an electron-deficient heteroarene or a nickel(II)-aryl species, to ultimately furnish the 
corresponding arylated products. Considering that a single electron reduction is key to these 
processes as well as ours, it would be expected that our conditions would effectively translate 
to the deaminative borylation of alkyl pyridinium salts (Scheme 49). This concept is currently 
being investigated by another member of the Aggarwal group. 
 
Scheme 49. Proposed deaminative borylation of Katritzky salts, under our decarboxylative borylation conditions, currently 
under investigation by another member of the Aggarwal group 
2.7.4 Decarboxylative borylation in flow 
Continuous flow photochemistry, a concept championed by Booker-Milburn,108 is potentially 
the most promising candidate for applying our decarboxylative borylation to the routine 
synthesis of boronic esters on large scale. Typical immersion-well batch photochemical reactors 
have limited application in large scale synthesis because the irradiation cannot penetrate far into 
the solution, thus flow reactors, which pass the reaction solution through very thin tubing, have 
emerged as enabling technologies for the application of photochemistry to large scale synthesis. 
It would therefore be prudent to investigate whether our decarboxylative borylation reaction 
will perform well in, or indeed be improved by, a continuous flow photoreactor, such as that 
designed by Booker-Milburn. 
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2.7.5 Further mechanistic investigations 
As detailed throughout section 2.4, there are currently a number of poorly understood aspects 
and unanswered questions within our mechanism that would benefit from further experimental 
and computational investigation. 
Starting with the photoinitiation step: the formation of a visible-light absorbing EDA complex 
is most likely considering our evidence (section 2.4.1), but it is not yet completely clear whether 
the EDA complex is formed from an NHPI ester and a free B2cat2 molecule, or an NHPI ester 
and a B2cat2-DMAc adduct. It is considerably more likely, however, that the NHPI ester 
complexes with free B2cat2 since the DMAc-B2cat2 adduct is poorly populated in solution and 
a similar visible light absorbing EDA complex has been detected using a solvent that does not 
coordinate to B2cat2 (methanol). Despite this, the interaction of the NHPI ester with 
B2cat2/DMAc-B2cat2 needs to be more thoroughly investigated computationally to 
unambiguously determine which is forming in solution and whether this has implications on 
the single electron transfer step. A Job plot109 could also be obtained to confirm the composition 
of the complex. 
Furthermore, what species are generated after single electron transfer and how to they react 
further? We have proposed that radical ion pair 45:105 is formed (section 2.4.2), however 
immediate back electron transfer to regenerate the neutral species is the most likely next step. 
There are two possibilities if back electron transfer does not occur (Scheme 30B and Scheme 
31B): 1) intra-complex trapping of radical anion 45 with radical cation 105 and subsequent 
B−B bond homolysis upon further complexation with DMAc, to ultimately give a DMAc-
stabilized boryl radical 107, borylated phthalimide 112 and the alkyl radical 46; or 2) diffusive 
separation, which is followed by 45 undergoing N−O bond homolysis and decarboxylation to 
yield the alkyl radical 46 (calculated to be a feasible process), and B2cat2 radical cation 105 
being somehow decomposed, suggested in Scheme 31 to be via complexation of two solvent 
DMAc molecules that homolytically cleave the B−B bond to give DMAc-Bcat cation and 
stabilized boryl radical 107. All of these possibilities should be explored computationally, and 
the by-products searched for using mild high-resolution mass spectrometry techniques. 
Next, which diboron species traps the alkyl radical? The B2cat2-DMAc adduct is poorly 
populated (Scheme 28) so it might be expected that, statistically, trapping with free B2cat2 
would be favoured. It is evident from our and Studer’s88 calculations that trapping with both 
free B2cat2 and the B2cat2-DMAc adduct are possible (Scheme 35), but some clarity could be 
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gained if we performed our own set of calculations, using the same alkyl radical and solvent 
across both experiments, to maximise their comparability. 
What is the mechanism of the reduction of the NHPI ester with a DMAc-stabilized boryl radical 
107– is it single electron transfer or a borylation (Scheme 38)? Studer88 has calculated that a 
DMF-stabilized boryl radical reduces trifluoromethyl iodide in a single electron transfer 
mechanism, though they comment that it could equally be an I-abstraction instead. We, on the 
other hand, have calculated that the DMAc-stabilized boryl radical 107 reacts via the boron 
atom with an amide oxygen of the phthalimide to give radical anion 127, though we did not 
consider any single electron transfer mechanisms at the time. As with the previous question, we 
should perform our own set of calculations to probe whether a single electron transfer 
mechanism is operable. 
The boryl radicals thought to be generated by B−B bond homolysis of B2cat2 through 
complexation of DMAc are also thought to be radical propagating species. A quantum yield96 
should be measured to see if a radical chain mechanism is operating, though this would not 
necessarily confirm the presence of DMAc-stabilized boryl radicals 107. 
What is happening in the thermal decarboxylative borylations when using B2cat2, B2pin2, 
B2neo2 and B2(OH)4 (Scheme 40)? The, albeit low yielding, success of these reactions is 
puzzling since it invokes the homolytic cleavage of the B−B bond of B2X2 using DMAc. This 
process with B2cat2 has been calculated to be very thermodynamically unfavourable
† (Scheme 
37) and, by extension, far less likely with the other diboron species since B2cat2 is by far the 
most Lewis acid97 and therefore most likely to yield B2cat2-DMAc mono and bis-adducts. 
Whilst an entirely different mechanism cannot be ruled out, we have not found any literature 
precedents that suggest other obvious possibilities. 
Finally, there are several classes of carboxylic acids, most notably -heteroatom, secondary 
benzylic and flexible tertiary, that are unsuccessful under our optimized conditions (Figure 6). 
The precise reason for these failures is elusive, although no experimental or computational 
studies have been undertaken. The current hypothesis is that the intermediate alkyl radicals are 
oxidized to the corresponding stabilized carbocations, so this should be probed computationally 
and experimentally. The starting NHPI esters are completely consumed during the reaction and 
there are no observable quantities of apolar compounds (as judged by thin-layer 
chromatography and analysis of the crude mixtures using 1H NMR spectroscopy), such as the 
radical-radical coupling or hydrodecarboxylation products, so there must be conversion to more 
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polar side-products. These should be found and identified to see if they are congruent with our 
working hypothesis. It might also be possible to probe the intermediacy of carbocations by 
using a range of benzylic carboxylic acids with varied electronic properties (Figure 14). For 
example, it might be expected that a secondary benzylic radical would be more difficult to 
oxidize to its corresponding carbocation if the aryl ring bears strongly electron-withdrawing 
substituents. This may favor borylation, rather than oxidation. Likewise, primary benzylic 
carboxylic acid successfully undergoes decarboxylative borylation (giving 61, Scheme 27A) 
under our optimized conditions. If we instead use a primary benzylic carboxylic acid where the 
aryl ring is bearing strongly electron-donating substituents, we would expect that oxidation of 
the intermediate radical to the corresponding carbocation would be more favorable than with 
the unsubstituted analogue, and thus the borylation would be halted. Using a range of differently 
electron-donating and electron-withdrawing substituents could allow determination of a cut-off 
point between borylation/oxidation, which might also suggest the reduction potential of the 
oxidizing species. Combined with calculation (or indeed experimental determination) of the 
oxidation potentials of the proposed benzylic radicals,110 these experiments might provide some 
evidence to support a radical oxidation process preventing borylation of some substrates. The 
oxidizing species also remains a mystery, though a prime candidate is the NHPI ester. Its 
identity will most likely be found by computational modelling of all proposed reaction 
intermediates and observing how they can interact. 
 
Figure 14. Can we modulate the oxidation potentials of benzylic radicals using electron-donating or -withdrawing groups to 
favor or disfavor borylation or oxidation? 
2.7.6 Decarboxylative borylation of -amino acids 
To date, an optimized procedure for a new -amino acid decarboxylative borylation process 
has been established. The next steps would be to attempt the decarboxylative borylation of other 
-amino acids to see if the current method is general, and to perform some mechanistic 
investigations, analogous to those discussed in section 2.4. 
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3. Regioselective homologation of 1,2-bis(boronic esters) 
3.1 The -elimination problem 
3.1.1 -Elimination of boronate complexes 
The development of new and improved boronic ester homologation reactions, as described in 
section 1.2.2, has continued unabated for almost 40 years.9,10e,f,20 It is now possible to perform 
iterative homologation sequences, of up to nine homologations, without isolation of any 
intermediates. It has also been applied to the successful syntheses of several complex natural 
products, such as (+)-kalkitoxin (Scheme 2) and (+)-hydroxyphthioceranic acid.2 Whilst the 
described methodologies are clearly highly successful in the preparation of molecules rich in 
apolar residues, particularly the methyl group (Scheme 9), its application to the introduction of 
more polar residues is much more challenging, primarily due to the requirement of highly 
reactive organolithiums which severely restricts functional group compatibility. In this context, 
1,3-diols are abundant in natural products but can not be prepared easily using boronic ester 
homologation reactions because the required -hydroxyl boronic esters (which must also be 
protected in order to be compatible with the reaction conditions and not undergo a boron−Wittig 
elimination during their preparation)111 would undergo -elimination upon forming the 
intermediate boronate complex.78 
 
Scheme 50. Experimental demonstration of the ‘-elimination’ problem. 
Indeed, -OTBS boronic ester 142 was prepared to demonstrate this point (Scheme 50). Upon 
reacting 142 with (+)-sp-Li-143, intermediate boronate complex 144 is formed. After refluxing 
overnight to induce 1,2-metalate rearrangement, the reaction products were quantified using 
crude 1H NMR spectroscopic analysis against an internal standard, 1,3,5-trimethoxybenzene. It 
was found that 26 % of 114 had converted to octene, the product of -elimination, alongside 
62 % of the desired 1,2-migration product 145. Evidently, -elimination of -hydroxyl boronate 
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complexes is an issue, which is likely to become worse if more structurally complex substrates 
are used. 
3.2 Project proposal 
 
The data presented in this section has been partially published in: A. Fawcett, D. Nitsch, M. 
Ali, J. M. Bateman, E. L. Myers and V. K. Aggarwal, Angew. Chem. Int. Ed. 2016, 55, 
14663−14667.112 Where indicated (†), the data presented was obtained by my co-workers, 
Dominik Nitsch and Joseph M. Bateman, and is included in this thesis to provide a complete 
picture of the work. 
 
3.2.1 Regioselective homologation of 1,2-bis(boronic esters) 
Our proposed solution to this problem was to mask the -functional group with another that 
does not undergo -elimination but could then also be transformed into any other desired 
functional group; the obvious choice was the boronic ester. We therefore proposed that if we 
could regioselectively homologate the primary boronic ester within a 1,2-bis(boronic ester) 146 
using lithium carbenoid 147 we would generate intermediate boronate complex 148, which is 
unable to undergo -elimination. 1,2-Metalate rearrangement would then result in the 
homologated 1,3-bis(boronic ester product) 149 (Scheme 51). Both boronic esters could then 
be engaged in any desired boronic ester transformation (section 1.2.3) to deliver the 
corresponding 1,3-bis(functionalized) product, which would include oxidation to form the 
corresponding 1,3-diol.  
 
Scheme 51. Proposed solution to the -elimination problem: the regioselective homologation of 1,2-bis(boronic esters) using 
lithium carbenoids. 
The power of this methodology lies in its potential to allow the preparation of any stereoisomer 
of any chosen 1,3-diol series, however this ultimately relies on three criteria: the ability to 
access the homologating reagent 147 and 1,2-bis(boronic ester) 146 starting materials in both 
enantiomeric forms; that a highly regioselective reaction can be achieved; and the absence of 
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match/mismatch effects in the proposed reaction. Our group has extensively researched the 
preparation and use of enantiomerically enriched lithium carbenoids (section 1.2.2), in both 
enantiomeric forms, for reagent-controlled homologation of mono boronic esters, so these 
building blocks would be easily accessible. 
3.2.2 Preparation of alkyl 1,2-bis(boronic esters) 
Considering only those that produce alkyl 1,2-bis(pinacol boronic esters) in both enantiomeric 
form,113 there are two technologies that enable the efficient enantioselective diboration of 
terminal alkenes to form the corresponding 1,2-bis(boronic esters). 
In 2009, Morken114 reported the first general enantioselective diboration of terminal olefins, 
which was improved upon later in 2013.115 In this most recent report, a range of alkyl and 
styrenyl unactivated terminal alkenes were subjected to platinum(0)(dibenzylideneacetone)3 
(Pt(dba)3), a chiral TADDOL-derived phosphonite ligand, and B2pin2 in THF to form the 
1,2-bis(boronic esters), which are isolated as the corresponding diols 150 after oxidation with 
a NaOH/H2O2 mixture (Scheme 52). With this procedure, a broad range of functional groups 
were tolerated, including those that can also undergo diboration, such as ketones, esters and 
amides, and it was possible to achieve high enantioselectivity and yield regardless of the 
substituents  to the olefin. In depth mechanistic studies have shown that the catalytic cycle 
starts with a rapid oxidative addition of the platinum(0) catalyst into the B−B bond of B2pin2. 
Next, the substrate alkene coordinates to the platinum(II)-(Bpin)2 intermediate, which then 
undergoes an irreversible and stereochemistry determining migratory insertion into one of the 
Pt−B bonds. Finally, reductive elimination furnishes the 1,2-bis(boronic ester) product and 
regenerates the active catalyst. 
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Scheme 52. Morken’s platinum-catalyzed diboration of unactivated terminal olefins. 
In 2013, Nishiyama116 described the enantioselective diboration of a range of alkyl and styrenyl 
unactivated terminal alkenes using a chiral ligand-bearing rhodium(III) catalyst, sodium tert-
butoxide, and B2pin2 in THF to form the enantioenriched 1,2-bis(boronic esters), which were 
isolated as the corresponding 1,2-diols 150 after oxidation, in generally good to excellent yields 
and enantiomeric ratios (Scheme 53). In comparison to Morken’s work, the scope is less broad 
in terms of its functional group tolerance, perhaps due to the requirement of the strong alkoxide 
base, but it exhibits a marginally greater enantioselectivity. The mechanism is proposed to begin 
with a transmetalation of the rhodium(III)-X catalyst, where X is either an acetate or tert-
butoxide ligand, with B2pin2 to deliver a rhodium(III)-boryl species. Complexation of the olefin 
to this then follows, which undergoes migratory insertion into the Rh−B bond to give a 
rhodium(III)-alkyl intermediate, where the rhodium is located on the terminal carbon of the 
alkyl chain. A final transmetalation with a boron species, either B2pin2 or Bpin(OtBu) 
(generated as by product of the previous transmetalation), delivers the 1,2-bis(boronic ester) 
product and regenerates an active catalytic species. 
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Scheme 53. Nishiyama’s rhodium-catalyzed diboration of unactivated terminal olefins. 
Both described methods provide access to a range of diversely substituted alkyl 1,2-bis(boronic 
esters) in good yields and high enantiomeric ratios, however Morken’s diboration system was 
selected for preparation of substrates for our proposed process due to its higher functional group 
tolerance and exceptional reliability. 
3.2.3 Previous selective reactions of alkyl 1,2-bis(boronic esters)  
Regioselective reactions of 1,2-bis(boronic esters) remain relatively unexplored, however there 
are a few notable examples that require discussion. 
Prior to our work, 1,2-bis(boronic esters) had, in fact, already been regioselectively 
homologated, albeit in a very limited manner (Scheme 54). Morken117 had shown that a small 
range of 1,2-bis(catechol boronic esters) 151, generated by the rhodium-catalyzed diboration 
of olefins,113a-b could be regioselectively homologated using TMS-diazomethane. Here, the 
TMS-diazomethane adds selectively to the less hindered primary boronic ester to form a 
transient boronate complex 152, which undergoes 1,2-metalate rearrangement to form the 
homologated product 153. Due to instability of catechol boronic esters to purification by silica 
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gel chromatography, the products 153 were oxidized and subsequently isolated as the 
corresponding 1,3-diols. The Aggarwal group has since demonstrated that performing the 
analogous transformation on 1,2-bis(pinacol boronic esters) does not result in any reaction and 
that all of the starting 1,2-bis(boronic ester) could be recovered.112 This is likely due to the 
decreased Lewis acidity of pinacol boronic esters relative to catechol boronic esters.97 
 
Scheme 54. The first regioselective homologation of a 1,2-bis(boronic ester) using TMS-diazomethane. 
Across several publications,118 Morken has described the regioselective Suzuki−Miyaura cross 
coupling of the primary boronic ester of a 1,2-bis(boronic ester) to form the corresponding 
mono arylated boronic ester (Scheme 55). Taking a representative example,119 enantioenriched 
1,2-bis(boronic esters) 146, generated by the platinum-catalyzed enantioselective diboration of 
terminal alkenes, underwent a regioselective Suzuki−Miyaura cross-coupling with an aryl 
halide, in the presence of palladium(II) acetate, RuPhos and potassium hydroxide in a mixture 
of water and tetrahydrofuran (THF), to furnish the cross-coupled products, which are isolated 
as the corresponding alcohols 154 after oxidation with a NaOH/H2O2 mixture. Importantly, the 
cross-coupling is performed in the same reaction vessel as the preceding diboration, so, in 
essence, unactivated terminal alkenes are converted directly to enantiomerically enriched bis-
functionalized products in a single operation. A modest substrate scope was presented, but it 
efficiently demonstrated that simple terminal olefins could be diborated with high 
enantioselectivity and then cross-coupled with a range of aromatic and vinylic units. It was 
found that the presence of the second boronic ester unit significantly enhances the rate of 
transmetalation of the primary boronic ester, since an analogous mono boronic ester, under 
otherwise identical conditions, only yielded trace quantities of the cross-coupled product. It is 
suggested that coordination of one pinacol oxygen atom of the primary boronic ester 
coordinates to the boron atom of the secondary boronic ester enables this rapid transmetalation 
process. This internal coordination ‘activates’ the primary boronic ester by elevating its Lewis 
acidity, and ‘deactivates’ the secondary boronic ester by forming a transient boronate complex. 
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Scheme 55. Morken’s regioselective Suzuki−Miyaura cross-coupling of 1,2-bis(boronic esters). 
An interesting development of these conditions have allowed for the regioselective cross-
coupling of the secondary boronic ester of a 1,2-bis(boronic ester), rather than the primary 
boronic ester (Scheme 56).120 Here, a hydroxyl group, which also directs the preceding 
diboration reaction,121 directs a palladium(II)-aryl intermediate to selectively undergo 
transmetalation with the secondary boronic ester. This is suggested to proceed via a covalent 
Pd−O linkage, which situates the secondary boronic ester in such a position to allow a facile 
inner-sphere stereoretentive transmetalation with the palladium(II) complex that ultimately 
results in the secondary cross-coupled product. The substrate scope was found to be broad, 
enabling the introduction of a wide range of aryl and vinyl groups into the secondary position 
of a small selection of 1,2-bis(boronic esters) in mostly moderate to good yields and high 
diastereoisomeric ratios. 
 
Scheme 56. Morken’s secondary selective hydroxyl directed cross-coupling of 1,2-bis(boronic esters). 
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3.3 Results and discussion 
3.3.1 Regio- and stereoselective homologation optimization 
The proposed regioselective homologation was first examined using octyl 1,2-bis(boronic ester) 
155 and carbamate 143 as model substrates (Table 3). In general terms, carbamate 143 was 
treated with sec-butyl lithium in the presence of (+)-sparteine in diethyl ether at −78 °C to form 
(+)-sparteine ligated lithiated carbamate (+)-sp-Li-143, which was then reacted with 
1,2-bis(boronic ester) 155 for 1 hour to form the intermediate boronate complex(s). The reaction 
mixture was then allowed to undergo 1,2-metalate rearrangement over 16 hours to give the 
homologated boronic ester(s), which were finally oxidized using a NaOH/H2O2 mixture to yield 
the corresponding diol product(s). In the first experiment, (+)-sp-Li-143 was treated with an 
equimolar amount of 155 and, to our surprise, ultimately resulted in 60 % of the desired 
regioselective homologation product 156, as a single diastereoisomer, alongside 3 % of the 
undesired doubly homologated product 157 (entry 1). Since the 1,2-bis(boronic ester) is added 
to a solution of (+)-sp-Li-143, which is known to react rapidly with mono boronic esters, that 
it was, in effect, being added to a large excess of carbenoid during the first few seconds of its 
addition. It was therefore hypothesized that that the bis(boronate complex) responsible for the 
formation of 157 was generated during this stage. A purpose built inverse-addition flask (see 
supporting information for more details) was therefore used to add (+)-sp-Li-143 to a solution 
of 155 at −78 °C, however no improvement in the yields of 156 or 157 were observed (entry 
2). Increasing the equivalents of carbenoid (+)-sp-Li-143 only resulted in an increase in the 
amount of doubly homologated product 157, without any considerable yield increase of 156 
(entry 3). When using this stoichiometry, addition of methanol after boronate complex 
formation, whilst still at −78 °C, led to a noticeable decrease in doubly homologated product 
157 (entry 4), which implies that the boronate complex responsible for 157 forms at −78 °C and 
not, for example, during warming of the reaction prior to 1,2-metalate rearrangement. 
Fortunately, increasing the quantity of 1,2-bis(boronic ester) 155 to 1.2 equivalents, gave a 
marginal yield increase of 156 to 66 %, and with only traces of 157 (entry 5). Finally, 
exchanging the reaction solvent to chloroform or addition of Lewis acid magnesium bromide 
after boronate complex formation, both of which are typically used in similar 
lithiation−borylation reactions to aid 1,2-metalate rearrangement, did not lead to any 
improvements (entries 6 and 7).  
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Table 3. Optimisation of the regioselective homologation of 1,2-bis(boronic ester) 155 with lithium carbenoids. 
 
With use of the carbamate 143 optimized, we next turned out attention to using the 
corresponding TIB ester 158.24 In an analogous manner to before, model TIB ester 158 was 
treated with sec-butyl lithium in the presence of (+)-sparteine in diethyl ether at −78 °C to form 
(+)-sparteine ligated lithiated benzoate (+)-sp-Li-158, which was then reacted with 
1,2-bis(boronic ester) 155 for 1 hour to form the intermediate boronate complex(s). The reaction 
mixture was then allowed to undergo 1,2-metalate rearrangement to give the homologated 
boronic ester(s), which were finally oxidized using a NaOH/H2O2 mixture to yield the 
corresponding diol product(s). In the first instance, equimolar amounts of (+)-sp-Li-158 and 
155 were reacted to form 53 % of the desired product 156 alongside 9 % of the undesired double 
homologation product 157 (entry 8). In contrast to its use with the carbamate, an inverse 
addition procedure did result in marginally improved selectivity, yielding 57 % of 156 and only 
2 % of 157 (entry 9), but it was not used further due to far greater experimental complexity. As 
would be expected, increasing the equivalents of (+)-sp-Li-158 to 1.2 equivalents resulted in an 
increased yield of 156, to 67 %, but also a large increase in 157 (entry 10). Addition of methanol 
after boronate complex formation, whilst using these increased equivalents of (+)-sp-Li-158, 
gave 66 % of 156 and only traces of 157 (entry 11), which showed that, when using the less 
reactive lithiated TIB esters, the double boronate complex that ultimately yields double 
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homologation product 157 forms during warming of the reaction mixture from −78 °C to 
ambient temperature. As with use of the carbamates, using 1.2 equivalents of 1,2-bis(boronic 
ester) 155 delivered an improved yield of 156, of 69 %, alongside traces of the double addition 
product 157 (entry 12). Since carbamates generally lithiate with a marginally better 
enantioselectivity than the comparable TIB esters, carbamates were selected for use in further 
experiments using conditions outlined in Table 3, entry 4. 
With these optimized conditions achieved, we next investigated whether they could be extended 
to the synthesis of all four isomers of 1,3-diol 156 without any major match/mismatch effects, 
which might lead to erosion of diastereoselectivity when forming a particular diastereomer. 
Thus, all four possible combinations of (+)-sp-Li-143, (−)-sp-Li-143 (generated by the 
deprotonation of carbamate 143 in the presence of (−)-sparteine), (R)-155 and (S)-155 were 
tested to good results: all four possible stereoisomers of 1,3-diol 156 were prepared in similarly 
high yields and all with perfect diastereoselectivity. This demonstrated that there are no 
match/mismatch effects (Scheme 57). 
 
Scheme 57. Preparation of all four stereoisomers of 1,3-diol 156 by the regioselective homologation of 1,2-bis(boronic ester) 
155 with lithium carbenoid sp-Li-143. 
3.3.2 Substrate scope 
Now confident that our procedure would be general, we applied it to a range of carbenoid 
precursors and 1,2-bis(boronic esters). For some of these examples, the method of generating 
the carbenoid might differ from that described above (please see supplementary materials), but 
for all experiments the optimized ratio of 1.2 equivalents of 1,2-bis(boronic ester) to one 
equivalent of carbamate/benzoate, which seems to be critical to achieving excellent 
regioselectivity, was maintained. 
The scope of carbenoids was first explored, using octyl 1,2-bis(boronic ester) 155 as a standard 
substrate, and it was found to be broad (Figure 15A). A range of primary carbamates/benzoates 
were successful (159−162), providing the desired 1,3-diols in good to excellent yields and with 
uniformly high diastereoselectivity. Interestingly, secondary carbamates/benzoates performed 
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very well in the transformation (163−167), to yield a range of secondary-tertiary 1,3-diols in 
good to excellent yields and perfect diastereoselectivity. These substrates are particularly 
noteworthy since the preparation of secondary-tertiary 1,3-diols with such generality and high 
diastereoselectivity is unprecedented.122 This first scope showed that the reaction is tolerant of 
several commonly encountered functional groups, including olefins (160), and silyl (161) and 
MOM protected alcohols (162). 
 
Figure 15. Substrate scope of the regioselective homologation of 1,2-bis(boronic esters): (A) lithium carbenoid scope; and 
(B) 1,2-bis(boronic ester) scope. 
Next, the scope of the 1,2-bis(boronic esters) was examined, using secondary benzylic 
carbamate 168 as the standard substrate, to yield similar results (Figure 15B). A range of 
structurally diverse 1,2-bis(boronic esters) were tested (169−176), including those bearing 
useful functional groups, such as tert-butyl esters (169) and carbamates (171), which gave the 
corresponding 1,3-diols in good to excellent yields and perfect diastereoselectivity. Finally, a 
protected derivative of cholesterol-lowering blockbuster drug Lipitor was prepared using the 
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requisite pyrrole- and amide-containing 1,2-bis(boronic ester), and a lithiated benzoate 
featuring a silyl protected alcohol, in good yield and as a single diastereoisomer (175).† 
3.3.3 On the origin of regioselectivity 
On the surface, selectivity for the less hindered primary boronic ester over the more hindered 
secondary boronic ester might seem unexceptional, however the observation of some double 
addition product during our optimization process hints that it might not be so unremarkable 
after all. 
We thus tested a range of other carbenoids to see whether any regioselectivity could be 
obtained. Octyl 1,2-bis(boronic ester) 155 was first reacted with in situ generated chloromethyl 
lithium 6, then the intermediate boronate complexes were allowed to undergo 1,2-metalate 
rearrangement to form the homologated boronic esters (Scheme 58A). These were oxidized 
with a NaOH/H2O2 mixture to give the corresponding diols which, unsurprisingly, were isolated 
as a very complex mixture that featured every possible product: 32 % of unreacted starting 
material, observed as diol 177; 10 % of the expected diol 178 resulting from regioselective 
homologation of the primary boronic ester of 155; 3 % of symmetrical diol 179, which, 
surprisingly, has arisen from regioselective homologation of the secondary boronic ester of 155; 
and finally, 32 % of diol 180, which has resulted from homologation of both boronic esters of 
155. These data clearly show that less hindered, more reactive carbenoids do not provide 
acceptable levels of regioselective homologation. 
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Scheme 58. Unselective homologations of 1,2-bis(boronic ester) 155 using (A) chloromethyl lithium, (B) diamine-free 
lithium carbenoid, and (C) TMEDA-ligated lithium carbenoid. 
We next examined use of carbamate 143, but without any bulky sparteine diamine ligand 
present. The corresponding tri-n-butyl stannane of 143 was thus prepared by trapping (+)-sp-
Li-143, with tri-n-butyl tin chloride. After isolation, this was treated with n-butyl lithium to 
regenerate the corresponding organolithium, Li-143, now without any bulky diamine ligand 
present. Octyl 1,2-bis(boronic ester) 155 was added to a solution of Li-143, before being heated 
to instigate 1,2-metalate rearrangement and oxidized with a NaOH/H2O2 mixture to provide the 
diol products (Scheme 58B). It was found that only 17 % of the expected regioselective 
homologation product 156 was formed, but this was alongside 37 % of the double homologation 
product 157 and 43 % of the oxidized starting boronic ester 177. Furthermore, when carbamate 
143 was lithiated in the presence of a less hindered diamine, TMEDA, to give TMEDA-Li-143, 
and subsequently reacted with 1,2-bis(boronic ester) 155, the resulting diol products after 1,2-
metalate rearrangement and oxidation were 5 % of regioselective homologation product 156, 
19 % of the double addition product 157, and 47 % starting boronic ester 177 (Scheme 58C). 
Both of these results clearly indicate that the bulky diamine ligand, sparteine, is critical to 
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achieving high primary selectivity in reactions of lithium carbenoids with 1,2-bis(boronic 
esters). 
We next wished to probe why we were obtaining such high regioselectivity for the primary 
boronic ester of the 1,2-bis(boronic ester). We thus designed two experiments to investigate 
whether the selectivity is purely a result of steric effects, or whether it is a result of an electronic 
effect. First, a competition experiment was designed to see the degree of selectivity that could 
be obtained when (+)-sp-Li-143 is given the choice to react with either a primary or secondary 
boronic ester, when both are not part of a 1,2-bis(boronic ester) moiety (Scheme 59A). A 
preference for the primary boronic ester would indicate that a steric effect is enabling our 
regioselective homologation of 1,2-bis(boronic esters). Mono boronic ester analogues of 
1,2-bis(boronic ester) 155, 181 and 182, were prepared, where 181 is 155 with the secondary 
boronic ester replaced with an isopropyl group, and 182 is 155 with the primary boronic ester 
replaced with an isopropyl group. These were then added simultanteously, in a 1:1 ratio, to a 
solution of (+)-sp-Li-143. The resulting boronate complexes were then allowed to undergo 
1,2-migration to give the homologated boronic esters, before being oxidized to the 
corresponding alcohols. An 80:20 mixture of 183:184 was obtained in a combined yield of 
85 %. This ratio shows that, when given the option between a primary boronic ester and a 
secondary boronic ester, (+)-sp-Li-143 would preferentially react with the primary boronic 
ester, which suggests that steric effects are responsible for the observed primary regioselectivity 
in reactions with 1,2-bis(boronic esters). The greater selectivity observed in our reaction (Table 
3) is potentially due to the increased size of the pinacol boronic ester relative to the isopropyl 
group.  
 
Scheme 59. (A) Competition experiment between primary and secondary boronic esters. (B) Competition experiment 
between a primary boronic ester and a 1,2-bis(boronic ester). 
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The second experiment was a competition reaction between mono primary boronic ester 181 
and 1,2-bis(boronic ester) 155. Here, both substrates have similar steric environments, however 
if there is an electronic activation of the primary boronic ester of 155, in a similar manner to 
that suggested by Morken (Scheme 55),119 then reaction of the primary boronic ester of 155 
would be preferred over reaction with mono boronic ester 181. A 1:1 mixture of 181 and 155 
was added to a solution of (+)-sp-Li-143, and the resulting alcohols quantified after 1,2-metalate 
rearrangement and oxidation, to deliver a 54:46 mixture of 183:156. Evidently, there is no 
preference for reaction with 155, which implies that there is no electronic activation of its 
primary boronic ester and that, as also demonstrated with the previous experiment, the 
selectivity is purely the result of a steric effect. The slight preference for reaction of 181 over 
155 is, again, potentially a result of the pinacol boronic ester group being bulkier than the 
isopropyl group of 181. 
3.4 Conclusions, impact, and future work 
3.4.1 Conclusions 
We have demonstrated that lithiation−borylation methodology can be applied to the synthesis 
of 1,3-diols. The problem of -leaving groups was overcome by using a masked functional 
group: a boronic ester. 1,2-Bis(boronic esters) were regio- and stereoselectively homologated 
using lithiated carbamates and benzoates with typically high yields and excellent 
diastereoselectivity, the resultant 1,3-bis(boronic esters) were subsequently oxidized to the 
corresponding 1,3-diols. This methodology was applied to the synthesis of all four possible 
stereoisomers of a particular 1,3-diol, proving that there are no significant match/mismatched 
effects in this process, and to a wide range of other substrates, including the synthesis of several 
secondary-tertiary 1,3-diols, which were previously difficult to access in any desired 
stereoisomeric form with broadly high diastereoselectivity. Exclusive reaction of the primary 
boronic ester in a 1,2-bis(boronic ester) was achieved, and this was found to be the result of 
steric effects only. Sparteine-ligated lithium carbenoids were also found to be unique in their 
ability to engender high regioselectivity; less hindered lithium carbenoids were found to 
provide poor regioselectivity. 
3.4.2 Application to the total syntheses of sch 725674 and baulamycins A and B 
Due to its ability to form a range of 1,3-diols with both high enantio- and diastereoselectivity, 
this regioselective homologation of 1,2-bis(boronic esters) has since been applied in the total 
syntheses of several natural products. 
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In our initial publication,112 we demonstrated use of our new methodology in the total synthesis 
of sch 725674,† which is a 14-membered macrolactone that exhibits moderate antifungal 
activity.123 The key step, using this methodology, united 1,2-bis(boronic ester) 185, which is 
prepared by an interesting desymmetrizing diboration of a substituted 1,4-pentadiene, with 
mono lithiated bis(benzoate) (−)-sp-Li-186, to deliver, after oxidation and silyl protection of 
the resultant alcohols, the regioselective homologation product 187 in good yield and high 
diastereoselectivity (Scheme 60). 
 
Scheme 60. Total synthesis of sch 725674 using the regioselective homologation of a 1,2-bis(boronic ester) as a key step. 
More recently, our methodology has been applied to the total synthesis of the baulamycins,124 
which are promising antimicrobial agents,125 where it acted as a linchpin to combine two varied 
and complex units into the desired 1,3-diols (Scheme 61). Unfortunately, the baulamycin 
structures had been misassigned, so it was of paramount importance to be able to access any 
desired 1,3-diol stereochemistry using the same building blocks, which our methodology 
enables, in order to prepare the true natural product without having to redesign the entire 
synthetic route. In the final synthesis of the fully reassigned natural products, 1,2-bis(boronic 
ester) 188 was united with polymethylated benzoates 189a/b to form, after oxidation, 1,3-diols 
190a/b in excellent yields and with excellent diastereoselectivity. 
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Scheme 61. The end-game of the total synthesis of baulamycin A and B using the regioselective homologation of a 
1,2-bis(boronic ester) as a key step. 
3.4.3 Iterative synthesis of 1,3-poly(boronic esters) 
So far we have only shown that 1,3-diols can be prepared using our new methodology, however 
there are numerous natural products that contain 1,3-polyol portions, where there are sometimes 
as many as nine contiguous, but skipped, stereocenters bearing hydroxyl groups. Bahamaolide 
A and B126 are two such compounds, both of which feature a 1,3-polyol region with nine 
stereodefined hydroxyl groups, as well as a macrocyclic lactone and a polyene fragment 
containing six conjugated olefins. 
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Scheme 62. (A) Retrosynthesis of bahamaolide A using regioselective homologations of 1,2-bis(boronic ester) moieties as 
key steps. (B) Proposed forward synthesis of key octaboronic ester 195 using a two-directional regioselective homologation 
strategy. 
We aim to prepare these natural products using our methodology, but with one critical 
modification: use of a homologating reagent, either a carbamate or a benzoate, that contains a 
pendent olefin. This will provide the functional group necessary to perform a subsequent 
diastereoselective diboration to install the required 1,2-bis(boronic ester) for re-entry into our 
regioselective homologation reaction. If the homologation−diboration sequence is performed 
multiple times, this would constitute an iterative synthesis of 1,3-poly(boronic esters) which 
could, upon oxidation of all installed boronic esters, expedite the synthesis of enantio- and 
diastereopure 1,3-polyols in any desired configuration. With this proposed methodology in 
mind, we aim to construct bahamaolide A from its corresponding poly(boronic ester) analogue 
191. A key insight was that the central section of the 1,3-poly(boronic ester) chain is C2-
symmetric, so it should be preparable using a two-directional chain elongation approach 
(Scheme 62A). Therefore, the initial plan is to construct this 1,3-poly(boronic ester) 191, 
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starting with commercially available 1,4-pentadiene, by performing an iterative 
diboration−homologation sequence: a first double diboration of 1,4-pentadiane gives 
1,2,4,5-tetraboronic ester 192; a double homologation using a homoallylic carbenoid 
(+)-sp-Li-193 to form 1,3-tetra(boronic ester) 194 then follows; and finally, another double 
diboration will generate 1,3-octa(boronic ester) 195 (Scheme 62B). The power of this two-
directional iterative sequence127 is evident: the construction of a key building block, featuring 
six stereocenters and eight highly useful functional groups, should be preparable in just three 
steps from commercially available materials. The synthesis would be finished from 195 by 
sequential regioselective homologation of its two primary boronic ester termini, using the 
requisite carbenoids, followed by diboration to install the final boronic ester, construction of 
the polyene fragment, macrolactonization, and finally oxidation of all boronic esters to reveal 
the bahamaolides. 
This impressive looking total synthesis is currently being investigated by another member of 
the Aggarwal group. 
3.4.4 Regioselective homologation of alkenyl 1,2-bis(boronic esters) 
To date, only alkyl 1,2-bis(boronic esters) have been regioselectively homologated using 
lithium carbenoids, however, it would be interesting if the analogous alkenyl 1,2-bis(boronic 
esters) 196 could also be used (Scheme 63). The products would be 1,3-bis(boronic esters) 197, 
which feature several useful functionalities: a vinyl boronic ester, a secondary allylic boronic 
ester, and a C−C -bond, all of which are highly useful motifs that could enable a range of 
orthogonal diversification strategies. 
 
Scheme 63. Proposed regioselective homologation of alkenyl 1,2-bis(boronic esters). 
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4. Carbofunctionalization of C−C -bonds 
4.1 The different reactivity modes of boronate complexes 
4.1.1 The reaction of C-C -bonds of boronate complexes 
Boronate complexes have been long appreciated to display several different modes of reactivity 
depending on their substitution (see section 1.2 for more discussion). 
The reaction of vinyl boronate complexes with an electrophile, iodine in most cases, results in 
a 1,2-metalate rearrangement where the migrating substituent and iodine are effectively added 
across the C−C -bond of the vinyl moiety. This -leaving group-bearing boronic ester then 
forms a transient boronate complex with an iodide or methoxide, a commonly employed reagent 
in reactions of this type, which leads to an elimination that regenerates the C−C -bond with 
loss of the two functional groups. This is the Zweifel reaction and enables the net transformation 
of boronic esters into olefins (Scheme 64A). This was discussed in more detail in section 1.2.3.  
 
Scheme 64. (A) The Zweifel reaction. (B) Aggarwal’s three-component coupling using vinyl boronate complexes. (C) Two 
competing 1,2-metalate rearrangement pathways to form the two diastereoisomers of 199. 
Aggarwal has recently expanded the Zweifel reaction to enable a three-component coupling 
process,128 where the same vinyl boronate complexes react with electrophiles to form products 
198 that do not undergo a subsequent elimination process (Scheme 64B). A broad electrophile 
scope was described. It is interesting to note that high diastereoselectivities were observed when 
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using polysubstituted vinyl groups, due to exclusive anti 1,2-migration. However, one particular 
example (199) was formed with an uncharacteristically low diastereoselectivity, of 88:12 d.r., 
which they rationalized was due to a competing syn 1,2-migration, where the migrating group 
of intermediate 200 migrates onto the same face as the selenium electrophile, that leads to the 
minor diastereoisomer (Scheme 64C). It is believed that partial ring-opening of seleniranium 
intermediate 200 allows this syn 1,2-migration process to occur. They found that addition of 
methanol or trifluoroethanol (TFE) to the reaction mixture supressed this unwanted pathway, 
to give a >95:5 d.r. when using TFE, though the exact reason why is not clear. It has been 
suggested that the hydrogen-bond donating ability of these two solvents could be stabilizing the 
intermediate boronate complex through bonding with the basic pinacol oxygen atoms. This 
would make the vinyl boronate complex less reactive and enable it to react with greater 
selectivity. 
Aryl boronate complexes display different reactivity modes depending on the nature of the aryl 
ring. Aggarwal has shown that when the aryl ring is electron-rich, one of its C−C -bonds can 
react with an electrophile to induce a concurrent 1,2-metalate rearrangement and electrophilic 
trapping, which adds the migrating boron substituent and the electrophile across the aromatic 
ring. As in the conceptually similar Zweifel reaction, a transient boronate complex forms with 
the dearomatized intermediate and a nucleophile, which eliminates the two incorporated 
functional groups to result in a net arylation of the original boronic ester (Scheme 65A).36 This 
was discussed in more detail in section 1.2.3. On the other hand, when the aryl ring is 
insufficiently electron-rich to react with an electrophile, the C(alkyl)−B bond acts as a 
nucleophile and reacts directly with an electrophile, in an SE2inv process, to yield a deboronative 
functionalization product with inversion of the original boronic ester stereochemistry (Scheme 
65B).42,43 This was also discussed in more detail in section 1.2.3. 
 
Scheme 65. (A) Coupling of a boronic ester with electron-rich aryl lithium reagents using Zweifel-type conditions. (B) 
Aggarwal’s nucleophilic boronate chemistry. 
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It is clear from this brief review of the reactivity of boronate complexes that a large proportion 
of the chemistry is based on the same theme: the reaction of an electron-rich -system of one 
of the boronate’s substituents with an external electrophile induces a 1,2-metalate 
rearrangement. The result is the formal addition of the migrating substituent and the electrophile 
across the C−C -bond. 
4.1.2 Less common reactivity modes of boronate complexes: strain release 
A less precedented class of boronate complexes are those that bear small, strained heterocycles, 
which can then undergo strain release-driven 1,2-metalate rearrangements. 
Aggarwal has shown that chiral lithiated epoxides can react with boronic esters to form the 
corresponding epoxy boronate complexes 201.129 The electronegativity of the oxygen atom, 
coupled with the ring strain of the epoxide unit (strain energy = ca. 26 kcal/mol), allows 201 to 
undergo a stereospecific 1,2-metalate rearrangement, which opens the epoxide ring, to yield the 
homologated -alkoxy boronic ester product 202 with full stereocontrol (Scheme 66A). These 
intermediates are prone to decomposition via boron-Wittig processes,111 which lead to the 
formation of an olefin, and so are protected and isolated as the corresponding triethylsilyl ethers. 
The power of this process was exemplified by treatment of 202 with another lithiated epoxide, 
which underwent the same sequence of boronate complex formation and 1,2-metalate 
rearrangement, and then followed by oxidation in this case, to yield 1,2,4-triols 203 with 
excellent diastereoselectivity. In a similar fashion, Aggarwal has shown that chiral lithiated 
aziridines can also be engaged with boronic esters to form the corresponding aziridyl boronate 
complexes 204 (strain energy = ca. 26 kcal/mol), which then undergo a strain releasing 
1,2-metalate rearrangement.130 Oxidation of the resulting -amino boronic esters gives the 
corresponding -amino alcohols 205 with perfect enantio- and diastereoselectivity (Scheme 
66B). 
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Scheme 66. Previous strain releasing 1,2-metalate rearrangements: (A) epoxy boronate complexes; (B) aziridyl boronate 
complexes; and (C) azetidinyl boronate complexes. 
More recently, Aggarwal has also shown that azetidinium ylides can be trapped with boronic 
esters to give azetidinyl boronate complexes 206 (strain energy = ca. 26 kcal/mol),131 which, 
much like the epoxy and aziridyl boronate complexes, were found to undergo strain releasing 
1,2-metalate rearrangements to deliver the corresponding high value -dimethylamino boronic 
esters 207 (Scheme 66C). Unfortunately, the azetidium ylides were chemically and 
configurationally unstable and so no enantioenrichment could be achieved. 
4.2 Project proposal 
4.2.1 Use of bicyclobutyl boronate complexes 
As highlighted in section 4.1.1, reactions of C−C -bonds of boronate complexes with 
electrophiles are well-represented, however there are no reported reactions of C−C -bonds of 
boronate complexes. Indeed, there are limited reactions, in general, that enable the reaction of 
C−C -bonds, which are generally considered to be inert.132 Inspired by our reports of strain 
release driven 1,2-metalate rearrangements of epoxy, aziridyl and azetidinyl boronate 
complexes (see section 4.1.2), we reasoned that to weaken a C−C -bond, and thereby promote 
its reaction with external electrophiles, a highly strained, and therefore highly reactive, C−C 
-bond containing boronate complex would need to be designed (Scheme 67). We thus 
identified bicyclo[1.1.0]butyl (bicyclobutyl) boronate complex 208 as the most promising 
initial candidate for two reasons: 1) the bicyclobutyl system has the greatest strain energy of all 
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fully saturated bicyclic carbocycles (ca. 66 kcal/mol);133 and 2) bicyclobutyl lithium 209, which 
would be required to form the desired boronate complex, had already been reported.134 
 
Scheme 67. Proposed synthesis and use of bicyclobutyl boronate complexes to enable a C−C -bond carbofunctionalization. 
Bicyclobutyl boronate complex 208 would be formed by reacting its corresponding boronic 
ester with bicyclobutyl lithium 209. Treatment with an external electrophile would then induce 
1,2-metalate rearrangement, in a very similar manner to the Zweifel reaction, with concomitant 
cleavage of the highly strained central C−C -bond of the bicyclobutane moiety and formation 
of a new C−E bond, to form cyclobutane product 210. We hoped that this transformation would 
be diastereoselective; if we view the strained central C−C -bond of the bicyclobutane to be 
effectively extending the nucleophilicity of the C−B bond then reaction from the exo face would 
be expected. This locates the migrating substituent and the incorporated electrophile on the 
same face of the product cyclobutane. 
The products of our proposed process are 1,1,3-trisubstituted cyclobutanes, where one 
substituent is the highly diversifiable boronic ester group.25 Cyclobutanes, and indeed many 
other small, strained ring systems, are becoming increasingly prominent structures in medicinal 
chemistry discovery programs.135 This interest primarily stems from their structural novelty, 
which allows the preparation of new classes of target compounds and provides access to poorly 
explored regions of chemical space, and their ability to confer a range of beneficial ‘drug-like’ 
properties. Due to their restricted conformation, the exit vectors (substituents) of these four-
membered rings are well-defined in their spatial disposition and thus allow for the orientation 
of a variety of functional groups along pre-selected vectors.  
 
Figure 16. The importance of cyclobutanes. 
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In recent years there has been an increased impetus towards the synthesis and study of three-
dimensional drug-molecules, moving beyond the flat (two-dimensional) structures that have 
long dominated small molecule screening libraries.136 The precise control of three-dimensional 
structure allows the improvement, alteration, or modulation, of both physicochemical and 
pharmaco-kinetic properties, such as lipophilicity, aqueous solubility, acidity/basicity, and 
stability against metabolic degradation. Indeed, it has been empirically demonstrated that 
replacing flat components within pre-existing or developing drug molecules with small three-
dimensional rings can be beneficial (Figure 16). For example, replacement of the phenyl ring 
within imatinib, a potent kinase inhibitor widely used for the treatment of leukaemia, with a 
range of small ring structures, including a cyclobutane, cyclopropane, cubane, and 
bicyclo[1.1.1]pentane (‘propellane’), resulted in improved thermodynamic solubility, fraction 
sp3, and clogP.137 Therefore, the cyclobutanes synthesized with our new methodology, 
particularly if they can be prepared in a diastereocontrolled fashion, could potentially have wide 
application in the design of pharmaceuticals, agrochemicals, or other functional molecules. 
4.2.2 Bicyclo[1.1.0]butane 
Bicyclo[1.1.0]butanes (bicyclobutanes) (Figure 17), which are formed of two cyclopropane 
rings fused together, are a fascinating class of organic molecules due to their small size and 
high ring strain.133 These properties have endowed the central, highly strained C(1)−C(3) bond 
with both - and -bond character, and thus it can access a wide range of different chemistries, 
including reaction with both electrophiles and nucleophiles, transition metals, and radicals.138 
Despite these alluring features, the chemical potential of bicyclobutanes has remained largely 
unexplored, presumably because of the synthetic challenge it presents and the dearth of natural 
products139 featuring this scaffold to drive further investigation. 
The defining feature of bicyclobutane is its high ring strain energy, calculated to be 
66.3 kcal/mol,140 which is noticeably more strained than the sum of its two cyclopropane 
constituents (29 kcal/mol each). Indeed, bicyclobutane is the most strained of all the fully 
saturated bicyclic carbocycles, and far more strained than the molecules chemists would 
typically consider to be strained, such as cyclopropanes (29 kcal/mol) or cyclobutanes (26.3 
kcal/mol).140 The origins of this additional strain are not completely clear, however there are 
two suggested possibilities: destabilizing 1,3-carbon−carbon interactions across the 
bicyclobutane ring;141 or the large angle deformations at the two methine carbon atoms.142 
Because of the central bridging C−C bond, bicyclobutanes are forced to adopt a highly puckered 
conformation, where the angle between the plane of the two cyclopropane rings is ca. 122 °. 
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Interestingly, all four bonds from the two terminal carbon atoms are within a single hemisphere, 
so they are said to have an inverted geometry. Despite their seemingly unstable nature, 
bicyclobutanes can be surprisingly stable and are often isolable using conventional methods. 
 
Figure 17. Structure and bonding of bicyclo[1.1.0]butane. 
The electronic structure of bicyclobutane, in particular the bonding of the central C(1)−C(3) 
bond, has been the focus of several studies. It has been calculated143 that this bond possess 96 % 
p character, meaning that it is formed almost exclusively of two unhybridized p-orbitals, one 
from C(1) and the other from C(3), that are canted towards each other at approximately 30° to 
the bond vector, to form a bent -bond. This bonding results in significant electron density 
protruding out from both faces of the bicyclobutane ring. Unsurprisingly, it is this electron 
density that is involved in the nucleophilic/electrophilic reactions of bicyclobutane; it has been 
extensively calculated that both nucleophiles and electrophiles approach from the exo face of 
the bicyclobutane ring along the C(1)−C(3) bond vector.144 
The bicyclobutane scaffold was first synthesized as ethyl bicyclo[1.1.0]butane-1-carboxylate 
in 1959 by Wiberg and Ciula,145 however the parent structure, bicyclobutane 211 itself, was not 
prepared until 1963 (Scheme 68).146 These early routes primarily focused on intramolecular 
Wurtz couplings, for example 211 was prepared by Wiberg146b from 1-chloro-3-
bromocyclobutane by treatment with sodium in refluxing 1,4-dioxane. Although this could be 
reliably performed on gram-scale,147 the route was not widely adopted, potentially due to the 
synthetic challenge it poses and the requirement to isolate a compound with a boiling point of 
8 °C. 
 
Scheme 68. Wiberg’s synthesis of bicyclobutane. 
Modern methods have primarily focused on the incorporation of the bicyclobutyl group using 
the corresponding bicyclobutyl lithium (Scheme 69), which offers a direct way of incorporating 
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bicyclobutane into an existing scaffold without having to design a de novo route to the desired 
bicyclobutane-containing structure. 1,1-Dibromo-2-(chloromethyl)cyclopropane 212, 
conveniently prepared by the dibromocyclopropanation of allyl chloride with bromoform in the 
presence of sodium hydroxide,134 can be treated with methyl lithium to perform a single lithium-
bromide exchange to form an intermediate organolithium, which subsequently cyclizes to form 
bromobicyclobutane 213. Finally, treatment of 213 with tert-butyl lithium generates 
bicyclobutyl lithium 209.134 In the first instance, this was trapped with ethyl chloroformate to 
give ethyl bicyclo[1.1.0]butane-1-carboxylate in 23 % yield. More recently, Wipf has reacted 
substituted bicyclobutyl lithiums, made from more substituted versions of 212, with aldehydes 
and imines to yield the corresponding bicyclobutyl alcohols and amines, respectively.148 
 
Scheme 69. Preparation of bicyclobutyl lithium 209 and its subsequent trapping with electrophiles. 
Other approaches to the bicyclobutane group are the cyclopropanation of an appropriate 
unsaturated functional group, such as the intramolecular cyclopropanation of an olefin,149 or 
the double cyclopropanation of an alkyne.148 Most recently, a range of chiral polysubstituted 
cyclobutanes have been prepared by an interesting enzyme-catalyzed double cyclopropanation 
of alkynes.150 
Due to the aforementioned structural and electronic features, bicyclobutanes can be engaged in 
a range of different transformations,138 however only a few of those most pertinent to our 
research will be discussed here. 
Bicyclobutanes can act as electrophiles when they bear an electron-withdrawing substituent on 
either C(1) or C(3). For example, Baran151 has recently shown that amines can undergo 
nucleophilic attack into bicyclobutyl sulfone 214 to ultimately result in the cyclobutylated 
amine 215 (Scheme 70). Here, the nucleophilic amine adds to the unsubstituted carbon atom, 
presumably from the exo face, to cleave the bicyclobutane ring and form a carbanion stabilized 
by the sulfone, which is finally protonated upon work-up. The scope and functional group 
tolerance was impressive; a cyclobutane unit could be easily added onto a wide range of amines, 
- 94 - 
 
including several drug molecules, in mostly good to excellent yields. Although the sulfone in 
the products was shown to be a useful functional handle for further transformation, the overall 
process only adds one non-proton substituent across the original C(1)−C(3) bond of 
bicyclobutane. 
 
Scheme 70. Baran’s ‘cyclobutylation’ of amines using bicyclobutyl sulfone 214. 
In a similar vein, Fox149a showed that organocuprates can add diastereoselectively to tert-butyl 
ester-bearing enantiomerically enriched bicyclobutanes 216 (Scheme 71). The organocuprate 
approached the bicyclobutane unit exclusively from the exo face to perform a diastereoselective 
Michael-type addition, where the central C(1)−C(3) bond is cleaved. The resultant enolate could 
then be trapped diastereoselectively with a range of electrophiles to form polysubstituted 
cyclobutanes 217. Whilst the displayed scope is not particularly broad, this is the first example 
of the addition of two non-proton units across the central bond of a bicyclobutane. 
 
Scheme 71. Fox’s diastereoselective addition of cuprates to bicyclobutyl tert-butyl esters with subsequent electrophilic 
trapping. 
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Bicyclobutanes can also react with transition metals.152 In a representative example, Wipf153 
found that amino bicyclobutanes 218 underwent rhodium(I)-catalyzed cycloisomerization 
reactions to furnish either pyrrolidines 219 or azepines 220, depending on the reaction 
conditions; using [Rh(=)2Cl]2 and triphenylphosphine favored the pyrrolidine, and using 
[Rh(CO)2Cl]2 and dppe favored the azepine (Scheme 72). A limited range of both substrates 
were synthesized, but in uniformly good to excellent yields. The mechanism is proposed to 
begin with the oxidative addition of the rhodium(I) catalyst into the highly strained central bond 
of amino bicyclobutane 218 to give rhodium(III) complex 221, which subsequently undergoes 
divergent cycloisomerizations, depending on the rhodium source/ligand used, to give rhodium 
carbenes 222 or 223, where internal carbene 222 is favored when using the less hindered 
monodentate triphenylphosphine, and terminal carbene 223 is favored when using the more 
hindered bidentate dppe. Intramolecular cyclopropanation of the pendent olefin of 222 and 223 
finally delivers the pyrrolidine 219 and azepine 220 products, respectively. 
 
Scheme 72. Wipf’s rhodium-catalyzed cycloisomerization of amino bicyclobutanes to form either pyrrolidines or azepines. 
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4.3 Results and discussion 
4.3.1 Invention of a convenient bicyclobutyl lithium precursor 
All work discussed in section 4.3.1 was performed by Tobias Biberger, under my direction. 
From the outset of the project we appreciated that the synthetic barrier to bicyclobutyl lithium 
209 was relatively high. We thus first sought an isolable, easy-to-handle latent organolithium 
that could be revealed under simple conditions. The corresponding bicyclobutyl sulfoxides 
224154 and stannanes were identified as suitable 209 precursors, however the sulfoxide was 
favored primarily due to its likelihood of being a crystalline solid. Bicyclobutyl stannane had 
been previously synthesized by trapping bicyclobutyl lithium with tri-n-butyl tin chloride in 
poor yield,155 and would have toxicity issues associated with the alkyl tin residue, so was 
immediately discounted. We therefore set out to prepare bicyclobutyl sulfoxide 224 in the hope 
that it would meet our expectations. 
Table 4. Optimisation of bicyclobutyl sulfoxide 224 synthesis from dibromocyclopropane 212. 
 
We first generated bicyclobutyl lithium 209 using Wipf’s conditions,148 and then treated it with 
methyl 4-methylbenzenesulfinate in the hope that bicyclobutyl sulfoxide 224 would form 
(Table 4). Promisingly, <5 % of the desired sulfoxide 224 (entry 1) was isolated, however the 
reaction was not selective as many difficult-to-identify products were observed upon thin-layer 
chromatography and 1H NMR spectroscopic analysis of the crude reaction mixture. We 
hypothesized that this could be the result of 224 decomposing via reaction with the large excess 
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of highly reactive organolithium, so transmetalation of the bicyclobutyl lithium 209 to the less 
reactive organo-cuprate, -zinc, or -Grignard reagents was attempted.155 The reactions using zinc 
or copper resulted in no product formation (entries 3 and 4), however, the reaction with the 
bicyclobutyl Grignard reagent (entry 2), formed by performing a transmetalation with 
magnesium bromide, performed well and allowed isolation of the desired sulfoxide 224 in 20 % 
yield. Gratifyingly, the isolated viscous oil crystallized to give crystals suitable for analysis by 
X-ray crystallography (see supporting information). A range of alterations were applied to the 
reaction, namely altered equivalents of all reagents and variation of the time allowed for each 
discrete reaction step, to mostly inferior results. However, three changes did lead to significant 
yield improvements: increasing the time of the first cyclisation step, i.e. lithium-halogen 
exchange of dibromocyclopropane 212 with methyl lithium followed by intramolecular 
cyclization, from one hour to 1.5 hours (entry 5); using 1.5 equivalents of starting 
dibromocyclopropane 212 and the organolithium reagents rather than two (entry 6); and 
allowing the reaction to stir for only 30 minutes at room temperature at the end of the reaction 
rather than two hours. These three alterations in combination gave 224 in 55 % overall yield 
(entry 7). We serendipitiously discovered that using only 1.2 equivalents of 212 and the 
requisite organolithiums also leads to the same yield (entry 8). This reaction has since been 
scaled-up to make, taking an average of 13 experiments, 1.30 g of sulfoxide 224, which 
corresponds to a yield of 52 % (entry 9). 
Having established a convenient route to a crystalline, and thus easy-to-handle, supposed 
precursor to bicyclobutyl lithium 209, we next turned our attention to using sulfoxide 224 to 
generate 209 on demand. The reaction of 224 with imine 225 was selected as a model because 
Wipf has previously synthesized the corresponding adduct 226 for subsequent use in rhodium-
catalyzed cyloisomerization reactions148 and so rapid analysis using 1H NMR spectroscopic 
analysis of crude mixtures versus an internal standard was immediately possible. Our previous 
experience154 with sulfoxides gave us a good starting point: sulfoxide 224 and imine 225 were 
mixed together in a 1:1 ratio in THF and cooled to −78 °C, this mixture was then treated with 
two equivalents of tert-butyl lithium before being allowed to stir for 30 minutes at this 
temperature. Analysis of the crude reaction mixture showed that 68 % of the addition product 
226 had formed (Scheme 73). Unfortunately, all alterations made to this procedure resulted in 
lower yields. It is noteworthy that all reactions conducted in an ex situ manner, where the two 
reaction components were not pre-mixed, resulted in significantly depressed yields,154 which 
implies that bicyclobutyl lithium 209 could be unstable over time in THF solution. 
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Scheme 73. Generation of bicyclobutyl lithium 209 on demand from bicyclobutyl sulfoxide 224. 
4.3.2 Optimization of electrophilic trapping 
With bicyclobutyl sulfoxide 224 and conditions for its conversion into the corresponding 
bicyclobutyl lithium in hand, we began to optimize the preparation of bicyclobutyl boronate 
complexes and their subsequent trapping with electrophiles. 
Treatment of a THF solution of cyclohexyl pinacol boronic ester and 1.3 equivalents of 
bicyclobutyl sulfoxide 224 with 2.6 equivalents of tert-butyl lithium resulted in complete 
formation of boronate complex 227 after 30 minutes at −78 °C, as judged by 11B NMR 
spectroscopic analysis of the crude mixture (single peak at  = 5.97 ppm) Sources of 
electrophilic bromine were used as the model electrophiles since they have performed well in 
previous nucleophilic boronate complex chemistry42 and Zweifel-type chemistry.36 
N-bromosuccinimide (NBS), N,N’-dibromodimethyl hydantoin (DBDMH) and bromine were 
tested, to mixed results: NBS provided 44 % of the desired cyclobutane product 228 with 
93:7 d.r., alongside an unidentified side-product; bromine gave approximately 60 % of 228, 
also with 93:7 d.r., however the product also contained the same side-product and further 
impurities; finally, DBDMH yielded 59 % of 228 with a 98:2 d.r. and, yet again, with the same 
side-product (Table 5, entries 1−3). In previous, similar chemistry, where vinyl boronate 
complexes were reacted with a range of electrophiles, it was discovered that low 
diastereoselectivities could be improved by addition of solvents such as methanol or 
trifluoroethanol.36,128 We also considered that the excess tert-butyl lithium could be interfering 
with the desired reactivity. Thus, we added a small amount of methanol after boronate complex 
formation, immediately before addition of the electrophile. Fortunately, a significant yield and 
selectivity increase was observed, from 59 % with 98:2 d.r., to 83 % with >99:1 d.r, as was a 
marked decrease in the presence of the side-product, however it was not entirely eliminated 
(entry 4). The exact reason for this yield and selectivity increase is not yet clear, however it is 
possible that, as suggested when methanol or trifluoroethanol has been used previously to 
similar effect, the hydrogen bond donating ability of methanol stabilizes the intermediate 
boronate complex through bonding with the basic oxygen atoms of the pinacol unit, thereby 
depressing the reactivity of the boronate complex and enabling it to react with greater 
selectivity. 
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The identity of the unknown side-product was found to be the product of electrophilic ring-
opening of boronate complex 227 with ‘Br+’ to produce carbocation 229 that, surprisingly, does 
not undergo 1,2-metalate rearrangement but instead reacts with a solvent THF molecule to form 
intermediate 230, which is then ring-opened by an adventitious bromide anion to give side-
product 231 (Scheme 74). Its identity was confirmed by performing the reaction in THF-d8, 
which, in the 1H NMR spectrum of the isolated products, showed the peaks arising from the 
cyclobutane core of 231 (numbered 1 and 2), but not the signals from the ring-opened THF-
derived side-chain (numbered 3 and 4). The simple fix to this problem was to use the more 
sterically hindered 2-methyl tetrahydrofuran (MeTHF) as solvent instead of THF, which 
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fortunately delivered a good yield of the desired product, albeit lower than that when using 
THF, and without the presence of any solvent incorporation side-products. There were, 
however, traces of other unidentified side-products (entry 5). 
 
Scheme 74. Identification of the side-product 231: (A) proposed mechanism of formation; (B) 1H NMR of reaction run in 
THF-d8; and (C) 1H NMR of reaction run in THF. 
Since brominating reagents such as NBS and DBDMH undergo radical based decomposition 
in THF/MeTHF solution to yield bromine,156 which is clearly observable by the solution turning 
a pale yellow, and then eventually orange, colour, it was suspected that this might be resulting 
in the trace impurities. Acetonitrile and DMF were qualitatively found to result in less radical-
based decomposition of DBDMH, by dissolving and observing any colour changes, and so 
acetonitrile and DMF solutions of DBDMH were added to the boronate complex. Due to the 
high melting points of these solvents, the reaction mixtures quickly froze, which we believed 
would have led to an ineffective reaction. Nevertheless, the crude reaction mixtures were 
analysed and were shown to contain significant quantities of 228 (entries 6 and 7). Even though 
yield improvements were not observed, it did demonstrate that the original one hour used in 
prior experiments for reaction with the electrophile was excessive. Therefore, a 1-minute 
reaction was used with this electrophile for all future experiments. At this stage it was also 
discovered that only one equivalent of DBDMH, rather than 2.6 equivalents, was sufficient to 
maintain a good yield (entries 8 and 9) and that adding the electrophile directly as a solid results 
in an improved yield and avoids freezing of the reaction mixture (entry 10). To confirm that 
radical-based decomposition is responsible for the trace impurities, a MeTHF solution of 
DBDMH and a small amount of BHT, a radical inhibitor, was added whilst protecting the 
solution from light (entry 11). This resulted in an identical yield to the experiment where no 
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In order to increase the operational simplicity of the procedure, fewer equivalents of 
bicyclobutyl sulfoxide 224 were used, however this resulted in marginally decreased yields, 
and so 1.3 equivalents were retained (entries 12 and 13). Furthermore, it was found that 
decreasing the time allowed for boronate formation from 30 minutes to just five minutes 
delivered a marginal yield decrease (entry 14), but with a large decrease in overall reaction 
time, and so this time was used for all following experiments. A lower volume of methanol 
unfortunately resulted in a decreased diastereoselectivity (entry 15), as did using isopropanol 
in its place (entry 16). Noticing how important the effect of the methanol was, the time allowed 
for the reaction to stir in the presence of methanol before electrophile addition was increased to 
15 min and found to provide a slight yield increase (entry 17). Warming the reaction to room 
temperature for 15 minutes after allowing for 5 minutes at −78 °C for boronate complex 
formation, gave an appreciable yield increase to 83 % (entry 18).  
Finally, since using a vast excess of tert-butyl lithium might limit the substrate and electrophile 
scope, particularly if the electrophile is incompatible with methanol or does not react with the 
boronate complex until at elevated temperatures (where the boronate complex would just get 
protonated by the methanol) an equimolar quantity of tert-butyl lithium was used (entry 19). 
Whilst a yield decrease was observed, a good yield was still maintained and provides suitable 
conditions for electrophile and boronic ester scope expansion. This is the subject of ongoing 
work (see section 4.4.2). 
The optimized conditions form the desired bromo cyclobutane 228 with very high 
diastereoselectivity. X-ray crystallographic analysis of a single crystal of 228 unambiguously 
shows that the major diastereoisomer has the cyclohexyl and bromide groups on the same face 
of the cyclobutane ring (Scheme 75B). This reaction product and the diastereoselectivity can 
be plausibly rationalized by the following mechanism (Scheme 75A). The bicyclobutyl 
boronate complex 208 can be viewed as an extended nucleophilic boronate complex, where the 
ring strain of the bicyclobutyl moiety transmits the nucleophilicity of the C(migrating)−B bond 
to its distal, -carbon, and so reaction at this center is favoured over reaction at either of the 
two carbon atoms  to the boronate center (nucleophilic boronate complex chemistry, see 
section 1.2.3). The electrophile now has two options: reaction at either the ‘top’, endo face; or 
the ‘bottom’, exo face. Boronate complex 208 must react in the conformation shown in Scheme 
75A, since this provides the required anti-periplanar alignment of the migrating substituent, R1, 
and the ‘leaving group’, in this case the cleaving central C−C -bond of the bicyclobutane unit. 
In this conformation, approach of the electrophilic species from the endo face is effectively 
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blocked by the bulky pinacol group, and so approach from the less hindered exo face is 
preferred. Furthermore, the central strained C−C bond of bicyclobutane is primarily comprised 
of unhybridized p-orbitals, which protrudes significant electron density out from the exo face 
of the -carbon (see section 4.2.2).143,144 Therefore, both steric and electronic factors favor 
reaction of the electrophile with the bicyclobutane ring on the exo face of its -carbon. The 
interaction of the electrophile with the boronate complex 208 thus induces 1,2-metalate 
rearrangement, where R1 migrates to the -carbon. The near perfect diastereoselectivity 
suggests a concerted mechanism, where 1,2-migration of R1 is simultaneous with cleavage of 
the highly strained central C−C -bond of the bicyclobutane and formation of a new C−X bond 
on the -carbon. This step constitutes a formal carbofunctionalization of a C−C -bond, albeit 
a highly strained one. To the best of our knowledge, an elementary step of this type has only a 
single precedent,149a where Fox added organocuprates, followed by a separate electrophile, 
across the central C−C -bond of tert-butyl ester-bearing bicyclobutanes (Scheme 71). It could 
also be described as a conjunctive functionalization of a C−C -bond, where the bicyclobutane 
unit has acted as a conjunctive reagent to enable the cross-coupling of two units across its 
original C−C -bond.157 
 
Scheme 75. (A) Mechanism of our C−C -bond carbofunctionalization. (B) X-ray crystal structure of 228, please see the 
supplementary materials for crystal data and structure refinement. 
 At this moment in time it is not clear how the minor diastereoisomer forms in some 
experiments. We postulate, however, that it arises from a competing syn 1,2-metalate 
rearrangement pathway, where the migrating group, rather than attacking the cleaving C−C 
-bond from an antiperiplanar angle, attacks syn to it (Scheme 76). This could be because the 
bicyclobutane is so strained that both migration pathways have minimal kinetic barriers and so 
are competing with each other. It is also possible that the bicyclobutane ring opens significantly 
upon first interacting with the electrophile leaving a partial positive charge on the carbon  to 
the boronate center, the diastereoselectivity would therefore depend on the relative populations 
of the syn and antiperiplanar conformations prior to the partial ring opening, the relative rates 
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of syn and antiperiplanar migration, and the relative rates of C(+)−B bond rotation in both 
conformers. 
 
Scheme 76. Potential competing syn and antiperiplanar 1,2-metalate rearrangement pathways that lead to different 
diastereoisomeric products. 
4.3.3 Carbopalladation of C−C -bonds 
In early 2016, a seminal report from Morken158 detailed a ground-breaking combination of 
Suzuki−Miyaura conditions and organoboron chemistry (Scheme 77). Here, vinyl boronate 
complexes, formed by the reaction of vinyl lithium with an alkyl or aryl boronic ester, are 
reacted with a chiral ligand-bearing palladium catalyst and an aryl or vinyl triflate. 
Suzuki−Miyaura chemistry would dictate that a transmetalation would take place between one 
of the C−B bonds of 232 and a palladium(II) intermediate, formed by oxidative addition of the 
triflate with palladium(0). However, this reactivity was subverted in favor of a 1,2-metalate 
rearrangement. The chiral electrophilic palladium(II) intermediate can coordinate to the C−C 
-bond of 232; this induces an enantioselective 1,2-metalate rearrangement, where new C−C 
and C−Pd bonds form on either terminus of the broken -bond. A reductive elimination delivers 
their final product, coined a conjunctive cross-coupling product, where two modular units, a 
boronic ester substituent and an aryl group, are added across an ethyl bridge. The boronic ester 
is retained in this transformation, which offers a useful handle for further reaction,25 but in this 
report all products were oxidized to the corresponding alcohols 233. The scope of this processes 
was found to be impressive, yielding a wide range of cross-coupled products in generally good 
yields and excellent enantioselectivities. This methodology has since been expanded to the 
preparation of allyl boronic esters using boronate complexes derived from vinyl boronic esters 
and vinyl lithium.159 
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Scheme 77. Morken’s seminal report on the conjunctive cross-coupling of boronic esters and aryl triflates across a vinyl unit. 
A considerable limitation of this work is the requirement to use halide-free vinyl lithium, and 
aryl triflates. The former, in particular, represents a significant barrier to its wide-spread 
adoption; its synthesis requires treating vinyl bromide with n-butyl lithium to perform a 
lithium−halogen exchange, followed by a low temperature crystallisation to isolate solid, 
halide-free vinyl lithium. It is believed these restrictions arise due to the ability of halide anions 
to coordinate to the intermediate cationic palladium(II)-aryl complex and thus outcompete the 
vinyl boronate complex for binding to the metal center. A solution to these issues was presented 
by Morken in 2017.160 It was discovered that addition of sodium triflate and use of DMSO as a 
co-solvent not only allowed use of aryl halide coupling partners, but also allowed use of 
commercially-available vinylmagnesium chloride to form the intermediate boronate complex. 
Whilst the beneficial action of DMSO was not entirely clear, it was empirically demonstrated 
that boronate complexes formed using vinylmagnesium chloride were more stable in the 
presence of this solvent and gave the desired products in better yield and enantioselectivities. 
The Aggarwal group has since shown that use of a THF/DMSO solvent mixture is essential to 
avoid triple addition of vinylmagnesium chloride to the boronic ester.31 Morken suggested that 
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sodium triflate acts as a scavenger by precipitating out any inhibitory halide anions; sodium 
triflate is very soluble in the reaction solvent (289 mg/mL in 1:1 THF:DMSO), whereas sodium 
halide salts, the result of the scavenging process, are very poorly soluble (e.g. NaCl, 0.32 
mg/mL in 1:1 THF:DMSO) and thus precipitate out and cannot inhibit the reaction.160 The 
scope of this improved process was similar to their previous report and demonstrated that a 
broad selection of boronic esters and aryl halides can be coupled with high yields and 
enantioselectivities across a bridging ethyl unit (Scheme 78). 
 
Scheme 78. Morken’s improved conjunctive cross-coupling conditions that allow use of vinylmagnesium chloride and aryl 
halides. 
Due to these inspiring precedents, electrophilic palladium(II)-aryl complexes were identified 
as among the most interesting potential electrophiles to use in combination with our 
bicyclobutyl boronate complexes. If successful it would represent the first example of a 
carbopalladation of a C−C -bond, which is an unusual elementary step in transition metal 
catalysis. If the reaction pathway is identical to that when using the electrophiles discussed in 
Scheme 75, the products would be diastereomerically pure 1,1,3-trisubstituted cyclobutanes 
decorated with two modular building blocks, one from the boronic ester and one from the aryl 
triflate/halide, and a boronic ester, which can be readily derivatized into a range of functional 
groups.25 
Using a combination of optimized conditions from section 4.3.2 and Morken’s original 
conjunctive cross-coupling conditions158 as a basis, we examined our proposal experimentally. 
In the first instance, we treated bicyclobutyl boronate complex 227, generated identically to that 
used in section 4.3.2, in MeTHF with 1.5 equivalents of phenyl triflate in the presence of 
3 mol% of a pre-formed complex of palladium(II) acetate and 
1,1’-bis(diisopropylphospino)ferrocene (dippf) at 40 °C for 24 hours and instantly observed our 
desired reactivity: an 82 % yield of the desired conjunctive cross-coupling product 234 as a 
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single diastereoisomer (>98:2 d.r. by 1H NMR spectroscopic analysis of the crude mixture using 
1,3,5-trimethoxybenzene as an internal standard), with the remaining mass balance accounted 
for by cyclohexyl pinacol boronic ester starting material (15 % by calibrated GC−FID analysis) 
(entry 1). The same reaction could be performed in an ‘in situ’ manner with no loss in yield or 
diastereopurity (entry 2). Here, ‘in situ’ means that all reagents, which now also includes the 
phenyl triflate, palladium(II) acetate and dippf ligand, were all premixed before cooling and 
treating with tert-butyl lithium for formation of the boronate complex. Unfortunately, all 
attempts at reproducing these high yields were not successful; consistent yields of 
approximately 65 % were recorded across several experiments. A careful screen of all reaction 
components identified that it was the catalyst pre-formation step that was the problem, though 
the exact reason for this issue was not clear. We also discovered that the reaction is complete 
after just 3 hours (entry 3) (though a 14 h reaction time was used thereafter for convenience, 
entry 4) and that elevated reaction temperatures are detrimental to the yield (entries 5 and 6). 
Table 6. Optimization of the C−C -bond carbopalladation using bicyclobutyl boronate complex 227 and phenyl triflate. 
 
Replacing palladium(II) acetate with bis(dibenzylideneacetone)palladium(0) (Pd(dba)2), under 
otherwise identical conditions to our first experiment, was found to reproducibly restore the 
yield of 234 to 82 % (with >98:2 d.r.), with an isolated yield of 77 % (entry 7). Unfortunately, 
- 107 - 
 
‘in situ’ conditions were found to be less successful with this new palladium source (entry 8), 
possibly because some of the tert-butyl lithium or the generated bicyclobutyl lithium was 
consumed by reacting with the carbonyl of the dibenzylideneacetone ligand. A final few 
experiments demonstrated that dippf was superior to other structurally related ligands (entries 
9 and 10), that the ligand is required for reactivity (entry 11), and that 40 °C is the optimal 
reaction temperature (entry 12). Thus, our final conditions are: tert-butyl lithium 
(1.3 equivalents) is added dropwise to a solution of boronic ester (1.0 equivalent) and 
bicyclobutyl sulfoxide 224 (1.3 equivalents) in MeTHF (0.1 M) at −78 °C and left to stir for 
5 min at this temperature, after warming to ambient temperature a solution of Pd(dba)2 
(3 mol%) and dippf (3.6 mol%) (pre-mixed for 20 minutes in 0.5 mL of MeTHF) is added, 
followed by the triflate (1.5 equivalents), and the resulting solution is stirred at 40 °C for 
14 hours. 
Whilst triflates are by no means inconvenient starting materials, they have limited commercial 
availability and thus most must be prepared from the corresponding phenols. We were therefore 
interested in replacing the triflates with either the corresponding bromides or iodides. Morken 
found that use of aryl halides resulted in little to no reactivity in the conjunctive cross-coupling 
using vinyl boronate complexes158 (Scheme 77) because the halide anion by-products were 
outcompeting the vinyl boronate complex for the vacant coordination site of the intermediate 
electrophilic palladium(II)-aryl complex. The solution was to add sodium triflate, which acted 
as a scavenger by precipitating out the inhibitory halide anions as insoluble sodium halide salts 
(Scheme 78).160 We therefore attempted our desired reaction, using conditions modified from 
Morken’s procedure using aryl halides and sodium or potassium triflate, and found that, whilst 
some product was formed in all instances, the yields were much lower than that achieved using 
aryl triflates and in some cases a decreased diastereoselectivity was observed. Furthermore, 
since these triflate salts are hygroscopic, we were detecting sometimes significant quantities of 
the product formed when the intermediate boronate complex is protonated at the -carbon of 
the bicyclobutane. For these reasons, we decided to abandon the use of aryl halides/triflate salts 
in favour of using the higher yielding aryl triflates. 
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Table 7. Attempted optimization of the C−C -bond carbopalladation reaction using aryl halides instead of triflates. 
 
We finally investigated whether it was possible to generate bicyclobutyl lithium 209 from its 
dibromocyclopropane precursor 212 and use it directly to form boronate complex 227, which 
would then be reacted under our optimized cross-coupling conditions. Boronate complex 227 
did form in this sequence (single peak at  = 5.97 ppm), however, after subjecting it to our 
optimized cross-coupling conditions, none of the desired cyclobutane 234 was observed. 
Instead, the starting cyclohexyl pinacol boronic ester was quantitatively recovered, indicating 
that the intermediate boronate complex 227 decomposed without undergoing the desired 
reaction. During the synthesis of 209, 1.3 equivalents of lithium chloride are formed. Morken 
has previously demonstrated that halide salts, including lithium chloride, inhibit a similar cross-
coupling process,160 therefore, it is likely that the lithium chloride formed in our reaction 
sequence is outcompeting 227 for coordination to the palladium(II)-aryl complex and inhibiting 
our reaction. Indeed, addition of one equivalent of lithium chloride to our optimized reaction 
conditions (Table 6, entry 7) resulted in just 12 % of 234, with 86 % of cyclohexyl pinacol 
boronic ester. Addition of 3 mol% of lithium chloride had a less pronounced effect, giving 69 % 
of 234 and 28 % of the starting material, yet still shows that halide salts efficiently inhibit our 
cross-coupling reaction. These results vindicate our early decision to pursue use of bicyclobutyl 
sulfoxide 224, since this intermediate enables the formation of 209 in the absence of inhibitory 
halide salts, as well as simplifiying our reaction conditions. 
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Scheme 79. Attempted cross-coupling using bicyclobutyl lithium 209 prepared directly from dibromocyclopropane 212. 
4.3.4 Substrate scope 
With optimal cross-coupling conditions in hand, we next investigated the scope of the two 
reaction partners (Scheme 80A). The triflate scope was first explored, using cyclohexyl pinacol 
boronic ester as a standard substrate, and was found to be broad, encompassing a wide range of 
electron-rich, electron-deficient, and heteroaromatic triflates. Electron-deficient 
4-trifluoromethyl (235), 3-fluoro (236), 3-chloro (237), 3-bromo (238) and 3-ethyl ester (239) 
substituted triflates all performed well, however, for unknown reasons, a 4-nitro substituted 
triflate (240) only resulted in 10 % of the cyclobutane product. Electron-rich 4-methoxy (241) 
and 3-dimethylamino (242) substituted triflates were good substrates, as was a sterically 
encumbered 2,6-dimethyl substituted triflate (243). A 4-pinacol boronic ester substituent (244) 
was also well tolerated, which, like the previous 3-bromo example, provides a useful functional 
handle for further transformation or cross-coupling. Two heteroaromatic triflates, including 2-
pyridyl (245) and 8-quinolinyl triflates (246), were also excellent substrates. Finally, 
cyclohexenyl (247) and vinyl triflates (248) performed well, which demonstrates that the 
transformation is not limited to the use of aryl triflates. 
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Scheme 80. (A) Triflate and (B) boronic ester scope for the carbopalladation of C−C -bonds. *para-methoxyphenyl triflate 
used instead of phenyl triflate. 
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We next examined the boronic ester scope, using phenyl triflate as the standard coupling 
partner, and it was found to be similarly broad (Scheme 80B). Primary, secondary, and tertiary 
boronic esters were all found to be excellent coupling partners, demonstrating that the reaction 
is tolerant of the full spectrum of steric demand. Notably, methyl, which is typically used as a 
non-migrating group,161 was found to be an excellent substrate (249). Cognizant of the 
beneficial properties methyl groups have on pharmaceutically-relevant compounds,162 this 
coupling was performed on gram-scale (representing a 29× scale-up), furnishing 1.12 g in a 
single operation, with minimal decrease in yield. All secondary boronic esters tested were good 
substrates (252−254), including an enantioenriched example which was coupled with complete 
retention of stereochemical information (252). Two -heteroatom substituted boronic esters, 
N-Boc-2-piperidine (255) and an -alkoxy boronic ester (256), which are challenging migrating 
groups,163 both performed well. Tertiary boronic esters (257−259), which are sometimes 
challenging to encourage to form boronate complexes,164 were also viable substrates and 
enabled the coupling of some interesting carbon-scaffolds, including adamantyl (257) and a 
cubanyl moiety (259).63 Finally, a wide-range of aryl and vinyl boronic esters were tested 
(260−267), which are particularly important since they are widely available, due to the 
importance of the Suzuki−Miyaura cross-coupling, and were also found to be good substrates. 
Of note, the intermediate boronate complex required to form cross-coupled product 261 is both 
an unsubstituted vinyl and bicyclobutyl boronate complex, which has two potential reaction 
pathways: 1) reaction of the palladium(II) complex at the -bond of the vinyl group (Morken’s 
conjunctive cross-coupling, Scheme 77); or 2) reaction with the palladium(II) complex at the 
strained -bond of the bicyclobutane (Scheme 81). Since 261 is exclusively formed, reaction 
of the palladium(II) complex at the -bond must be favored over the reaction at the -bond, 
presumably because of the driving force offered by cleavage of the -bond. 
 
Scheme 81. Two possible reaction products when using a bicyclobutyl-vinyl boronate complex. 
We finally tested a range of natural product-derived triflates and boronic esters. These included 
derivatives of sesamol (268), eugenol (269), estrone (270), hymecromone (271), tyrosine (272), 
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pregnenolone (273) and cholesterol (274), which, in all cases, were transformed into the 
corresponding cross-coupled products in moderate to good yields (Figure 18). 
 
Figure 18. Natural product-derived triflate and boronic ester scope for the carbopalladation of C−C -bonds. 
In addition to the successful substrates described above, there were also many that were 
unsuccessful. Paracetamol-derived triflate 275 did not provide any of the desired cross-coupled 
product, instead it yielded 93 % of the protonated boronate complex 276. The relatively acid 
N−H bond is likely protonating the intermediate boronate complex to give 276 before any cross-
coupling can occur. Allylic boronic ester 277 was also unsuccessful, presumably because the 
intermediate boronate complex underwent elimination alongside reaction at the -bond.165 
Unfortunately, it is not understood why the other boronic esters and triflates shown in Scheme 
82 were unsuccessful. 
 
Scheme 82. Triflates and boronic esters that are unsuccessful in our C−C -bond carbopalladation reaction. 
Boronic esters are invaluable building blocks and synthetic intermediates because they can be 
transformed into a broad range of other functional groups.25 Since our cyclobutane products 
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retain this moiety, we wished to showcase that they too were competent reaction partners in 
these diverse transformations. Therefore, pharmaceutically-relevant methyl substituted 
cyclobutane 249, previously synthesized on gram-scale, was subjected to a range of boronic 
ester transformation reactions, including: oxidation to the alcohol (278), arylation to a furan 
(279)36 and pyridine (280),37 amination (281),166 vinylation (282),31 alkynylation (283),34 and 
formation of the trifluoroborate salt (284).167 In all cases, good to excellent yields were obtained 
with complete retention of stereochemistry. 
 
Figure 19. Boronic ester functionalizations of the cyclobutylboronic esters produced using our new cross-coupling 
methodology. 
4.3.5 Mechanism 
All arylated cyclobutanes were formed as single diastereoisomers, as judged by both 1H (on the 
crude mixture and purified product) and 13C NMR spectroscopic analysis. Single crystals of 
cyclobutanes 235, 243 and 263 were obtained and subjected to X-ray crystallographic analysis. 
This unambiguously proved that, much like with the bromide adduct 238 prepared in section 
4.3.2, the boron and aryl groups were incorporated onto the same face of the cyclobutane ring. 
All other cyclobutane products in Scheme 80 and Figure 18 were assigned by analogy.  
 
Figure 20. Crystal structures of (from left to right) 235, 243 and 263. See the supplementary materials for crystal data and 
structure refinement. 
The reaction products and the diastereoselectivity can be plausibly rationalized by the following 
mechanism (Scheme 83). Oxidative addition of the triflate with the palladium(0) catalyst 
generates an electrophilic palladium(II)-aryl species. Since the triflate anion is an outer-sphere, 
non-coordinating counter ion, the palladium(II)-aryl complex, crucially, has a vacant 
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coordination site that can interact with the boronate complex.158 The ring strain of the 
bicyclobutyl moiety transmits the nucleophilicity of the C(migrating)−B bond to its distal, 
-carbon, and so reaction at this center is favored over transmetalation of one of the C−B bonds, 
which is the pathway observed in Suzuki−Miyaura reactions. The palladium(II)-aryl complex 
now has two options: reaction at either the ‘top’, endo face; or the ‘bottom’, exo face. Boronate 
complex 208 must react in the conformation shown in Scheme 83, since this provides the 
required anti-periplanar alignment of the migrating substituent, R1, and the ‘leaving group’, in 
this case the cleaving central C−C -bond of the bicyclobutane unit. In this conformation, 
approach of the large palladium(II)-aryl species from the endo face is effectively blocked by 
the bulky pinacol group, and so approach from the less hindered exo face is preferred. 
Furthermore, the central strained C−C -bond of bicyclobutane is primarily comprised of 
unhybridized p-orbitals, which protrudes significant electron density out from the exo face of 
the -carbon.143,144 Therefore, both steric and electronic factors favor reaction of 208 with the 
bicyclobutane ring on the exo face of its -carbon. The interaction of the palladium(II)-aryl 
complex with the boronate complex 208 thus induces 1,2-metalate rearrangement, where R1 
migrates to the -carbon. The near perfect diastereoselectivity suggests a concerted mechanism, 
where 1,2-migration of R1 is simultaneous with cleavage of the highly strained central C−C 
-bond of the bicyclobutane and formation of a new C−Pd bond on the -carbon. This step 
constitutes a carbopalladation of a C−C -bond (albeit a highly strained one), which is a highly 
unusual and unprecedented process. Finally, reductive elimination regenerates the palladium(0) 
species and forms a new Csp2−Csp3 -bond. The overall result is a ‘distal’ cross-coupling, 
where the two reaction partners are linked, diastereoselectively, across a cyclobutane unit. 
 
Scheme 83. Proposed catalytic cycle for the carbopalladation of C−C -bonds. 
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4.4 Conclusions, Impact, and Future work 
4.4.1 Conclusions 
We have disclosed a method for the carbofunctionalization of C−C -bonds of highly strained 
boronate complexes. To achieve this, a novel reagent, the bicyclobutyl sulfoxide 224, was 
invented. This solid, easy-to-handle reagent can be treated with tert-butyl lithium at −78 °C to 
quantitatively generate bicyclobutyl lithium 209, which then reacts in situ with a boronic ester 
to form a strained boronate complex. These can be reacted with external electrophiles, which 
are trapped diastereoselectively upon 1,2-metalate rearrangement and C−C -bond cleavage, to 
form 1,1,3-trisubstituted cyclobutanes, which are becoming increasingly important 
pharmaceutical motifs. These reactions represent one of the first reports of the 
carbofunctionalization of C−C -bonds, albeit highly strained ones, where a carbon-based unit, 
from the boronic ester, and another functional group, from the electrophile, are added across 
the central strained bond of the bicyclobutane group. To date, reactions with a brominating 
reagent, DBDMH, and electrophilic palladium(II)-aryl complexes have been successfully 
achieved. The latter of which has been fully optimized and expanded to cover a wide variety of 
aryl groups and boronic esters. It is expected that this new reactivity, alongside the now facile 
entry to the bicyclobutyl moiety, will stimulate further research into strain release reactions, 
and, in particular, those merging transition metal catalysis and strain release chemistry. 
4.4.2 Expansion of electrophile scope 
The next step is to test a range of electrophiles to see how they perform under our optimized 
conditions (Figure 21). The list of potential electrophiles is extensive, however there are a 
number of key functional groups that will be the focus of our examination due to their 
pharmaceutical-relevance, these include the fluoro, trifluoromethyl, amino, and ester groups. 
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Figure 21. Other products currently synthesized using our C−C -bond carbofunctionalization methodology. 
To date, we have had mixed success across a range of electrophiles,† however these studies will 
not be detailed in this thesis. 
The most efficient electrophile for the ring-opening of bicyclobutyl boronate complexes, 
excepting palladium(II)-aryl species, is DBDMH, which provides diastereomerically pure 
brominated cyclobutanes in good yields (although to date only the cyclohexyl-bearing 
cyclobutane, 228, has been prepared). It would be interesting to see whether these brominated 
cyclobutanes can be transformed further to potentially access the functionalized products that 
cannot be synthesized through direct electrophilic trapping of bicyclobutyl boronate complexes. 
It would be particularly useful if the bromide can be easily converted into the organozinc and 
then reacted further with a range of electrophiles, where there are many that are known to 
perform very well (Scheme 84). The Negishi cross-coupling would also be a useful application 
of these organozincs. There would be considerable cross-over with our current methodology 
involving electrophilic palladium(II)-aryl complexes, however, it would likely enable coupling 
of a wider range of aryl groups, particularly heteroaromatics, because there is no longer the 
requirement for the use of aryl triflates. 
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Scheme 84. Proposed synthetic uses of converting cyclobutyl bromide 228 to its corresponding organozinc and then reacting 
with electrophiles. 
4.4.3 More substituted bicyclobutanes 
We currently only have access to 1,1,3-substituted cyclobutane products, since the bicyclobutyl 
sulfoxide 224 is unsubstituted. There is a report detailing syntheses of further substituted 
bicyclobutyl lithium reagents,148 however they all require the de novo synthesis of the requisite 
dibromocyclopropane precursor, which limits their accessibility. An attractive route into 
substituted bicyclobutyl lithiums would be to somehow modify bicyclobutyl sulfoxide 224 to 
directly incorporate new substituents and functionality. Bicyclobutyl sulfones can be 
deprotonated with n-butyl lithium to form an intermediate bicyclobutyl lithium that could be 
trapped with a range of electrophiles.168 If a similar deprotonation is possible with our 
bicyclobutyl sulfoxide 224, then it would enable access to a spectrum of 3-substituted 
bicyclobutyl sulfoxides that, presumably, would be able to be engaged in the reactivity 
described in sections 4.3.2 and 4.3.3 to form 1,1,3,3-tetrasubstituted cyclobutane products with 
high diastereoselectivity. We have preliminarily shown that treatment of 224 with two 
equivalents of lithium diisopropylamide (LDA), instead of n-butyl lithium, to minimise any 
sulfoxide−lithium exchange, resulted in efficient production of the desired bicyclobutyl lithium 
reagent, which was subsequently trapped with iodomethane to deliver methylated bicyclobutyl 
sulfoxide 285 in 83 % yield. This reaction has only been performed once, however it gives a 
glimpse at what should be possible after a full investigation. 
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Scheme 85. Preliminary results showing the deprotonation of bicyclobutyl sulfoxide 224 with LDA, and some potential 
electrophilic trapping products. 
Unfortunately, there is likely no simple route to 2- or 4-(poly)substituted bicyclobutane 
sulfoxide reagents from the parent bicyclobutyl sulfoxide 224. These reagents would require 
the de novo synthesis of the requisite dibromocylopropane precursors, which could present a 
significant synthetic challenge. 
4.4.4 Different ring sizes 
To date, bicyclobutane is the only strained bi-cycle that has been used, however there are a 
range of other bi-cycles that could be investigated. For example, bicyclo[2.1.0]pentane 286 
(strain energy = 54.7 kcal/mol) and bicyclo[2.2.0]hexane 287 (strain energy = 52.1 kcal/mol)140 
are both highly strained and, in theory, should react similarly to bicyclobutane (strain energy = 
66.3 kcal/mol) once they have been incorporated into boronate complexes. It is possible, 
however, that they do not possess enough ring strain to react as rapidly as bicyclobutane does. 
We have shown that a cyclopropyl boronate complex is unable to undergo 1,2-metalate 
rearrangement with ring-opening of the cyclopropane (strain energy = 29.0 kcal/mol)140 with 
either DBDMH or a palladium(II)-aryl species as the electrophile (see supplementary 
materials), so there is evidently a threshold strain energy for reactivity, but the two suggested 
bi-cycles do have considerably more strain energy than cyclopropane. Furthermore, the 
synthesis of the corresponding organolithiums is unprecedented, so the preparation of the 
requisite sulfoxides 288 and 289 could pose a considerable synthetic challenge. Also, as just 
described in section 4.4.3, it is plausible that deprotonation of 288 and 289 will be possible, 
which will facilitate the preparation of further substituted sulfoxides. If successful, however, it 
would enable the synthesis of diastereo- and regioisomerically pure polysubstituted borylated 
cyclopentanes and cyclohexanes, which are both useful units in organic synthesis. 
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Scheme 86. Proposed extension of our methodology to larger ring sizes. 
4.4.5 Use of azabicyclo[1.1.0]butane 
Azabicyclo[1.1.0]butane (azabicyclobutane) 290, is analogous to bicyclobutane in terms of its 
structure and strain energy,169 but features a bridgehead nitrogen atom rather than a methine. If 
azabicyclobutyl lithium 291 can be prepared, and subsequently trapped with a sulfinate ester, 
then azabicyclobutyl sulfoxide 292 would be formed which, if engaged in similar chemistry to 
that described in this chapter, would enable the homologation of boronic esters with an azetidine 
unit. The resultant azetidine boronic esters are potentially useful for the preparation of diverse 
azetidines for use in medicinal chemistry programs. This is currently being explored by myself 
and another member of the Aggarwal group (whose work will be denoted with a ‘†’). 
To date, azabicyclobutane, generated in situ from a commercially available amine salt by 
treatment with 3 equivalents of phenyl lithium, has been found to undergo facile 3-lithiation 
using sec-butyl lithium and TMEDA to form azabicyclobutyl lithium 291, which, after 
treatment with methyl 4-methylbenzenesulfinate, can be converted to the corresponding 
azabicyclobutyl sulfoxide 292 in 62 % on gram-scale (Scheme 87A).† This easy-to-handle 
solid, can be treated identically to bicyclobutyl sulfoxide 224, namely treatment with tert-butyl 
lithium, to quantitatively regenerate azabicyclobutyl lithium 291. This can be trapped in situ 
with a range of boronic esters to form the corresponding azabicyclobutyl boronate complexes, 
which, upon treatment with acetic acid, undergo protonation and 1,2-migration to deliver the 
azetidine homologated boronic esters. These are finally protected with the 
tert-butyloxycarbonyl group to yield isolable Boc-protected azetidine boronic esters. When 
using cyclohexyl pinacol boronic ester, azetidine product 293 was isolated in 75 % yield 
(Scheme 87B). The scope of this transformation has been found to be very broad (Scheme 
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87C), encompassing primary, secondary, tertiary, aryl and vinyl boronic esters, however the 
products formed using the last two categories cannot be isolated due to instability on silica gel 
during flash column chromatography. 
 
Scheme 87. Application of azabicyclobutyl lithium 291 to the preparation of borylated azetidines. (A) Preparation of 
azabicyclobutane 290, azabicyclobutyl lithium 291, and azabicyclobutyl sulfoxide 292.† (B) Homologation of cyclohexyl 
pinacol boronic ester using azabicyclobutyl lithium 291 to form the corresponding borylated azetidine 293. (C) Selected 
substrate scope. 
An extension to this work, in analogy to the expansion outlined in section 4.4.4, would be to 
synthesize other nitrogen-containing bi-cycles, such as azabicyclo[2.1.0]pentane 294 and 
azabicyclo[2.2.0]hexane 295, and form their corresponding sulfoxides 296 and 297 in the same 
way as azabicyclobutyl sulfoxide 292 is prepared (Scheme 88). Use of these in a similar manner 
to 292, would result in the homologation of boronic esters by a pyrrolidine or piperidine unit, 
both of which are important heterocycles in medicinal chemistry.170 
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Scheme 88. Proposed extension of the aza-ring chemistry to larger ring sizes. 
4.4.6 Use of novel bicyclobutane substituted boronic esters and beyond 
In all the methodologies described in this chapter, the bicyclobutane unit has acted as a linchpin 
to enable reactivity that had previously been difficult to access. We believe the challenges 
associated with introducing (aza)bicyclobutane moieties into greater chemical structures has 
impeded the thorough investigation of their value in organic synthesis. However, we now have 
facile access to nucleophilic (aza)bicyclobutane from solid, easy-to-handle, and potentially 
commercializable reagents. Therefore, the incorporation of the (aza)bicyclobutane structure 
into other organic scaffolds, and its subsequent reactivity therein, should be investigated. 
For example, if it is possible to react (aza)bicyclobutane regioselectively with a strained three-
membered ring, such as an epoxide, aziridine, or thiirane, we would generate a novel 
(aza)bicyclobutane incorporated product which bears a pendent nucleophilic heteroatom 
(Scheme 89). Upon treatment with an external electrophile, nucleophilic attack of the pendent 
heteroatom onto the proximal carbon of the (aza)bicyclobutane core should result in 
simultaneous electrophilic trapping at the distal atom. As with our previously described 
methodology, stereoelectronic restrictions should render this process diastereoselective. If 
successful, it will enable the modular synthesis of pharmaceutically-relevant 
heterospiro[3.3]heptanes171 in both enantio- and diasteroenriched form. 
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Scheme 89. Proposed use of (A) bicyclobutyl lithium 209 and (B) azabicyclobutyl lithium 291 as linchpin reagents for the 
modular synthesis of spirocycles. 
There are also potential further applications within the field of organoboron chemistry. For 
example, nucleophilic radicals, generated via the decarboxylation of alkyl carboxylic acids, are 
known to add to vinyl boronic esters.172 If bicyclobutyl pinacol boronic ester 298 can be 
prepared155 then it might also be possible to use it as a vinyl boronic ester analogue and add 
nucleophilic radicals into its highly strained central C−C -bond (Scheme 90A). This is 
currently being explored by another member of the Aggarwal group. Furthermore, if 3-chloro 
bicyclobutyl pinacol boronic ester 299 can be prepared then radical addition to this would 
generate a radical  to the boron center. Upon reduction of this radical, a stabilized -boryl 
anion is formed, which could then cyclise, with expulsion of chloride,173 to reform the 
bicyclobutane unit (Scheme 90B). The overall result would be the replacement of the chloride 
by a carbon-based substituent, which would provide an easy route to functionalized 
bicyclobutyl boronic esters 300, whose chemistry is yet to be explored. 
 
Scheme 90. Proposed (A) radical addition to bicyclobutyl pinacol boronic ester 298, and (B) ‘radical-polar cross-over’ 
cyclisation by the radical addition to chlorobicyclobutyl pinacol boronic ester 299. 
On the theme of using bicylobutane as an olefin analogue, boronic esters bearing an 
-(aza)bicyclobutane unit 301 should be preparable from the corresponding -chloro boronic 
ester and (aza)bicyclobutyl lithium (Scheme 91). An allylic boronic ester analogue is formed, 
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which, considering the importance of allylic boronic esters,174 is likely to have rich chemistry. 
A potential application is to extend our previously reported nucleophilic allylic boronate 
complex chemistry.165 Here, an -(aza)bicyclobutyl boronate complex will be formed by the 
addition of an aryl lithium to the corresponding boronic ester, which, simultaneous with 
elimination of the boronate center, can react with electrophiles at the distal atom of the 
(aza)bicyclobutane unit. The product would be a disubstituted methylene 
cyclobutane/azetidine, where both substituents are highly modular. 
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5. Overall summary and conclusions 
This thesis introduced organoboron chemistry as a three-stage process (incorporation, 
homologation, then functionalization) (section 1.2) and set out to describe novel contributions 
to each of these three stages. The three main contributions detailed in this thesis are summarized 
in Scheme 92. 
 
Scheme 92. (A) The three-stage approach to organoboron chemistry. (B) Decarboxylative borylation. (C) The regio- and 
stereoselective homologation of 1,2-bis(boronic esters). (D) The preparation and reaction of bicyclobutyl boronate complexes. 
A novel method of boron incorporation, a decarboxylative borylation, was first described  in 
chapter 2 (Scheme 92B).63 It was discovered that N-hydroxyphthalimide activated alkyl 
carboxylic acids could be converted to their corresponding alkyl boronic esters by treatment 
with B2cat2 in DMAc under blue LED irradiation, and then pinacol and triethylamine to effect 
transesterification of the intermediate catechol boronic ester into the stable, isolable pinacol 
boronic ester. These conditions successfully converted a wide range of carboxylic acid 
substrates into the corresponding boronic esters in mostly good to excellent yields, which 
included primary, secondary, constrained tertiary, and drug- and natural product-derived 
examples, with a wide functional group tolerance. This process is proposed to proceed via a 
unique mechanism. The reaction is initiated by a photoexcited EDA complex of an NHPI ester 
and B2cat2 undergoing an intra-complex single electron transfer, which ultimately results in 
fragmentation and decarboxylation of the NHPI ester to deliver an alkyl radical. This radical 
finally reacts with B2cat2. The DMAc solvent is intrinsic to the proposed mechanism, as we 
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propose that it is responsible for aiding B−B bond cleavage to form the boronic ester product 
and a DMAc-stabilized boryl radical, the latter of which is a key species in propagating a radical 
chain process. 
A contribution to boron homologation, the regio- and stereoselective homologation of 1,2-
bis(boronic esters), was next discussed in chapter 3 (Scheme 92C).112 It was demonstrated that 
lithiation−borylation methodology can be applied to the synthesis of 1,3-diols. The primary 
boronic esters of 1,2-bis(boronic esters) were found to undergo regio- and stereoselective 
homologation using lithiated carbenoids with generally high yields and excellent 
diastereoselectivities. This methodology was applied to the synthesis of all four possible 
stereoisomers of a representative 1,3-diol, proving that there are no significant 
match/mismatched effects in this process, and to a wide range of other substrates, including the 
synthesis of several secondary-tertiary 1,3-diols, which were previously difficult to access in 
any desired stereoisomeric form with broadly high diastereoselectivity. The exclusive reaction 
of the primary boronic ester was found to be the result of steric effects only. 
Finally, a novel method of boron functionalization, using highly strained bicyclobutyl boronate 
complexes, was presented in chapter 4 (Scheme 92D). To achieve this, a novel reagent, the 
bicyclobutyl sulfoxide was invented. This solid, easy-to-handle reagent can be treated with tert-
butyl lithium to quantitatively generate bicyclobutyl lithium, which then reacts in situ with a 
boronic ester to form the corresponding bicyclobutyl boronate complex. These can be reacted 
with external electrophiles, which are trapped diastereoselectively upon 1,2-metalate 
rearrangement and C−C -bond cleavage, to form 1,1,3-trisubstituted cyclobutanes. These 
reactions represent one of the first reports of the carbofunctionalization of C−C -bonds, albeit 
highly strained ones, where a carbon-based unit, from the boronic ester, and another functional 
group, from the electrophile, are added across the central strained bond of the bicyclobutane 
group. To date, reactions with a brominating reagent, DBDMH, and electrophilic palladium(II)-
aryl complexes have been successfully achieved. The latter of which has been fully optimized 
and expanded to cover a wide variety of aryl groups and boronic esters. 
It is hoped that the new reactivity presented within this thesis will stimulate further research 
into radical-based borylations of underexploited starting materials, selective homologations of 
poly(boronic esters), and the formation and usage of highly strained boronate complexes, and 
therefore broaden the applicability of the ‘three-stage organoboron chemistry’ approach to the 
synthesis of complex organic molecules.
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1. General Experimental  
1.1 Solvents and Reagents 
All air- and water-sensitive reactions were carried out in flame-dried glassware under a nitrogen 
atmosphere using standard Schlenk manifold technique. Anhydrous solvents were 
commercially supplied or provided by the communal stills of the School of Chemistry, 
University of Bristol, and were dried using a purification column composed of activated 
alumina and stored over thoroughly dried 3 Å mol sieves.175 
B2cat2 [CAS: 13826-27-2] was purchased from both Sigma-Aldrich (473286) and Fluorochem 
(211650), and both yielded the same results (despite their appearances differing). We have 
noticed that different batches contain differing amounts of catechol, however this does not 
appear to either positively or negatively affect the yield. Anhydrous DMAc [CAS: 127-19-5] 
was purchased from Sigma-Aldrich (271012). Pd(dba)2 [CAS: 32005-36-0] was purchased 
from Sigma-Aldrich and used as received. Cyclohexyl pinacol boronic ester [CAS: 87100-15-0] 
was purchased from Alfa-Aesar and was purified by flash column chromatography (SiO2; 95:5 
pentane:Et2O) before use. Anhydrous 2-methyl tetrahydrofuran [CAS: 96-47-9] was purchased 
from Sigma-Aldrich and used as received. tert-Butyl lithium (1.7 M in pentane) [CAS: 
594-19-4] was purchased from Sigma-Aldrich and used as received. Methyl lithium (1.6 M in 
Et2O) [CAS: 917-54-4] was purchased from Acros and used as received. (+)-Sparteine and 
(−)-sparteine were obtained from the commercially available sulfate pentahydrate salt (99%, 
Acros) and isolated according to literature procedure.176 The sparteine free base readily absorbs 
atmospheric carbon dioxide (CO2) and so should be stored under argon/nitrogen at −20 °C in a 
sealed Schlenk-tube. sec-BuLi was purchased from Acros as a 1.3 M solution in 
cyclohexane:hexane 98:2. The molarity of organolithium solutions were regularly determined 
by titration using N-benzyl benzamide as an indicator.177 
All other reagents were purchased from various commercial sources and used as received or 
synthesized according to the procedures given. 
1.2 Chromatography and Data Analysis  
Flash column chromatography was carried out using Sigma-Aldrich silica gel 60 (40‒63 µm). 
All reactions were followed by thin-layer chromatography (TLC) when practical, using Merck 
Kieselgel 60 F254 fluorescent treated silica, which was visualised under UV light, or by staining 
with an aqueous solution of KMnO4 followed by heating. 
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1H, 13C, 11B and 19F NMR spectra were recorded using Jeol ECS 400 MHz, Varian VNMR 
400 MHz and Varian VNMR 500 MHz spectrometers. Chemical shifts () are given in parts 
per million (ppm), and coupling constants (J) are given in Hertz (Hz), rounded to the nearest 
0.1 Hz. The 1H NMR spectra are reported as follows: ppm (multiplicity, coupling constants, 
number of protons, assignment). NMR assignments are made according to spin systems, using 
two-dimensional NMR spectroscopy (COSY, HSQC, HMBC), where appropriate, to assist the 
assignment. Where an assignment could not be made unambiguously, no assignments are given. 
13C signals adjacent to boron are generally not observed due to quadrupolar relaxation. 
High resolution mass spectra (HRMS) were recorded on a Bruker Daltonics MicrOTOF II 
by Electrospray Ionisation (ESI) or on a VG Micromass Autospec (Triple-sector) by Electronic 
Impact (EI) or on a Bruker Daltonics UltrafleXtreme (MALDI). 
IR spectra were recorded on a Perkin Elmer Spectrum One FT-IR as a thin film, if an oil, or in 
the solid state, if solid. Only selected absorption maxima (νmax) are reported. 
Melting points were recorded in degrees Celsius (°C) using a Kofler hot-stage microscope 
apparatus. 
Optical rotation ([𝜶]𝐃
𝑻 ) was measured on a Bellingham and Stanley Ltd. ADP220 polarimeter.  
Gas Chromatography (GC) was performed on an Agilent 7890A using an Agilent HP-5 
column (15 m x 0.25 mm x 0.25 μm). 
GC-MS was performed on an Agilent 6890 Series GC and 5973 detector using a HP-5MS UI 
column (15 m x 0.25 mm x 0.25 μm). 
Chiral high performance liquid chromatography (HPLC) separations were performed on 
an Agilent 1100 Series HPLC unit equipped with UV-vis diode array detector. 
UV-visible spectroscopy was performed using a Lambda 35 spectrometer with standard glass 
cells with a 1 cm path length at wavelengths 200−800 nm. 
X-ray diffraction experiments on 224, 235, 243 and 263 were carried out at 100(2) K on a 
Bruker APEX II diffractometer using Mo-Kα radiation (λ = 0.71073 Å). Data collections were 
performed using a CCD. Intensities were integrated in SAINT178 and absorption corrections 
based on equivalent reflections were applied using SADABS.179 Structure 224 was solved using 
Superflip180,181 while the other structures were solved using ShelXT,182 all of the structures were 
refined by full matrix least squares against F2 in ShelXL183,184 using Olex2.185 All of the non-
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hydrogen atoms were refined anisotropically, while all of the hydrogen atoms were located 
geometrically and refined using a riding model.  In the case of 235 the molecule displayed 
disorder, the occupancies of the fragments were determined by refining them against a free 
variable with the sum of the sites set to equal 1. The occupancies of the fluorines in the CF3 
group were then fixed at the refined values, restraints and constraints were used to maintain 
sensible geometries and thermal parameters. The structure of 243 also displayed disorder, the 
occupancies of the disordered fragments was determined by refining them against a free 
variable with the sum of the two sites set to equal 1, similarity distance restraints were used to 
maintain sensible geometries and restraints and constraints were applied to maintain sensible 
thermal parameters. Crystallographic data for compounds 224, 235, 243 and 263 have been 
deposited in the Cambridge Crystallographic Data Center as supplementary publication CCDC 
1835072 (224), 1847415 (235), 1835073 (243) and 1847416 (263). Copies of the data can be 
obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK 
[fax(+44) 1223 336033, e-mail: deposit@ccdc.cam.ac.uk]. 
1.3 Naming of Compounds  
Compound names are those generated by ChemBioDraw 13.0 software (PerkinElmer), 
following the IUPAC nomenclature. 
1.4 Photoreactor 
Photo-reactors comprised of a 5.0 m strip of Fluxia blue SMD3528 LEDs (purchased from 
http://cpc.farnell.com/fluxia/153-732uk/led-tape-kit-5m-amber/dp/LA05165) coiled around a 
glass crystallising dish. The average power output per LED was recorded at 3.05 mW on a 
Coherent LabMax-TOP laser power meter equipped with a Coherent Power/Max PS10 sensor 
with a 10 mm diameter aperture, 10 mm from aperture. 
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The emission spectra of the blue LEDs were recorded on an Ocean Optics HR4000CG-UV-
NIR spectrometer. The spectrum was normalised to 1.0 at the maximum (450 nm). 
Figure 22. Photoreactor setup and emisson spectrum of LEDs. 
 1.5 The Fawcett Flask 
The Fawcett Flask was first conceived by Alexander Fawcett as a means to create a simple 
method to add a stirred solution at a cryogenic temperature to a second stirred solution at the 
same temperature. The final form was settled upon after many discussions with Professor 
Varinder K. Aggarwal, Dr Eddie L. Myers and Dr Daniel J. Blair. All Fawcett Flasks were 
constructed by the University of Bristol School of Chemistry glassblower, Duncan Tarling. 
Alternative names are: Aggarwal Inverse-Addition Vessel, Tipping Flask, Myers Mixer and the 
Tarling Tipper. 
 
Figure 23. The Fawcett Flask – custom glassware for the addition of solutions at cryogenic temperatures to a 
second solution at the same temperature. 
Emission Wavelength (nm)
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Operation: After flame-drying, the flask is attached to a Schlenk manifold, and the two ground-
glass joints are stoppered with suba-seals, before applying a high vacuum until the glassware 
has cooled to ambient temperature. The necessary reagents and solvents are then added into the 
appropriate sides of the flask (we typically add the reagents as a solution to the receiving flask 
a few minutes prior to transfer as it can be difficult to control the stirring in both halves when 
the flask is clamped into position). The flask can then be comfortably lowered into a cooling 
bath for the required reaction time. To perform the inverse-addition procedure, the flask needs 
to be unclamped (we have found that the flask can sit happily in a cooling bath without the need 
for clamping for short periods of time) and held at an angle to allow proper stirring in both 
halves. Simple tipping of the flask, without removing either side from the cooling bath, will 
allow the solution in the delivering half to pour across into the receiving half. We have found 
that it is easy to control the rate of addition, so that it is comparable to dropwise or small portion-
wise addition. To pour the final few drops across it is necessary to close the Schlenk tap on the 
side of the receiving flask and insert a needle into the suba-seal of the receiving flask. A finger 
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2. Chapter 2 – Supplementary Materials 
2.1 All General Procedures 
2.1.1 Synthesis of N-Hydroxyphthalimide (NHPI) Esters 
 
General Procedure A: Most NHPI esters were prepared according to a literature 
procedures.64,65,68,69,70,186 N-Hydroxyphthalimide (1.0 eq), DMAP (0.1 equiv) and, if solid, 
carboxylic acid (1.0 equiv) was added to a round-bottomed flask. Dichloromethane (0.1 M) and, 
if liquid, carboxylic acid (1.0 eq) were then added, followed by DIC (1.0 equiv). The reaction 
mixture was allowed to stir at room temperature overnight, before concentrating under reduced 
pressure. The crude residue was directly purified by flash-column chromatography (SiO2; 
typically DCM with either pentane or Et2O) to yield pure NHPI ester. If solid and not pure, the 
NHPI ester can be recrystallized from DCM/MeOH or EtOAc to give pure material. 
Notes: Unless stated, no precautions were taken throughout the syntheses of the NHPI esters. 
No attempts were made to optimize for yield. DCM, with either pentane or Et2O as co-solvent, 
was found to be the best eluent for purification by flash-column chromatography. Sometimes 
impurities co-elute with the product when using DCM, but this can be avoided by using 
pentane/hexane instead. All reagents were commercially bought and used without purification. 
Ethanol-free DCM should be used to prevent the formation of the ethyl ester. 
2.1.2 Decarboxylative Borylation of Alkyl Carboxylic Acids 
 
General Procedure B: NHPI ester (1.0 equiv, 0.13 mmol) and B2cat2 (40 mg, 1.25 equiv, 
0.16 mmol) were carefully weighed into a flame-dried 7 mL vial containing a small magnetic 
stirrer bar. DMAc (1.3 mL, 0.1 M) was added and then the headspace of the vial was purged 
with a gentle stream of argon for approximately 10 seconds (IMPORTANT!). The vial was 
tightly sealed and stirred under blue LED irradiation for 14 h. Pinacol (63 mg, 0.53 mmol, 
4 equiv) was dissolved in Et3N (0.45 mL), added to the reaction mixture and stirred for 1 h. The 
reaction mixture was transferred into a vial containing EtOAc (15 mL), H2O (3 mL), NH4Cl 
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(saturated aqueous solution, 3 mL). After vigorously shaking and allowing the two layers to 
separate, the top organic layer was carefully removed with a pipette. This was repeated twice 
more with EtOAc (5 mL). The organic layers were combined and concentrated under reduced 
pressure. The crude residue was directly purified using a short silica gel column to yield the 
desired boronic ester. Notes: The most important precaution to take to ensure good yields is 
purging of the vial headspace with Ar or N2; DMAc was anhydrous and sparged with argon for 
approximately 15 min before use; Et2O or hexane/pentane can be used instead of EtOAc for the 
extraction (especially for more volatile substrates); column chromatography should be done 
very quickly to prevent decomposition of the product on silica (this is generally important when 
purifying boronic esters; we can purify in less than 2 min on this scale); don’t make the silica 
gel column too short (approx. 4 cm of silica for a 2 cm diameter column is normally 
appropriate); for more polar compounds, that elute close to phthalimide byproducts, a better 
separation is generally observed using acetone/pentane or acetone/hexane as eluent; do not 
leave the crude reaction mixture around for prolonged periods of time; if traces of phthalimide 
are still observed by NMR after purification, the product is dissolved in EtOAc (5 mL) and 
washed with NaOH (1 M aqueous solution, 5 mL); if pinacol is still present after purification, 
it can be easily removed by azeotropic distillation.167 
2.2 Mechanistic Investigations 
2.2.1 Radical Ring-Opening 
2-(But-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (68) 
 
Activation: NHPI ester 114 was prepared according to a known procedure.69 Borylation: NHPI 
ester 114 (33 mg, 0.13 mmol) was borylated according to General Procedure B. The crude 
reside was purified by flash column chromatography (SiO2; 95:5 pentane:Et2O) to afford 
boronic ester 68 (14 mg, 56 %) as a colorless oil. Note: the intermediate alkyl radical undergoes 
radical ring opening, and the product is volatile! TLC: Rf = 0.29 (95:5 pentane:Et2O). 1H NMR: 
(400 MHz, CDCl3) δ 5.88 (ddt, J = 17.0, 10.2, 7.3 Hz, 1H, CH=), 5.03 – 4.95 (m, 1H, =CH
aHb), 
4.92 – 4.87 (m, 1H, =CHaHb), 2.17 (app q, J = 7.3 Hz, 2H, CH2CH=), 1.24 (s, 12H, C(CH3)2), 
0.88 (t, J = 7.3 Hz, 2H, CH2Bpin) ppm. 13C NMR: (101 MHz, CDCl3) δ 140.8 (=CH), 113.3 
(=CH2), 83.1 (C(CH3)2), 28.1 (CH2), 25.0 (C(CH3)2) ppm. All data matched that reported in the 
literature.187 
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2.2.2 Radical Cyclization 
2-(Cyclopentylmethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (117) and 2-(Hex-5-en-1-
yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (116) 
 
Activation: The carboxylic acid (150 mg, 1.17 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 90:10 hexane:acetone) to afford the corresponding NHPI ester  115 
(215 mg, 67 %) as a colorless oil. TLC: Rf = 0.27 (hexane:acetone 80:20). 1H NMR: (400 MHz, 
CDCl3) δ 7.88 (m, 2H, 2×Ar-H), 7.78 (m, 2H, 2×Ar-H), 5.81 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 
5.04 (ddt, J = 17.0, 2.2, 1.7 Hz, 1H), 4.98 (ddt, J = 10.2, 2.2, 1.2 Hz, 1H), 2.67 (t, J = 7.4 Hz, 
2H, CH2CO2R), 2.12 (dddt, J = 7.4, 6.7, 1.7, 1.2 Hz, 2H, CH2(CH2)3CO2R), 1.81 (app. p, J
app. 
= 7.4 Hz, 2H, CH2CH2CO2R), 1.55 (app. p, J
app. = 7.4 Hz, 2H, CH2(CH2)2CO2R) ppm. 13C 
NMR: (101 MHz, CDCl3) δ 169.6 (CO2R), 162.1 (2×CO), 138.2 (H2CCHR), 134.9 (2×HCAr), 
129.1 (2×CAr), 124.1 (2×HCAr), 115.2 (H2CCHR), 33.3 (CH2(CH2)3CO2R), 31.0 (CH2CO2R), 
28.1 (CH2(CH2)2CO2R), 24.2 (CH2CH2CO2R) ppm. HRMS (m/z): (ESI) calc’d for 
C15H15NNaO4 [M+Na]
+: 296.0893, found: 296.0883. IR (neat) νmax: 3076, 2934, 2865, 1815, 
1787, 1738, 1467, 1362, 1185, 1081, and 877 cm−1. Borylation: NHPI ester 115 (36 mg, 
0.13 mmol) was borylated according to General Procedure B. The crude reside was purified 
by flash column chromatography (SiO2; 100:0 → 90:10 pentane:Et2O) to afford a 57:43 mixture 
of linear:cyclized boronic esters 116 and 117 (21 mg, 77 %) as a colorless oil. Note: Product 
volatile! TLC: Rf = 0.55 (pentane:Et2O 95:5). Linear product (116): 1H NMR: (400 MHz, 
CDCl3) δ 5.81 (ddt, J = 17.1, 10.1, 6.6 Hz, 1H, H2CCHR), 4.98 (d, J = 17.1 Hz, 1H), 4.91 (d, 
J = 10.1 Hz, 1H), 2.04 (td, J = 7.0, 6.6 Hz, 2H, H2CCHCH2), 1.45 – 1.34 (m, 4H, 2×CH2), 1.24 
(s, 12H, 4×CH3), 0.77 (t, J = 7.3 Hz, 2H, CH2Bpin) ppm. 13C NMR: (101 MHz, CDCl3) δ 139.3 
(H2CCHR), 114.2 (H2CCHR), 83.0 (2×OC(CH3)2), 33.7 (CH2(CH2)3Bpin), 31.8 (CH2), 25.0 
(4×CH3), 23.7 (CH2) ppm. All data matched that reported in the literature.
188 Cyclized product 
(117): 1H NMR: (400 MHz, CDCl3) δ 1.95 (m, 1H, CHCH2Bpin), 1.76 (m, 2H), 1.60 (m, 2H), 
1.50 (m, 2H), 1.05 (m, 2H), 0.83 (d, J = 7.4 Hz, 2H, CH2Bpin). 13C NMR: (101 MHz, CDCl3) 
δ 82.9 (2×OC(CH3)2), 36.3 (CHCH2Bpin), 35.2 ((CH2)2CHCH2Bpin), 25.3 
((CH2CH2)2CHCH2Bpin), 25.0 (4×CH3) ppm. All data matched that reported in the literature.
189 
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We investigated how the linear:cylized products ratio varied upon changing the reaction 
concentration. The results are summarized in Table 8. 
Table 8. Results from radical cyclization experiments when varying the reaction concentration. 
 Conc. (M) Lin. (116) Yield/ % Cyc. (117) Yield/ % Total Yield/ % 116:117 
1 1.00 36.5 6.3 42.8 5.8:1 
2 0.50 41.1 9.1 50.3 4.5:1 
3 0.20 48.6 20.3 68.9 2.4:1 
4 0.10 46.0 31.0 77.0 1.5:1 
5 0.01 34.3 48.8 83.1 0.7:1 
 
Standard procedure for cyclization experiments: NHPI ester 115 (36 mg, 0.13 mmol) and 
B2cat2 (40 mg, 0.16 mmol, 1.25 equiv) were carefully weighed into a flame-dried 7 mL vial 
containing a small magnetic stirrer bar. DMAc was added and then the headspace of the vial 
was purged with a gentle stream of argon for approximately 10 seconds. The vial was tightly 
sealed and stirred under light irradiation for 14 h. Pinacol (63 mg, 0.53 mmol, 4 equiv) was 
dissolved in Et3N (0.45 mL), added to the reaction mixture and stirred for 1 h. The reaction 
mixture was transferred into a vial containing 15 mL of EtOAc, H2O (3 mL), NH4Cl (saturated 
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aqueous solution, 3 mL) and 1,3,5-trimethoxybenzene (as a stock solution: 21.86 mg/ 1.00 mL). 
After vigorously shaking and allowing to two layers to separate, 0.50 mL of the top organic 
layer was filtered through a short plug of silica for GC analysis. Notes: All solvents were 
anhydrous and sparged with argon for approximately 15 min. 
2.2.3 Reaction with DMAP 
 
 
NHPI ester 55 (50 mg, 0.13 mmol, 1.0 equiv), B2cat2 (40 mg, 0.16 mmol, 1.25 equiv), and 
DMAP (33 mg, 0.26 mmol, 2.0 equiv) were carefully weighed into a flame-dried 7 mL vial 
containing a small magnetic stirrer bar. DCM (1.3 mL) was added and then the headspace of 
the vial was purged with a gentle stream of argon for approximately 10 seconds. The vial was 
tightly sealed and stirred under light irradiation or in the dark for 14 h. Pinacol (63 mg, 
0.53 mmol, 4 equiv) was dissolved in Et3N (0.45 mL), added to the reaction mixture and stirred 
for 1 h. The reaction mixture was transferred into a vial containing 15 mL of EtOAc, H2O 
(3 mL), NH4Cl (saturated aqueous solution, 3 mL) and 1,3,5-trimethoxybenzene (as a stock 
solution: 21.86 mg/ 1.00 mL). After vigorously shaking and allowing to two layers to separate, 
0.50 mL of the top organic layer was filtered through a short plug of silica for GC analysis. 
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2.3 Decarboxylative Borylation Reaction 
2.3.1 Optimization 
 
Scheme 93. Model system for development of the decarboxylative borylation of standard alkyl substrates. 
Table 9. Optimization of the decarboxylative borylation of standard alkyl substrates. *Yields were measured 
using a calibrated GC with 1,3,5-trimethoxybenzene as internal standard. Unless otherwise stated, all reactions 
were performed a 0.13 mmol scale with 1.3 mL of solvent (0.10 M). 
 Light Solv. Time B source %* Notes 
Cs2CO3 additive 
1 Blue LEDs DMF 16 h B2cat2 (1.00 equiv) 8 With 1.5 equiv Cs2CO3 
2 Blue LEDs DMF 16 h B2cat2 (1.00 equiv) 69  
Solvent 
3 Blue LEDs DMAc 14 h B2cat2 (1.00 equiv) 71  
4 Blue LEDs DMI 14 h B2cat2 (1.00 equiv) 41  
5 Blue LEDs DMPU 14 h B2cat2 (1.00 equiv) 68  
6 Blue LEDs TMU 14 h B2cat2 (1.00 equiv) 43  
7 Blue LEDs Acetone 14 h B2cat2 (1.00 equiv) 1  
8 Blue LEDs PhMe 14 h B2cat2 (1.00 equiv) <1  
9 Blue LEDs DCM 14 h B2cat2 (1.00 equiv) <1  
10 Blue LEDs Hexane 14 h B2cat2 (1.00 equiv) <1  
11 Blue LEDs Dioxane 14 h B2cat2 (1.00 equiv) <1  
12 Blue LEDs Et2O 14 h B2cat2 (1.00 equiv) 2  
13 Blue LEDs MeCN 14 h B2cat2 (1.00 equiv) <1  
14 Blue LEDs THF 14 h B2cat2 (1.00 equiv) 2  
15 Blue LEDs EtOAc 14 h B2cat2 (1.00 equiv) <1  
16 Blue LEDs DMC 14 h B2cat2 (1.00 equiv) <1  
17 Blue LEDs DMSO 14 h B2cat2 (1.00 equiv) <1  
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Equivalents of B2cat2 
18 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 91 87 % isolated 
19 Blue LEDs DMAc 14 h B2cat2 (1.50 equiv) 90  
20 Blue LEDs DMAc 14 h B2cat2 (1.75 equiv) 81  
21 Blue LEDs DMAc 14 h B2cat2 (2.00 equiv) 82  
Light Source 
22 White bulb DMAc 14 h B2cat2 (1.25 equiv) 91  
23 None DMF 14 h B2cat2 (1.25 equiv) 5 Control 
24 None DMAc 14 h B2cat2 (1.25 equiv) 36 63 % after 70 h 
25 None DMAc 14 h B2cat2 (1.25 equiv) 30 80 °C 
Concentration 
26 Blue LEDs DMF 14 h B2cat2 (1.25 equiv) 86 0.05 M 
27 Blue LEDs DMF 14 h B2cat2 (1.25 equiv) 91 0.20 M 
Time 
28 Blue LEDs DMAc 4 h B2cat2 (1.25 equiv) 86  
Setup 
29 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 91 25 °C (others ~45 °C) 
30 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 33 NHPI in situ 
31 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 35 No dry or degas 
32 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 62 1.5 equiv pinacol added 
33 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 0 2.5 equiv pinacol added 
34 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 91 Tetrachlorophthalimide 
35 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 90 No flame dry 
36 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 90 N2 instead of Ar 
37 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 90 No solvent degas 
38 Lab light DMAc 14 h B2cat2 (1.25 equiv) 43 ‘Ambient light’ 
39 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 81 1 equiv H2O added 
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40 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 86 Rigorously degassed (freeze 
pump thaw) 
41 Blue LEDs DMAc 14 h B2cat2 (1.25 equiv) 87 All materials rigorously 
purified 
42 Blue LEDs DMAc 14 h B2(OH)4 (1.00 equiv) 77 Catechol (1.0 equiv) 
43 Blue LEDs DMAc 14 h B2(OH)4 (1.00 equiv) 32  
44 Dark DMAc 14 h B2(OH)4 (1.00 equiv) 19  
 
Standard Procedure for optimization experiments:  All solids (including NHPI ester 55 
(50 mg, 0.13 mmol), B2cat2, Cs2CO3 and pinacol) were carefully weighed into a flame-dried 
7 mL vial containing a small magnetic stirrer bar. Solvent (1.3 mL) was added and then the 
headspace of the vial was purged with a gentle stream of argon for approximately 10 seconds. 
The vial was tightly sealed and stirred under light irradiation for 14 h. Pinacol (63 mg, 
0.53 mmol, 4 equiv) was dissolved in Et3N (0.45 mL), added to the reaction mixture and stirred 
for 1 h. The reaction mixture was transferred into a vial containing 15 mL of EtOAc, H2O 
(3 mL), NH4Cl (saturated aqueous solution, 3 mL) and 1,3,5-trimethoxybenzene (as a stock 
solution: 21.86 mg/ 1.00 mL). After vigorously shaking and allowing to two layers to separate, 
0.50 mL of the top organic layer was filtered through a short plug of silica for GC analysis. 
Notes: All solvents were anhydrous and sparged with argon for approximately 15 min. 
2.3.2 Substrate Scope 
2-Benzyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (61) 
 
Activation: The carboxylic acid (1.30 g, 10.0 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 90:10 hexane:EtOAc) to afford the corresponding NHPI ester (2.28 g, 
85 %) as a white solid. m.p.: 54 – 58 °C (DCM/MeOH). TLC: Rf = 0.24 (90:10 hexane:EtOAc). 
1H NMR (400 MHz, CDCl3) δ 7.89 – 7.84 (m, 2H, phthalimide ArH), 7.79 – 7.74 (m, 2H, 
phthalimide ArH), 7.40 – 7.30 (m, 5H, ArH), 4.00 (s, 2H, CH2) ppm. 13C NMR (101 MHz, 
CDCl3) δ 167.8 (C=O), 161.9 (C=O), 134.9 (phthalimide ArCH), 131.6 (ArC), 129.4 (ArCH), 
129.0 (phthalimide ArC), 127.9 (ArCH), 124.1 (phthalimide ArCH), 37.8 (ArCH2) ppm (ArC 
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of phenyl ring not observed). HRMS (m/z): (ESI) calc’d for C16H11NO4Na [M+Na]
+: 304.0580, 
found: 304.0591. IR (solid state) νmax: 1736, 1363, 1184, 1133, 1060, 969 and 876 cm−1. 
Borylation: The NHPI ester (37 mg, 0.13 mmol) was borylated according to General 
Procedure B. The crude reside was purified by flash column chromatography (SiO2; 80:20 
pentane:Et2O) to afford boronic ester 61 (24 mg, 83 %) as a colorless oil. TLC: Rf = 0.77 (95:5 
pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.26 – 7.10 (m, 5H, ArH), 2.29 (s, 2H, CH2Bpin), 
1.23 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 138.8 (ArC), 129.1 (ArCH), 128.4 




Activation: The carboxylic acid (500 mg, 3.52 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 20:80 pentane:DCM) to afford the corresponding NHPI ester  (878 mg, 
87 %) as a colorless oil. TLC: Rf = 0.36 (20:80 pentane:DCM). 1H NMR (400 MHz, CDCl3) 
δ 7.90 – 7.86 (m, 2H, phthalimide ArH), 7.81 – 7.77 (m, 2H, phthalimide ArH), 7.36 – 7.32 (m, 
2H, ArH), 7.14 – 7.12 (m, 1H, ArH), 4.03 (s, 2H, CH2) ppm. 13C NMR (101 MHz, CDCl3) δ 
167.3 (C=O), 161.9 (C=O), 135.0 (phthalimide ArCH), 130.9 (ArC), 129.0 (phthalimide ArC), 
128.3 (ArH), 126.4 (ArH), 124.1 (phthalimide ArCH), 123.9 (ArH), 32.6 (CH2) ppm. HRMS 
(m/z): (ESI) calc’d for C14H9NO4SNa [M+Na]
+: 310.0144, found: 310.0145. IR (neat) νmax: 
3103, 1786, 1735, 1357, 1185, 1063, 974, 876 and 783 cm−1. Borylation: The NHPI ester 
(38 mg, 0.13 mmol) was borylated according to General Procedure B. The crude reside was 
purified by flash column chromatography (SiO2; 90:10 pentane:Et2O) to afford boronic ester 
62 (17 mg, 57 %) as a colorless oil. Note: Product volatile! Product unstable on silica gel. TLC: 
Rf = 0.34 (90:10 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.20 (dd, J = 4.7, 3.0 Hz, 1H, 
ArH), 6.95 – 6.93 (m, 2H, ArH), 2.28 (s, 2H, CH2), 1.25 (s, 12H, C(CH3)2) ppm. 13C NMR 
(101 MHz, CDCl3) δ 137.7 (ArC), 129.6 (ArCH), 124.9 (ArCH), 120.2 (ArCH), 83.6 








Activation: The carboxylic acid (500 mg, 2.64 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 20:80 pentane:DCM) to afford the corresponding NHPI ester  (809 mg, 
92 %) as a white solid. m.p.: 120 – 122 °C (DCM/MeOH). TLC: Rf = 0.26 (20:80 
pentane:DCM). 1H NMR (400 MHz, CDCl3) δ 7.89 – 7.84 (m, 2H, phthalimide ArH), 7.78 – 
7.74 (m, 2H, phthalimide ArH), 7.64 (d, J = 7.9 Hz, 1H, NCH), 7.31 (d, J = 8.1 Hz, 1H, ArH), 
7.25 (t, J = 7.5 Hz, 1H, ArH), 7.18 – 7.15 (m, 2H, ArH), 4.14 (s, 2H, CH2), 3.77 (s, 3H, NCH3) 
ppm. 13C NMR (101 MHz, CDCl3) δ 168.2 (C=O), 162.1 (C=O), 137.0 (ArC), 134.9 
(phthalimide ArCH), 129.1 (phthalimide ArC), 128.2 (ArCH), 127.5 (ArC), 124.1 (phthalimide 
ArCH), 122.2 (ArCH), 119.6 (ArCH), 118.9 (NCH), 109.5 (ArCH), 104.4 (ArC), 32.9 (NCH3), 
28.1 (CH2) ppm. HRMS (m/z): (ESI) calc’d for C19H14NO4Na [M+Na]
+: 357.0846, found: 
357.0853. IR (solid state) νmax: 3074, 2917, 1729, 1187, 1061, 970, 876, 736, 693 and 
518 cm−1. Borylation: The NHPI ester (45 mg, 0.13 mmol) was borylated according to 
General Procedure B. The crude reside was purified by flash column chromatography (SiO2; 
70:30 pentane:Et2O) to afford boronic ester 63 (25 mg, 69 %) as a colorless oil. TLC: Rf = 0.40 
(70:30 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 7.9 Hz, 1H, ArH), 7.27 (d, 
J = 8.2 Hz, 1H, ArH), 7.21 (t, J = 7.5 Hz, 1H, ArH), 7.09 (t, J = 7.4 Hz, 1H, ArH), 6.94 (s, 1H, 
NCH), 3.74 (s, 3H, NCH3), 2.34 (s, 2H, CH2), 1.29 (s, 12H, C(CH3)2) ppm. 13C NMR (101 
MHz, CDCl3) δ 137.1 (ArC), 128.9 (ArC), 126.7 (NCH), 121.3 (ArCH), 119.3 (ArCH), 118.3 
(ArCH), 110.2 (ArC), 109.0 (ArCH), 83.5 (C(CH3)3), 32.7 (CH3), 25.0 (C(CH3)2) ppm. All data 
matched that reported in the literature.192 
2-(4-Bromobutyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (64) 
 
Activation: The carboxylic acid (2.37 g, 13.1 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 90:10 hexane:EtOAc) to afford the corresponding NHPI ester  (4.10 g, 
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96 %) as a white solid. m.p.: 53 – 56 °C (DCM/MeOH). TLC: Rf = 0.24 (90:10 hexane:EtOAc). 
1H NMR: (400 MHz, CDCl3) δ 7.91 – 7.86 (m, 2H, phthalimide ArCH), 7.81 – 7.77 (m, 2H, 
phthalimide ArCH), 3.46 (t, J = 5.9 Hz, 2H, CH2C=O), 2.72 (t, J = 7 Hz, 2H, CH2Br), 2.07 – 
1.92 (m, 4H, 2×CH2) ppm. 13C NMR: (101 MHz, CDCl3) δ 169.2 (C=O), 162.0 (C=O), 134.9 
(phthalimide ArCH), 129.0 (phthalimide ArC), 124.1 (phthalimide ArCH), 32.7 (CH2C=O), 
31.5 (CH2), 30.2 (CH2Br), 23.3 (CH2) ppm. HRMS (m/z): (ESI) calc’d for C13H12BrNO4Na 
[M+Na]+: 347.9842, found: 347.9840. IR (solid state) νmax: 1738, 1374, 1186, 1138, 1065, 968 
and 858 cm−1. Borylation: The NHPI ester (44 mg, 0.13 mmol) was borylated according to 
General Procedure B. The crude reside was purified by flash column chromatography (SiO2; 
80:20 pentane:Et2O) to afford boronic ester 64 (23 mg, 67 %) as a colorless oil. Note: Product 
volatile! 1H NMR: (400 MHz, CDCl3) δ 3.40 (t, J = 7.4 Hz, 2H, CH2Br), 1.87 (p, J = 7.4 Hz, 
2H, CH2CH2Br), 1.54 (p, J = 7.4 Hz, 2H, CH2CH2Bpin), 1.24 (s, 12H, C(CH3)2), 0.79 (t, J = 
7.4 Hz, 2H, CH2Bpin), 10.5 (br, CH2Bpin) ppm. 13C NMR: (101 MHz, CDCl3) δ 83.2 
(C(CH3)2), 35.5 (CH2Br), 33.8 (CH2), 25.0 (C(CH3)2), 22.9 (CH2) ppm. All data matched that 




Activation: The carboxylic acid (500 mg, 2.18 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 98:2 DCM:Et2O) to afford the corresponding NHPI ester  (628 mg, 
77 %) as a colorless oil that crystallized over several days to give a white amorphous solid. 
TLC: Rf = 0.21 (98:2 DCM:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.93 – 7.71 (br m, 4H, 
phthalimide ArCH), 4.31 – 4.08 (br m, NCH), 3.48 – 3.09 (br m, 3H, NCH2 and CH
aHbC=O), 
2.83 – 2.60 (br m, CHaHbC=O), 2.24 – 2.09 (br m, CHaHb), 2.01 – 1.78 (br m, CH2 and CH
aHb) 
ppm. 13C NMR (126 MHz, CDCl3) δ 167.6 and 167.5 (C=O), 162.0 (C=O), 154.5 and 154.2 
(C=O), 134.9 and 134.8 (phthalimide ArCH), 129.0 (phthalimide ArC), 124.1 (phthalimide 
ArCH), 80.2 and 79.7 (OC(CH3)3), 54.2 and 54.1 (NCH), 46.9 and 46.5 (CH2C=O), 36.3 and 
35.2 (CH2), 31.2 and 30.3 (CH2), 28.6 (C(CH3)3), 23.8 and 23.0 (CH2) ppm (Doubling up of 
signals due to presence of rotamers). HRMS (m/z): (ESI) calc’d for C19H22N2NaO6 [M+Na]
+: 
397.1370, found: 397.1372. IR (solid state) νmax: 2973, 2893, 1739 (C=O), 1698 (C=O), 1678 
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(C=O), 1365, 1165, 1108, 1081, 956, 877, 697 and 519 cm−1. Borylation: The NHPI ester (50 
mg, 0.13 mmol) was borylated according to General Procedure B. The crude reside was 
purified by flash column chromatography (SiO2; 95:5 pentane:acetone) to afford boronic ester 
66 (34 mg, 81 %) as a colorless oil.. TLC: Rf = 0.34 (60:40 pentane:Et2O). 1H NMR (400 MHz, 
CDCl3) δ 4.01 – 3.82 (br m, 1H, NCH), 3.45 – 3.21 (br m, 2H, NCH2), 2.06 – 1.94 (m, 1H, 
CHaHb), 1.87 – 1.77 (m, 1H, CHaHb), 1.75 – 1.66 (m, CHaHb), 1.63 – 1.36 (br m, 2H, CHaHb 
and CHaHbBpin), 1.43 (s, 9H, OC(CH3)3), 1.21 (s, 6H, C(CH3)2), 1.20 (s, 6H, C(CH3)2), 1.04 – 
0.81 (br m, 1H, CHaHbBpin) ppm. 13C NMR (101 MHz, CDCl3) δ 154.6 and 154.4 (C=O), 83.0 
(C(CH3)2), 78.9 (OC(CH3)3), 54.3 (NCH), 46.5 and 46.3 (NCH2), 33.4 and 33.1 (CH2), 28.7 
(OC(CH3)3), 25.0 and 24.8 (C(CH3)2), 23.8 and 23.3 (CH2), 18.3 (br, CH2Bpin) ppm (Doubling 
up of signals due to presence of rotamers). HRMS (m/z): (ESI) calc’d for C16H31NBO4 
[M+H]+: 312.2344, found: 312.2341. IR (neat) νmax: 2975, 1691 (C=O), 1365, 1166, 1141, 
1108 and 848 cm−1. 
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate (60) 
 
Activation: NHPI ester 55 was prepared according to a known procedure.68 Borylation: NHPI 
ester 55 (50 mg, 0.13 mmol) was borylated according to General Procedure B. The crude 
reside was purified by flash column chromatography (SiO2; 75:25 pentane:Et2O) to afford 
boronic ester 60 (35 mg, 87 %) as a colorless oil. TLC: Rf = 0.28 (75:25 pentane:Et2O). 1H 
NMR (400 MHz, CDCl3) δ 3.85 – 3.70 (m, 2H, NCH
aHb), 2.95 – 2.88 (m, 2H, NCHaHb), 1.65 
– 1.60 (m, 2H, CHaHb), 1.51 – 1.38 (m, 2H, CHaHb), 1.43 (s, 9H, OC(CH3)3), 1.22 (s, 12H, 
C(CH3)2), 1.06 (m, 1H, CHBpin) ppm. 13C NMR (126 MHz, CDCl3) δ 155.0 (C=O), 83.3 
(C(CH3)2), 79.1 (OC(CH3)3), 45.0 (NCH2), 28.6 (OC(CH3)3), 27.1 (CH2), 24.9 (C(CH3)2), 20.0 










Activation: NHPI ester 55 was prepared according to a known procedure.68 Borylation: NHPI 
ester 55 (50 mg, 0.13 mmol) was borylated according to General Procedure B but with a 
modified workup. After the 14 h stir under irradiation with blue LEDs methyliminodiacetic acid 
(MIDA, 79 mg, 0.53 mmol, 4.0 equiv) was added and the reaction mixture was stirred for 24 h 
at 60 °C (oil bath). The reaction mixture was transferred into a vial containing EtOAc (15 mL) 
and H2O (6 mL). After vigorously shaking and allowing to two layers to separate, the top 
organic layer was carefully removed with a pipette. This was repeated twice more with EtOAc 
(5 mL). The organic layers were combined and concentrated under reduced pressure. The crude 
reside was purified by flash column chromatography (SiO2; THF) to afford boronic ester 72 
(24 mg, 53 %) as a white amorphous solid. Note: The THF must be BHT free. TLC: Rf = 0.21 
(THF). 1H NMR (500 MHz, CDCl3) δ 4.07 – 4.04 (br m, 2H, NCH
aHb), 3.95 (d, J = 16.9 Hz, 
2H, C=OCHaHb), 3.78 (d, J = 16.9 Hz, 2H, C=OCHaHb), 2.93 (s, 3H, NCH3), 2.73 – 2.60 (br 
m, 2H, NCHaHb), 1.61 – 1.58 (br m, 2H, CHaHb), 1.44 (s, 9H, C(CH3)3), 1.31 – 1.19 (m, 2H, 
CHaHb), 0.93 (tt, J = 12.3, 3.2 Hz, CHBpin) ppm. 13C NMR (126 MHz, CDCl3) δ 169.0 (C=O), 
155.4 (C=O), 79.4 (OC(CH3)3), 63.2 (C=OCH2), 46.4 (NCH3), 28.6 (C(CH3)3), 27.9 (CH2) 
ppm. NCH2 not observed.
 HRMS (m/z): (ESI) calc’d for C15H25BN2NaO6 [M+Na]
+: 363.1701, 





Activation: NHPI ester 113 was prepared according to a known procedure.68 Borylation: 
NHPI ester 113 (42 mg, 0.13 mmol) was borylated according to General Procedure B. The 
crude reside was purified by flash column chromatography (SiO2; 70:30 pentane:Et2O) to afford 
boronic ester 76 (28 mg, 82 %, 1.4:1 d.r.) as a colorless oil. TLC: Rf = 0.36 (70:30 
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pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 3.64 and 3.64 (s, 3H C=OOCH3), 2.82 – 2.67 
(m, 1H, CHC=O), 2.12 – 1.35 (m, 7H, CHBpin and CH2 ×3), 1.22 and 1.21 (s, 12H, C(CH3)2) 
ppm. 13C NMR (101 MHz, CDCl3) δ 177.3 and 177.0 (C=O), 83.2 and 83.1 (C(CH3)2), 51.7 
and 51.6 (C=OOCH3), 45.2 and 44.3 (CHC=O), 33.3 and 32.3 (CH2), 31.3 and 30.5 (CH2), 28.9 
and 27.9 (CH2), 24.9 and 24.8 (C(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C13H23BNaO4 
[M+Na]+: 277.1584, found: 277.1580. IR (neat) νmax: 2977, 2952, 2872, 1733, 1381, 1315, 
1197, 1143, 973 and 858 cm−1. 
1,2-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexane (80) 
 
Activation: The carboxylic acid (500 mg, 3.24 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A with all reagents doubled in quantity. The crude residue 
was purified by flash column chromatography (SiO2; DCM) to afford the corresponding NHPI 
ester (709 mg, 47 %) as a white solid. m.p.: 188 – 192 °C (DCM/MeOH). TLC: Rf = 0.21 
(DCM). 1H NMR (400 MHz, CDCl3) δ 7.89 – 7.85 (m, 2H, phthalimide ArH), 7.79 – 7.75 (m, 
2H, phthalimide ArH), 3.28 – 3.21 (m, 2H, CHC=O), 2.44 – 2.37 (br m, 2H, CHCHaHb ×2), 
1.94 – 1.87 (br m, 2H, CHaHb ×2), 1.84 – 1.75 (br m, 2H, CHCHaHb ×2), 1.53 – 1.46 (br m, 
2H, CHaHb ×2) ppm. 13C NMR (101 MHz, CDCl3) δ 170.3 (C=O), 161.8 (C=O), 134.8 
(phthalimide ArCH), 129.2 (phthalimide ArC), 124.1 (phthalimide ArC), 41.7 (CHC=O), 28.4 
(CH2CHC=O), 24.4 (CH2CH2CHC=O) ppm. HRMS (m/z): (ESI) calc’d for C24H18N2NaO8 
[M+Na]+: 485.0955, found: 485.0955. IR (solid state) νmax: 2937, 2862, 1783, 1734, 1468, 
1358, 1186, 1123, 1082, 997, 970, 876, 693 and 518 cm−1. Borylation: The NHPI ester (62 mg, 
0.13 mmol) was borylated according to General Procedure B with double the amount of 
B2cat2. The crude reside was purified by flash column chromatography (SiO2; 90:10 
pentane:Et2O) to afford boronic ester 80 (30 mg, 67 %, 90:10 d.r.) as an amorphous white solid. 
TLC: Rf = 0.31 (90:10 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 1.72 – 1.62 (br m, 4H, 
CH2 ×2), 1.25 – 1.17 (m, 4H, CH2 ×2), 1.21 (s, 24H, C(CH3)2), 1.01 – 0.94 (br m, 2H, CHBpin) 
ppm. 13C NMR (101 MHz, CDCl3) δ 82.8 (C(CH3)2), 28.5 (CH2), 27.3 (CH2), 25.0 (C(CH3)2), 
24.8 (C(CH3)2), 22.9 (br, CHBpin) ppm. HRMS (m/z): (ESI) calc’d for C18H34B2NaO4 
[M+Na]+: 359.2542, found: 359.2543. IR (solid state) νmax: 2977, 2918, 2848, 1370, 1312, 
1138, 972 and 861 cm−1. 





Activation: The carboxylic acid194 (500 mg, 2.00 mmol) was coupled with 
N-hydroxyphthalimide according to General Procedure A. The crude residue was purified by 
flash column chromatography (SiO2; 40:60 pentane:DCM) to afford the corresponding NHPI 
ester  (677 mg, 86 %) as a white solid. m.p.: 180 – 184 °C (DCM/MeOH). TLC: Rf = 0.29 
(30:70 pentane:DCM). 1H NMR (400 MHz, CDCl3) δ 7.89 – 7.82 (m, 2H, phthalimide ArH), 
7.78 – 7.74 (m, 2H, phthalimide ArH), 7.52 – 7.48 (m, 1H, ArH), 7.41 – 7.37 (m, 1H, ArH), 
7.35 – 7.25 (m, 2H, ArH), 7.18 – 7.11 (m, 4H, ArH), 4.90 (d, J = 2.3 Hz, 1H, CHCHC=O), 4.42 
(t, J = 2.6 Hz, 1H, CHCH2), 3.30 – 3.26 (m, 1H, CHC=O), 2.22 – 2.12 (m, 2H, CH2) ppm. 13C 
NMR (101 MHz, CDCl3) δ 170.2 (C=O), 162.0 (C=O), 143.5 (ArC), 143.4 (ArC), 141.9 (ArC), 
138.6 (ArC), 134.8 (phthalimide ArCH), 129.1 (phthalimide ArC), 126.8 (ArCH), 126.7 
(ArCH), 126.2 (ArCH), 126.1 (ArCH), 125.9 (ArCH), 124.1 (phthalimide ArCH), 123.9 
(ArCH), 123.8 (ArCH), 123.2 (ArCH), 47.2 (CHCHC=O), 43.7 (CHCH2), 41.8 (CHC=O), 31.4 
(CH2) ppm. HRMS (m/z): (ESI) calc’d for C25H17NNaO4 [M+Na]
+: 418.1050, found: 
418.1048. IR (solid state) νmax: 3024, 2954, 1743 (C=O), 1466, 1087, 996, 964, 762 and 
695 cm−1. Borylation: The NHPI ester (53 mg, 0.13 mmol) was borylated according to 
General Procedure B. The crude reside was purified by flash column chromatography (SiO2; 
98:2 pentane:Et2O) to afford boronic ester 81 (23 mg, 53 %) as an amorphous white solid. TLC: 
Rf = 0.21 (95:5 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.28 – 7.24 (m, 4H, ArH), 7.10 
– 7.01 (m, 4H, ArH), 4.47 (d, J = 2.3 Hz, 1H, CHCHBpin), 4.33 (t, J = 2.6 Hz, 1H, CHCH2), 
1.90 (ddd, J = 11.8, 5.4, 2.5 Hz, 1H, CHaHb), 1.82 (app td, J = 11.8, 2.5 Hz, 1H, CHaHb), 1.43 
(ddd, J = 10.7, 5.4, 2.5 Hz, 1H, CHBpin), 1.12 (s, 6H, C(CH3)2), 1.02 (s, 6H, C(CH3)2) ppm. 
13C NMR (101 MHz, CDCl3) δ 145.2 (ArC), 144.3 (ArC), 143.9 (ArC), 142.8 (ArC), 125.7 
(ArCH), 125.5 (ArCH), 125.4 (ArCH), 125.1 (ArCH), 124.3 (ArCH), 123.4 (ArCH), 123.3 
(ArCH), 122.8 (ArCH), 83.4 (C(CH3)2), 45.7 (CHCHBpin), 44.6 (CHCH2), 29.6 (CH2), 24.9 
(C(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C22H25BNaO2 [M+Na]
+: 355.1844, found: 
355.1837. IR (solid state) νmax: 2982, 2940, 2870, 1458, 1366, 1315, 1249, 1138, 981, 854, 
753, 743 and 701 cm−1. 




Activation: The carboxylic acid (500 mg, 3.52 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 40:60 pentane:DCM) to afford the corresponding NHPI ester  (740 mg, 
73 %) as a white solid. m.p.: 78 – 80 °C (DCM/MeOH). TLC: Rf = 0.21 (40:60 pentane:DCM). 
1H NMR (400 MHz, CDCl3) δ 7.89 – 7.84 (m, 2H, phthalimide ArCH), 7.78 – 7.74 (m, 2H, 
phthalimide ArCH), 1.52 (s, 1H, CHC=O), 1.30 (s, 6H, CH3 ×2), 1.27 (6H, CH3 ×2) ppm. 13C 
NMR (101 MHz, CDCl3) δ 167.8 (C=O), 162.6 (C=O), 134.7 (phthalimide ArCH), 129.2 
(phthalimide ArC), 124.0 (phthalimide ArCH), 33.4 (C(CH3)2), 32.4 (CHC=O), 23.4 (CH3), 
16.5 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C16H17NNaO4 [M+Na]
+: 310.1050, found: 
310.1052. IR (solid state) νmax: 2950, 2924, 1773, 1731, 1467, 1357, 1094, 1021, 997, 977, 
877, 847, 783 and 691 cm−1. Borylation: The NHPI ester (38 mg, 0.13 mmol) was borylated 
according to General Procedure B. The crude reside was purified by flash column 
chromatography (SiO2; 95:5 pentane:Et2O) to afford boronic ester 82 (25 mg, 83 %) as an 
amorphous white solid. TLC: Rf = 0.60 (80:20 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 
1.21 (s, 12H, Bpin C(CH3)2), 1.15 (s, 6H, C(CH3)2 ×2), 1.14 (s, 6H, C(CH3)2 ×2), −0.46 (s, 1H, 
CHBpin) ppm. 13C NMR (101 MHz, CDCl3) δ 82.5 (Bpin C(CH3)2), 27.2 (C(CH3)2, 25.0 (Bpin 
C(CH3)2), 24.7 (CH3), 19.9 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C13H25BNaO2 [M+Na]
+: 
247.1842, found: 247.1840. IR (solid state) νmax: 2979, 2925, 2867, 1418, 1396, 1343, 1311, 
1235, 1142, 1106, 857 and 706 cm−1. 
2-((3r,5r,7r)-Adamantan-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (84) 
 
Activation: The NHPI ester was prepared according to a known procedure.68 Borylation: The 
NHPI ester (43 mg, 0.13 mmol) was borylated according to General Procedure B. The crude 
reside was purified by flash column chromatography (SiO2; 80:20 pentane:Et2O) to afford 
boronic ester 84 (26 mg, 74 %) an amorphous white solid. Gram Scale Borylation: The NHPI 
ester (2.0 g, 6.15 mmol) and B2cat2 (1.83 g, 7.68 mmol) were carefully weighed into a flame-
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dried Schlenk tube containing a small magnetic stirrer bar. DMAc (12.3 mL, 0.5 M) was added 
and then the headspace of the vial was purged with a gentle stream of argon for approximately 
30 seconds. The tube was sealed and stirred under blue LED irradiation for 14 h. Pinacol 
(2.91 g, 24.59 mmol) was dissolved in Et3N (4.14 mL) and added to the reaction mixture and 
stirred for 1 h. The reaction mixture was transferred into a separating funnel containing EtOAc 
(40 mL), H2O (20 mL), NH4Cl (saturated aqueous solution, 20 mL). After vigorously shaking 
and allowing to two layers to separate, the organic layer was collected. This was repeated twice 
more with EtOAc (40 mL). The organic layers were combined, dried over MgSO4, and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 80:20 pentane:Et2O) to afford boronic ester 84 (1.11g, 69 %) as an 
amorphous white solid. 1H NMR (400 MHz, CDCl3) δ 1.91 – 1.71 (br m, 15H, CH ×3 and CH2 
×6), 1.21 (s, 12H, C(CH3)2) ppm. 13C NMR (101 MHz, CDCl3) δ 82.7 (C(CH3)2), 38.1 (CH2), 
37.7 (CH2), 27.7 (CH), 24.8 (C(CH3)3) ppm. All data matched that reported in the literature.
187 
Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cubane-1-carboxylate (86) 
 
Activation: The NHPI ester was prepared according to a known procedure.68 Borylation: The 
NHPI ester (47 mg, 0.13 mmol) was borylated according to General Procedure B. The crude 
reside was purified by flash column chromatography (SiO2; 60:40 pentane:Et2O) to afford 
boronic ester 86 (18 mg, 46 %) an amorphous solid. TLC: Rf = 0.42 (50:50 pentane:Et2O). 1H 
NMR (400 MHz, CDCl3) δ 4.31 – 4.27 (m, 3H, CH), 4.04 – 3.99 (m, 3H, CH), 3.69 (s, 3H, 
C=OOCH3), 1.25 (s, 12H, C(CH3)2) ppm. 13C NMR (126 MHz, CDCl3) δ 172.6 (C=O), 83.2 
(C(CH3)2), 55.3 (CC=O), 51.5 (C=OOCH3), 49.8 (CH), 45.1 (CH), 24.8 (C(CH3)2) ppm. 
HRMS (m/z): (ESI) calc’d for C16H21BNaO4 [M+Na]
+: 311.1428, found: 311.1420. IR (solid 










Activation: The carboxylic acid (1.62 gg, 6.54 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 98:2 DCM:Et2O) followed by recrystallization from DCM/MeOH to 
afford the corresponding NHPI ester (2.24 g, 76 %) as a white solid. m.p.: 180 – 183 °C 
(DCM/MeOH). TLC: Rf = 0.30 (98:2 DCM:Et2O). 1H NMR (500 MHz, CDCl3) δ 7.91 – 7.88 
(m, 2H, phthalimide ArCH), 7.81 – 7.78 (m, 2H, phthalimide ArCH), 4.46 – 4.44 (m, 3H, CH), 
4.30 – 4.28 (m, 3H, CH), 1.48 (s, 9H, OC(CH3)3) ppm. 13C NMR (126 MHz, CDCl3) δ 170.8 
(C=O), 167.2 (C=O), 162.2 (C=O), 134.9 (ArCH), 129.1 (ArC), 124.1 (ArCH), 80.9 
(OC(CH3)3), 57.0 (C), 53.1 (C), 47.8 (CH), 47.6 (CH), 28.3 (OC(CH3)3) ppm. HRMS (m/z): 
(ESI) calc’d for C22H19NNaO6 [M+Na]
+: 416.1105, found: 416.1101. IR (solid state) νmax: 
2993, 1777, 1739, 1710, 1364, 1329, 1217, 1162, 1143, 1086, 1022, 1007, 878 and 840 cm−1. 
Borylation: The NHPI ester (265 mg, 0.67 mmol) was borylated according to General 
Procedure B. The crude reside was purified by flash column chromatography (SiO2; 70:30 
pentane:Et2O then 99:1 DCM:Et2O) to afford boronic ester 87 (100 mg, 45 %) as a white solid. 
m.p.: 170 – 173 °C (Et2O). TLC: Rf = 0.44 (70:30 pentane:Et2O). 1H NMR (500 MHz, CDCl3) 
δ 4.22 – 4.20 (m, 3H, CH), 3.98 – 3.96 (m, 3H, CH), 1.46 (s, 9H, OC(CH3)3), 1.26 (s, 12H, 
Bpin) ppm. 13C NMR (126 MHz, CDCl3) δ 172.1 (C=O), 83.3 (OC(CH3)2), 80.1 (OC(CH3)3), 
56.5 (C), 49.9 (CH), 45.0 (CH), 28.3 (OC(CH3)3), 24.9 (OC(CH3)2) ppm. HRMS (m/z): (ESI) 
calc’d for C19H27BNaO4 [M+Na]
+: 353.1898, found: 353.1905. IR (solid state) νmax: 2982, 
1703, 1392, 1312, 1228, 1162, 1142, 1087, 1070 and 850 cm−1. 
2-(Bicyclo[1.1.1]pentan-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (88) 
 
Activation: The carboxylic acid (110 mg, 0.98 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 60:40 pentane:Et2O) to afford the corresponding NHPI ester  (187 mg, 
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74 %) as an amorphous white solid. TLC: Rf = 0.23 (50:50 pentane:DCM). 1H NMR 
(500 MHz, CDCl3) δ 7.89 – 7.86 (m, 2H, phthalimide ArH), 7.80 – 7.76 (m, 2H, phthalimide 
ArH), 2.55 (s, 1H, CH), 2.33 (s, 6H, CH2) ppm. 13C NMR (126 MHz, CDCl3) δ 164.7 (C=O), 
162.0 (C=O), 134.8 (phthalimide ArCH), 129.1 (phthalimide ArC), 124.1 (phthalimide ArCH), 
52.5 (CH2), 40.0 (CC=O), 29.3 (CH) ppm. HRMS (m/z): (ESI) calc’d for C14H11NNaO4 
[M+Na]+: 280.0580, found: 280.0594. IR (solid state) νmax: 3001, 2887, 1776, 1736, 1372, 
1185, 1039, 875, 789, 692, 606 and 518 cm−1. Borylation: The NHPI ester (34 mg, 0.13 mmol) 
was borylated according to General Procedure B. The crude reside was purified by flash 
column chromatography (SiO2; 90:10 pentane:Et2O) to afford boronic ester 88 (11 mg, 42 %) 
a colorless oil (due to the product’s volatility, a small amount of pentane remained). Note: 
product is volatile and unstable on silica. TLC: Rf = 0.24 (90:10 pentane:Et2O). 1H NMR 
(500 MHz, CDCl3) δ 2.48 (s, 1H, CH), 1.95 (s, 6H, CH2), 1.22 (s, 12H, C(CH3)2) ppm. 13C 
NMR (126 MHz, CDCl3) δ 83.3 (C(CH3)2), 52.0 (CH2), 34.7 (CH), 24.9 (C(CH3)2) ppm. 
HRMS (m/z): (EI) calc’d for C11H19BNaO2 [M+Na]
+: 217.1372, found: 217.1369. IR (neat) 
νmax: 2923, 1399, 1317, 1216, 1135, 852 and 662 cm−1. 
2-Heptadecyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (89) 
 
Activation: Stearic acid (1.0 g, 3.52 mmol) was coupled with N-hydroxyphthalimide according 
to General Procedure A. The crude residue was purified by flash column chromatography 
(SiO2; 60:40 pentane:DCM) to afford the corresponding NHPI ester  (1.07 mg, 71 %) as a white 
solid. TLC: Rf = 0.32 (50:50 pentane:DCM). 1H NMR (400 MHz, CDCl3) δ 7.91 – 7.86 (m, 
2H, phthalimide ArH), 7.81 – 7.76 (m, 2H, phthalimide ArH), 2.66 (t, J = 7.5 Hz, 2H, CH2C=O), 
1.78 (p, J = 7.5 Hz, CH2CH2C=O), 1.44 (p, J = 7.5 Hz, CH2CH2CH2C=O), 1.37 – 1.21 (m, 26H, 
CH2 ×13), 0.88 (t, J = 7.0 Hz, 3H, CH3) ppm. 13C NMR (101 MHz, CDCl3) δ 169.8 (C=O), 
162.1 (C=O), 134.8 (phthalimide ArCH), 129.1 (phthalimide ArC), 124.1 (phthalimide ArCH), 
32.1 (CH2C=O), 31.1 (CH2), 29.8 – 29.7 (CH2 ×9), 29.5 (CH2), 29.3 (CH2), 29.0 (CH2), 24.8 
(CH2), 22.8 (CH2), 14.3 (CH3) ppm. All data matched that reported in the literature.
195 
Borylation: The NHPI ester (57 mg, 0.13 mmol) was borylated according to General 
Procedure B. The crude reside was purified by flash column chromatography (SiO2; 90:10 
pentane:Et2O) to afford boronic ester 89 (41 mg, 84 %) as colorless oil. TLC: Rf = 0.56 (90:10 
pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 1.43 – 1.17 (m, 30H, CH2 ×15), 1.24 (s, 12H, 
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C(CH3)2), 0.88 (t, J = 6.8 Hz, 3H, CH3), 0.76 (t, J = 7.7 Hz, 2H, CH2Bpin) ppm. 13C NMR 
(101 MHz, CDCl3) δ 83.0 (C(CH3)2), 32.6 (CH2), 32.1 (CH2), 29.9 – 29.5 (CH2 ×9), 25.0 
(C(CH3)2), 24.2 (CH2), 22.9 (CH2), 14.3 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C23H48BO2 
[M+H]+: 367.3746, found: 367.3745. IR (neat) νmax: 2922, 2853, 1377, 1316, 1145, 968, 847 




Activation: The NHPI ester was prepared according to a known procedure.69 Borylation: The 
NHPI ester (67 mg, 0.13 mmol) was borylated according to General Procedure B. The crude 
reside was purified by flash column chromatography (SiO2; 95:5 pentane:acetone) to afford 
boronic ester 94 (28 mg, 47 %) a colorless oil. TLC: Rf = 0.31 (70:30 pentane:Et2O). 1H NMR 
(400 MHz, CDCl3) δ 7.64 (d, J = 8.6 Hz, 2H, ArH), 7.45 (d, J = 7.6 Hz, 2H, ArH), 6.93 (d, J = 
9.0 Hz, 2H, ArH), 6.65 (dd, J = 9.0, 2.5 Hz, 1H, ArH), 3.84 (s, 3H, OCH3), 2.29 (s, 3H, CH3), 
2.18 (s, 2H, CH2Bpin), 1.23 (s, 12H, C(CH3)2) ppm. 13C NMR (126 MHz, CDCl3) δ 168.3 
(C=O), 156.0 (ArC), 138.8 (ArC), 134.7 (ArC), 133.2 (ArC), 132.0 (ArC), 131.2 (ArCH), 131.1 
(ArC), 129.1 (ArCH), 116.7 (ArC), 115.0 (ArCH), 111.3 (ArCH), 101.7 (ArCH), 83.7 
(C(CH3)2), 55.8 (OCH3), 24.9 (C(CH3)2), 13.8 (CH3) ppm. HRMS (m/z): (ESI) calc’d for 
C24H27BClNNaO4 [M+Na]
+: 462.1618, found: 462.1618. IR (neat) νmax: 2977, 1676, 1476, 
1454, 1321, 1222, 1140, 1088, 1061, 846, 732 cm−1. 
 (Z)-2-(Heptadec-8-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (97) 
 
Activation: Oleic acid (1.0 mL, 3.15 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 60:40 pentane:DCM) to afford the corresponding NHPI ester  (1.04 g, 
77 %) as a colorless oil. TLC: Rf = 0.28 (50:50 pentane:DCM). 1H NMR (400 MHz, CDCl3) 
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δ 7.90 – 7.86 (m, 2H, phthalimide ArH), 7.80 – 7.76 (m, 2H, phthalimide ArH), 5.39 – 5.31 (m, 
2H, =CH ×2), 2.66 (t, J = 7.5 Hz, 2H, CH2C=O), 2.06 – 1.97 (m, 4H, =CHCH2 ×2), 1.78 (tt, 
J = 7.5 Hz, 2H, CH2CH2C=O), 1.47 – 1.23 (m, 20H, CH2 ×10), 0.87 (t, J = 7.0 Hz, 3H, CH3) 
ppm. 13C NMR (101 MHz, CDCl3) δ 169.7 (C=O), 162.1 (C=O), 134.8 (phthalimide ArCH), 
130.2 (=CH), 129.8 (=CH), 129.1 (phthalimide ArC), 124.1 (phthalimide ArCH), 32.0 (CH2), 
31.1 (CH2C=O), 29.9 (CH2), 29.8 (CH2), 29.7 (CH2), 29.5 (CH2), 29.4 (CH2), 29.2 (CH2 ×2), 
28.9 (CH2), 27.4 (=CHCH2), 27.3 (=CHCH2), 24.8 (CH2CH2C=O), 22.8 (CH2), 14.2 (CH3) 
ppm. All data matched that reported in the literature.196 Borylation: The NHPI ester (57 mg, 
0.13 mmol) was borylated according to General Procedure B. The crude reside was purified 
by flash column chromatography (SiO2; 95:5 pentane:Et2O) to afford boronic ester 97 (44 mg, 
90 %) as colorless oil. TLC: Rf = 0.55 (95:5 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 
5.39 – 5.30 (m, 2H, =CH ×2), 2.05 – 1.98 (m, 4H, =CHCH2 ×2), 1.43 – 1.21 (m, 22H, CH2 
×11), 1.24 (s, 12H, C(CH3)2), 0.88 (t, J = 7.0 Hz, 3H, CH3), 0.76 (t, J = 7.7 Hz, 2H, CH2Bpin) 
ppm. 13C NMR (101 MHz, CDCl3) δ 130.1 (=CH), 130.0 (=CH), 83.0 (C(CH3)2), 32.6 (CH2), 
32.1 (CH2), 29.9 (CH2 ×2), 29.9 (CH2), 29.7 (CH2), 29.5 (CH2 ×2), 29.4 (CH2), 27.4 (=CHCH2), 
27.4 (=CHCH2), 25.0 (C(CH3)2), 24.2 (CH2), 22.8 (CH2), 14.3 (CH3) ppm. HRMS (m/z): (ESI) 
calc’d for C23H46BO2 [M+H]
+: 365.3590, found: 365.3589. IR (neat) νmax: 2978, 2923, 2854, 
1377, 1371, 1316, 1146, 958 and 847 cm−1. 
1,3-Dioxoisoindolin-2-yl (E)-non-3-enoate 
 
Activation: The carboxylic acid197 (1.62 g, 10.39 mmol) was coupled with 
N-hydroxyphthalimide according to General Procedure A. The crude residue was purified by 
flash column chromatography (SiO2; 50:50 pentane:DCM) to afford the corresponding NHPI 
ester  (2.64 g, 84 %) as a colorless oil. TLC: Rf = 0.33 (pentane:DCM 50:50). 1H NMR: 
(400 MHz, CDCl3) δ 7.90 – 7.85 (m, 2H, phthalimide ArH), 7.80 – 7.75 (m, 2H, phthalimide 
ArH), 5.77 – 5.70 (m, 1H, =CH), 5.59 – 5.51 (m, 1H, =CH), 3.39 – 3.37 (m, 2H, CH2C=O), 
2.06 (q, J = 7.6 Hz, 2H, CH2CH=), 1.43 – 1.24 (m, 6H, 3x CH2), 0.88 (t, J = 6.9 Hz, 3H, CH3) 
ppm. 13C NMR: (126 MHz, CDCl3) δ 168.2 (C=O), 162.0 (C=O), 137.2 (=CH), 134.9 
(phthalimide ArCH), 129.0 (phthalimide ArC), 124.1 (phthalimide ArCH), 118.8 (=CH), 34.7 
(CH2C=O), 32.6 (CH2CH=), 31.4 (CH2), 28.8 (CH2), 22.6 (CH2), 14.2 (CH3) ppm. HRMS 
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(m/z): (ESI) calc’d for C17H19NNaO4 [M+Na]
+: 324.1206, found: 324.1200. IR (neat) νmax: 
2927, 1788, 1740, 1467, 1360, 1185, 1132, 1080, 1060, 967, 877 and 785 cm−1. 
1,3-Dioxoisoindolin-2-yl (E)-4-phenylbut-3-enoate 
 
Activation: The carboxylic acid (500 mg, 3.08 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 50:50 pentane:DCM) to afford the corresponding NHPI ester  (677 mg, 
72 %) as a white solid. m.p.: 94 – 98 °C (DCM/MeOH). TLC: Rf = 0.16 (pentane:DCM 50:50). 
1H NMR: (400 MHz, CDCl3) δ 7.91 – 7.87 (m, 2H, phthalimide ArH), 7.81 – 7.77 (m, 2H, 
phthalimide ArH), 7.41 (d, J = 7.3 Hz, 2H, ArH), 7.33 (t, J = 7.3 Hz, 2H, ArH), 7.26 (t, J = 
7.3 Hz, 2H, ArH), 6.67 (d, J = 15.9 Hz, 1H, ArCH=), 6.31(dt, J = 15.9, 6.9 Hz, 1H, ArCH=CH), 
3.62 (dd, J = 6.9 Hz, 1.2 Hz, 2H, CH2C=O) ppm. 13C NMR: (101 MHz, CDCl3) δ 167.8 (C=O), 
162.0 (C=O), 136.5 (ArC), 135.4 (ArCH=), 134.9 (phthalimide ArCH), 129.0 (phthalimide 
ArC), 128.7 (ArCH), 128.1 (ArCH), 126.6 (ArCH), 124.2 (phthalimide ArCH), 118.8 
(ArCH=CH), 35.0 (CH2C=O) ppm. HRMS (m/z): (ESI) calc’d for C18H13NNaO4 [M+Na]
+: 
330.0737, found: 330.0745. IR (solid state) νmax: 3057, 3028, 1788, 1736, 1361, 1138, 1050, 
968, 877, 756 and 696 cm−1. 
1,3-Dioxoisoindolin-2-yl (E)-3-(4-chlorophenyl)acrylate 
 
Activation: The carboxylic acid (500 mg, 2.74 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 40:60 pentane:DCM) and then recrystallized from DCM/MeOH to 
afford the corresponding NHPI ester  (476 mg, 53 %) as a crystalline white solid. TLC: Rf = 
0.36 (pentane:DCM 20:80). 1H NMR: (400 MHz, CDCl3) δ 7.93 – 7.88 (m, 3H, phthalimide 
ArH and ArCH=), 7.82 – 7.78 (m, 2H, phthalimide ArH), 7.54 – 7.51 (m, 2H, ArH), 7.42 – 7.39 
(m, 2H, ArH), 6.63 (d, J = 16.1 Hz, 1H, =CHC=O) ppm. 13C NMR: (101 MHz, CDCl3) δ 162.9 
(C=O), 162.1 (C=O), 148.5 (ArCH=), 137.7 (ArC), 134.9 (phthalimide ArCH), 132.1 (ArC), 
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129.9 (ArCH), 129.6 (ArCH), 129.1 (phthalimide ArC), 124.1 (phthalimide ArCH), 112.5 
(=CHC=O) ppm. All data matched that reported in the literature.198 
1,3-Dioxoisoindolin-2-yl 3-(diphenylphosphaneyl)propanoate 
 
Activation: The carboxylic acid (500 mg, 1.94 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 40:60 pentane:DCM) to afford the corresponding NHPI ester  (577 mg, 
74 %) as a white solid. m.p.: 113 – 116 °C (DCM/MeOH). TLC: Rf = 0.25 (pentane:DCM 
30:70). 1H NMR: (400 MHz, CDCl3) δ 7.90 – 7.86 (m, 2H, phthalimide ArH), 7.81 – 7.76 (m, 
2H, phthalimide ArH), 7.48 – 7.43 (m, 4H, ArH), 7.40 – 7.34 (m, 6H, ArH), 2.76 – 2.70 (m, 
2H, CH2C=O), 2.50 – 2.46 (CH2P) ppm. 13C NMR: (101 MHz, CDCl3) δ 169.5 (d, J = 17.1 Hz, 
C=O), 162.0 (C=O), 137.2 (d, J = 12.5 Hz, ArCP), 134.9 (phthalimide ArCH), 132.9 (d, J = 
18.9 Hz, ArCH), 129.2 (ArCH), 129.0 (phthalimide ArC), 128.9 (d, J = 6.8 Hz, ArCH), 124.1 
(phthalimide ArCH), 27.9 (d, J = 20.9 Hz, CH2C=O), 22.9 (d, J = 13.9 Hz, CH2P) ppm. HRMS 
(m/z): (ESI) calc’d for C23H18NNaO4P [M+Na]
+: 426.0866, found: 426.0858. IR (solid state) 
νmax: 3067, 1739, 1355, 1185, 1078, 960, 875 and 696 cm−1. 
1,3-Dioxoisoindolin-2-yl 1,3-dithiane-2-carboxylate 
 
Activation: The carboxylic acid199 (500 mg, 3.04 mmol) was coupled with 
N-hydroxyphthalimide according to General Procedure A. The crude residue was purified by 
flash column chromatography (SiO2; 70:30 pentane:DCM) to afford the corresponding NHPI 
ester  (450 mg, 48 %) as a white solid. m.p.: 156 – 160 °C (DCM/MeOH). TLC: Rf = 0.43 
(DCM). 1H NMR: (400 MHz, CDCl3) δ 7.93 – 7.88 (m, 2H, phthalimide ArH), 7.83 – 7.78 (m, 
2H, phthalimide ArH), 4.45 (s, 1H, CHC=O), 3.43 (ddd, J = 14.8, 12.8, 2.6 Hz, 2H, SCHaHb), 
2.67 – 2.61 (m, 2H, SCHaHb), 2.23 – 2.15 (m, 2H, CH2), 2.10 – 1.99 (m, 2H, CH2) ppm. 13C 
NMR: (101 MHz, CDCl3) δ 165.9 (C=O), 161.8 (C=O), 135.0 (phthalimide ArCH), 129.0 
(phthalimide ArC), 124.2 (phthalimide ArCH), 36.3 (CHC=O), 25.6 (2x CH2), 24.6 (CH2) ppm. 
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HRMS (m/z): (ESI) calc’d for C13H11NNaO4S [M+Na]
+: 332.0022, found: 332.0037. IR (solid 
state) νmax: 2960, 2920, 1784, 1734, 1353, 1185, 1132, 1051, 968, 875, 858, 791 and 694 cm−1. 
1,3-Dioxoisoindolin-2-yl 2-(phenylthio)acetate 
 
Activation: The carboxylic acid (500 mg, 2.97 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 30:70 pentane:DCM) to afford the corresponding NHPI ester  (745  mg, 
80 %) as a colorless oil. m.p.: 68 – 70 °C (DCM/MeOH). TLC: Rf = 0.18 (pentane:Et2O 90:10). 
1H NMR: (500 MHz, CDCl3) δ 7.88 (m, 2H, 2×Ar-H), 7.79 (m, 2H, 2×Ar-H), 7.58 (m, 1H, Ar-
H), 7.57 (m, 1H, Ar-H), 7.37 (m, 2H, Ar-H), 7.31 (m, 1H, Ar-H), 3.89 (s, 2H, CH2) ppm. 13C 
NMR: (126 MHz, CDCl3) δ 166.4 (CO2R), 161.7 (2×CO), 135.0 (2×HCAr), 133.4 (CAr), 132.1 
(2×HCAr), 129.5 (2×HCAr), 129.0 (2×CAr), 128.4 (HCAr), 124.2 (2×HCAr), 34.7 (CH2) ppm. 
HRMS (m/z): (ESI) calc’d for C16H11NNaO4S [M+Na]
+: 336.0301, found: 336.0306. IR (solid 




Activation: The carboxylic acid (500 mg, 2.97 mmol) was coupled with N-hydroxyphthalimide 
according to General Procedure A. The crude residue was purified by flash column 
chromatography (SiO2; 50:50 pentane:DCM) to afford the corresponding NHPI ester  (794 mg, 
85 %) as a colorless oil. TLC: Rf = 0.29 (pentane:DCM 50:50). 1H NMR: (400 MHz, CDCl3) 
δ 7.88 – 7.84 (m, 2H, phthalimide ArH), 7.79 – 7.74 (m, 2H, phthalimide ArH), 4.95 (d, J = 
7.6 Hz, 1H, =CH), 2.22 – 2.18 (m, 1H, CHC=O), 1.74 (s, 3H, =CH3), 1.72 (s, 3H, =CH3), 1.69 
(d, J = 5.3 Hz, 1H, =CHCH), 1.33 (s, CH3), 1.24 (s, CH3) ppm. 13C NMR: (101 MHz, CDCl3) 
δ 168.7 (C=O), 162.3 (C=O), 137.3 (=C(CH3)2), 134.8 (phthalimide ArCH), 129.1 (phthalimide 
ArC), 124.0 (phthalimide ArCH), 119.9 (=CH), 35.2 (CHC=O), 31.3 (C(CH3)2), 31.2 
(=CHCH), 25.7 (=C(CH3)
a(CH3)
b), 22.0 (CH3), 20.5 (CH3), 18.7 (=C(CH3)
a(CH3)
b) ppm. 
HRMS (m/z): (ESI) calc’d for C18H19NNaO4 [M+Na]
+: 336.1206, found: 336.1203. IR (neat) 
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νmax: 2959, 2925, 2877, 1774, 1739, 1359, 1186, 1096, 975, 877, 695 and 518 cm−1. [𝛂]𝐃
𝟐𝟓:  
+68 (c 1.0, CHCl3). 
2.4 Decarboxylative borylation of -amino acids  
 
Scheme 94. Model system for development of the decarboxylative borylation N-Boc proline NHPI ester. 
Table 10. Optimization of the decarboxylative borylation of N-Boc proline NHPI ester. *Yields were measured 
using a calibrated GC with 1,3,5-trimethoxybenzene as internal standard. Unless otherwise stated, all reactions 
were performed a 0.13 mmol scale with 1.3 mL of solvent (0.10 M). #TCNHPI = tetrachlorophthalimide 
 Light? Solv. Time B source %* Notes 
1) ‘Standard conditions’ 
1 Y DMAc 14 h B2cat2 (1.25 equiv) 8 Et3N workup 
2) Additive 
2 Y DMAc 14 h B2cat2 (1.25 equiv) 22 2 equiv DMAP, Et3N workup 
3 Y DMAc 14 h B2cat2 (1.25 equiv) <1 2 equiv DMAP, TCNHPI#, 
Et3N workup 
4 Y DMAc 14 h B2cat2 (1.25 equiv) 3 5 equiv DMAP, Et3N workup 
5 Y DMAc 14 h B2cat2 (1.25 equiv) <1 1 equiv DMAP, Et3N workup 
6 Y DMAc 14 h B2cat2 (1.25 equiv) 28 2 equiv 4-MeO-pyridine, Et3N 
workup 
3) Work-up procedure 
7 Y DMAc 14 h B2cat2 (1.25 equiv) 52 2 equiv 4-MeO-pyridine, 
AcOH workup 
4) Boron Source 
8 Y DMAc 14 h B2cat2 (0.25 equiv), 
B2(OH)4 (0.75 equiv) 
55 2 equiv 4-MeO-pyridine, 
AcOH workup 
9 Y DMAc 14 h B2(OH)4 (1.00 equiv) <1 2 equiv 4-MeO-pyridine, 
AcOH workup 
10 Y DMAc 14 h B2cat2 (0.50 equiv), 
B2(OH)4 (1.00 equiv) 
73 2 equiv 4-MeO-pyridine, 
AcOH workup 
5) Solvent 
11 Y DME 14 h B2cat2 (0.50 equiv), 
B2(OH)4 (1.00 equiv) 
83 2 equiv 4-MeO-pyridine, 
AcOH workup 
12 Y acetone 14 h B2cat2 (0.50 equiv), 
B2(OH)4 (1.00 equiv) 
76 2 equiv 4-MeO-pyridine, 
AcOH workup 
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13 Y THF 14 h B2cat2 (0.50 equiv), 
B2(OH)4 (1.00 equiv) 
79 2 equiv 4-MeO-pyridine, 
AcOH workup 
14 Y DMPU 14 h B2cat2 (0.50 equiv), 
B2(OH)4 (1.00 equiv) 
71 2 equiv 4-MeO-pyridine, 
AcOH workup 
6) Light 
15 N DME 14 h B2cat2 (0.50 equiv), 
B2(OH)4 (1.00 equiv) 
72 2 equiv 4-MeO-pyridine, 
AcOH workup 
16 N DMAc 14 h B2cat2 (0.50 equiv), 
B2(OH)4 (1.00 equiv) 
82 2 equiv 4-MeO-pyridine, 
AcOH workup 
 
Section 2 - Other additives tried (2 equiv) (yields in brackets): pyridine (3), pyridine as 
solvent (<1), DABCO (13), pyridine N-oxide (<1), DBU (5), quinuclidine (18), HMPA (1), 
DBN (<1), TMG (5), TBD (4), MTBD (<1), zinc (<1), MTBD (4), tetramethylthiourea (<1), 
bipyridine (<1), thio DMF (<1), quinoline (<1), isoquinoline (<1), 2,6-lutidine (<1), 2-picoline 
(3), 4-picoline (19), 3-picoline (<1), pyrazine (<1), pyrimidine (<1), pyridazine (<1), imidazole 
(4), K2CO3 (4), triethylamine (16), 4-cyanopyridine (<1), 4-phenylpyridine (12). 
Sections 2 and 5 - Solvents tested (including as mixtures with DMAc) (yields in brackets): 
toluene, acetone, dioxane, diethyl ether, tetrahydrofuran, dimethoxyethane, dichloromethane, 
acetonitrile, hexane, ethyl acetate, chloroform, DMI, DMPU, NMP, 
Section 4 - Other ratios of B2cat2:B2(OH)4 tested (yields in brackets): 0.50:0.50 (66), 
0.25:1.00 (64), 0.25:1.25 (62), 0.25:2.00 (48). 
Other notes: acetic acid can be added to the reaction with little to no loss of yield. 
General procedure: All solids (including NHPI ester 137 (48 mg, 0.13 mmol), B2cat2, B2(OH)4 
etc) were carefully weighed into a flame-dried 7 mL vial containing a small magnetic stirrer 
bar. Solvent (1.3 mL) was added and then the headspace of the vial was purged with a gentle 
stream of argon for approximately 10 seconds. The vial was tightly sealed and stirred under 
light irradiation for 14 h. Pinacol (63 mg, 0.53 mmol, 4 equiv) was then added, followed by 
either Et3N (0.45 mL) or glacial acetic acid (0.03 mL), and the reaction mixture was  stirred for 
1 h. The reaction mixture was transferred into a vial containing 15 mL of EtOAc, H2O (3 mL), 
NH4Cl (saturated aqueous solution, 3 mL) and 1,3,5-trimethoxybenzene (as a stock solution: 
21.86 mg/ 1.00 mL). After vigorously shaking and allowing to two layers to separate, 0.50 mL 
of the top organic layer was filtered through a short plug of silica for GC analysis. Notes: All 
solvents were anhydrous and sparged with argon for approximately 10 min. 
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2.5 Functionalization of borylated cubanes 
tert-Butyl (1r,2R,3r,8S)-4-(furan-2-yl)cubane-1-carboxylate 
 
According to a literature procedure,36 n-butyl lithium (in hexane, 0.18 mmol, 1.2 equiv) was 
added dropwise to a solution of furan (0.01 mL, 0.18 mmol, 1.2 equiv) in THF (0.6 mL) 
at −78 °C (dry ice/acetone) before warming to ambient temperature and stirring for 1 h. The 
reaction was cooled to ‒78 °C (dry ice/acetone) before adding boronic ester 87 (50 mg, 
0.15 mmol, 1.0 equiv) in THF (0.6 mL) dropwise and stirring for a further 1 h. 
N-Bromosuccinimide (32 mg, 0.18 mmol, 1.2 equiv) was quickly dissolved in THF (0.6 mL) 
and added, before stirring for a final 1 h. Na2S2O3 (saturated aqueous solution, 1 mL) was then 
added and the mixture was allowed to warm to ambient temperature. The reaction mixture was 
extracted with Et2O (3× 10 mL), and the combined organic phases were combined, dried 
(MgSO4), and concentrated under reduced pressure. The crude residue was purified by flash 
column chromatography (SiO2; 90:10 pentane:Et2O) to afford the corresponding furan (29 mg, 
71 %) as a white solid. m.p.: 84 – 87 °C (Et2O). TLC: Rf = 0.39 (90:10 pentane:Et2O). 1H 
NMR (500 MHz, CDCl3) δ 7.38 – 7.37 (m, 1H, ArH), 6.35 – 6.34 (m, 1H, ArH), 6.05 – 6.04 
(m, 1H, ArH), 4.19 – 4.12 (m, 6H, 6× CH), 1.48 (s, 9H, C(CH3)3) ppm. 13C NMR (126MHz, 
CDCl3) δ 171.9 (C=O), 155.4 (ArC), 142.0 (ArC), 110.4 (ArCH), 105.1 (ArCH), 80.3 
(C(CH3)3), 57.4 (C), 53.6 (C), 48.1 (CH), 46.7 (CH), 28.3 (C(CH3)3) ppm. HRMS (m/z): (ESI) 
calc’d for C17H18O3Na [M+Na]
+: 293.1148, found: 293.1135. IR (solid state) νmax: 2990, 1703, 
1367, 1336, 1226, 1146, 1087, 837 and 748 cm−1. 
tert-Butyl (1r,2R,3r,8S)-4-(1-methyl-1H-indol-2-yl)cubane-1-carboxylate 
 
According to a literature procedure,36 tert-butyl lithium (in pentane, 0.24 mmol, 1.6 equiv) was 
added dropwise to a solution of N-methyl indole (0.03 mL, 0.24 mmol, 1.6 equiv) in THF 
(1.0 mL) at ‒78 °C (dry ice/acetone) before warming to ambient temperature and stirring for 
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1 h. The reaction was cooled to ‒78 °C (dry ice/acetone) before adding boronic ester 87 (50 mg, 
0.15 mmol, 1.0 equiv) in THF (0.6 mL) dropwise and stirring for a further 1 h. 
N-Iodosuccinimide (55 mg, 0.24 mmol, 1.6 equiv) was quickly dissolved in THF (1.0 mL) and 
added, before stirring for a final 1 h. Na2S2O3 (saturated aqueous solution, 1 mL) was then 
added and the mixture was allowed to warm to ambient temperature. The reaction mixture was 
extracted with Et2O (3× 10 mL), and the combined organic phases were combined, dried 
(MgSO4), and concentrated under reduced pressure. The crude residue was purified by flash 
column chromatography (SiO2; 90:10 pentane:Et2O) to afford the corresponding indole (19 mg, 
38 %) as a colorless oil. TLC: Rf = 0.23 (90:10 pentane:Et2O). 1H NMR (500 MHz, CDCl3) δ 
7.56 (d, J = 7.8 Hz, 1H, ArH), 7.27 (d, J = 8.8 Hz, 1H, ArH), 7.19 (t, J = 7.6 Hz, 1H, ArH), 
7.08 (t, J = 7.4 Hz, 1H, ArH), 6.22 (s, 1H, =CH), 4.29 – 4.24 (m, 6H, 6× CH), 3.65 (s, 3H, 
NCH3), 1.51 (s, 9H, C(CH3)3) ppm. 13C NMR (126MHz, CDCl3) δ 171.8 (C=O), 140.4 (ArC), 
138.2 (ArC), 127.9 (ArC), 121.3 (ArCH), 120.4 (ArCH), 119.5 (ArCH), 108.6 (ArCH), 98.4 
(=CH), 80.5 (C(CH3)3), 56.9 (C), 54.7 (C), 48.1 (CH), 46.5 (CH), 30.6 (NCH3), 28.3 (C(CH3)3) 
ppm. HRMS (m/z): (ESI) calc’d for C22H23NNaO2 [M+Na]
+: 356.1621, found: 356.1635. IR 




According to a literature procedure,37 n-butyl lithium (in hexane, 0.30 mmol, 2.0 equiv) was 
added dropwise to a solution of N,N-diisopropyl amine (0.04 mL, 0.32 mmol, 2.0 equiv) in 
anhydrous THF (0.6 mL) at ‒78 °C (dry ice/acetone) and allowed to react for 1 h. A solution 
of 3-bromopyridine (0.03 mL, 0.32 mmol, 2.0 equiv) in anhydrous THF (0.5 mL) was then 
added dropwise before stirring for 30 min. Next, a solution of boronic ester 87 (50 mg, 
0.15 mmol, 1.0 equiv) in THF (0.6 mL) was added dropwise and stirred for 30 min. 
2,2,2-Trichloroethyl chloroformate (0.08 mL, 0.61 mmol, 4.0 equiv) was finally added 
dropwise, before allowing the reaction mixture to warm slowly to ambient temperature 
overnight (the dry ice/acetone bath was not removed). The mixture was transferred to a 
separating funnel and diluted with Et2O (10 mL) and NaHCO3 (saturated aqueous solution, 
10 mL). The layers were separated, and the aqueous phase was extracted with Et2O (2× 10 mL). 
- 161 - 
 
The combined organic phases were dried (MgSO4) and concentrated under reduced pressure. 
The residue was dissolved in THF (2 mL) and cooled to 0 °C. NaOH (3 M aqueous solution, 
1 mL) and H2O2 (30 % aqueous solution, 1 mL) were slowly added before warming to ambient 
temperature and stirring for 14 h. The solution was transferred to a separating funnel with Et2O 
(5 mL) and water (10 mL) was added. The aqueous phase was extracted with Et2O (2× 5 mL) 
and then the combined organic phases were dried (MgSO4) and concentrated under reduced 
pressure. The crude residue was purified by flash column chromatography (SiO2; 50:50 
pentane:Et2O) to yield the desired pyridine (23 mg, 42 %) as a colorless oil. TLC: Rf = 0.26 
(50:50 pentane:Et2O). 1H NMR (500 MHz, CDCl3) δ 8.62 (s, 1H, ArH), 8.46 (d, J = 4.9 Hz, 
1H, ArH), 7.03 (m, J = 4.9 Hz, 1H, ArH), 4.32 – 4.30 (m, 3H, 3× CH), 4.22 – 4.20 (m, 3H, 3× 
CH), 1.48 (s, 9H, C(CH3)3) ppm. 13C NMR (126 MHz, CDCl3) δ 171.7 (C=O), 151.9 (ArCH), 
148.7 (ArC), 148.3 (ArCH), 122.1 (ArCH), 120.9 (ArC), 80.5 (C(CH3)3), 60.7 (C), 56.2 (C), 
47.5 (CH), 46.1 (CH), 28.3 (C(CH3)3) ppm. HRMS (m/z): (ESI) calc’d for C18H18BrNNaO2 
[M+Na]+: 382.0413, found: 382.0419. IR (thin film) νmax: 2982, 1708, 1579, 1320, 1220, 1157, 
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3. Chapter 3 – Supplementary Materials  
3.1 Synthesis of starting materials 
3-(4-Methoxyphenyl)propyl diisopropylcarbamate (143), 3-(4-methoxyphenyl)propyl 2,4,6-
triisopropylbenzoate (158),42 2-hexyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane,200 isobutyl 
2,4,6-triisopropylbenzoate,201 (R)-3-(4-methoxyphenyl)-1-(tributylstannyl)propyl diisopropyl 
carbamate,202 3-((tert-butyldimethylsilyl)oxy)propan-1-ol,203 pent-4-en-1-yl diisopropyl 
carbamate,204 (S)-tert-butyl(pent-4-en-2-yloxy)diphenylsilane,205 (S)-4,8-dimethylnona-1,7-
diene,206 tert-butyl(((2R,4S)-2,4-dimethylhex-5-en-1-yl)oxy)diphenylsilane,207 isobutyl 2,4,6-
triisopropylbenzoate,201 (2R,4S)-5-(methoxymethoxy)-2,4-dimethylpentyl diisopropyl 
carbamate,208 (S,E)-pent-3-en-2-yl diisopropylcarbamate,209 (S)-4-phenyl-2-(trimethylstannyl) 
butan-2-yl 2,4,6-triisopropylbenzoate,210 (S)-1-(4-methoxyphenyl)ethyl diisopropyl 
carbamate,211 (S)-1-phenylethyl diisopropylcarbamate (168)212 and (S)-1-(4-fluorophenyl)ethyl 




According to modified literature procedures,213 ICy.HCl (173 mg, 0.64 mmol, 3 mol%), 
copper(I) chloride (64 mg, 0.64 mmol, 3 mol%) and sodium tert-butoxide (124 mg, 1.29 mmol, 
6 mol%) were added to a flame-dried Schlenk-tube purged with argon. Anhydrous toluene 
(6 mL) was added before stirring the reaction for 5 min. B2pin2 (5.45 g, 21.46 mmol, 1.00 equiv) 
and anhydrous toluene (15 mL) were then added before stirring for a further 10 min. Freshly 
distilled heptanal (3.00 mL, 21.46 mmol, 1.00 equiv) and anhydrous methanol (1.74 mL, 
42.93 mmol, 2.00 equiv) were finally added before stirring the mixture for 1.5 h at ambient 
temperature. The mixture was quickly passed through a wetted plug of silica, eluting with Et2O 
(40 mL). The combined solutions were diluted with CH2Cl2 (40 mL) and then imidazole (4.38 g, 
64.39 mmol, 3.00 equiv) and TBSCl (3.56 g, 23.61 mmol, 1.10 equiv) were added before 
stirring for 3 h. The reaction mixture was passed through a wetted plug of silica, eluting with 
Et2O (100 mL), and concentrated under reduced pressure. The crude residue was purified by 
flash column chromatography (SiO2; 98:2 pentane:Et2O) to yield the boronic ester (2.07 g, 
27 %) as a colorless oil. TLC: Rf = 0.52 (95:5 pentane:Et2O). 1H NMR: (400 MHz, CDCl3) δ 
3.51 (dd, J = 7.9, 6.0 Hz, 1H, CHOSi), 1.64 – 1.47 (m, 2H, CH2CHOSi), 1.47 – 1.03 (m, 8H, 
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4×CH2), 1.26 (s, 6H, C(CH3)2), 1.24 (s, 6H, C(CH3)2), 0.89 s, 9H, SiC(CH3)3), 0.87 (t, J = 7.0 
Hz, 3H, CH3), 0.05 (s, 3H, SiCH3), 0.04 (s, 3H, SiCH3) ppm. 13C NMR: (101 MHz, CDCl3) δ 
83.7 (C(CH3)2), 34.7 (CH2), 32.0 (CH2), 29.5 (CH2), 26.5 (CH2), 26.2 (SiC(CH3)3), 25.2 
(C(CH3)2), 24.7 (C(CH3)2), 22.8 (CH2), 18.7 (SiC(CH3)3), 14.2 (CH3), −4.7 (SiCH3), −4.8 
(SiCH3) ppm. HRMS (m/z): (ESI) calc’d for C19H41BO3SiNa [M+Na]
+: 379.2814, found: 




A solution of the -OTBS boronic ester (140 mg, 0.39 mmol, 1.00 equiv) and 
bromochloromethane (0.08 mL, 1.18 mmol, 3.00 equiv) in anhydrous Et2O (2.0 mL) was cooled 
to −78 °C (dry ice/acetone) before adding n-BuLi (0.61 mL, 1.60 M, 0.98 mmol, 2.50 equiv) 
dropwise. After the addition of n-BuLi was complete the mixture was allowed to stir for 30 min 
at the same temperature before warming to ambient temperature. The reaction mixture was 
filtered through a wetted plug of silica, eluting with Et2O (10 mL), and concentrating under 
reduced pressure to yield 142 (153 mg, >95%) as a colorless oil. TLC: Rf = 0.48 (95:5 
pentane:Et2O). 1H NMR: (400 MHz, CDCl3) δ 3.97 – 3.87 (m, 1H, CHO), 1.50 – 1.14 (m, 10H, 
5×CH2), 1.23 (s, 6H, C(CH3)2), 1.22 (s, 6H, C(CH3)2), 1.13 – 1.02 (m, 2H, CHBpin), 0.90 – 
0.83 (m, 12H, CH3 and SiC(CH3)3), 0.05 (s, 3H, SiCH3), 0.04 (s, 3H, SiCH3) ppm. 13C NMR: 
(101 MHz, CDCl3) δ 83.0 (C(CH3)2), 70.1 (CHO), 39.5 (CH2), 32.0 (CH2), 29.5 (CH2), 26.1 
(SiC(CH3)3), 25.7 (CH2), 25.2 (C(CH3)2), 24.8 (C(CH3)2), 22.8 (CH2), 18.3 (SiC(CH3)3), 14.3 
(CH3), −4.1 (SiCH3), −4.3 (SiCH3) ppm. HRMS (m/z): (ESI) calc’d for C20H43BO3SiNa 
[M+Na]+: 393.2971, found: 393.2980. IR (neat) νmax: 2956, 2928, 2857, 1371, 1319, 1253, 









Pt(dba)3 (286.1 mg, 0.32 mmol, 1.0 mol%), L (347.6 mg, 0.38 mmol, 1.2 mol%) and B2pin2 
(8.50 g, 33.5 mmol, 1.05 equiv) were added to a flame-dried Schlenk-tube purged with N2. THF 
(32 mL) was added before sealing the flask and heating at 80 °C (oil bath) for 30 mins. After 
cooling to ambient temperature 1-octene (5.00 mL, 31.86 mmol, 1.00 equiv) was added before 
re-sealing and heating for 3 h at 60 °C (oil bath). The solution was then cooled to ambient 
temperature and concentrated under reduced pressure. The crude residue was directly purified 
by flash column chromatography (SiO2; 95:5 pentane:Et2O) to yield the enantioenriched 
1,2-bis(boronic esters) as pale yellow oils. For (R)-155 (using R,R-L): 7.52 g, 64%. For 
(S)-155 (using S,S-L): 7.98 g, 68 %. TLC: Rf = 0.28 (90:10 pentane:Et2O). 1H NMR: 
(400 MHz, CDCl3) δ 1.22 (m, 1H, CH2, CHBpin), 1.22 (s, 12H, 2×C(CH3)2), 1.22 (s, 12H, 
2×C(CH3)2), 0.86 (dd, J = 15.8, 7.9 Hz, 1H, CH
aCHbBpin), 0.86 (t, J = 6.9 Hz, 3H, CH3), 0.78 
(dd, J = 15.8, 5.9 Hz, 1H, CHaCHbBpin) ppm. 13C NMR: (101 MHz, CDCl3) δ 82.9 (C(CH3)2), 
82.9 (C(CH3)2), 34.0 (CH2), 32.0 (CH2), 29.7 (CH2), 29.0 (CH2), 25.1 (C(CH3)2), 25.0 
(C(CH3)2), 24.9 (C(CH3)2), 24.9 (C(CH3)2), 22.8 (CH2), 14.2 (CH3) ppm. HRMS (m/z): (ESI) 
calc’d for C20H40B2O4Na [M+Na]
+: 389.3012, found: 389.3019. IR (neat) νmax: 2978, 2924, 
2855, 1370, 1310, 1140, 968 and 846 cm−1. For (R)-155 (using R,R-L), [𝜶]𝐃
𝟐𝟒: −9.0 (c = 10.0, 
CHCl3). For (S)-155 (using S,S-L), [𝜶]𝐃
𝟐𝟒: +10.0 (c = 10.0, CHCl3). 
Racemic 1,2-bis(boronic ester) rac-155 was synthesized using the following procedure:214 
 
Cs2CO3 (1.56 g, 4.78 mmol, 15 mol%) and B2pin2 (8.90 g, 35.1 mmol, 1.10 equiv) were added 
to a flame-dried Schlenk-tube purged with N2. THF (125 mL), MeOH (6.45 mL, 159 mmol, 
5.00 equiv) and 1-octene (5.00 mL, 31.9 mmol, 1.00 equiv) were then added and the mixture 
was heated at 70 °C (oil bath) for 6 h. The reaction mixture was cooled to ambient temperature 
and concenterd under reduced pressure. The crude residue was directly purified by flash column 
chromatography (SiO2; 95:5 pentane:Et2O) to yield the racemic 1,2-bis(boronic ester) 155  
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(7.87 g, 67 %) as a colorless oil. The collected data was identical to that described above. 
Aliquots of the reaction mixtures were oxidized and protected as acetonides for analysis of 
enantiomeric purity by chiral-GC. 
 
Chiral-GC: Chiraldex β-DM, injector T = 250 °C, detector T = 300 °C. Oven conditions: T = 
80 °C for 5 min, then ramp (1 °C/min) until 100 °C, then ramp (20 °C/min) until 180 °C and 
hold for 5 min. He carrier gas at 2.0 mL/min. 
Racemic: 
 
For (R)-155 (using (R,R)-L): 95.3:4.7 e.r. [tR= 19.2 min (minor), tR = 18.8 min (major)] 
 
For (S)-155 (using (S,S)-L): 96.5:3.5 e.r. [tR = 19.1 min (minor), tR = 20.1 min (major)] 










































































DIAD (5.96 mL, 30.29 mmol, 1.10 equiv) was added drop-wise over 10 min to a stirred solution 
of PPh3 (7.94 g, 30.29 mmol, 1.10 equiv), 3-methyl-1-butanol (3.00 mL, 27.53 mmol, 
1.00 equiv) and 2,4,6-triisopropylbenzoic acid (7.86 g, 31.66 mmol, 1.15 equiv) in anhydrous 
THF (41 mL) at 0 °C (ice/water). After warming slowly to ambient temperature over 16 h the 
solvent was removed under reduced pressure. Pentane (50 mL) was added and the mixture 
stirred for 10 min. The white suspension was filtered and the filter cake washed with pentane 
(50 mL). The solvent was removed under reduced pressure and the crude residue was purified 
by flash column chromatography (SiO2; 99.75:0.25 pentane:Et2O) to yield the TIB ester (7.55 g, 
86 %) as a colorless oil. TLC: Rf = 0.17 (99.75:0.25 pentane:Et2O). 1H NMR: (400 MHz, 
CDCl3) δ 7.02 (s, 2H, ArH), 4.35 (t, J = 6.8 Hz, 2H, CH2O), 2.95 – 2.82 (m, 3H, ArCH(CH3)2), 
1.85 – 1.70 (m, 1H, CH2CH(CH3)2), 1.63 (q, J = 6.8 Hz, 2H, CH2CH2O), 1.26 (d, J = 6.9 Hz, 
12H, 2×CH(CH3)2), 1.26 (d, J = 7.0 Hz, 6H, CH(CH3)2), 0.96 (d, J = 6.6 Hz, 6H, CH2CH(CH3)2) 
ppm. 13C NMR: (101 MHz, CDCl3) δ 171.2 (C=O), 150.2 (ArC), 144.9 (ArC), 130.9 (ArC), 
121.0 (ArH), 63.6 (CH2O), 37.5 (CH2), 34.6 (ArCH(CH3)2), 31.6 (ArCH(CH3)2), 25.1 
(CH2CH), 24.3 (2×ArCH(CH3)2), 24.1 (ArCH(CH3)2), 22.5 (CH2CH(CH3)2) ppm. HRMS 
(m/z): (ESI) calc’d for C21H34O2Na [M+Na]
+: 341.2451, found: 341.2459. IR (neat) νmax: 
2959, 2870, 1724 (CO), 1607, 1462, 1250, 1136, 1103, 1075 and 876 cm−1. 
 
 







































sec-BuLi (5.44 mL, 1.30 m, 7.08 mmol, 1.50 equiv) was added drop-wise to a solution of TIB 
ester (2.26 g, 7.08 mmol, 1.50 equiv) and TMEDA (1.06 mL, 7.08 mmol, 1.50 equiv) in 
anhydrous Et2O (35 mL) at −78 °C (dry ice/acetone). The resultant mixture was stirred at this 
temperature for 2 h before adding 2-hexyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.00 g, 
4.72 mmol, 1.00 equiv) dropwise over 20 min. After allowing to stir for a further 1 h the mixture 
was allowed to warm to ambient temperature before heating at 35 °C (oil bath) for 2 h. HCl 
(30 mL, 1.0 M aqueous solution) was added and the phases separated. The aqueous phase was 
extracted with Et2O (30 mL) and the combined organic phases were dried over MgSO4, filtered 
and concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; pentane) to yield 182 (555 mg, 42 %) as a colorless oil. TLC: Rf = 0.38 
(98:2 pentane:Et2O). 1H NMR: (400 MHz, CDCl3) δ 1.60 – 1.50 (m, 1H, CH(CH3)2), 1.43 – 
0.97 (m, 13H, 6×CH2 and CHBpin), 1.23 (s, 12H, C(CH3)2), 0.89 – 0.85 (m, 9H, CH(CH3)2 and 
CH3) ppm. 13C NMR: (101 MHz, CDCl3) δ 82.9 (C(CH3)2), 41.0 (CH2), 32.0 (CH2), 31.9 
(CH2), 29.8 (CH2), 29.4 (CH2), 27.5 (CH(CH3)2), 25.0 (C(CH3)2), 24.9 (C(CH3)2), 23.3 
(CH(CH3)2), 22.8 (CH2), 22.7 (CH(CH3)2), 14.3 (CH3) ppm. HRMS (m/z): (EI) 239 ([M−
iPr]+, 
33%), 267 ([M−Me]+, 100%), 283 ([M+H]+, 7%). Despite repeated attempts, a HRMS could 




sec-BuLi (5.44 mL, 1.30 m, 7.08 mmol, 1.50 equiv) was added drop-wise to a solution of 
isobutyl 2,4,6-triisopropylbenzoate (2.15 g, 7.07 mmol, 1.50 equiv) and TMEDA (1.06 mL, 
7.07 mmol, 1.50 equiv) in anhydrous Et2O (35 mL) at −78 °C (dry ice/acetone). The resulting 
mixture was stirred at this temperature for 2 h before adding 2-hexyl-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (1.00 g, 4.71 mmol, 1.00 equiv) dropwise over 20 min. After allowing to stir for 
a further 1 h the mixture was allowed to warm to ambient temperature before heating at 35 °C 
(oil bath) for 2 h. HCl (30 mL, 1.0 M aqueous solution) was added and the phases separated. 
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The aqueous phase was extracted with Et2O (30 mL) and the combined organic phases were 
dried over MgSO4, filtered and concentrated under reduced pressure. The crude residue was 
purified by flash column chromatography (SiO2; 99:1 pentane:CH2Cl2) to yield the boronic 
ester (513 mg, 41 %) as a colorless oil. TLC: Rf = 0.15 (99:1 pentane:CH2Cl2). 1H NMR: 
(400 MHz, CDCl3) δ 1.75 – 1.63 (m, 1H, CH(CH3)2), 1.46 – 1.14 (m, 10H, 5×CH2), 1.25 (s, 
12H, C(CH3)2), 0.92 (d, J = 6.7 Hz, 3H, CH(CH3)2), 0.91 (d, J = 6.7 Hz, 3H, CH(CH3)2), 0.87 
(t, J = 6.8 Hz, 3H, CH3), 0.85 – 0.78 (m, 1H, CHBpin) ppm. 13C NMR: (101 MHz, CDCl3) δ 
82.9 (C(CH3)2), 32.0 (CH2), 29.8 (CH(CH3)2 and CH2), 29.8 (CH2), 29.4 (CH2), 25.1 (C(CH3)2), 
25.0 (C(CH3)2), 22.8 (CH2), 22.5 (CH(CH3)2), 22.0 (CH(CH3)2), 14.23 (CH3) ppm. HRMS 
(m/z): (EI) 253 ([M−Me]+, 100%), 269 ([M+H]+, 16%). Despite repeated attempts, a HRMS 




A solution of the boronic ester (486 mg, 1.81 mmol, 1.00 equiv) and bromochloromethane 
(0.35 mL, 5.44 mmol, 3.00 equiv) in anhydrous Et2O (12 mL) was cooled to −98 °C (liquid 
N2/MeOH) before adding n-BuLi (2.83 mL, 1.60 M, 4.53 mmol, 2.50 equiv) dropwise. After 
the addition of n-BuLi was complete the mixture was allowed to stir for 1.5 h at the same 
temperature before warming to ambient temperature. The reaction mixture was filtered through 
a wetted plug of silica, eluting with Et2O (20 mL), and concentrating under reduced pressure to 
yield 181 (511 mg, >95 %) as a colorless oil. TLC: Rf = 0.16 (pentane). 1H NMR: (400 MHz, 
CDCl3) δ 1.68 – 1.58 (m, 1H, CH(CH3)2), 1.53 – 1.44 (m, 1H, CHCH(CH3)2), 1.35 – 1.08 (m, 
10H, 5×CH2), 1.24 (s, 12H, C(CH3)2), 0.87 (t, J = 6.5 Hz, 3H, CH3), 0.84 (d, J = 6.8 Hz, 3H, 
CH(CH3)2), 0.79 (d, J = 6.8 Hz, 3H, CH(CH3)2), 0.74 (dd, J = 15.4, 5.9 Hz, 1H, CH
aHbBpin), 
0.63 (dd, J = 15.4, 8.3 Hz, 1H, CHaHbBpin) ppm. 13C NMR: (101 MHz, CDCl3) δ 82.9 
(C(CH3)2), 40.2 (CHCH(CH3)2), 33.8 (CH2), 32.1 (CH2), 31.6 (CH(CH3)2), 30.0 (CH2), 27.6 
(CH2), 25.0 (C(CH3)2), 24.9 (C(CH3)2), 22.9 (CH2), 20.0 (CH(CH3)2), 18.5 (CH(CH3)2), 14.3 
(CH3) ppm. LRMS (m/z): (EI) 239 ([M−
iPr]+, 100%), 267 ([M−Me]+, 39%). Despite repeated 
attempts, a HRMS could not be obtained. IR (neat) νmax: 2957, 2927, 2872, 1466, 1371, 1317, 
1146, 967 and 848 cm−1. 





3-((tert-Butyldimethylsilyl)oxy)propan-1-ol (2.00 g, 10.51 mmol, 1.00 equiv), 
diisopropylcarbamoyl chloride (2.06 g, 12.61 mmol, 1.20 equiv), triethylamine (1.90 mL, 
13.66 mmol, 1.30 equiv) and anhydrous toluene (10.51 mL) were added to a flame-dried 
microwave vial. After sealing the reaction vessel was heated in a microwave reactor for 2 h at 
150 °C. After cooling to ambient temperature, the mixture was filtered through a short plug of 
silica, eluting with diethyl ether (30 mL), and concentrated under reduced pressure. The crude 
residue was purified by flash column chromatography (SiO2; 90:10 pentane:Et2O) to yield the 
carbamate (2.68 g, 80 %) as a colorless oil. 
TLC: Rf = 0.36 (80:20 pentane:Et2O). 1H NMR: (500 MHz, CDCl3) δ 4.14 (t, J = 6.3 Hz, 2H, 
COOCH2), 4.22 – 3.58 (br m, 2H, NCH(CH3)2), 3.70 (t, J = 6.3 Hz, 2H, CH2OSi), 1.85 (app p, 
J = 6.3 Hz, 2H, CH2), 1.18 (d, J = 6.8 Hz, 12H, NCH(CH3)2), 0.87 (s, 9H, SiC(CH3)3), 0.03 (s, 
6H, Si(CH3)2) ppm. 13C NMR: (126 MHz, CDCl3) δ 155.8 (C=O), 61.6 (COOCH2), 60.1 
(CH2OSi), 46.1 (br, NCH(CH3)2), 45.5 (br, NCH(CH3)2), 32.5 (CH2), 26.0 (SiC(CH3)3), 21.1 
(br, NCH(CH3)2), 18.4 (SiC(CH3)3), −5.3 (Si(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for 
C16H35O3NSiNa [M+Na]
+: 340.2278, found: 340.2265. IR (neat) νmax: 2957, 2930, 2858, 1692 
(CO), 1435, 1308, 1288, 1071, 834 and 772 cm−1. 
tert-Butyl hept-6-enoate 
 
DCC (11.42 g, 55.36 mmol, 1.50 eq) was added in one portion to a solution of 6-heptenoic acid 
(5.00 mL, 36.90 mmol, 1.00 eq), tert-butanol (49.41 mL, 516.66 mmol, 14.00 equiv) and 
DMAP (902 mg, 7.38 mmol, 0.20 equiv) in dichloromethane (95 mL) at 0 °C (ice water). The 
solution was allowed to warm to ambient temperature and stir for 48 h. The solution was then 
filtered through a wetted plug of celite, eluting with dichloromethane (50 mL). The combined 
solutions were washed with NaHCO3 (sat. aq. solution, 50 mL), dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 90:10 pentane:CH2Cl2) to yield the ester (2.32 g, 34 %) as a colorless 
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oil. TLC: Rf = 0.10 (90:10 pentane:CH2Cl2). 1H NMR: (400 MHz, CDCl3) δ 5.79 (ddt, J = 
16.9, 10.2, 6.7 Hz, 1H, =CH), 5.03 – 4.97 (m, 1H, =CHaHb), 4.96 – 4.92 (m, 1H, =CHaHb), 2.21 
(t, J = 7.5 Hz, 2H, CH2CO), 2.06 (app q, J = 7.2 Hz, 2H, =CHCH2), 1.64 – 1.54 (m, 2H, 
CH2CH2CO), 1.44 (s, 9H, OC(CH3)3), 1.46 – 1.37 (m, 2H, CH2) ppm. 13C NMR: (101 MHz, 
CDCl3) δ 173.3 (C=O), 138.7 (CH=), 114.7 (=CH2), 80.1 (OC(CH3)3), 35.6 (CH2CO), 33.6 
(CH2CH=), 28.5 (CH2), 28.3 (OC(CH3)3), 24.7 (CH2CH2CO) ppm. LRMS (m/z): (EI) 57 
([tBu]+, 100%), 83 ([M−CO2
tBu]+, 34%), 111 ([M−OtBu]+, 46%), 128 ([M−tBu]+, 25%). 
Despite repeated attempts, a HRMS could not be obtained. IR (neat) νmax: 2978, 2932, 1730 
(CO), 1367, 1148 and 910 cm−1. 
tert-Butyl (R)-6,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)heptanoate 
 
Pt(dba)3 (49 mg, 0.05 mmol, 1.0 mol%), (R,R)-L (59 mg, 0.07 mmol, 1.2 mol%) and B2pin2 
(1.45 g, 5.70 mmol, 1.05 equiv) were added to a flame-dried Schlenk-tube purged with N2. THF 
(5.43 mL) was added before sealing the flask and heating at 80 °C (oil bath) for 30 mins. After 
cooling to ambient temperature, the alkene (1.0 g, 5.43 mmol, 1.00 equiv) was added before re-
sealing and heating for 3 h at 60 °C (oil bath). The solution was then cooled to ambient 
temperature and concentrated under reduced pressure. The crude residue was directly purified 
by flash column chromatography (SiO2; 85:15 pentane:Et2O) to yield the 1,2-bis(boronic ester) 
(2.09 g, 92 %) as a pale yellow viscous oil. TLC: Rf = 0.20 (85:15 pentane:Et2O). 1H NMR: 
(400 MHz, CDCl3) δ 2.17 (t, J = 7.6 Hz, 2H, COCH2), 1.55 (p, J = 7.6 Hz, 2H, COCH2CH2), 
1.49 (m, 5H, 2×CH2 and CHBpin), 1.42 (s, 9H, OC(CH3)3), 1.21 (s, 24H, C(CH3)2), 0.85 (dd, 
J = 15.8, 9.5 Hz, CHaHbBpin), 0.77 (dd, J = 15.8, 5.9 Hz, CHaHbBpin) ppm. 13C NMR: 
(101 MHz, CDCl3) δ 173.5 (C=O), 83.0 (C(CH3)2), 82.9 (C(CH3)2), 79.9 (OC(CH3)3), 35.8 
(COCH2), 33.5 (CH2), 28.5 (CH2), 28.3 (OC(CH3)3), 25.5 (CH2), 25.0 (C(CH3)2), 25.0 
(C(CH3)2), 24.9 (C(CH3)2), 24.9 (C(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C23H44B2O6Na 
[M+Na]+: 461.3224, found: 461.3226. IR (neat) νmax: 2977, 2930, 1730 (CO), 1368, 1311, 
1140, 968 and 846 cm−1. [𝜶]𝐃
𝟐𝟒: +3.0 (c = 1.0, CHCl3). 
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A racemic sample was synthesized using the following procedure: 
 
Cs2CO3 (133 mg, 0.41 mmol, 15 mol%) and B2pin2 (758 mg, 2.98 mmol, 1.10 equiv) were 
added to a flame-dried Schlenk-tube purged with N2. THF (10.9 mL), MeOH (0.55 mL, 
13.57 mmol, 5.00 equiv) and the alkene (500 mg, 2.71 mmol, 1.00 equiv) were then added and 
the mixture was heated at 70 °C (oil bath) for 6 h. The reaction mixture was cooled to ambient 
temperature and concenterd under reduced pressure. The crude residue was directly purified by 
flash column chromatography (SiO2; 85:15 pentane:Et2O) to yield the rac-1,2-bis(boronic 
ester) (923 mg, 78 %) as a viscous colorless oil. The collected data was identical to that 
described above. Aliquots of the reaction mixtures were oxidized and protected as acetonides 
for analysis of enantiomeric purity by chiral-GC. 
 
Chiral-GC: Chiraldex β, injector T = 250 °C, detector T = 300 °C. Oven conditions: T = 70 °C 
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Pt(dba)3 (34 mg, 0.04 mmol, 1.0 mol%), (R,R)-L (41 mg, 0.05 mmol, 1.2 mol%) and B2pin2 
(1.00 g, 3.95 mmol, 1.05 equiv) were added to a flame-dried Schlenk-tube purged with N2. THF 
(3.80 mL) was added before sealing the flask and heating at 80 °C (oil bath) for 30 mins. After 
cooling to ambient temperature 4-vinylanisole (0.50 mL, 3.76 mmol, 1.00 equiv) was added 
before re-sealing and heating for 3 h at 60 °C (oil bath). The solution was then cooled to ambient 
temperature and concentrated under reduced pressure. The crude residue was directly purified 
by flash column chromatography (SiO2; 90:10 pentane:Et2O) to yield the 1,2-bis(boronic ester) 
(1.16 g, 80 %) as a colorless paste. TLC: Rf = 0.23 (80:20 pentane:Et2O). 1H NMR: (400 MHz, 
CDCl3) δ 7.14 (d, J = 8.6 Hz, 2H, ArH), 6.78 (d, J = 8.6 Hz, 2H, ArH), 3.76 (s, 3H, OCH3), 
2.46 (dd, J = 10.9, 5.8 Hz, 1H, ArCHBpin), 1.33 (dd, J = 16.0, 10.9 Hz, 1H, CHaHbBpin), 1.20 
(s, 12H, C(CH3)2), 1.19 (s, 6H, C(CH3)2), 1.17 (s, 6H, C(CH3)2), 1.08 (dd, J = 16.0, 5.8 Hz, 1H, 
CHaHbBpin) ppm. 13C NMR: (101 MHz, CDCl3) δ 157.3 (ArCOMe), 137.6 (ArC), 128.9 
(ArH), 113.8 (ArH), 83.3 (C(CH3)2), 83.1 (C(CH3)2), 55.3 (OCH3), 25.1 (C(CH3)2), 24.8 
(C(CH3)2), 24.8 (C(CH3)2), 24.6 (C(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C21H34B2O5Na 
[M+Na]+: 411.2492, found: 411.2483. IR (neat) νmax: 2978, 2933, 1509, 1369, 1317, 1244, 
1033, 967, 851, 828 and 673 cm−1. [𝜶]𝐃
𝟐𝟒: −14.0 (c = 1.0, CHCl3). 
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A racemic sample was synthesized using the following procedure: 
 
Pt(dba)3 (34 mg, 0.04 mmol, 1.0 mol%), B2pin2 (1.00 g, 3.95 mmol, 1.05 equiv) and 
4-vinylanisole (0.50 mL, 3.76 mmol, 1.00 equiv) were added to a flame-dried Schlenk-tube 
purged with N2. THF (3.76 mL) was added before sealing the flask and heating at 60 °C (oil 
bath) for 3 h. The solution was then cooled to ambient temperature and concentrated under 
reduced pressure. The crude residue was directly purified by flash column chromatography 
(SiO2; 90:10 pentane:Et2O) to yield the rac-1,2-bis(boronic ester) (887 mg, 54 %) as a colorless 
paste. The collected data was identical to that described above. 
Chiral SFC: Chiralpak Whelk-01, 125 bar, 40 °C, 4 mL/min, 10% co-colvent (50% 
IPA/hexane); tR = 10.4 min (minor), tR = 11.8 min (major), 94:6 e.r. 
 






Pt(dba)3 (42 mg, 0.05 mmol, 1.0 mol%), (R,R)-L (51 mg, 0.06 mmol, 1.2 mol%) and B2pin2 
(1.25 g, 4.92 mmol, 1.05 equiv) were added to a flame-dried Schlenk-tube purged with N2. THF 
(4.69 mL) was added before sealing the flask and heating at 80 °C (oil bath) for 30 mins. After 
cooling to ambient temperature the alkene (1.00 g mL, 4.69 mmol, 1.00 equiv) was added before 
re-sealing and heating for 3 h at 60 °C (oil bath). The solution was then cooled to ambient 
temperature and concentrated under reduced pressure. The crude residue was directly purified 
by flash column chromatography (SiO2; 70:30 pentane:Et2O) to yield the 1,2-bis(boronic ester) 
(1.91 g, 86 %) as a pale yellow viscous oil. TLC: Rf = 0.21 (70:30 pentane:Et2O). 1H NMR: 
(400 MHz, CDCl3) δ 4.23 – 3.51 (m, 2H, NCH(CH3)2), 4.03 (t, J = 6.5 Hz, 2H, OCH2), 1.70 – 
1.61 (m, 2H, OCH2CH2), 1.60 – 1.48 (m, 1H, CH
aHb), 1.46 – 1.33 (m, 1H, CHaHb), 1.22 (s, 
12H, C(CH3)2), 1.22 (s, 12H, C(CH3)2), 1.18 (d, J = 1.18 Hz, 12H, NCH(CH3)2), 0.88 (dd, J = 
15.8, 9.6 Hz, 1H, CHaHbBpin), 0.80 (dd, J = 15.8, 5.8 Hz, CHaHbBpin) ppm. 13C NMR: 
(101 MHz, CDCl3) δ 156.1 (C=O), 83.0 (C(CH3)2), 83.0 (C(CH3)2), 65.3 (OCH2), 45.6 (br, 
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NCH(CH3)2), 30.6 (CH2), 28.6 (OCH2CH2), 25.0 (C(CH3)2), 25.0 (C(CH3)2), 24.9 (C(CH3)2), 
24.9 (C(CH3)2), 21.0 (br, NCH(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C24H47B2O6NNa 
[M+Na]+: 490.3490, found: 490.3483. IR (neat) νmax: 2976, 2932, 1689 (CO), 1369, 1308, 
1289, 1139, 968, 846 and 773 cm−1. [𝜶]𝐃
𝟐𝟒: −5.0 (c = 1.0, CHCl3). 
A racemic sample was synthesized using the following procedure: 
 
Cs2CO3 (115 mg, 0.35 mmol, 15 mol%) and B2pin2 (655 mg, 2.58 mmol, 1.10 equiv) were 
added to a flame-dried Schlenk-tube purged with N2. THF (9.40 mL), MeOH (0.47 mL, 
11.72 mmol, 5.00 equiv) and the alkene (500 mg, 2.34 mmol, 1.00 equiv) were then added and 
the mixture was heated at 70 °C (oil bath) for 6 h. The reaction mixture was cooled to ambient 
temperature and concenterd under reduced pressure. The crude residue was directly purified by 
flash column chromatography (SiO2; 80:20 pentane:Et2O) to yield the rac-1,2-bis(boronic 
ester) (730 mg, 66 %) as a colorless oil. The collected data was identical to that described 
above. Aliquots of the reaction mixtures were oxidized and protected as acetonides for analysis 
of enantiomeric purity by chiral-GC. 
 
Chiral-GC: Chiraldex β, injector T = 250 °C, detector T = 300 °C. Oven conditions: T = 70 °C 
for 5 min, then ramp (1 °C/min) until 180 °C and hold for 5 min. He carrier gas at 1.0 mL/min. 
Racemic: 
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Pt(dba)3 (63 mg, 0.07 mmol, 1.0 mol%), (R,R)-L (76 mg, 0.08 mmol, 1.2 mol%) and B2pin2 
(1.85 g, 7.30 mmol, 1.05 equiv) were added to a flame-dried Schlenk-tube purged with N2. THF 
(7.00 mL) was added before sealing the flask and heating at 80 °C (oil bath) for 30 mins. After 
cooling to ambient temperature 4,4-dimethyl-1-pentene (1.00 mL, 6.96 mmol, 1.00 equiv) was 
added before re-sealing and heating for 3 h at 60 °C (oil bath). The solution was then cooled to 
ambient temperature and concentrated under reduced pressure. The crude residue was directly 
purified by flash column chromatography (SiO2; 95:5 pentane:Et2O) to yield the 
1,2-bis(boronic ester) (2.11 g, 86 %) as a white solid. TLC: Rf = 0.33 (90:10 petroleum ether 
60/40:Et2O). m.p.: 41–44 °C (pentane). 1H NMR: (400 MHz, CDCl3) δ 1.58 (dd, J = 13.0, 
10.1 Hz, 1H, CHaHb), 1.32 – 1.06 (m, 2H, CHBpin and CHaHb), 1.22 (s, 24H, C(CH3)2), 0.90 
– 0.82 (m, 1H, CHaHbBpin), 0.73 (dd, J = 15.5, 7.9 Hz, 1H, CHaHbBpin) ppm. 13C NMR: 
(101 MHz, CDCl3) δ 83.0 (C(CH3)2), 82.8 (C(CH3)2), 48.5 (CH2), 31.3 (C(CH3)3), 29.9 
(C(CH3)3), 25.1 (C(CH3)2), 25.0 (C(CH3)2), 24.9 (C(CH3)2) ppm. HRMS (m/z): (ESI) calc’d 
for C19H38B2O4Na [M+Na]
+: 375.2855, found: 375.2862. IR (neat) νmax: 2977, 2949, 1352, 
1315, 1141, 968, 841 and 671 cm−1. [𝜶]𝐃
𝟐𝟒: +10.0 (c = 1.0, CHCl3). 
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A racemic sample was synthesized using the following procedure: 
 
Cs2CO3 (170 mg, 0.52 mmol, 15 mol%) and B2pin2 (972 mg, 3.83 mmol, 1.10 equiv) were 
added to a flame-dried Schlenk-tube purged with N2. THF (13.90 mL), MeOH (0.70 mL, 
17.39 mmol, 5.00 equiv) and 4,4-dimethyl-1-pentene (0.50 mL, 3.48 mmol, 1.00 equiv) were 
then added and the mixture was heated at 70 °C (oil bath) for 6 h. The reaction mixture was 
cooled to ambient temperature and concenterd under reduced pressure. The crude residue was 
directly purified by flash column chromatography (SiO2; 95:5 pentane:Et2O) to yield the 
rac-1,2-bis(boronic ester) (887 mg, 73 %) as a colorless amorphous solid. The collected data 
was identical to that described above. Aliquots of the reaction mixtures were oxidized and 
protected as acetonides for analysis of enantiomeric purity by chiral-GC. 
 
Chiral-GC: Chiraldex β, injector T = 250 °C, detector T = 300 °C. Oven conditions: T = 30 °C 
for 5 min, then ramp (1 °C/min) until 80 °C and hold for 5 min, then ramp (10 °C/min) until 
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Pt(dba)3 (55 mg, 0.06 mmol, 1.0 mol%), (R,R)-L (67 mg, 0.07 mmol, 1.2 mol%) and B2pin2 
(1.64 g, 6.47 mmol, 1.05 equiv) were added to a flame-dried Schlenk-tube purged with N2. THF 
(6.16 mL) was added before sealing the flask and heating at 80 °C (oil bath) for 30 mins. After 
cooling to ambient temperature the alkene (2.00 g, 6.16 mmol, 1.00 equiv) was added before 
re-sealing and heating for 3 h at 60 °C (oil bath). The solution was then cooled to ambient 
temperature and concentrated under reduced pressure. The crude residue was directly purified 
by flash column chromatography (SiO2; 95:5 pentane:Et2O) to yield the 1,2-bis(boronic ester) 
(3.21 g, >95:5 d.r., 90 %) as a pale yellow viscous oil. TLC: Rf = 0.26 (90:10 pentane:Et2O). 
1H NMR: (400 MHz, CDCl3) δ 7.72 – 7.67 (m, 4H, ArH), 7.42 – 7.32 (m, 6H, ArH), 3.92 (dqd, 
J = 7.3, 6.0, 5.9 Hz, 1H, CHO), 1.86 (ddd, J = 13.2, 8.8, 5.9 Hz, 1H, CHaHb), 1.42 (app dt, J = 
13.2, 7.3 Hz, 1H, CHaHb), 1.27 – 1.19 (m, 1H, CHBpin), 1.21 (s, 12H, C(CH3)2), 1.14 (s, 12H, 
C(CH3)2), 1.05 (s, 9H, SiC(CH3)3), 1.02 (d, J = 6.0 Hz, 3H, CH3), 0.79 (d, J = 7.6 Hz, 2H, 
CH2Bpin) ppm. 13C NMR: (101 MHz, CDCl3) δ 136.0 (ArH), 135.4 (ArC), 134.8 (ArC), 129.4 
(ArH), 129.3 (ArH), 127.5 (ArH), 127.4 (ArH), 82.9 (C(CH3)2), 82.8 (C(CH3)2), 68.7 (CHO), 
43.7 (CH2), 27.3 (SiC(CH3)3), 25.0 (C(CH3)2), 24.9 (C(CH3)2), 24.9 (C(CH3)2), 24.8 (C(CH3)2), 
23.6 (CH3), 19.4 (SiC(CH3)3) ppm. HRMS (m/z): (ESI) calc’d for C33H52B2O5SiNa [M+Na]
+: 
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601.3674, found: 601.3675. IR (neat) νmax: 2976, 2930, 2857, 1370, 1312, 1139, 1106, 701 
and 611 cm−1. [𝜶]𝐃




Pt(dba)3 (59 mg, 0.07 mmol, 1.0 mol%), (R,R)-L (72 mg, 0.08 mmol, 1.2 mol%) and B2pin2 
(1.75 g, 6.90 mmol, 1.05 equiv) were added to a flame-dried Schlenk-tube purged with N2. THF 
(6.57 mL) was added before sealing the flask and heating at 80 °C (oil bath) for 30 mins. After 
cooling to ambient temperature, the alkene (1.0 g, 6.57 mmol, 1.00 equiv) was added before re-
sealing and heating for 3 h at 60 °C (oil bath). The solution was then cooled to ambient 
temperature and concentrated under reduced pressure. The crude residue was directly purified 
by flash column chromatography (SiO2; 95:5 pentane:Et2O) to yield the 1,2-bis(boronic ester) 
(2.25 g, >95:5 d.r., 84 %) as a pale yellow viscous oil. TLC: Rf = 0.31 (90:10 pentane:Et2O). 
1H NMR: (400 MHz, CDCl3) δ 5.09 (t, J = 7.0 Hz, 1H, =CH), 2.04 – 1.85 (m, 2H, =CHCH2), 
1.66 (s, 3H, =C(CH3)
a(CH3)
b), 1.58 (s, 3H, =C(CH3)
a(CH3)
b), 1.52 – 1.41 (m, 1H, CH), 1.38 – 
1.04 (m, 5H, CHBpin, 2×CH2), 1.22 (s, 12H, C(CH3)2), 1.22 (s, 12H, C(CH3)2), 0.82 (d, J = 
6.6 Hz, 3H, CH3), 0.79 (d, J = 7.4 Hz, 2H, CH2Bpin) ppm. 13C NMR: (101 MHz, CDCl3) δ 
130.8 (=C(CH3)2), 125.4 (=CH), 82.9 (C(CH3)2), 82.8 (C(CH3)2), 40.9 (CH2), 37.4 (CH2), 31.1 
(CH), 25.8 (=C(CH3)
a(CH3)
b), 25.7 (=CHCH2), 25.0 (C(CH3)2), 25.0 (C(CH3)2), 24.9 
(C(CH3)2), 19.6 (CH3), 17.8 (=C(CH3)
a(CH3)
b) ppm. HRMS (m/z): (ESI) calc’d for 
C23H44B2O4Na [M+Na]
+: 429.3326, found: 429.3320. IR (neat) νmax: 2977, 2914, 1370, 1310, 
1140, 968 and 847 cm−1. [𝜶]𝐃











Pt(dba)3 (12 mg, 0.01 mmol, 1.0 mol%), (S,S)-L (15 mg, 0.02 mmol, 1.2 mol%) and B2pin2 
(364 g, 1.43 mmol, 1.05 equiv) were added to a flame-dried Schlenk-tube purged with N2. THF 
(1.36 mL) was added before sealing the flask and heating at 80 °C (oil bath) for 30 mins. After 
cooling to ambient temperature the alkene (500 mg, 1.36 mmol, 1.00 equiv) in THF (1.36 mL) 
was added before re-sealing and heating for 3 h at 60 °C (oil bath). The solution was then cooled 
to ambient temperature and concentrated under reduced pressure. The crude residue was 
directly purified by flash column chromatography (SiO2; 95:5 pentane:Et2O) to yield the 
1,2-bis(boronic ester) (637 mg, >95:5 d.r., 75 %) as a pale yellow viscous oil. TLC: Rf = 0.24 
(90:10 pentane:EtOAc). 1H NMR: (400 MHz, CDCl3) δ 7.72 – 7.62 (m, 4H, ArH), 7.43 – 7.34 
(m, 6H, ArH), 3.61 (dd, J = 9.8, 4.5 Hz, 1H, OCHaHb), 3.30 (dd, J = 9.8, 7.6 Hz, 1H, OCHaHb), 
1.83 – 1.73 (m, 1H, OCH2CH), 1.57 – 1.47 (m, 1H, CH), 1.38 – 1.28 (m, 1H, CH
aHb), 1.21 (s, 
12H, C(CH3)2), 1.19 (s, 6H, C(CH3)2), 1.18 (s, 6H, C(CH3)2), 1.15 – 1.08 (m, 1H, CH
aHb), 1.05 
(s, 9H, SiC(CH3)3), 0.96 (d, J = 6.6 Hz, 3H, OCH2CHCH3), 0.94 – 0.85 (m, 2H, CH
aHbBpin 
and CHBpin), 0.83 (d, J = 6.7 Hz, 3H, CH3), 0.68 (dd, J = 15.8, 5.1 Hz, 1H, CH
aHbBpin) ppm. 
13C NMR: (101 MHz, CDCl3) δ 135.8 (ArH), 134.4 (ArC), 134.3 (ArC), 129.5 (ArH), 129.5 
(ArH), 127.7 (ArH), 127.6 (ArH), 82.9 (C(CH3)2), 82.8 (C(CH3)2), 69.3 (CH2O), 40.6 (CH2), 
34.2 (CH), 33.4 (CH), 27.1 (SiC(CH3)3), 25.1 (C(CH3)2), 25.1 (C(CH3)2), 25.0 (C(CH3)2), 24.9 
(C(CH3)2), 19.4 (SiC(CH3)3), 18.7 (CH3), 18.23 (CH3) ppm. HRMS (m/z): (ESI) calc’d for 
C36H58B2O5SiNa [M+Na]
+: 643.4145, found: 643.4158. IR (neat) νmax: 2976, 2930, 2858, 
1369, 1308, 1140, 1110 and 700 cm−1. [𝜶]𝐃
𝟐𝟒: −13.0 (c = 10.0, CHCl3). 
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3.2 Why the need for a hydroxyl surrogate?  
3.2.1 β-Elimination Studies 
 
sec-BuLi (0.51 mL, 1.30 M, 0.66 mmol, 1.20 equiv) was added dropwise to a solution of 143 
(203 mg, 0.69 mmol, 1.25 equiv) and (+)-sparteine (0.16 mL, 0.69 mmol, 1.25 equiv) in 
anhydrous Et2O (3.46 mL) at −78 °C (dry ice/acetone). After 2 h and solution of 142 (205 mg, 
0.55 mmol, 1.00 equiv) in anhydrous Et2O (0.55 mL) was added dropwise and the resulting 
solution was allowed to react for a further 1 h. The solution was warmed to ambient temperature 
and then heated at 35 °C (oil bath) for 16 h. After cooling to ambient temperature 
1,3,5-trimethoxybenzene (internal standard) (30.8 mg, 0.183 mmol) was added, and then a 
0.7 mL sample of the reaction mixture was analysed by 1H NMR. This revealed 1-octene (26%) 
as a side-product, which confirms β-elimination has occurred. Water (10 mL) was added and 
the reaction mixture was extracted with Et2O (3×10 mL). The combined organic fractions were 
dried over MgSO4, filtered and concentrated under reduced pressure. The crude residue was 
purified by flash column chromatography (SiO2; 98:2 pentane:Et2O) to yield the 1,2-migration 
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TLC: Rf = 0.39 (95:5 pentane:Et2O). 1H NMR: (400 MHz, CDCl3) δ 7.09 (d, J = 7.9 Hz, 2H, 
ArH), 6.81 (d, J = 7.9 Hz, 2H, ArH), 6.09 (impurity, 1,3,5-trimethoxybenzene), 3.78 (s, 3H, 
OCH3), 3.77 (impurity, 1,3,5-trimethoxybenzene), 3.73 – 3.55 (m, 1H, CHOSi), 2.64 – 2.45 (m, 
2H, ArCH2), 1.79 – 1.01 (m, 27H, 7×CH2, CHBpin and OC(CH3)2), 0.92 – 0.84 (m, 12H, CH3 
and SiC(CH3)3), 0.07 – 0.02 (m, 6H, Si(CH3)2) ppm (mixture of diastereoisomers). 13C NMR: 
(101 MHz, CDCl3) δ 161.7 (impurity, 1,3,5-trimethoxybenzene), 157.8 (ArCOMe), 135.3 
(ArC), 129.4 (ArH), 113.8 (ArH), 93.1 (impurity, 1,3,5-trimethoxybenzene), 83.1 (OC(CH3)2, 
47%), 83.0 (OC(CH3)2, 53%), 72.6 (CHO, 53%), 71.5 (CHO, 47%), 55.5 (impurity, 1,3,5-
trimethoxybenzene), 55.4 (CH2), 39.1 (CH2), 39.0 (CH2), 38.0 (CH2), 36.7 (CH2), 34.8 (CH2), 
34.4 (CH2), 32.1 (CH2), 29.6 (CH2), 26.2 (SiC(CH3)3), 26.1 (SiC(CH3)3), 25.3 (CH2), 25.3 
(CH2), 25.1 (SiC(CH3)3), 25.1 (SiC(CH3)3), 25.0 (SiC(CH3)3), 25.0  (SiC(CH3)3), 22.8 (CH2), 
18.3 (SiC(CH3)3), 14.3 (CH3), −4.1 (Si(CH3)2), −4.1 (Si(CH3)2), −4.1 (Si(CH3)2), −4.3 
(Si(CH3)2) ppm (mixture of diastereoisomers; observed signals; diastereoisomeric ratio given 
when peaks are well resolved and conclusively come from the same environment within each 
diastereoisomer). HRMS (m/z): (ESI) calc’d for C30H55BO4SiNa [M+Na]
+: 541.3861, found: 
541.3862. IR (neat) νmax: 2928, 2856, 1611, 1512, 1245, 1144, 1068, 1041, 834 and 773 cm−1. 
3.2.2 Non-Selective homologations of 1,2-bis(boronic esters) 
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Entry 1 – Matteson homologation: 
 
2,2'-(Octane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (155) (100 mg, 0.27 mmol, 
1.0 equiv), bromochloromethane (0.02 mL, 0.30 mmol, 1.10 equiv) and anhydrous Et2O 
(1.40 mL) were added to a flame-dried Schlenk-tube purged with N2. The solution was cooled 
to –78 °C (dry ice/acetone) and n-BuLi (1.6 M, 0.17 mL, 0.27 mmol, 1.0 equiv) was added 
dropwise (one drop every 20 seconds) before leaving the mixture for 20 min at this temperature. 
After warming to ambient temperature and leaving for 1 h, THF (1.4 mL) was added and the 
resultant mixture was cooled to 0 °C (ice/water). A pre-mixed 2:1 v:v mixture of 3 M NaOH 
and 30% H2O2 (1.0 mL) was then added, before warming to ambient temperature. After 1 h 
EtOAc (3 mL) and H2O (2 mL) were added, and the mixture was extracted 3× with EtOAc 
(3 mL). The combined organic fractions were dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The crude residue was passed through a plug of silica gel, eluting with 
EtOAc, and concentrated under reduced pressure to yield a mixture of 177, 178, 179, 180 and 
pinacol as a colorless oil. 
Analysis of the crude mixture, with 1,3,5-trimethoxybenzene as internal standard, by 1H and 
13C NMR showed a ratio of 10:3:1:10 of 177:178:179:180, which corresponds to yields of 
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Entry 2 – Diamine-free homologation 
 
n-BuLi (1.6 M, 0.34 mL, 0.54 mmol, 1.0 equiv) was added dropwise to a solution of (R)-3-(4-
methoxyphenyl)-1-(tributylstannyl)propyl diisopropylcarbamate (317 mg, 0.54 mmol, 
1.0 equiv) in Et2O (2.72 mL) at ‒78 °C (dry ice/acetone). After 1 h a solution of 155 (199 mg, 
0.54 mmol, 1.0 equiv) in Et2O (0.54 mL) was added rapidly and the resulting solution was 
allowed to stir at the same temperature for 1 h. The solution was warmed to ambient temperature 
and then heated at 35 °C (oil bath) for 16 h. After cooling to ambient temperature, the solution 
was cooled to 0 °C (ice/water) before adding a 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) 
and 30 % aqueous H2O2 (2 mL), which was prepared at 0 °C (ice/water) and degassed by gently 
bubbling N2 through the solution. The mixture was subsequently warmed to ambient 
temperature and allowed to react for 1 h. 2 M aqueous HCl (10 mL) was carefully added and 
the reaction mixture was extracted with EtOAc (3×20 mL). The combined organic fractions 
were dried over Na2SO4, filtered and concentrated under reduced pressure. The broad regions 
containing products 177, and 156 and 157, were collected by purification of the crude residue 
by flash column chromatography (SiO2; 40:60 EtOAc:pentane) to yield 177 as a 1:2.27 mixture 
with pinacol (97 mg, 43 % 177) as a colorless viscous oil, and a 1:2.13 mixture of  156 and 157 
(117 mg, 17 % 156, 37 % 157) as a colorless viscous oil. 
Entry 3 – TMEDA-ligated carbenoid homologation 
 
sec-BuLi (0.42 mL, 1.30 M, 0.55 mmol, 1.00 equiv) was added dropwise to a solution of 143 
(168 mg, 0.57 mmol, 1.05 equiv) and TMEDA (0.09 mL, 0.57 mmol, 1.05 equiv) in anhydrous 
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Et2O (2.87 mL) at −78 °C (dry ice/acetone). After 2 h and solution of rac-155 (200 mg, 
0.55 mmol, 1.00 equiv) in anhydrous Et2O (0.55 mL) was added dropwise and the resulting 
solution was allowed to react for a further 1 h. The solution was warmed to ambient temperature 
and then heated at 35 °C (oil bath) for 16 h. After cooling to ambient temperature, the solution 
was cooled to 0 °C (ice/water) before adding a 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) 
and 30 % aqueous H2O2 (2 mL), which was prepared at 0 °C (ice/water) and degassed by gently 
bubbling N2 through the solution. The mixture was subsequently warmed to ambient 
temperature and allowed to react for 1 h. 2 M aqueous HCl (10 mL) was carefully added and 
the reaction mixture was extracted with EtOAc (3×20 mL). The combined organic fractions 
were dried over Na2SO4, filtered and concentrated under reduced pressure. The broad regions 
containing products 177, and 156, and 157, were collected by purification of the crude residue 
by flash column chromatography (SiO2; 40:60 EtOAc:CH2Cl2) to yield 177 (70 mg, 47 %) as a 
colorless viscous oil, 156 and 157 (27 mg, 5 % 156; 46 mg, 19 % 157) as a colorless viscous 
oil. 
Entry 4 – TMS-diazomethane homologation 
 
According to a modified literature procedure, 155 (100 mg, 0.27 mmol, 1.00 equiv) was 
dissolved in anhydrous toluene (1.00 mL) and trimethylsilyldiazomethane (0.55 mL, 2.0 M 
solution in hexanes, 1.09 mmol, 4.00 equiv) was added. The resulting solution was heated for 
8 h at 80 °C (oil bath) before cooling to ambient temperature, adding another portion of 
trimethylsilyldiazomethane (0.55 mL, 2.0 m solution in hexanes, 1.09 mmol, 4.00 equiv) and 
heating at 80 °C (oil bath) for 16 h. After cooling to ambient temperature a few drops of acetic 
acid were added to quench any unreacted trimethylsilyldiazomethane. Analysis of the crude 
reaction mixture by GC−MS only showed the starting 1,2-bis(boronic ester) (155) and no other 
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3.3 Final Procedures 
3.3.1 Synthesis of all stereoisomers of 156. 
(3S,5S)-1-(4-Methoxyphenyl)undecane-3,5-diol (S,S-156) 
 
3-(4-Methoxyphenyl)propyl diisopropylcarbamate (167 mg, 0.57 mmol, 1.05 equiv), 
(+)-sparteine (0.13 mL, 0.57 mmol, 1.05 equiv) and anhydrous Et2O (2.85 mL) were added to 
a flame-dried Schlenk-tube purged with N2. The solution was cooled to −78 °C (dry ice/acetone) 
before adding sec-BuLi (0.42 mL, 1.30 M, 0.55 mmol, 1.00 equiv) dropwise over 5 min and 
leaving to react for 2 h at this temperature. (R)-155 (242 mg, 0.66 mmol, 1.20 equiv) was 
dissolved in anhydrous Et2O (0.66 mL) and added dropwise to the reaction mixture over 1 min 
before leaving to react for a further 1 h at the same temperature. After warming to ambient 
temperature, the Schlenk-tube was sealed and heated at 35 °C (oil bath) for 16 h. The flask was 
allowed to cool to ambient temperature before adding THF (2.85 mL) and one crystal of BHT 
and was then cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 
30% aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently bubbling 
N2 through the solution. This aqueous solution was added dropwise to the vigorously stirred 
reaction mixture, which was subsequently warmed to ambient temperature and allowed to react 
for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was extracted 
with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 75:25 petroleum ether 40/60:EtOAc) to yield (S,S)-156 (106 mg, 66 %) 
as a gummy white solid. TLC: Rf = 0.18 (60:40 petroleum ether 40/60:EtOAc). 1H NMR: 
(500 MHz, CDCl3) δ 7.90 – 7.14 (m, 2H, ArH), 6.85 – 6.81 (m, 2H, ArH), 3.99 – 3.91 (m, 2H, 
CHOH), 3.78 (s, 3H, OCH3), 2.73 (ddd, J = 13.8, 9.8, 5.7 Hz, 1H, ArCH
aHb), 2.62 (ddd, J = 
13.8, 9.6, 6.43, 1H, ArCHaHb), 2.40 (br s, 2H, OH), 1.87 – 1.80 (m, 1H, ArCH2CH
aHb), 1.78 – 
1.69 (m, 1H, ArCH2CH
aHb), 1.63 (ddd, J = 6.8, 3.9, 2.1 Hz, 2H, CHOHCH2CHOH), 1.57 – 
1.20 (m, 10H, 5× CH2), 0.88 (t, J = 6.8 Hz, 3H, CH3) ppm. 13C NMR: (126 MHz, CDCl3) δ 
157.9 (ArCOCH3), 134.2 (ArC), 129.40 (ArH), 114.0 (ArH), 69.6 (CHOH), 69.0 (CHOH), 55.4 
(OCH3), 42.6 (CHOHCH2CHOH), 39.5 (ArCH2CH2), 37.7 (CH2), 31.9 (CH2), 31.4 (ArCH2), 
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29.4 (CH2), 25.9 (CH2), 22.7 (CH2), 14.2 (CH3) ppm. HRMS (m/z): (ESI) calc’d for 
C18H30O3Na [M+Na]
+: 317.2087, found: 317.2095. IR (solid state) νmax: 3284, 2924, 1611, 
1512, 1248, 1033 and 705 cm−1. [𝜶]𝐃
𝟐𝟒: −7.0 (c = 1.0, CHCl3). 
(3R,5S)-1-(4-Methoxyphenyl)undecane-3,5-diol (R,S-156) 
 
3-(4-Methoxyphenyl)propyl diisopropylcarbamate (167 mg, 0.57 mmol, 1.05 equiv), 
(−)-sparteine (0.13 mL, 0.57 mmol, 1.05 equiv) and anhydrous Et2O (2.85 mL) were added to 
a flame-dried Schlenk-tube purged with N2. The solution was cooled to −78 °C (dry ice/acetone) 
before adding sec-BuLi (0.42 mL, 1.30 M, 0.55 mmol, 1.00 equiv) dropwise over 5 min and 
leaving to react for 2 h at this temperature. (R)-155 (242 mg, 0.66 mmol, 1.20 equiv) was 
dissolved in anhydrous Et2O (0.66 mL) and added dropwise to the reaction mixture over 1 min 
before leaving to react for a further 1 h at the same temperature. After warming to ambient 
temperature, the Schlenk-tube was sealed and heated at 35 °C (oil bath) for 16 h. The flask was 
allowed to cool to ambient temperature before adding THF (2.85 mL) and one crystal of BHT 
and was then cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 
30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently bubbling 
N2 through the solution. This aqueous solution was added dropwise to the vigorously stirred 
reaction mixture, which was subsequently warmed to ambient temperature and allowed to react 
for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was extracted 
with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 75:25 petroleum ether 40/60:EtOAc) to yield (R,S)-156 (118 mg, 73 %) 
as a colorless oil. TLC: Rf = 0.23 (60:40 petroleum ether 40/40:EtOAc). 1H NMR: (500 MHz, 
CDCl3) δ 7.14 – 7.09 (m, 2H, ArH), 6.85 – 6.80 (m, 2H, ArH), 3.90 – 3.81(m, 2H, CHOH), 
3.79 (s, 3H, OCH3), 2.85 (br s, 2H, OH), 2.75 – 2.59 (m, 2H, ArCH2), 1.85 – 1.67 (m, 2H, 
ArCH2CH2), 1.64 – 1.23 (m, 12H, 6× CH2), 0.88 (t, J = 7.1 Hz, 3H, CH3) ppm. 13C NMR: 
(126 MHz, CDCl3) δ 157.9 (ArCOCH3), 134.1 (ArC), 129.4 (ArH), 114.0 (ArH), 73.4 (CHOH), 
72.5 (CHOH), 55.4 (OCH3), 43.1 (CH2), 40.1 (ArCH2CH2), 38.5 (CH2), 31.9 (CH2), 30.9 
(ArCH2), 29.4 (CH2), 25.4 (CH2), 22.7 (CH2), 14.2 (CH3) ppm. HRMS (m/z): (ESI) calc’d for 
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C18H30O3Na [M+Na]
+: 317.2087, found: 317.2092. IR (neat) νmax: 3358, 2928, 2856, 1512, 
1244, 1037 and 820 cm−1. [𝜶]𝐃
𝟐𝟒: +11.0 (c = 1.0, CHCl3). 
(3R,5R)-1-(4-Methoxyphenyl)undecane-3,5-diol (R,R-156) 
 
3-(4-Methoxyphenyl)propyl diisopropylcarbamate (167 mg, 0.57 mmol, 1.05 equiv), 
(−)-sparteine (0.13 mL, 0.57 mmol, 1.05 equiv) and anhydrous Et2O (2.85 mL) were added to 
a flame-dried Schlenk-tube purged with N2. The solution was cooled to −78 °C (dry ice/acetone) 
before adding sec-BuLi (0.42 mL, 1.30 M, 0.55 mmol, 1.00 equiv) dropwise over 5 min and 
leaving to react for 2 h at this temperature. (S)-155 (242 mg, 0.66 mmol, 1.20 equiv) was 
dissolved in anhydrous Et2O (0.66 mL) and added dropwise to the reaction mixture over 1 min 
before leaving to react for a further 1 h at the same temperature. After warming to ambient 
temperature, the Schlenk-tube was sealed and heated at 35 °C (oil bath) for 16 h. The flask was 
allowed to cool to ambient temperature before adding THF (2.85 mL) and one crystal of BHT 
and was then cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 
30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently bubbling 
N2 through the solution. This aqueous solution was added dropwise to the vigorously stirred 
reaction mixture, which was subsequently warmed to ambient temperature and allowed to react 
for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was extracted 
with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 75:25 petroleum ether 40/60:EtOAc) to yield (R,R)-156 (105 mg, 65 %) 
as a gummy white solid. [𝜶]𝐃
𝟐𝟒: +.0 (c = 1.0, CHCl3). All other physical data matched that 









3-(4-Methoxyphenyl)propyl diisopropylcarbamate (167 mg, 0.57 mmol, 1.05 equiv), 
(+)-sparteine (0.13 mL, 0.57 mmol, 1.05 equiv) and anhydrous Et2O (2.85 mL) were added to 
a flame-dried Schlenk-tube purged with N2. The solution was cooled to −78 °C (dry ice/acetone) 
before adding sec-BuLi (0.42 mL, 1.30 M, 0.55 mmol, 1.00 equiv) dropwise over 5 min and 
leaving to react for 2 h at this temperature. (S)-155 (242 mg, 0.66 mmol, 1.20 equiv) was 
dissolved in anhydrous Et2O (0.66 mL) and added dropwise to the reaction mixture over 1 min 
before leaving to react for a further 1 h at the same temperature. After warming to ambient 
temperature the Schlenk-tube was sealed and heated at 35 °C (oil bath) for 16 h. The flask was 
allowed to cool to ambient temperature before adding THF (2.85 mL) and one crystal of BHT 
and was then cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 
30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently bubbling 
N2 through the solution. This aqueous solution was added dropwise to the vigorously stirred 
reaction mixture, which was subsequently warmed to ambient temperature and allowed to react 
for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was extracted 
with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 75:25 petroleum ether 40/60:EtOAc) to yield (S,R)-156 (117 mg, 72 %) 
as a colorless oil. [𝜶]𝐃




Collected from reactions corresponding to Entries 1−12 from Table 1. TLC: Rf = 0.26 (60:40 
petroleum ether 40/40:EtOAc). 1H NMR: (400 MHz, CDCl3) δ 7.13 – 7.10 (m, 4H, ArH), 6.86 
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– 6.80 (m, 4H, ArH), 3.79 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 3.83 – 3.77 (m, 1H, CHOH), 
3.69 (dt, J = 9.3, 2.8 Hz, 1H, CHOH), 2.80 – 2.67 (m, 2H, ArCH2), 2.60 (m, 2H ArCH2), 2.50 
(br s, 2H, OH), 1.82 – 1.63 (m, 6H, CH/CHaHb/2×CH2), 1.47 – 1.39 (m, 1H, CH
aHb), 1.35 – 
1.18 (m, 5×2H), 0.88 (t, J = 6.9 Hz, 1H) ppm. 13C NMR: (101 MHz, CDCl3) δ 158.0 
(ArCOCH3), 157.9 (ArCOCH3), 134.3 (ArC), 134.2 (ArC), 129.4 (ArH), 129.4 (ArH), 114.0 
(ArH), 114.0 (ArH), 74.4 (COH), 68.5 (COH), 55.4 (OCH3), 55.4 (OCH3), 40.2 (CH), 39.8 
(CH2), 38.7 (CH2), 35.4 (CH2), 32.3 (CH2), 31.9 (CH2), 31.6 (CH2), 29.7 (CH2), 29.5 (CH2), 
27.8 (CH2), 22.8 (CH2), 14.2 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C28H42O4Na [M+Na]
+: 
465.2975, found: 465.2964. IR (neat) νmax: 3310, 2927, 2855, 1747, 1612, 1511, 1243, 1176, 
1036, 823 and 753 cm−1. [𝜶]𝐃
𝟐𝟑: +2.0 (c = 1.0, CHCl3). 
3.3.2 Substrate Scope 
(3R,5R)-2-Methylundecane-3,5-diol (159) 
 
Isobutyl 2,4,6-triisopropylbenzoate (175 mg, 0.57 mmol, 1.05 equiv), (+)-sparteine (0.13 mL, 
0.57 mmol, 1.05 equiv) and anhydrous Et2O (2.85 mL) were added to a flame-dried Schlenk-
tube purged with N2. The solution was cooled to −78 °C (dry ice/acetone) before adding 
sec-BuLi (0.42 mL, 1.30 M, 0.55 mmol, 1.00 equiv) dropwise over 5 min and leaving to react 
for 3 h at this temperature. (S)-155 (240 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous 
Et2O (0.66 mL) and added dropwise to the reaction mixture over 1 min before leaving to react 
for a further 1 h at the same temperature. After warming the solution to ambient temperature 
THF (2.85 mL) and one crystal of BHT was added, and then it cooled to 0 °C (ice/water). A 
2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 30 % aqueous H2O2 (2 mL) was prepared at 
0 °C (ice/water) and degassed by gently bubbling N2 through the solution. This aqueous solution 
was added dropwise to the vigorously stirred reaction mixture, which was subsequently warmed 
to ambient temperature and allowed to react for 1 h. 2 M aqueous HCl (10 mL) was carefully 
added and the reaction mixture was extracted with EtOAc (3×20 mL). The combined organic 
fractions were dried over Na2SO4, filtered and concentrated under reduced pressure. The crude 
residue was purified by flash column chromatography (SiO2; 90:10 pentane:EtOAc) to yield 
159 (86 mg, 78 %) as a viscous colorless oil. TLC: Rf = 0.18 (80:20 pentane:EtOAc). 1H NMR: 
(400 MHz, CDCl3) δ 3.86 – 3.78 (m, 1H, CHO), 3.66 – 3.58 (m, 1H, CHO), 3.15 (br s, 2H, 
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OH), 1.71 – 1.17 (m, 13H, 6×CH2 and CH(CH3)2), 0.91 (d, J = 6.9 Hz, 6H, CH(CH3)2), 0.88 (t, 
J = 6.9 Hz, 3H, CH3) ppm. 13C NMR: (101 MHz, CDCl3) δ 78.2 (CHO), 73.5 (CHO), 39.5 
(CH2), 38.5 (CH2), 34.4 (CH(CH3)2), 32.0 (CH2), 29.5 (CH2), 25.5 (CH2), 22.7 (CH2), 18.4 
(CH(CH3)2), 17.6 (CH(CH3)2), 14.2 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C12H26O2Na 
[M+Na]+: 225.1825, found: 225.1823. IR (neat) νmax: 3346 (br), 2956, 2927, 2857, 1465, 1064 
and 846 cm−1. [𝜶]𝐃
𝟐𝟒: +4.0 (c = 1.0, CHCl3). 
(5S,7R)-Tridec-1-ene-5,7-diol (160) 
 
Pent-4-en-1-yl diisopropylcarbamate (122 mg, 0.57 mmol, 1.05 equiv), (+)-sparteine (0.13 mL, 
0.57 mmol, 1.05 equiv) and anhydrous Et2O (2.85 mL) were added to a flame-dried Schlenk-
tube purged with N2. The solution was cooled to −78 °C (dry ice/acetone) before adding 
sec-BuLi (0.42 mL, 1.30 M, 0.55 mmol, 1.00 equiv) dropwise over 5 min and leaving to react 
for 5 h at this temperature. (S)-155 (240 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous 
Et2O (0.66 mL) and added dropwise to the reaction mixture over 1 min before leaving to react 
for a further 1 h at the same temperature. After warming to ambient temperature, the Schlenk-
tube was sealed and heated at 35 °C (oil bath) for 16 h. The flask was allowed to cool to ambient 
temperature before adding THF (2.85 mL) and one crystal of BHT and was then cooled to 0 °C 
(ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 30 % aqueous H2O2 (2 mL) 
was prepared at 0 °C (ice/water) and degassed by gently bubbling N2 through the solution. This 
aqueous solution was added dropwise to the vigorously stirred reaction mixture, which was 
subsequently warmed to ambient temperature and allowed to react for 1 h. 2 M aqueous HCl 
(10 mL) was carefully added and the reaction mixture was extracted with EtOAc (3×20 mL). 
The combined organic fractions were dried over Na2SO4, filtered and concentrated under 
reduced pressure. The crude residue was purified by flash column chromatography (SiO2; 85:15 
pentane:EtOAc) to yield 160 (81 mg, 69 %) as a viscous colorless oil. TLC: Rf = 0.37 (60:40 
petroleum ether 40/40:EtOAc). 1H NMR: (500 MHz, CDCl3) δ 5.84 (ddt, J = 16.9, 10.2, 6.7 
Hz, 1H, =CH), 5.05 (app dq, J = 17.1, 1.8 Hz, 1H, =CHaHb), 4.98 (ddt, J = 10.2, 1.8, 1.2 Hz, 
1H, =CHaHb), 3.93 – 3.81 (m, 2H, 2×CHO), 2.85 (br s, 2H, 2×OH), 2.25 – 2.08 (m, 2H, 
CH2CH=), 1.63 – 1.22 (m, 14H, 7×CH2), 0.88 (t, J = 6.7 Hz, CH3) ppm. 13C NMR: (126 MHz, 
CDCl3) δ 138.6 (CH=), 115.0 (=CH2), 73.4 (CHO), 72.8 (CHO), 43.0 (CH2), 38.4 (CH2), 37.3 
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(CH2), 32.0 (CH2), 29.9 (CH2), 29.4 (CH2CH=), 25.4 (CH2), 22.7 (CH2), 14.2 (CH3) ppm. 
HRMS (m/z): (ESI) calc’d for C13H26O2Na [M+Na]
+: 237.1825, found: 237.1823. IR (neat) 
νmax: 3366 (br), 2927, 2857, 1641, 1405, 1321, 909 and 665 cm−1. [𝜶]𝐃
𝟐𝟒: −3.0 (c = 1.0, CHCl3). 
(3S,5R)-1-((tert-Butyldimethylsilyl)oxy)undecane-3,5-diol (161) 
 
3-((tert-Butyldimethylsilyl)oxy)propyl diisopropylcarbamate (182 mg, 0.57 mmol, 1.05 equiv), 
(+)-sparteine (0.13 mL, 0.57 mmol, 1.05 equiv) and anhydrous Et2O (2.85 mL) were added to 
a flame-dried Schlenk-tube purged with N2. The solution was cooled to −78 °C (dry ice/acetone) 
before adding sec-BuLi (0.42 mL, 1.30 M, 0.55 mmol, 1.00 equiv) dropwise over 5 min and 
leaving to react for 5 h at this temperature. (S)-155 (240 mg, 0.66 mmol, 1.20 equiv) was 
dissolved in anhydrous Et2O (0.66 mL) and added dropwise to the reaction mixture over 1 min 
before leaving to react for a further 1 h at the same temperature. After warming to ambient 
temperature, the Schlenk-tube was sealed and heated at 35 °C (oil bath) for 16 h. The flask was 
allowed to cool to ambient temperature before adding THF (2.85 mL) and one crystal of BHT 
and was then cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 
30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently bubbling 
N2 through the solution. This aqueous solution was added dropwise to the vigorously stirred 
reaction mixture, which was subsequently warmed to ambient temperature and allowed to react 
for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was extracted 
with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 85:15 pentane:EtOAc) to yield 161 (101 mg, 58 %) as a viscous 
colorless oil. TLC: Rf = 0.26 (80:20 pentane:EtOAc). 1H NMR: (400 MHz, CDCl3) δ 4.09 (app 
tt, J = 8.3, 3.5 Hz, 1H, CHO), 4.03 (br s, 1H, OH), 3.94 – 3.78 (m, 3H, CHO and CH2OSi), 3.67 
(br s, 1H OH), 1.77 – 1.20 (m, 14H, 7×CH2), 0.90 (s, 9H, SiC(CH3)3), 0.88 (t, J = 7.0 Hz, 3H, 
CH3), 0.08 (s, 6H, Si(CH3)2) ppm. 13C NMR: (101 MHz, CDCl3) δ 73.7 (CHO), 72.6 (CHO), 
62.7 (CH2OSi), 43.4 (CH2), 38.9 (CH2), 38.1 (CH2), 32.0 (CH2), 29.5 (CH2), 26.0 (SiC(CH3)3), 
25.5 (CH2), 22.8 (CH2), 18.3 (SiC(CH3)3), 14.2 (CH3), −5.4 (Si(CH3)2), −5.4 (Si(CH3)2) ppm. 
HRMS (m/z): (ESI) calc’d for C17H38O3SiNa [M+Na]
+: 341.2482, found: 341.2488. IR (neat) 
νmax: 3351 (br), 2928, 2857, 1254, 1090, 834 and 775 cm−1. [𝜶]𝐃
𝟐𝟒: +10.0 (c = 1.0, CHCl3). 




(2R,4S)-5-(Methoxymethoxy)-2,4-dimethylpentyl diisopropylcarbamate (207 mg, 0.68 mmol, 
1.25 equiv), (+)-sparteine (0.16 mL, 0.68 mmol, 1.25 equiv) and anhydrous Et2O (3.41 mL) 
were added to a flame-dried Schlenk-tube purged with N2. The solution was cooled to −78 °C 
(dry ice/acetone) before adding sec-BuLi (0.50 mL, 1.30 M, 0.66 mmol, 1.20 equiv) dropwise 
over 5 min and leaving to react for 5 h at this temperature. (S)-155 (242 mg, 0.55 mmol, 
1.00 equiv) was dissolved in anhydrous Et2O (0.55 mL) and added dropwise to the reaction 
mixture over 1 min before leaving to react for a further 1 h at the same temperature. After 
warming to ambient temperature the Schlenk-tube was sealed and heated at 35 °C (oil bath) for 
16 h. The flask was allowed to cool to ambient temperature before adding THF (2.85 mL) and 
one crystal of BHT, and was then cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous 
NaOH (4 mL) and 30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed 
by gently bubbling N2 through the solution. This aqueous solution was added dropwise to the 
vigorously stirred reaction mixture, which was subsequently warmed to ambient temperature 
and allowed to react for 1 h. Water (10 mL) was added and the reaction mixture was extracted 
with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 70:30 pentane:EtOAc) to yield 162 (72 mg, 43 %) as a viscous colorless 
oil. TLC: Rf = 0.23 (70:30 pentane:EtOAc). 1H NMR: (500 MHz, CDCl3) δ 4.61 (s, 2H, 
OCH2O), 3.86 – 3.76 (m, 2H, 2×CHO), 3.38 (dd, J = 9.4, 5.9 Hz, 1H, CH
aHbO), 3.35 (s, 3H, 
OCH3), 3.32 (dd, J = 9.4, 6.3 Hz, 1H, CH
aHbO), 3.21 (br s, 1H, OH), 3.01 (br s, 1H, OH), 1.89 
– 1.78 (m, 1H, CHCH2O), 1.64 – 1.22 (m, 13H, 6×CH2 and CH
aHb), 1.04 – 0.93 (m, 1H, 
CHaHb), 0.95 (d, J = 6.7 Hz, 3H, CHCH3), 0.89 (d, J = 6.7 Hz, 3H, CHCH3), 0.88 (t, J = 7.2 Hz, 
3H, CH3) ppm. 13C NMR: (126 MHz, CDCl3) δ 96.8 (OCH2O), 75.6 (CHO), 73.5 (CHO), 73.3 
(CH2O), 55.3 (OCH3), 40.0 (CH2), 38.4 (CH2), 37.2 (CH2), 36.6 (CHCH3), 32.0 (CH2), 30.9 
(CHCH3), 29.5 (CH2), 25.5 (CH2), 22.8 (CH2), 18.4 (CHCH3), 14.7 (CHCH3), 14.2 (CH3) ppm. 
HRMS (m/z): (ESI) calc’d for C17H36O4Na [M+Na]
+: 327.2506, found: 327.2514. IR (neat) 
νmax: 3416, 2926, 2857, 1405, 1109, 1042, 919, 733 and 667 cm−1. [𝜶]𝐃
𝟐𝟒: +6.0 (c = 1.0, CHCl3). 




(S,E)-Pent-3-en-2-yl diisopropylcarbamate (117 mg, 0.55 mmol, 1.00 equiv) and anhydrous 
Et2O (3.30 mL) were added to a flame-dried Schlenk-tube purged with N2. The solution was 
cooled to −78 °C (dry ice/acetone) before adding sec-BuLi (0.46 mL, 1.30 M, 0.60 mmol, 
1.10 equiv) dropwise over 5 min and leaving to react for 15 min at this temperature. (S)-155 
(241 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous Et2O (0.66 mL) and added 
dropwise to the reaction mixture over 1 min before leaving to react for a further 1 h at the same 
temperature. A 1 M solution of MgBr2 in MeOH (0.83 mL, 0.83 mmol, 1.50 equiv) was added 
dropwise over 2 min and the mixture was allowed to react for a further 2 min before warming 
to ambient temperature. THF (2.85 mL) and one crystal of BHT were added, and the mixture 
was subsequently cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) 
and 30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently 
bubbling N2 through the solution. This aqueous solution was added dropwise to the vigorously 
stirred reaction mixture, which was subsequently warmed to ambient temperature and allowed 
to react for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was 
extracted with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The crude residue was purified by flash 
column chromatography (SiO2; 80:20 pentane:EtOAc) to yield 163 (78 mg, 66 %) as a viscous 
colorless oil. TLC: Rf = 0.25 (80:20 pentane:EtOAc). 1H NMR: (500 MHz, CDCl3) δ 5.74 – 
5.46 (m, 2H, 2×=CH), 4.19 – 3.92 (m, 1H, CHO), 3.18 (br s, 1H, OH), 2.54 (br s, 1H, OH), 
1.82 – 1.18 (m, 12H, 6×CH2), 1.69 (dd, J = 6.2, 1.3 Hz, 3H, =CHCH3), 1.35 (s, 3H, CCH3), 
0.88 (t, J = 6.9 Hz, 3H, CH3) ppm. 13C NMR: (126 MHz, CDCl3) δ 139.4 (=CH), 122.5 (=CH), 
73.4 (CO), 69.4 (CHO), 47.4 (CH2), 38.4 (CH2), 32.0 (CH2), 29.5 (CH2), 26.9 (CCH3), 25.6 
(CH2), 22.8 (CH2), 17.8 (=CHCH3), 14.2 (CH3) ppm. HRMS (m/z): (ESI) calc’d for 
C13H26O2Na [M+Na]
+: 237.1825, found: 237.1830. IR (neat) νmax: 3368 (br), 2928, 2857, 
1409, 1473, 1311, 1132, 966, 849 and 665 cm−1. [𝜶]𝐃
𝟐𝟒: −5.0 (c = 1.0, CHCl3). 
 
 




(S)-4-Phenyl-2-(trimethylstannyl)butan-2-yl 2,4,6-triisopropylbenzoate (300 mg, 0.55 mmol, 
1.00 equiv) TMEDA (0.09 mL, 0.61 mmol, 1.10 equiv) and anhydrous Et2O (2.76 mL) were 
added to a flame-dried Schlenk-tube purged with N2. The solution was cooled to −78 °C (dry 
ice/acetone) before adding n-BuLi (0.38 mL, 1.60 M, 0.61 mmol, 1.10 equiv) dropwise over 
10 min and leaving to react for 2 h at this temperature. (S)-155 (243 mg, 0.66 mmol, 1.20 equiv) 
was dissolved in anhydrous Et2O (0.66 mL) and added dropwise to the reaction mixture over 
1 min before leaving to react for a further 1 h at the same temperature. After warming the 
solution to ambient temperature THF (2.85 mL) and one crystal of BHT was added, and then it 
cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 30 % aqueous 
H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently bubbling N2 through the 
solution. This aqueous solution was added dropwise to the vigorously stirred reaction mixture, 
which was subsequently warmed to ambient temperature and allowed to react for 1 h. 2 M 
aqueous HCl (10 mL) was carefully added and the reaction mixture was extracted with EtOAc 
(3×20 mL). The combined organic fractions were dried over Na2SO4, filtered and concentrated 
under reduced pressure. The crude residue was purified by flash column chromatography (SiO2; 
80:20 pentane:EtOAc) to yield 164 (123 mg, 80 %) as a viscous colorless oil. TLC: Rf = 0.19 
(80:20 pentane:EtOAc). 1H NMR: (500 MHz, CDCl3) δ 7.33 – 7.24 (m, 2H, ArH), 7.24 – 7.15 
(m, 3H, ArH), 4.09 – 3.91 (m, 1H CHO), 3.18 (br s, 2H, OH), 2.72 (ddd, J = 13.4, 12.1, 5.0 Hz, 
1H, ArCHaHb), 2.60 (ddd, J = 13.4, 12.0, 5.3 Hz, ArCHaHb), 1.96 (ddd, J = 13.6, 12.0, 5.0 Hz, 
1H, ArCH2CH
aHb), 1.87 (ddd, J = 13.6, 12.1, 5.4 Hz, 1H, ArCH2CH
aHb), 1.73 – 1.21 (m, 15H, 
6×CH2 and CCH3), 0.88 (t, J = 7.0 Hz, 3H, CH3) ppm. 13C NMR: (126 MHz, CDCl3) δ 142.5 
(ArC), 128.6 (ArH), 128.4 (ArH), 126.0 (ArH), 73.5 (CO), 69.6 (CHO), 46.7 (CH2), 42.5 
(ArCH2CH2), 38.7 (CH2), 31.9 (CH2), 31.1 (ArCH2), 29.4 (CH2), 28.8 (CCH3), 25.5 (CH2), 22.7 
(CH2), 14.2 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C18H30O2Na [M+Na]
+: 301.2138, found: 
301.2142. IR (neat) νmax: 3348 (br), 2928, 2857, 1700, 1605, 1130, 741 and 697 cm−1. [𝜶]𝐃
𝟐𝟒: 
+7.0 (c = 1.0, CHCl3). 
 




(S)-1-(4-Methoxyphenyl)ethyl diisopropylcarbamate (155 mg, 0.55 mmol, 1.00 equiv), 
TMEDA (0.09 mL, 0.61 mmol, 1.10 equiv) and anhydrous Et2O (2.70 mL) were added to a 
flame-dried Schlenk-tube purged with N2. The solution was cooled to −78 °C (dry ice/acetone) 
before adding sec-BuLi (0.48 mL, 1.30 M, 0.62 mmol, 1.12 equiv) dropwise over 5 min and 
leaving to react for 15 min at this temperature. (S)-155 (244 mg, 0.66 mmol, 1.20 equiv) was 
dissolved in anhydrous Et2O (0.66 mL) and added dropwise to the reaction mixture over 1 min 
before leaving to react for a further 1 h at the same temperature. A 1 M solution of MgBr2 in 
MeOH (0.61 mL, 0.61 mmol, 1.10 equiv) was added dropwise over 2 min and the mixture was 
allowed to react for a further 2 min before warming to ambient temperature. Water (10 mL) 
was added and the organic phase was collected, followed by extraction of the aqueous phase 
(3×15 mL Et2O). The combined organic phases were dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude residue was dissolved in THF (6 mL) and one 
crystal of BHT was added, then the mixture was subsequently cooled to 0 °C (ice/water). A 
2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 30 % aqueous H2O2 (2 mL) was prepared at 
0 °C (ice/water) and degassed by gently bubbling N2 through the solution. This aqueous 
solution was added dropwise to the vigorously stirred reaction mixture, which was subsequently 
warmed to ambient temperature and allowed to react for 1 h. 2 M aqueous HCl (10 mL) was 
carefully added and the reaction mixture was extracted with EtOAc (3×20 mL). The combined 
organic fractions were dried over Na2SO4, filtered and concentrated under reduced pressure. 
The crude residue was purified by flash column chromatography (SiO2; 80:20 pentane:EtOAc) 
to yield 165 (150 mg, 94 %) as a viscous colorless oil. TLC: Rf = 0.21 (80:20 pentane:EtOAc). 
1H NMR: (400 MHz, CDCl3) δ 7.38 (d, J = 8.8 Hz, 2H, ArH), 6.87 (d, J = 8.8 Hz, 2H, ArH), 
4.12 – 4.03 (m, 1H, CHO), 3.80 (s, 3H, OCH3), 3.30 (br s, 2, OH), 1.83 (dd, J = 14.7, 9.7 Hz, 
1H, CHOCHaHbC), 1.77 (dd, J = 14.7, 2.7 Hz, 1H, CHOCHaHbC), 1.64 (s, 3H, CCH3), 1.53 – 
1.09 (m, 10H, 5×CH2), 0.88 (t, J = 6.6 Hz, 3H, CH3) ppm. 13C NMR: (101 MHz, CDCl3) δ 
158.5 (ArC), 141.7 (ArC), 125.7 (ArH), 113.7 (ArH), 74.9 (CO), 69.9 (CHO), 55.4 (OCH3), 
49.6 (CHOCH2C), 38.4 (CH2), 31.9 (CH2), 29.4 (CH2), 28.1 (CCH3), 25.5 (CH2), 22.7 (CH2), 
14.2 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C17H28O3Na [M+Na]
+: 303.1931, found: 
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303.1928. IR (neat) νmax: 3346 (br), 2927, 2856, 1611, 1511, 1463, 1301, 1247, 1177, 1092, 
1034 and 829 cm−1. [𝜶]𝐃
𝟐𝟒: +21.0 (c = 1.0, CHCl3). 
(2R,4R)-2-Phenyldecane-2,4-diol (166) 
 
(S)-1-Phenylethyl diisopropylcarbamate (168) (138 mg, 0.55 mmol, 1.00 equiv) and anhydrous 
Et2O (2.77 mL) were added to a flame-dried Schlenk-tube purged with N2. The solution was 
cooled to −78 °C (dry ice/acetone) before adding sec-BuLi (0.48 mL, 1.30 M, 0.62 mmol, 
1.12 equiv) dropwise over 5 min and leaving to react for 15 min at this temperature. (S)-155 
(243 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous Et2O (0.66 mL) and added 
dropwise to the reaction mixture over 1 min before leaving to react for a further 1 h at the same 
temperature. A 1 M solution of MgBr2 in MeOH (0.83 mL, 0.83 mmol, 1.50 equiv) was added 
dropwise over 2 min and the mixture was allowed to react for a further 2 min before warming 
to ambient temperature. Water (10 mL) was added and the organic phase was collected, 
followed by extraction of the aqueous phase (3×15 mL Et2O). The combined organic phases 
were dried over MgSO4, filtered and concentrated under reduced pressure. The crude residue 
was dissolved in THF (6 mL) and one crystal of BHT was added, then the mixture was 
subsequently cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 
30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently bubbling 
N2 through the solution. This aqueous solution was added dropwise to the vigorously stirred 
reaction mixture, which was subsequently warmed to ambient temperature and allowed to react 
for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was extracted 
with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 80:20 pentane:EtOAc) to yield 166 (101 mg, 73 %) as a viscous 
colorless oil. TLC: Rf = 0.24 (80:20 pentane:EtOAc). 1H NMR: (500 MHz, CDCl3) δ 7.47 (d, 
J = 7.3 Hz, 2H, ArH), 7.35 (t, J = 7.7 Hz, 2H, ArH), 7.25 (t, J = 7.3 Hz, 1H, ArH), 4.12 (app tt, 
J = 8.5, 4.1 Hz, 1H, CHO), 2.62 (br s, 2H, OH), 1.89 – 1.77 (m, 2H, CHOCH2C), 1.67 (s, 3H, 
CCH3), 1.62 – 1.14 (m, 10H, 5×CH2), 0.88 (6.7 Hz, 3H, CH3) ppm. 13C NMR: (126 MHz, 
CDCl3) δ 149.4 (ArC), 128.4 (ArH), 126.9 (ArH), 124.5 (ArH), 75.1 (CO), 69.9 (CHO), 49.5 
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(CHOCH2C), 38.5 (CH2), 31.9 (CH2), 29.4 (CH2), 28.2 (CCH3), 25.5 (CH2), 22.7 (CH2), 14.2 
(CH3) ppm. HRMS (m/z): (ESI) calc’d for C16H26O2Na [M+Na]
+: 273.1825, found: 273.1831. 
IR (neat) νmax: 3351, 2927, 2856, 1375, 1412, 1446, 1071, 762 and 698 cm−1. [𝜶]𝐃
𝟐𝟒: +22.0 
(c = 1.0, CHCl3). 
(2R,4R)-2-(4-Fluorophenyl)decane-2,4-diol (167) 
 
(S)-1-(4-Fluorophenyl)ethyl diisopropylcarbamate (146 mg, 0.55 mmol, 1.00 equiv) and 
anhydrous Et2O (2.73 mL) were added to a flame-dried Schlenk-tube purged with N2. The 
solution was cooled to −78 °C (dry ice/acetone) before adding sec-BuLi (0.47 mL, 1.30 M, 
0.62 mmol, 1.12 equiv) dropwise over 5 min and leaving to react for 15 min at this temperature. 
(S)-155 (240 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous Et2O (0.66 mL) and added 
dropwise to the reaction mixture over 1 min before leaving to react for a further 1 h at the same 
temperature. A 1 M solution of MgBr2 in MeOH (0.82 mL, 0.82 mmol, 1.50 equiv) was added 
dropwise over 2 min and the mixture was allowed to react for a further 2 min before warming 
to ambient temperature. Water (10 mL) was added and the organic phase was collected, 
followed by extraction of the aqueous phase (3×15 mL Et2O). The combined organic phases 
were dried over MgSO4, filtered and concentrated under reduced pressure. The crude residue 
was dissolved in THF (6 mL) and one crystal of BHT was added, then the mixture was 
subsequently cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 
30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently bubbling 
N2 through the solution. This aqueous solution was added dropwise to the vigorously stirred 
reaction mixture, which was subsequently warmed to ambient temperature and allowed to react 
for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was extracted 
with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 80:20 pentane:EtOAc) to yield 167 (121 mg, 82 %) as a viscous 
colorless oil. TLC: Rf = 0.20 (80:20 pentane:EtOAc). 1H NMR: (500 MHz, CDCl3) δ 7.47 – 
7.37 (m, 2H, ArH), 7.05 – 6.96 (m, 2H, ArH), 4.15 – 4.05 (m, 1H, CHO), 3.67 (s, 1H, OH), 
2.76 (s, 1H, OH), 1.85 – 1.73 (m, 2H, CHOCH2C), 1.64 (s, 3H, CH3), 1.55 – 1.16 (m, 10H, 
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5×CH2), 0.88 (t, J = 7.1 Hz, 3H, CH3) ppm. 13C NMR: (126 MHz, CDCl3) δ 161.8 (d, J = 244.7 
Hz, ArCF), 145.3 (ArC), 126.3 (d, J = 7.9 Hz, ArH), 115.0 (d, J = 21.2 Hz, ArH), 114.9 (ArH), 
74.7 (CO), 70.0 (CHO), 49.5 (CHOCH2C), 38.5 (CH2), 31.9 (CH2), 29.4 (CH2), 28.2 (CCH3), 
25.5 (CH2), 22.7 (CH2), 14.2 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C16H25O2FNa 
[M+Na]+: 291.1731, found: 291.1732. IR (neat) νmax: 3344, 2928, 2857, 1602, 1509, 1416, 
11375, 1225, 1159, 1088 and 834 cm−1. [𝜶]𝐃
𝟐𝟒: +16.0 (c = 1.0, CHCl3). 
tert-Butyl (6S,8R)-6,8-dihydroxy-8-phenylnonanoate (169) 
 
(S)-1-Phenylethyl diisopropylcarbamate (168) (138 mg, 0.55 mmol, 1.00 equiv) and anhydrous 
Et2O (2.77 mL) were added to a flame-dried Schlenk-tube purged with N2. The solution was 
cooled to −78 °C (dry ice/acetone) before adding sec-BuLi (0.48 mL, 1.30 M, 0.62 mmol, 
1.12 equiv) dropwise over 5 min and leaving to react for 15 min at this temperature. The 
1,2-bis(boronic ester) (291 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous Et2O 
(0.66 mL) and added dropwise to the reaction mixture over 1 min before leaving to react for a 
further 1 h at the same temperature. A 1 M solution of MgBr2 in MeOH (0.83 mL, 0.83 mmol, 
1.50 equiv) was added dropwise over 2 min and the mixture was allowed to react for a further 
2 min before warming to ambient temperature. Water (10 mL) was added and the organic phase 
was collected, followed by extraction of the aqueous phase (3×15 mL Et2O). The combined 
organic phases were dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude residue was dissolved in THF (6 mL) and one crystal of BHT was added, then the mixture 
was subsequently cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) 
and 30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently 
bubbling N2 through the solution. This aqueous solution was added dropwise to the vigorously 
stirred reaction mixture, which was subsequently warmed to ambient temperature and allowed 
to react for 1 h. Water (10 mL) was added and the reaction mixture was extracted with EtOAc 
(3×20 mL). The combined organic fractions were dried over Na2SO4, filtered and concentrated 
under reduced pressure. The crude residue was purified by flash column chromatography (SiO2; 
70:30 pentane:EtOAc) to yield 169 (126 mg, 71 %) as a viscous colorless oil. TLC: Rf = 0.40 
(60:40 pentane:EtOAc). 1H NMR: (500 MHz, CDCl3) δ 7.44 – 7.38 (m, 2H, ArH), 7.37 – 7.29 
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(m, 2H, ArH), 7.26 – 7.18 (m, 1H, ArH), 4.38 (s, 1H, OH), 3.50 – 3.33 (m, 1H, CHO), 2.89 (s, 
1H, OH), 2.15 (t, J = 7.4 Hz, 2H, COCH2), 2.01 (dd, J = 14.6, 2.0 Hz, 1H, CHOCH
aHbC), 1.90 
(dd, J = 14.6, 10.6 Hz, 1H, CHOCHaHbC), 1.55 – 1.15 (m, 6H, 3×CH2), 1.50 (s, 3H, CCH3), 
1.41 (s, 9H, OC(CH3)3) ppm. 13C NMR: (126 MHz, CDCl3) δ 173.3 (C=O), 147.6 (ArC), 128.3 
(ArH), 126.5 (ArH), 125.0 (ArH), 80.3 (OC(CH3)3), 75.7 (CO), 70.1 (CHO), 48.4 (CHOCH2C), 
37.9 (CH2), 35.4 (C=OCH2), 32.7 (CCH3), 28.2 (OC(CH3)3), 24.9 (CH2), 24.7 (CH2) ppm. 
HRMS (m/z): (ESI) calc’d for C19H30O4Na [M+Na]
+: 345.2036, found: 345.2034. IR (neat) 
νmax: 3378 (OH), 2975, 2932, 1726 (CO), 1366, 1147, 1098, 845, 766 and 701 cm−1. [𝜶]𝐃
𝟐𝟒: 
+11.0 (c = 1.0, CHCl3). 
(1R,3R)-1-(4-Methoxyphenyl)-3-phenylbutane-1,3-diol (170) 
 
(S)-1-Phenylethyl diisopropylcarbamate (168) (138 mg, 0.55 mmol, 1.00 equiv) and anhydrous 
Et2O (2.77 mL) were added to a flame-dried Schlenk-tube purged with N2. The solution was 
cooled to −78 °C (dry ice/acetone) before adding sec-BuLi (0.48 mL, 1.30 M, 0.62 mmol, 
1.12 equiv) dropwise over 5 min and leaving to react for 15 min at this temperature. The 
1,2-bis(boronic ester) (258 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous Et2O 
(0.66 mL) and added dropwise to the reaction mixture over 1 min before leaving to react for a 
further 1 h at the same temperature. A 1 M solution of MgBr2 in MeOH (0.83 mL, 0.83 mmol, 
1.50 equiv) was added dropwise over 2 min and the mixture was allowed to react for a further 
2 min before warming to ambient temperature. Water (10 mL) was added and the organic phase 
was collected, followed by extraction of the aqueous phase (3×15 mL Et2O). The combined 
organic phases were dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude residue was dissolved in THF (6 mL) and one crystal of BHT was added, then the mixture 
was subsequently cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) 
and 30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently 
bubbling N2 through the solution. This aqueous solution was added dropwise to the vigorously 
stirred reaction mixture, which was subsequently warmed to ambient temperature and allowed 
to react for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was 
extracted with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, 
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filtered and concentrated under reduced pressure. The crude residue was purified by flash 
column chromatography (SiO2; 80:20 pentane:EtOAc) to yield 170 (116 mg, 77 %) as a viscous 
colorless oil. TLC: Rf = 0.15 (80:20 pentane:EtOAc). 1H NMR: (400 MHz, CDCl3) δ 7.53 – 
7.48 (m, 2H, ArH), 7.44 – 7.37 (m, 2H, ArH), 7.32 – 7.26 (m, 1H, ArH), 7.18 – 7.12 (m, 2H, 
ArH), 6.86 – 6.81 (m, 2H, ArH), 4.43 (dd, J = 10.8, 2.2 Hz, 1H, CHO), 3.78 (s, 3H, OCH3), 
2.27 (dd, J = 14.8, 10.8 Hz, 1H, CHaHb), 2.16 (dd, J = 14.8, 2.2 Hz, 1H, CHaHb), 1.53 (s, 3H, 
CH3) ppm. 13C NMR: (101 MHz, CDCl3) δ 159.2 (ArCOCH3), 147.4 (ArC), 136.7 (ArC), 128.4 
(ArH), 126.9 (ArH), 126.6 (ArH), 125.1 (ArH), 114.0 (ArH), 75.6 (CO), 72.6 (CHO), 55.4 
(OCH3), 50.9 (CH2), 32.6 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C17H20O3Na [M+Na]
+: 
295.1305, found: 295.1308. IR (neat) νmax: 3331 (OH), 2971, 2836, 1611, 1511, 1443, 1242, 
1173, 1072, 1029, 828, 762 and 701 cm−1. [𝜶]𝐃
𝟐𝟒: −28.0 (c = 1.0, CHCl3). 
(4S,6R)-4,6-Dihydroxy-6-phenylheptyl diisopropylcarbamate (171) 
 
(S)-1-Phenylethyl diisopropylcarbamate (168) (138 mg, 0.55 mmol, 1.00 equiv) and anhydrous 
Et2O (2.77 mL) were added to a flame-dried Schlenk-tube purged with N2. The solution was 
cooled to −78 °C (dry ice/acetone) before adding sec-BuLi (0.48 mL, 1.30 M, 0.62 mmol, 
1.12 equiv) dropwise over 5 min and leaving to react for 15 min at this temperature. The 
1,2-bis(boronic ester) (310 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous Et2O 
(0.66 mL) and added dropwise to the reaction mixture over 1 min before leaving to react for a 
further 1 h at the same temperature. A 1 M solution of MgBr2 in MeOH (0.83 mL, 0.83 mmol, 
1.50 equiv) was added dropwise over 2 min and the mixture was allowed to react for a further 
2 min before warming to ambient temperature. Water (10 mL) was added and the organic phase 
was collected, followed by extraction of the aqueous phase (3×15 mL Et2O). The combined 
organic phases were dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude residue was dissolved in THF (6 mL) and one crystal of BHT was added, then the mixture 
was subsequently cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) 
and 30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently 
bubbling N2 through the solution. This aqueous solution was added dropwise to the vigorously 
stirred reaction mixture, which was subsequently warmed to ambient temperature and allowed 
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to react for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was 
extracted with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The crude residue was purified by flash 
column chromatography (SiO2; 60:40 pentane:EtOAc) to yield 171 (149 mg, 76 %) as a viscous 
colorless oil. TLC: Rf = 0.38 (60:40 pentane:EtOAc). 1H NMR: (400 MHz, CDCl3) δ 7.50 – 
7.41 (m, 2H, ArH), 7.39 – 7.30 (m, 2H, ArH), 7.26 – 7.19 (m, 1H, ArH), 4.20 – 3.56 (br m, 1H, 
NCH(CH3)2), 4.07 – 3.94 (m, 2H, OCH2), 3.56 – 2.90 (br m, 1H, NCH(CH3)2), 3.50 – 3.43 (m, 
1H, CHO), 2.02 (dd, J = 14.5, 2.2 Hz, 1H, CHCHaHbC), 1.94 (dd, J = 14.6, 10.2 Hz, 1H, 
CHCHaHbC), 1.70 – 1.35 (m, 4H, 2×CH2), 1.52 (s, 3H, CH3), 1.17 (d, J = 6.8 Hz, 12H, 
NCH(CH3)2) ppm. 13C NMR: (101 MHz, CDCl3) δ 156.0 (C=O), 147.5 (ArCOCH3), 128.4 
(ArH), 126.5 (ArH), 125.0 (ArH), 75.7 (CO), 70.0 (CHO), 64.5 (OCH2), 48.6 (CHCH2C), 34.6 
(CH2), 32.8 (CH3), 25.2 (CH2), 20.9 (br, NCH(CH3)2) ppm. The signal corresponding to 
NCH(CH3)2 was too broad to observe. HRMS (m/z): (ESI) calc’d for C20H33O4NNa [M+Na]
+: 
374.2302, found: 374.2311. IR (neat) νmax: 3376 (OH), 2970, 2933, 1665 (CO), 1441, 1369, 
1299, 1134, 1069, 767 and 701 cm−1. [𝜶]𝐃
𝟐𝟒: + (c = 1.0, CHCl3). 
(2R,4S)-6,6-Dimethyl-2-phenylheptane-2,4-diol (172) 
 
(S)-1-Phenylethyl diisopropylcarbamate (168) (138 mg, 0.55 mmol, 1.00 equiv) and anhydrous 
Et2O (2.77 mL) were added to a flame-dried Schlenk-tube purged with N2. The solution was 
cooled to −78 °C (dry ice/acetone) before adding sec-BuLi (0.48 mL, 1.30 M, 0.62 mmol, 
1.12 equiv) dropwise over 5 min and leaving to react for 15 min at this temperature. The 
1,2-bis(boronic ester) (234 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous Et2O 
(0.66 mL) and added dropwise to the reaction mixture over 1 min before leaving to react for a 
further 1 h at the same temperature. A 1 M solution of MgBr2 in MeOH (0.83 mL, 0.83 mmol, 
1.50 equiv) was added dropwise over 2 min and the mixture was allowed to react for a further 
2 min before warming to ambient temperature. Water (10 mL) was added and the organic phase 
was collected, followed by extraction of the aqueous phase (3×15 mL Et2O). The combined 
organic phases were dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude residue was dissolved in THF (6 mL) and one crystal of BHT was added, then the mixture 
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was subsequently cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) 
and 30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently 
bubbling N2 through the solution. This aqueous solution was added dropwise to the vigorously 
stirred reaction mixture, which was subsequently warmed to ambient temperature and allowed 
to react for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was 
extracted with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The crude residue was purified by flash 
column chromatography (SiO2; 80:20 pentane:EtOAc) to yield 172 (72 mg, 55 %) as a viscous 
colorless oil. TLC: Rf = 0.23 (80:20 pentane:EtOAc). 1H NMR: (500 MHz, CDCl3) δ 7.44 (d, 
J = 7.4 Hz, 2H, ArH), 7.35 (t, J = 7.7 Hz, 2H, ArH), 7.24 (t, J = 7.3 Hz, 1H, ArH), 4.21 (br s, 
1H, OH), 3.66 – 3.54 (m, 1H, CHO), 2.23 (br s, 1H, OH), 2.01 – 1.97 (m, 2H, CH2), 1.51 (s, 
3H, CCH3), 1.39 (dd, J = 14.6, 7.1 Hz, 1H, CHOCH
aHbC), 1.27 (dd, J = 14.6, 3.5 Hz, 1H, 
CHOCHaHbC), 0.79 (s, 9H, C(CH3)3) ppm. 13C NMR: (126 MHz, CDCl3) δ 147.5 (ArC), 128.3 
(ArH), 126.5 (ArH), 125.0 (ArH), 75.7 (CO), 68.5 (CHO), 52.6 (CHOCH2C), 50.5 (CH2), 32.8 
(CCH3), 30.3 (OC(CH3)3), 30.1 (OC(CH3)3) ppm. HRMS (m/z): (ESI) calc’d for C15H24O2Na 
[M+Na]+: 259.1669, found: 259.1678. IR (neat) νmax: 3369 (OH), 2957, 2922, 2867, 1364, 
1145, 1075, 853, 767 and 700 cm−1. [𝜶]𝐃
𝟐𝟒: +22.0 (c = 1.0, CHCl3). 
(2R,4S,6S)-6-((tert-Butyldiphenylsilyl)oxy)-2-phenylheptane-2,4-diol (173) 
 
(S)-1-Phenylethyl diisopropylcarbamate (168) (138 mg, 0.55 mmol, 1.00 equiv) and anhydrous 
Et2O (2.77 mL) were added to a flame-dried Schlenk-tube purged with N2. The solution was 
cooled to −78 °C (dry ice/acetone) before adding sec-BuLi (0.48 mL, 1.30 M, 0.62 mmol, 
1.12 equiv) dropwise over 5 min and leaving to react for 15 min at this temperature. The 
1,2-bis(boronic ester) (384 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous Et2O 
(0.66 mL) and added dropwise to the reaction mixture over 1 min before leaving to react for a 
further 1 h at the same temperature. A 1 M solution of MgBr2 in MeOH (0.83 mL, 0.83 mmol, 
1.50 equiv) was added dropwise over 2 min and the mixture was allowed to react for a further 
2 min before warming to ambient temperature. Water (10 mL) was added and the organic phase 
was collected, followed by extraction of the aqueous phase (3×15 mL Et2O). The combined 
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organic phases were dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude residue was dissolved in THF (6 mL) and one crystal of BHT was added, then the mixture 
was subsequently cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) 
and 30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently 
bubbling N2 through the solution. This aqueous solution was added dropwise to the vigorously 
stirred reaction mixture, which was subsequently warmed to ambient temperature and allowed 
to react for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was 
extracted with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The crude residue was purified by flash 
column chromatography (SiO2; 80:20 pentane:EtOAc) to yield 173 (234 mg, 91 %) as white 
solid. TLC: Rf = 0.34 (80:20 pentane:EtOAc). m.p.: 82 – 85 °C (CH2Cl2). 1H NMR: (400 MHz, 
CDCl3) δ 7.73 – 7.21 (m, 15H, ArH), 4.86 (br s, 1H, OH), 4.03 – 3.90 (m, 1H, CHOSi), 3.88 – 
3.31 (m, 2H, CHO and OH), 1.99 (dd, J = 14.2, 10.7 Hz, 1H, CHCHaHbC), 1.92 (dd, J = 14.2, 
2.3 Hz, 1H, CHCHaHbC), 1.74 – 1.61 (m, 1H, CHCHaHbCH), 1.51 (s, 3H, CH3), 1.46 – 1.36 
(m, 1H, CHCHaHbCH), 0.96 (s, 9H, SiC(CH3)3), 0.86 (d, J = 6.1 Hz, 3H, CHCH3) ppm. 13C 
NMR: (101 MHz, CDCl3) δ 148.0 (ArC), 135.9 (ArH), 135.9 (ArH), 134.3 (ArC), 133.2 (ArC), 
130.0 (ArH), 129.8 (ArH), 128.2 (ArH), 127.9 (ArH), 127.7 (ArH), 126.3 (ArH), 125.2 (ArH), 
75.3 (CO), 70.9 (CHOSi), 69.8 (CHO), 49.0 (CHCH2C), 46.4 (CH2), 32.3 (CH3), 27.0 
(SiC(CH3)3), 24.2 (CHCH3), 19.2 (SiC(CH3)3) ppm. HRMS (m/z): (ESI) calc’d for 
C29H38O3SiNa [M+Na]
+: 485.2482, found: 485.2480. IR (neat) νmax: 3324 (OH), 2967, 2940, 
2857, 1427, 1380, 1102, 1070, 1006, 739 and 699 cm−1. [𝜶]𝐃
𝟐𝟒: +20.0 (c = 1.0, CHCl3). 
(2R,4S,6S)-6,10-Dimethyl-2-phenylundec-9-ene-2,4-diol (174) 
 
(S)-1-Phenylethyl diisopropylcarbamate (168) (138 mg, 0.55 mmol, 1.00 equiv) and anhydrous 
Et2O (2.77 mL) were added to a flame-dried Schlenk-tube purged with N2. The solution was 
cooled to −78 °C (dry ice/acetone) before adding sec-BuLi (0.48 mL, 1.30 M, 0.62 mmol, 
1.12 equiv) dropwise over 5 min and leaving to react for 15 min at this temperature. The 
1,2-bis(boronic ester) (270 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous Et2O 
(0.66 mL) and added dropwise to the reaction mixture over 1 min before leaving to react for a 
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further 1 h at the same temperature. A 1 M solution of MgBr2 in MeOH (0.83 mL, 0.83 mmol, 
1.50 equiv) was added dropwise over 2 min and the mixture was allowed to react for a further 
2 min before warming to ambient temperature. Water (10 mL) was added and the organic phase 
was collected, followed by extraction of the aqueous phase (3×15 mL Et2O). The combined 
organic phases were dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude residue was dissolved in THF (6 mL) and one crystal of BHT was added, then the mixture 
was subsequently cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) 
and 30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently 
bubbling N2 through the solution. This aqueous solution was added dropwise to the vigorously 
stirred reaction mixture, which was subsequently warmed to ambient temperature and allowed 
to react for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was 
extracted with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The crude residue was purified by flash 
column chromatography (SiO2; 80:20 pentane:EtOAc) to yield 174 (140 mg, 87 %) as a viscous 
colorless oil. TLC: Rf = 0.25 (80:20 pentane:EtOAc). 1H NMR: (500 MHz, CDCl3) δ 7.43 (d, 
J = 7.5 Hz, 2H, ArH), 7.35 (t, J = 7.5 Hz, 2H, ArH), 7.23 (t, J = 7.5 Hz, 1H, ArH), 5.02 (t, J = 
7.1 Hz, 1H, =CH), 4.18 (br s, 1H, OH), 3.57 – 3.47 (m, 1H, CHO), 2.28 (br s, 1H, OH), 2.06 
(dd, J = 14.6, 1.8 Hz, 1H, CHOCHaHbC), 1.97 – 1.79 (m, 2H, =CHCH2), 1.85 (dd, J = 14.6, 
10.5 Hz, 1H, CHOCHaHbC), 1.67 (s, 3H, =C(CH3)
a(CH3)
b), 1.56 (s, 3H, =C(CH3)
a(CH3)
b), 1.52 
(s, 3H, CCH3), 1.45 – 1.31 (m, 2H, CHCH3 and CH
aHb), 1.30 – 1.15 (m, 2H, CHaHb and 
CHaHb), 1.11 – 0.99 (m, 1H, CHaHb), 0.71 (d, J = 6.5 Hz, 3H, CHCH3) ppm. 13C NMR: (126 
MHz, CDCl3) δ 147.6 (ArC), 131.5 (=C(CH3)2), 128.3 (ArH), 126.5 (ArH), 124.9 (ArH), 124.7 
(=CH), 75.7 (CO), 68.8 (CHO), 48.4 (CHOCH2C), 45.8 (CH2), 37.2 (CH2), 32.8 (CCH3), 29.1 
(CHCH3), 25.8 (=C(C
aH3)(C
bH3)), 25.4 (=CHCH2), 19.9 (CHCH3), 17.8 (=C(C
aH3)(C
bH3)) 
ppm. HRMS (m/z): (ESI) calc’d for C19H30O2Na [M+Na]
+: 313.2138, found: 313.2135. IR 
(neat) νmax: 3339, 2965, 2914, 1444, 1375, 1072, 765 and 700 cm−1. [𝜶]𝐃











(S)-1-Phenylethyl diisopropylcarbamate (168) (138 mg, 0.55 mmol, 1.00 equiv) and anhydrous 
Et2O (2.77 mL) were added to a flame-dried Schlenk-tube purged with N2. The solution was 
cooled to −78 °C (dry ice/acetone) before adding sec-BuLi (0.48 mL, 1.30 M, 0.62 mmol, 
1.12 equiv) dropwise over 5 min and leaving to react for 15 min at this temperature. The 
1,2-bis(boronic ester) (412 mg, 0.66 mmol, 1.20 equiv) was dissolved in anhydrous Et2O 
(0.66 mL) and added dropwise to the reaction mixture over 1 min before leaving to react for a 
further 1 h at the same temperature. A 1 M solution of MgBr2 in MeOH (0.83 mL, 0.83 mmol, 
1.50 equiv) was added dropwise over 2 min and the mixture was allowed to react for a further 
2 min before warming to ambient temperature. Water (10 mL) was added and the organic phase 
was collected, followed by extraction of the aqueous phase (3×15 mL Et2O). The combined 
organic phases were dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude residue was dissolved in THF (6 mL) and one crystal of BHT was added, then the mixture 
was subsequently cooled to 0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) 
and 30 % aqueous H2O2 (2 mL) was prepared at 0 °C (ice/water) and degassed by gently 
bubbling N2 through the solution. This aqueous solution was added dropwise to the vigorously 
stirred reaction mixture, which was subsequently warmed to ambient temperature and allowed 
to react for 1 h. 2 M aqueous HCl (10 mL) was carefully added and the reaction mixture was 
extracted with EtOAc (3×20 mL). The combined organic fractions were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The crude residue was purified by flash 
column chromatography (SiO2; 80:20 pentane:EtOAc) to yield 176 (221 mg, 79 %) as a viscous 
colorless oil. TLC: Rf = 0.32 (80:20 pentane:EtOAc). 1H NMR: (500 MHz, CDCl3) δ 7.69 – 
7.63 (m, 4H, ArH), 7.50 – 7.30 (m, 10H, ArH), 7.28 – 7.21 (m, 1H, ArH), 4.04 – 3.97 (m, 1H, 
CHO), 3.53 (br s, 1H, OH), 3.52 (dd, J = 10.0, 5.3 Hz, 1H, OCHaHb), 3.44 (dd, J = 10.0, 6.2 Hz, 
1H, OCHaHb), 2.59 (br s, 1H, OH), 1.87 (dd, J = 14.7, 10.7 Hz, 1H, CHOCHaHbC), 1.81 – 1.70 
(m, 1H, CHCH3), 1.69 (dd, J = 14.7, 1.8 Hz, 1H, CHOCH
aHbC), 1.64 (CCH3), 1.59 – 1.47 (m, 
2H, CHCH3 and CH
aHb), 1.06 (s, 9H, SiC(CH3)3), 0.99 – 0.93 (m, 1H, CH
aHb), 0.95 (d, J = 
6.7 Hz, 3H, CHCH3), 0.83 (d, J = 6.7 Hz, 3H, CHCH3) ppm. 13C NMR: (101 MHz, CDCl3) δ 
149.7 (ArC), 135.8 (ArH), 134.0 (ArC), 129.7 (ArH), 128.4 (ArH), 127.8 (ArH), 126.8 (ArH), 
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124.5 (ArH), 74.8 (CO), 72.5 (CHO), 68.7 (OCH2), 46.7 (CHOCH2C), 37.0 (CHCH2CH), 36.7 
(CH), 33.2 (CH), 28.0 (CCH3), 27.1 (SiC(CH3)3), 19.4 (SiC(CH3)3), 18.4 (CHCH3), 14.6 
(CHCH3) ppm. HRMS (m/z): (ESI) calc’d for C32H44O3SiNa [M+Na]
+: 527.2952, found: 
527.2941. IR (neat) νmax: 3354 (OH), 2957, 2930, 2857, 1427, 1111, 1069, 737, 699 and 614 
cm−1. [𝜶]𝐃
𝟐𝟒: + (c = 1.0, CHCl3). 
3.4 Rationalizing the regioselectivity 
We attempted to probe the reason we were getting such high regioselectivity for the primary 
boronic ester of a 1,2-bis(boronic ester). 
Experiment A 
 
sec-BuLi (0.42 mL, 1.30 M, 0.55 mmol, 1.00 equiv) was added dropwise to a solution of 143 
(168 mg, 0.57 mmol, 1.05 equiv) and (+)-sparteine (0.13 mL, 0.57 mmol, 1.05 equiv) in 
anhydrous Et2O (2.87 mL) at −78 °C (dry ice/acetone). After 2 h, a 1:1 mixture of 181 (154 mg, 
0.55 mmol, 1.00 equiv) and 182 (154 mg, 0.55 mmol, 1.00 equiv) in anhydrous Et2O (0.55 mL) 
was quickly added and the resulting solution was left to react for a further 1 h. After warming 
to ambient temperature the solution was heated at 35 °C (oil bath) for 16 h. After cooling to 
ambient temperature HCl (5 mL, 2 M aqueous solution) was added the the phases separated. 
The aqueous phase was extracted with Et2O (3 × 5 mL), dried over MgSO4, filtered and 
concentrated under reduced pressure. The broad regions containing unreacted starting boronic 
esters and homologated product boronic esters were separated by flash column chromatography 
(SiO2; 97:3 pentane:Et2O). The ratio of remaining starting boronic esters was 80:20 182:181 by 
13C NMR. The mixture of products (174 mg, 85 %) was dissolved in THF (6 mL) and cooled 
to 0 °C, and then a 2:1 v:v mixture of 3 M aqueous NaOH (4 mL) and 30 % aqueous H2O2 
(2 mL) was prepared at 0 °C (ice/water) and degassed by gently bubbling N2 through the 
solution. This aqueous solution was added dropwise to the vigorously stirred reaction mixture, 
which was subsequently warmed to ambient temperature and allowed to react for 1 h. 2 M 
aqueous HCl (10 mL) was carefully added and the reaction mixture was extracted with EtOAc 
(3×10 mL). The combined organic fractions were dried over Na2SO4, filtered and concentrated 
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under reduced pressure. The crude residue was analysed by 13C NMR and found to contain an 








sec-BuLi (0.27 mL, 1.30 M, 0.35 mmol, 1.00 equiv) was added dropwise to a solution of 143 
(108 mg, 0.37 mmol, 1.05 equiv) and (+)-sparteine (0.08 mL, 0.37 mmol, 1.05 equiv) in 
anhydrous Et2O (1.84 mL) at −78 °C (dry ice/acetone). After 2 h, a 1:1 mixture of 181 (99 mg, 
0.35 mmol, 1.00 equiv) and rac-155 (129 mg, 0.35 mmol, 1.00 equiv) in anhydrous Et2O 
(0.35 mL) was quickly added and the resulting solution was left to react for a further 1 h. After 
warming to ambient temperature the solution was heated at 35 °C (oil bath) for 16 h. The flask 
was allowed to cool to ambient temperature before adding THF (2 mL), and was then cooled to 
0 °C (ice/water). A 2:1 v:v mixture of 3 M aqueous NaOH (2 mL) and 30 % aqueous H2O2 
(1 mL) was prepared at 0 °C (ice/water) and degassed by gently bubbling N2 through the 
solution. This aqueous solution was added dropwise to the vigorously stirred reaction mixture, 
which was subsequently warmed to ambient temperature and allowed to react for 1 h. 2 M 
aqueous HCl (5 mL) was carefully added and the reaction mixture was extracted with EtOAc 
(3 × 10 mL). The combined organic fractions were dried over Na2SO4, filtered and concentrated 
under reduced pressure. The crude residue was analysed by 13C NMR and found to contain a 
54:46 ratio of 183:156. 
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4. Chapter 4 – Supplementary materials 
4.1 Electrophilic trapping procedures 
4.1.1 Bicyclobutyl boronate complex trapping with DBDMH 
 
tert-Butyl lithium (in pentane, 0.62 mmol, 2.6 equiv) was added dropwise to a solution of BCB-
sulfoxide 224 (60 mg, 0.31 mmol, 1.30 equiv) and cyclohexyl pinacol boronic ester (50 mg, 
0.24 mmol, 1.0 equiv) in anhydrous 2-methyl tetrahydrofuran (2.1 mL) at ‒78 °C (dry 
ice/acetone) and allowed to stir for 5 min. The cooling bath is then removed, and the solution 
is allowed to stir at ambient temperature for 15 min. The reaction is cooled back down to ‒78 
°C (dry ice/acetone) and then methanol (0.2 mL) is added dropwise before stirring for a further 
15 min. DBDMH (82 mg, 0.29 mmol, 1.2 equiv) is quickly added as a solid and the mixture is 
stirred for a further 1 min before removing the cooling bath and warming to ambient 
temperature. After 1 min at this temperature, Na2S2O3 (saturated aqueous solution, 2 mL) was 
added. The solution was transferred to a 28 mL vial and the flask was washed with Et2O 
(15 mL). Water (10 mL) was then added, and the flask was sealed and shaken vigorously. The 
layers were allowed to separate, and the top organic phase was carefully collected using a 
pipette. The aqueous phase was subsequently washed with Et2O (2× 10 mL) and then the 
combined organic phases were dried (MgSO4), filtered, and concentrated under reduced 
pressure. At this stage a crude 1H NMR was taken to assess the diastereomeric ratio of the 
product, which showed >98:2 d.r. The crude residue was purified by flash column 
chromatography (SiO2; pentane:Et2O 99:1) to yield the desired cyclobutane 228 (68 mg, 83 %, 
>98:2 d.r.) as a colorless oil which quickly solidifies to give a colorless solid. TLC: Rf = 0.31 
(pentane:Et2O 99:1). 1H NMR (500 MHz, CDCl3) δ 4.41 – 4.34 (CHBr), 2.79 – 2.75 (m, 2H, 
(CHaHb)2), 2.26 – 2.22 (m, 2H, (CH
aHb)2), 1.72 – 1.59 (m, 5H, 5× Cy-H), 1.43 – 1.36 (m, 1H, 
CH), 1.24 (s, 12H, Bpin), 1.23 – 0.91 (m, 5H, 5× Cy-H) ppm. 13C NMR (126 MHz, CDCl3) δ 
83.5 (OC(CH3)2), 49.5 (CH), 43.6 (CH(CH2)2), 39.9 (CHBr), 29.1 (CH2), 26.8 (CH2), 26.7 
(CH2), 24.9 (OC(CH3)2) ppm. HRMS (m/z): (MALDI) calc’d for C16H28BBrO2Na [M+Na]
+: 
365.1261, found: 365.1270. IR (solid state) νmax: 2976, 2923, 2849, 1446, 1380, 1371, 1357, 
1313, 1182, 1140, 856, 787 and 758 cm−1. 
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4.1.2 General Procedure C: Distal Cross-Coupling 
 
General Procedure C: tert-Butyl lithium (in pentane, 0.31 mmol, 1.30 equiv)A was added 
dropwiseB to a solution of BCB-sulfoxide 224 (60 mg, 0.31 mmol, 1.30 equiv) and the boronic 
ester (0.24 mmol, 1.0 equiv) in anhydrous 2-methyl tetrahydrofuran (2.1 mL) at ‒78 °C (dry 
ice/acetone) and allowed to stir for 5 min. After removing the cooling bath a solution of 
Pd(dba)2 (4.1 mg, 7.2 μmol, 3.0 mol%) and dippf (3.6 mg, 8.6 μmol, 3.6 mol%) in 2-methyl 
tetrahydrofuran (0.5 mL) (pre-mixed under argon for 20 min) was then added followed by the 
triflate (0.29 mmol, 1.20 equiv)C. The flask was sealed and heated at 40 °C (oil bath) for 14 h. 
After cooling to ambient temperature, the solution was transferred to a 28 mL vial and the flask 
was washed with pentaneD (15 mL). H2O (5 mL) and NH4Cl or NaHCO3 (saturated aqueous 
solution, 5 mL) were then added, and the flask was sealed and shaken vigorously. The layers 
were allowed to separate, and the top organic phase was carefully collected using a pipette. The 
aqueous phase was subsequently washed with pentaneD (2× 7 mL) and then the combined 
organic phases were dried (MgSO4), filtered, and concentrated under reduced pressure. At this 
stage a crude 1H NMR was taken to assess the diastereomeric ratio of the product. The crude 
residue was purified by flash column chromatography (SiO2) to yield the desired cyclobutanes. 
Notes: (A) tert-Butyl lithium should be carefully titrated prior to use.177 (B) On this scale this 
dropwise addition takes approximately 30 sec. (C) Oils were added via syringe, and solids were 
added. On the rare occasions when the triflate was insufficiently fluid to syringe, it was added 
as a solution in 2-methyl tetrahydrofuran (0.5 mL). (D) Pentane was most commonly used, 
however if there was large quantities of undissolved solid then either Et2O or EtOAc was used 
instead. 
4.1.3 Synthesis of BCB-sulfoxide (224) 
Methyl 4-methylbenzenesulfinate 
 
Recrystallized N-bromosuccinimide (28.6 g, 161 mmol, 2.0 equiv) was added in one portion to 
a vigorously stirring solution of 4-methylbenzenethiol (10 g, 80.4 mmol, 1.0 equiv) in DCM 
(100 mL) and methanol (100 mL) at 0 °C (ice/water) before warming to ambient temperature 
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and stirring for 1 h. The mixture was poured into NaHCO3 (saturated aqueous solution, 200 mL) 
at 0 °C (ice/water) and shaken until discoloration. The organic phase was collected, and the 
aqueous phase was extracted with DCM (2× 100 mL). The combined organic phases were dried 
(MgSO4) and concentrated under reduced pressure. The residue was purified by flash column 
chromatography (SiO2; 67:30:3 pentane:DCM:EtOAc) to yield the sulfinate (10.5 g, 76 %) as 
a colorless oil. TLC: Rf = 0.24 (67:30:3 pentane:DCM:EtOAc). 1H NMR (400 MHz, CDCl3) 
δ 7.60 – 7.57 (m, 2H, 2× ArH), 7.35 – 7.33 (m, 2H, 2× ArH), 3.46 (s, 3H, OCH3), 2.43 (s, 3H, 
ArCH3) ppm. 13C NMR (101 MHz, CDCl3) δ 143.0 (ArC), 141.1 (ArC), 129.9 (ArCH), 125.5 




According to a modified procedure,134 a 250 mL pressure flask was charged with allyl chloride 
(14.5 mL, 178 mmol, 1.5 equiv), bromoform (10.4 mL, 119 mmol, 1 equiv), 
triethylbenzylammonium chloride (1.35 g, 5.94 mmol, 5 mol%) and DCM (90 mL). Finely 
powdered sodium hydroxide (47.5 g, 1.19 mol, 10 equiv) was then added. The pressure flask 
was sealed and sonicated for 2 hA. The black reaction mixture was filtered over celite, and the 
plug was washed several times with pentane. The combined organic phases were concentrated 
under reduced pressure to give a crude residue which was purified by flash column 
chromatography (SiO2; hexane). After concentrating under reduced pressure, the yellow liquid 
was distilled (Kugelrohr, 1 mbar, 70 – 85 °C, cooling the flask with dry ice/acetone) to obtain 
the dibromocyclopropane 2 (8.08 g, 27 %) as a colorless oilB. Notes: (A) The reaction can easily 
be monitored by observing the disappearance of bromoform by 1H NMR. Bromoform is the 
most challenging impurity to remove. (B) The dibromocyclopropane is a dense, colorless oil, 
which should be stored in a freezer under argon. TLC: Rf = 0.65 (hexane). 1H NMR (400 MHz, 
CDCl3) δ 3.65 (d, J = 7.4 Hz, 2H, CH2Cl), 2.08 – 2.00 (m, 1H, CH), 1.93 (dd, J = 10.3, 7.6 Hz, 
1H, CHaHb), 1.48 (app t, J = 7.5 Hz, 1H, CHaHb) ppm. 13C NMR (101 MHz, CDCl3) δ 46.3 
(CH2Cl), 32.3 (CH), 29.1 (CH2), 25.8 (CBr2) ppm. All other data matches that reported in the 
literature.134 
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1-(p-Tolylsulfinyl)bicyclo[1.1.0]butane (BCB-sulfoxide) (224) 
A flame-dried nitrogen-flushed 500 mL three-necked flask was charged with 1,1-dibromo-2-
(chloromethyl)cyclopropane 212 (3.85 g, 15.51 mmol, 1.2 equiv) and Et2O (80 mL). The 
solution was cooled to –78 °C (dry ice/acetone) then methyl lithium (in Et2O, 15.51 mmol, 
1.2 equiv)A was added at a rate of 0.6 mL/min (syringe pump). The reaction was allowed to stir 
for 30 min at –78 °C followed by 1 h at –50 °CB. The solution was then cooled back to –78 °C 
(dry ice/acetone) and a high vacuum was applied for 2 min in order to remove the volatile MeBr. 
tert-Butyl lithium (in pentane, 15.51 mmol, 1.2 equiv)C was then added at a rate of 0.6 mL/min 
(syringe pump) and stirred for 20 min. A solution of freshly prepared MgBr2•Et2O
D in a separate 
flask was then quickly added via a Teflon cannulaE. After stirring for 2 h at –78 °C, a solution 
of methyl 4-methylbenzenesulfinate (2.20 g, 12.92 mmol, 1 equiv) in THF (13 mL) was added 
at a rate of 3.5 mL/min (syringe pump) and then the reaction mixture was stirred for 5 min at –
78 °C and finally for 30 min at ambient temperature. NH4Cl (saturated aqueous solution, 
100 mL) was added and the organic layer was collected. The aqueous phase was washed with 
EtOAc (3× 100 mL) and then the combined organic phases were dried (MgSO4), filtered, and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 60:40 EtOAc:pentane) to afford the BCB-sulfoxide 224 (avg. 1.30 g, 
avg. 52 % over 13 experiments) as a colorless oil which quickly solidifies to give a white – pale 
yellow crystalline solidF. Notes: (A) Methyl lithium should be carefully titrated before use.177 
(B) A ‒50 °C cooling bath is most conveniently prepared by adding chunks of dry ice to an 
acetone bath until the desired temperature is reached. The reaction is carefully, but quickly, 
transferred from the ‒78 °C bath into the ‒50 °C bath. (C) tert-Butyl lithium should be carefully 
titrated prior to use.177 (D) MgBr2•Et2O was prepared as follows: A flame-dried nitrogen-
flushed 250 mL flask, equipped with a reflux condenser, was charged with Mg turnings (3.06 g, 
124 mmol, 9.6 equiv) and Et2O (40 mL). 1,2-dibromoethane (2.67 mL, 31.02 mmol, 2.4 equiv) 
was added dropwise until reflux was initiated. The suspension was then cooled to 0 °C 
(ice/water) and the remaining 1,2-dibromoethane was added dropwise. After gas evolution had 
ceased, the mixture was stirred for additional 30 min at ambient temperature. (This should be 
prepared during the 1 h stir at ‒50 °C.) (E) A Teflon cannula is not a necessity but is the easiest 
to use. These can be prepared by cutting a piece of HPLC tubing to the required length and 
- 216 - 
 
threading this through two appropriately sized suba-seals. We used BOLA PTFE tubing (ID 
1.5 mm, OD 2.5 mm) purchased from Sigma-Aldrich. (F) The BCB-sulfoxide is slightly 
hygroscopic and should be stored in a freezer under an inert atmosphere. TLC: Rf = 0.24 (60:40 
EtOAc:pentane). 1H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 8.1 Hz, 2H, 2× ArH), 7.32 (d, J = 
8.1 Hz, 2H, 2× ArH), 2.42 (s, 3H, CH3), 2.38 – 2.36 (m, 1H, (CH
aHb)a), 2.11 – 2.08 (m, 1H, 
(CHaHb)b), 2.06 – 2.03 (m, 1H, CH), 1.38 – 1.36 (m, 1H, (CHaHb)b),1.21 – 1.19 (m, 1H, 
(CHaHb)a) ppm. 13C NMR (126 MHz, CDCl3) δ 141.6 (ArC), 141.5 (ArC), 130.0 (ArCH), 124.6 
(ArCH), 37.6 (CH2
b), 34.1 (CH2
a), 25.1 (C), 21.6 (CH3), 8.6 (CH) ppm. HRMS (m/z): (ESI) 
calc’d for C11H12NaOS [M+Na]
+: 215.0507, found: 215.0499. IR (solid state) νmax: 3077, 
3039, 2973, 2956, 2930, 1788. 1491, 1298, 1104, 1081, 1036, 1013, 809 and 771 cm−1. 
Table 11. Crystal data and structure refinement for 224. 
Empirical formula  C11H12OS  
Formula weight  192.27  
Temperature/K  100(2)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  6.2461(2)  
b/Å  6.9103(2)  
c/Å  22.7041(6)  
α/°  90  
β/°  94.1036(16)  
γ/°  90  
Volume/Å3  977.45(5)  
Z  4  
ρcalcg/cm3  1.307  
μ/mm-1  0.286  
F(000)  408.0  
Crystal size/mm3  0.412 × 0.254 × 0.137  
Radiation  MoKα (λ = 0.71073)  
2θ range for data collection/°  3.596 to 54.2  
Index ranges  
-8 ≤ h ≤ 8,  
-8 ≤ k ≤ 8,  
-29 ≤ l ≤ 28  
Reflections collected  15603  
Rint / Rsigma 0.0368 / 0.0202  
Data/restraints/parameters  2139/0/119  
Goodness-of-fit on F2  1.050  
Final R indexes [I>=2σ (I)]  
R1 = 0.0305,  
wR2 = 0.0816  
Final R indexes [all data]  
R1 = 0.0341,  
wR2 = 0.0839  
Largest diff. peak/hole / e Å-3  0.34/-0.29  
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Figure 24. Illustration of the structure of 224 with the anisotropic displacement parameters depicted at the 50% 
probability level. 
4.1.3 Synthesis/purchasing of triflates and boronic esters 
Triflates were prepared according to published procedures216,217,218,219,220,221,222,223,224 or 
purchased from commercial vendors: please see Figure 25 for details. 
 
Figure 25. Synthesis/purchasing of triflates 
Boronic esters were prepared according to published procedures36,39,42,63,112,131,204,225,226 
,227,228,229 or purchased from commercial vendors: please see Figure 26 for details. 
 
- 218 - 
 
 
Figure 26. Synthesis/purchasing of boronic esters. 
3-Fluorophenyl trifluoromethanesulfonate 
 
Trifluoromethanesulfonic anhydride (1.0 M in DCM, 6.63 mL, 6.63 mmol, 1.2 equiv) was 
slowly added to a solution of the 3-fluorophenol (0.50 mL, 5.52 mmol, 1.0 equiv) and pyridine 
(0.54 mL, 6.63 mmol, 1.2 equiv) in anhydrous DCM (8.8 mL) at 0 °C (ice/water). The mixture 
was allowed to warm to room temperature and allowed to react for 1 h. The reaction mixture 
was transferred to a separating funnel with Et2O and then HCl (3 M aqueous solution) was 
added. The aqueous phase was removed and the organic phase was washed sequentially with 
NaHCO3 (saturated aqueous solution) and brine, before being dried (MgSO4), filtered, and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 90:10 pentane:DCM) to afford the desired triflate (1.12 g, 83 %) as a 
colorless oil. TLC: Rf = 0.30 (90:10 pentane:DCM). 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.42 
(m, 1H, ArH), 7.16 – 7.10 (m, 2H, 2× ArH), 7.07 – 7.03 (m, 1H, ArH) ppm. 13C NMR (101 
MHz, CDCl3) δ 143.2 – 142.7 (m), 140.6 – 140.1 (m), 139.8 – 139.4 (m), 137.2 – 136.9 (m), 
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124.2 – 123.9 (m), 118.8 (q, J = 320.9 Hz, CF3) ppm. 19F NMR (377 MHz, CDCl3) δ −72.8, 
−108.2 ppm. HRMS (m/z): HRMS could not be obtained, but a weak molecular ion, alongside 
expected fragments, was observed by GC−MS. IR (thin film) νmax: 1603, 1486, 1424, 1205, 
1137, 1101, 947, 861, 834, 778 and 676 cm−1. 
3-(Dimethylamino)phenyl trifluoromethanesulfonate 
 
Trifluoromethanesulfonic anhydride (1.0 M in DCM, 6.63 mL, 6.63 mmol, 1.2 equiv) was 
slowly added to a solution of 3-(dimethylamino)phenol (500 mg, 3.64 mmol, 1.0 equiv) and 
N-ethyl-N-isopropylpropan-2-amine (0.79 mL, 4.56 mmol, 1.25 equiv) in anhydrous DCM 
(18 mL) at ‒78 °C (dry ice/acetone). The mixture was allowed to react for 30 min. The reaction 
mixture was transferred to a separating funnel with DCM and then NaHCO3 (saturated aqueous 
solution) was added. The aqueous phase was extracted with DCM (2×) before being dried 
(MgSO4), filtered, and concentrated under reduced pressure. The crude residue was purified by 
flash column chromatography (SiO2; 90:10 pentane:EtOAc) to afford the desired triflate 
(745 mg, 76 %) as a colorless oil. TLC: Rf = 0.35 (90:10 pentane:EtOAc). 1H NMR (400 MHz, 
CDCl3) δ 7.24 (t, J = 8.3 Hz, 1H, ArH), 6.68 – 6.65 (m, 1H, ArH), 6.57 (dd, J = 8.1, 2.2 Hz, 
1H, ArH), 6.50 (t, J = 2.4 Hz, 1H, ArH), 2.98 (s, 6H, N(CH3)2) ppm. 13C NMR (101 MHz, 
CDCl3) δ 152.0 (ArC), 151.0 (ArC), 130.4 (ArCH), 118.9 (d, J = 320.6 Hz, CF3), 111.8 (ArCH), 
108.1 (ArCH), 104.6 (ArCH), 40.4 (N(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for 
C9H11F3NO3S [M+H]
+: 270.0406, found: 270.0408. IR (thin film) νmax: 2815, 1615, 1508, 
1416, 1202, 1139, 1117, 992, 976, 900 and 809 cm−1. 
Vinyl trifluoromethanesulfonate 
 
n-Butyl lithium (in hexane, 8.0 mmol, 1.0 equiv) was added to anhydrous THF (6.2 mL) and 
stirred at ambient temperature for 14 h. The solution was cooled to 0 °C (ice/water) and 
N-phenyl-bis(trifluoromethanesulfonimide) (3.72 g, 10.40 mmol, 1.3 equiv) in DMPU (5 mL) 
was added dropwise and the resulting mixture was allowed to warm to ambient temperature 
over 4 h. The solution was distilled (oil bath heating, atmospheric pressure) and all distillate 
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between 70 – 100 °C was collected to give the desired triflate as a 14.8 % w/w solution in 
THF/hexane. 
1H NMR (500 MHz, CDCl3) δ 6.72 (dd, J = 13.3, 5.6 Hz, 1H, =CH), 5.27 (dd, J = 13.3, 3.5 Hz, 
1H, =CHaHb), 5.01 (dd, J = 5.6, 3.5 Hz, 1H, =CHaHb) ppm. 13C NMR (126 MHz, CDCl3) δ 
142.3 (=CH), 104.6 (=CH2) ppm. CF3 was not observed. 19F NMR (377 MHz, CDCl3) δ −73.6 
ppm. 
Tris Boc protected L-tyrosine methyl ester 
 
Di-tert-butyl dicarbonate (8.94 mL, 40.98 mmol, 4.0 equiv) was slowly added to a suspension 
of L-tyrosine methyl ester (2.0 g, 10.24 mmol, 1.0 equiv) and Na2CO3 (6.52 g, 61.47 mmol, 
6.0 equiv) in THF (36 mL) and water (18 mL) at 0 °C. The resulting mixture was stirred at 
ambient temperature overnight. The mixture was added to EtOAc (50 mL) and the layers were 
separated. The organic layer was washed with water (20 mL) and brine (20 mL), dried (MgSO4), 
and concentrated under reduced pressure. The crude residue and DMAP (626 mg, 5.12 mmol, 
0.5 equiv) were dissolved in acetonitrile (100 mL) and then di-tert-butyl dicarbonate (8.94 mL, 
40.98 mmol, 4.0 equiv) was slowly added. The resulting mixture was stirred at ambient 
temperature overnight. The mixture was added to EtOAc (50 mL) and the layers were separated. 
The organic layer was washed with water (20 mL) and brine (20 mL), dried (MgSO4), and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (SiO2; 85:15 pentane:EtOAc) to afford the desired tyrosine derivative (4.91 g, 
97 %) as a colorless oil. TLC: Rf = 0.21 (85:15 pentane:EtOAc). 1H NMR (400 MHz, CDCl3) 
δ 7.20 – 7.16 (m, 2H, ArH), 7.08 – 7.05 (m, 2H, ArH), 5.13 (dd, J = 10.1, 5.2 Hz, 1H, 
CHNBoc2), 3.74 (s, 3H, OCH3), 3.42 (dd, J = 14.1, 5.2 Hz, 1H, CH
aHb), 3.19 (dd, J = 14.1, 
10.1 Hz, 1H, CHaHb), 1.54 (s, 9H, OC=OOC(CH3)3), 1.39 (s, 18H, N(C=OOC(CH3))2) ppm. 
13C NMR (101 MHz, CDCl3) δ 170.9 (C), 151.9 (C), 151.9 (C), 150.0 (C), 135.3 (ArC), 130.6 
(ArCH), 121.3 (ArCH), 83.5 (OC(CH3)3), 83.3 (OC(CH3)3), 59.4 (CHNBoc2), 52.4 (OCH3), 
35.8 (CH2), 28.0 (OC(CH3)3), 27.8 (OC(CH3)3) ppm. HRMS (m/z): (ESI) calc’d for 
C25H37NNaO9 [M+Na]
+: 518.2361, found: 518.2357. IR (thin film) νmax: 2980, 1754, 1699, 
1368, 1253 and 1136 cm−1. [𝜶]𝐃
𝟐𝟒: −75 (c = 1.0, CHCl3). 
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NBoc2 L-tyrosine methyl ester 
 
Tris Boc protected L-tyrosine methyl ester (1.00 g, 2.02 mmol, 1.0 equiv) was dissolved in 
DCM (30 mL) and piperidine (30 mL) and stirred overnight.230 The mixture was poured into 
EtOAc (100 mL) and the layers were separated. The organic layer was washed with NH4Cl 
(saturated aqueous solution, 5× 40 mL), dried (MgSO4), and concentrated under reduced 
pressure. The crude residue was purified by flash column chromatography (SiO2; 90:10 
DCM:EtOAc) to yield the desired phenol (692 mg, 87 %) as a colorless oil. TLC: Rf = 0.24 
(90:10 DCM:EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.05 – 7.01 (m, 2H, ArH), 6.75 – 6.71 
(m, 2H, ArH), 5.26 (br s, 1H, OH), 5.08 (dd, J = 10.4, 5.0 Hz, 1H, CHNBoc2), 3.74 (s, 3H, 
OCH3), 3.35 (dd, J = 14.2, 5.0 Hz, 1H, CH
aHb), 3.14 (dd, J = 14.2, 10.4 Hz, 1H, CHaHb), 1.39 
(s, 18H, OC(CH3)3) ppm. 13C NMR (101 MHz, CDCl3) δ 171.1 (C=O), 154.8 (C), 151.8 (C), 
130.8 (ArCH), 129.5 (ArC), 115.4 (ArCH), 83.3 (OC(CH3)3), 59.8 (CHNBoc2), 52.4 (OCH3), 
35.4 (CH2), 28.0 (OC(CH3)3) ppm. HRMS (m/z): (ESI) calc’d for C20H29NNaO7 [M+Na]
+: 
418.1836, found: 418.1833. IR (thin film) νmax: 3431, 2980, 1732, 1517, 1368 and 1138 cm−1. 
[𝜶]𝐃
𝟐𝟒: ‒83 (c = 1.0, CHCl3). 
NBoc2 L-tyrosine methyl ester trifluoromethanesulfonate 
 
Trifluoromethanesulfonic anhydride (1.0 M in DCM, 1.64 mL, 1.64 mmol, 1.3 equiv) was 
slowly added to a solution of NBoc2 L-tyrosine methyl ester (500 mg, 1.26 mmol, 1.0 equiv) 
and N-ethyl-N-isopropylpropan-2-amine (0.28 mL, 1.58 mmol, 1.25 equiv) in anhydrous DCM 
(6 mL) at ‒78 °C (dry ice/acetone). The mixture was allowed to react for 1 h. The reaction 
mixture was transferred to a separating funnel with DCM and then NaHCO3 (saturated aqueous 
solution) was added. The aqueous phase was extracted with DCM (2×) before being dried 
(MgSO4), filtered, and concentrated under reduced pressure. The crude residue was purified by 
flash column chromatography (SiO2; DCM) to afford the desired triflate (632 mg, 95 %) as a 
colorless oil. TLC: Rf = 0.30 (DCM). 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.26 (m, 2H, ArH), 
7.20 – 7.16 (m, 2H, ArH), 5.15 (dd, J = 10.1, 5.3 Hz, 1H, CHNBoc2), 3.75 (s, 3H, OCH3), 3.46 
(dd, J = 14.2, 5.3 Hz, 1H, CHaHb), 3.24 (dd, J = 14.2, 10.1 Hz, 1H, CHaHb), 1.40 (s, 18H, 
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OC(CH3)3) ppm. 13C NMR (101 MHz, CDCl3) δ 170.7 (C=O), 151.9 (C), 148.5 (C), 138.6 (C), 
131.5 (ArCH), 121.3 (ArCH), 83.5 (OC(CH3)3), 59.0 (CHNBoc2), 52.6 (OCH3), 35.7 (CH2), 
28.0 (OC(CH3)3) ppm. CF3 was not observed. 19F NMR (377 MHz, CDCl3) δ −72.9 ppm. 
HRMS (m/z): (ESI) calc’d for C21H28F3NNaO9S [M+Na]
+: 550.1329, found: 550.1324. IR 
(thin film) νmax: 2982, 1747, 1698, 1368, 1208, 1134, 886 and 609 cm−1. [𝜶]𝐃
𝟐𝟐: −65 (c = 1.0, 
CHCl3). 
4.2 Distal Cross-Coupling 
2-(1-Cyclohexylcyclobutyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (276) 
 
TLC: Rf = 0.28 (99:1 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 2.11 – 2.02 (m, 2H, CH2), 
1.85 – 1.60 (m, 10H, 5× CH2), 1.33 – 0.86 (m, 7H, CH, 3× CH2), 1.26 (s, 12H, Bpin) ppm. 13C 
NMR (126 MHz, CDCl3) δ 83.0 (OC(CH3)2), 48.3 (CH), 29.6 (CH2), 29.2 (CH2), 27.0 (CH2), 
27.0 (CH2), 24.9 (OC(CH3)2), 18.2 (CH2) ppm. HRMS (m/z): (EI) calc’d for C16H29BNaO2 
[M+Na]+: 287.2156, found: 287.2158. IR (thin film) νmax: 2976, 2923, 2851, 1383, 1307, 1298, 
1234, 1144, 967 and 862 cm−1. 
4.2.1 Stereochemical analysis 
The relative stereochemistry of the reaction products is based on analogy to the configurations 
observed by X-ray analysis of products 235, 243 and 263. In all cases a syn relationship between 
the incorporated boronic ester and triflate substituents was observed, so this relative 
configuration was given for all other reaction products. Whilst we have no proof that all others 
truly have this configuration, it is likely based on the high similarities in the 1H and 13C NMR 
data for the cyclobutane core for all reaction products. 
 
Figure 27. Crystal structure of (from left to right) 235, 243 and 263. See the individual compounds in section 4 
for crystal data and structure refinement. 
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According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude 
residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography (SiO2; 
60:20:20 hexane:DCM:PhMe) to afford the corresponding cyclobutane 234 (62 mg, 77 %, 
>98:2 d.r.) as a colorless oil that crystallised slowly to a white solid. m.p.: 50 – 54 °C (pentane). 
TLC: Rf = 0.36 (60:20:20 hexane:DCM:PhMe). 1H NMR (400 MHz, CDCl3) δ 7.31 – 7.25 (m, 
2H, 2× ArH), 7.23 – 7.18 (m, 2H, 2× ArH), 7.17 – 7.13 (m, 1H, ArH), 3.34 – 3.25 (m, 1H, 
ArCH), 2.59 – 2.53 (m, 2H, ArCH(CHaHb)2), 1.90 – 1.83 (m, 2H, ArCH(CH
aHb)2), 1.76 – 1.62 
(m, 5H, 2× CH2, CH
aHb), 1.35 – 0.93 (m, 6H, 2× CH2, CH, CH
aHb), 1.31 (s, 12H, Bpin) ppm. 
13C NMR (101 MHz, CDCl3) δ 146.8 (ArC), 128.2 (ArCH), 126.5 (ArCH), 125.6 (ArCH), 83.2 
(OC(CH3)2), 49.2 (CH), 37.6 (ArCCH(CH2)2), 35.9 (ArCCH), 29.2 (CH2), 27.0 (CH2), 26.9 
(CH2), 24.9 (OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C22H34BO2 [M+H]
+: 341.2650, 





According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 4-trifluoromethylphenyl triflate (84 mg, 0.29 mmol, 1.2 equiv) were coupled to 
give a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column 
chromatography (SiO2; 80:20 pentane:DCM) to afford the corresponding cyclobutane 235 
(75 mg, 77 %, >98:2 d.r.) as a white solid. m.p.: 106 – 109 °C (pentane). TLC: Rf = 0.30 (80:20 
pentane:DCM). 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 8.3 Hz, 2H, 2× ArH), 7.28 (d, J = 
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8.3 Hz, 2H, 2× ArH), 3.39 (m, 1H, ArCCH), 2.60 – 2.55 (m, 2H, ArCH(CHaHb)2), 1.88 – 1.83 
(m, 2H, ArCH(CHaHb)2), 1.74 – 1.67 (m, 5H, 2× CH2, CH
aHb), 1.35 – 0.93 (m, 6H, 2× CH2, 
CH, CHaHb), 1.31 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 150.8 (ArC), 126.8 
(ArCH), 125.1 (q, JC–F = 3.8 Hz, ArCH), 83.3 (OC(CH3)2), 49.2 (CH), 37.4 (ArCCH(CH2)2), 
35.6 (ArCCH), 29.1 (CH2), 26.9 (CH2), 26.9 (CH2), 25.0 (OC(CH3)2) ppm. CF3 and ArCCF3 
were low intensity and so were not picked. 19F NMR (377 MHz, CDCl3) δ –62.2 ppm. HRMS 
(m/z): (ESI) calc’d for C23H32BF3NaO2 [M+Na]
+: 431.2344, found: 431.2335. IR (solid state) 
νmax: 2924, 2854, 1615, 1321, 1158, 1120, 1064 and 834 cm−1. 
Table 12. Crystal data and structure refinement for 235. 
Empirical formula  C23H32BF3O2  
Formula weight  408.29  
Temperature/K  100(2)  
Crystal system  orthorhombic  
Space group  Pbca  
a/Å  12.6803(3)  
b/Å  18.1268(4)  
c/Å  19.0140(4)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  4370.43(17)  
Z  8  
ρcalcg/cm3  1.241  
μ/mm-1  0.093  
F(000)  1744.0  
Crystal size/mm3  0.47 × 0.34 × 0.33  
Radiation  
MoKα  
(λ = 0.71073)  
2θ range for data collection/°  4.284 to 52.74  
Index ranges  
-15 ≤ h ≤ 15,  
-22 ≤ k ≤ 22,  
-13 ≤ l ≤ 23  
Reflections collected  33660  
Rint / Rsigma  0.0565 / 0.0353  
Data/restraints/parameters  4466/451/379  
Goodness-of-fit on F2  1.235  
Final R indexes [I>=2σ (I)]  
R1 = 0.0899,  
wR2 = 0.1832  
Final R indexes [all data]  
R1 = 0.1030,  
wR2 = 0.1878  
Largest diff. peak/hole / e Å-3  0.38/-0.35  
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Figure 28. Illustration of the structure of 235 with the anisotropic displacement parameters depicted at the 50% 





According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 3-fluorophenyl triflate (70 mg, 0.29 mmol, 1.2 equiv) were coupled to give a 
crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 80:20 pentane:DCM) to afford the corresponding cyclobutane 236 (66 mg, 78 %, >98:2 
d.r.) as a colorless oil that slowly solidified on standing. TLC: Rf = 0.25 (80:20 pentane:DCM). 
1H NMR (400 MHz, CDCl3) δ 7.24 – 7.19 (m, 1H, ArH), 6.96 – 6.94 (m, 1H, ArH), 6.90 – 
6.81 (m, 2H, 2× ArH), 3.32 – 3.23 (m, 1H, ArCCH), 2.57 – 2.52 (m, 2H, ArCH(CHaHb)2), 1.85 
– 1.80 (m, 2H, ArCH(CHaHb)2), 1.74 – 1.64 (m, 5H, 2× CH2, CH
aHb), 1.35 – 0.92 (m, 6H, 2× 
CH2, CH, CH
aHb), 1.30 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 163.1 (d, JC–F = 
244.9 Hz, ArCF), 149.6 (d, JC–F = 6.8 Hz, ArC), 129.6 (d, JC–F = 8.3 Hz, ArCH), 122.2 (d, JC–F 
= 2.7 Hz, ArCH), 113.4 (d, JC–F = 20.8 Hz, ArCH), 112.4 (d, JC–F = 21.2 Hz, ArCH), 83.3 
(OC(CH3)2), 49.2 (CH), 37.5 (ArCCH(CH2)2), 35.6 (ArCCH), 29.2 (CH2), 26.9 (CH2), 26.9 
(CH2), 24.9 (OC(CH3)2) ppm. 19F NMR (377 MHz, CDCl3) δ –114.1 (ddd, J = 10.3, 8.7, 6.1 
Hz) ppm. HRMS (m/z): (ESI) calc’d for C22H32BFNaO2 [M+Na]
+: 381.2376, found: 381.2376. 
IR (thin film) νmax: 2976, 2923, 2851, 1614, 1588, 1385, 1308, 1142, 966, 859, 780 and 
692 cm−1. 





According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 3-chlorophenyl triflate (74 mg, 0.29 mmol, 1.2 equiv) were coupled to give a 
crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 80:20 pentane:DCM) to afford the corresponding cyclobutane 237 (72 mg, 81 %, 
>98:2 d.r.) as a colorless oil. TLC: Rf = 0.25 (80:20 pentane:DCM). 1H NMR (400 MHz, 
CDCl3) δ 7.21 – 7.10 (m, 3H, 3× ArH), 7.06 (d, J = 7.5 Hz, 1H, ArH), 3.31 – 3.21 (m, 1H, 
ArCCH), 2.57 – 2.52 (m, 2H, ArCH(CHaHb)2), 1.85 – 1.80 (m, 2H, ArCH(CH
aHb)2), 1.73 – 
1.66 (m, 5H, 2× CH2, CH
aHb), 1.40 – 0.92 (m, 6H, 2× CH2, CH, CH
aHb), 1.30 (s, 12H, Bpin) 
ppm. 13C NMR (101 MHz, CDCl3) δ 148.9 (ArCCl), 134.1 (ArC), 129.5 (ArCH), 126.8 
(ArCH), 125.8 (ArCH), 124.8 (ArCH), 83.3 (OC(CH3)2), 49.2 (CH), 37.5 (ArCCH(CH2)2), 35.6 
(ArCCH), 29.2 (CH2), 26.9 (CH2), 26.9 (CH2), 24.9 (OC(CH3)2) ppm. HRMS (m/z): (ESI) 
calc’d for C22H32BClNaO2 [M+Na]
+: 397.2080, found: 397.2084. IR (thin film) νmax: 2976, 




According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 3-bromophenyl triflate (87 mg, 0.29 mmol, 1.2 equiv) were coupled to give a 
crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 80:20 pentane:DCM) to afford the corresponding cyclobutane 238 (62 mg, 62 %, 
>98:2 d.r.) as a colorless oil. TLC: Rf = 0.28 (80:20 pentane:DCM). 1H NMR (400 MHz, 
CDCl3) δ 7.33 – 7.32 (m, 1H, ArH), 7.29 – 7.25 (m, 2H, ArH), 7.15 – 7.09 (m, 2H, 2× ArH), 
3.30 – 3.21 (m, 1H, ArCCH), 2.56 – 2.51 (m, 2H, ArCH(CHaHb)2), 1.84 – 1.79 (m, 2H, 
ArCH(CHaHb)2), 1.73 – 1.66 (m, 5H, 2× CH2, CH
aHb), 1.35 – 0.92 (m, 6H, 2× CH2, CH, 
CHaHb), 1.30 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 149.2 (ArC), 129.8 (ArCH), 
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129.7 (ArCH), 128.7 (ArCH), 125.2 (ArCH), 122.5 (ArCBr), 83.3 (OC(CH3)2), 49.2 (CH), 37.5 
(ArCCH(CH2)2), 35.6 (ArCCH), 29.2 (CH2), 26.9 (CH2), 26.9 (CH2), 24.9 (OC(CH3)2) ppm. 
HRMS (m/z): (MALDI) calc’d for C22H32BBrNaO2 [M+Na]
+: 441.1575, found: 441.1582. IR 




According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 3-ethyl ester phenyl triflate (85 mg, 0.29 mmol, 1.2 equiv) were coupled to give 
a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 50:50 pentane:DCM) to afford the corresponding cyclobutane 239 (46 mg, 47 %, 
>98:2 d.r.) as a colorless oil. TLC: Rf = 0.20 (50:50 pentane:DCM). 1H NMR (400 MHz, 
CDCl3) δ 7.86 – 7.82 (m, 2H, 2× ArH), 7.40 – 7.31 (m, 2H, 2× ArH), 4.37 (q, J = 7.1 Hz, 2H, 
OCH2), 3.38 – 3.29 (m, 1H, ArCCH), 2.60 – 2.55 (m, 2H, ArCH(CH
aHb)2), 1.89 – 1.84 (m, 2H, 
ArCH(CHaHb)2), 1.73 – 1.64 (m, 5H, 2× CH2, CH
aHb), 1.39 (t, J = 7.1 Hz, 3H, CH3), 1.31 (s, 
12H, Bpin), 1.22 – 0.93 (m, 6H, 2× CH2, CH, CH
aHb) ppm. 13C NMR (101 MHz, CDCl3) δ 
167.1 (C=O), 147.0 (ArC), 131.1 (ArCH), 130.4 (ArC), 128.2 (ArCH), 127.7 (ArCH), 126.9 
(ArCH), 83.3 (OC(CH3)2), 61.0 (OCH2), 49.2 (CH), 37.6 (ArCCH(CH2)2), 35.7 (ArCCH), 29.2 
(CH2), 26.9 (CH2), 26.9 (CH2), 25.0 (OC(CH3)2), 14.5 (CH3) ppm. HRMS (m/z): (ESI) calc’d 
for C25H37BNaO4 [M+Na]
+: 435.2682, found: 435.2681. IR (thin film) νmax: 2976, 2924, 2851, 




According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 4-nitrophenyl triflate (77 mg, 0.29 mmol, 1.2 equiv) were coupled to give a crude 
residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography (SiO2; 
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70:30 pentane:DCM) to afford the corresponding cyclobutane 240 (9 mg, 10 %, >98:2 d.r.) as 
a white solid. m.p.: 113 – 116 °C (pentane). TLC: Rf = 0.14 (70:30 pentane:DCM). 1H NMR 
(400 MHz, CDCl3) δ 8.15 – 8.11 (m, 2H, 2× ArH), 7.32 – 7.30 (m, 2H, 2× ArH), 3.43 – 3.34 
(m, 1H, ArCCH), 2.62 – 2.58 (m, 2H, ArCH(CHaHb)2), 1.89 – 1.83 (m, 2H, ArCH(CH
aHb)2), 
1.74 – 1.65 (m, 5H, 2× CH2, CH
aHb), 1.31 (s, 12H, Bpin), 1.19 – 0.91 (m, 6H, 2× CH2, CH, 
CHaHb) ppm. 13C NMR (101 MHz, CDCl3) δ 154.6 (ArCNO2), 146.2 (ArC), 127.3 (ArCH), 
123.6 (ArCH), 83.4 (OC(CH3)2), 49.2 (CH), 37.4 (ArCCH(CH2)2), 35.8 (ArCCH), 29.1 (CH2), 
26.9 (CH2), 26.8 (CH2), 25.0 (OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C22H32BNNaO4 
[M+Na]+: 408.2321, found: 408.2325. IR (solid state) νmax: 2924, 2851, 1598, 1517, 1385, 




According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 4-methoxyphenyl triflate (73 mg, 0.29 mmol, 1.2 equiv) were coupled to give a 
crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 97:3 pentane:Et2O) to afford the corresponding cyclobutane 241 (71 mg, 81 %, 
>98:2 d.r.) as a white solid. m.p.: 98 – 102 °C (pentane). TLC: Rf = 0.23 (97:3 pentane:Et2O). 
1H NMR (400 MHz, CDCl3) δ 7.14 – 7.11 (m, 2H, 2× ArH), 6.84 – 6.81 (m, 2H, 2× ArH), 3.78 
(s, 3H, OCH3), 3.27 – 3.18 (m, 1H, ArCCH), 2.55 – 2.51 (m, 2H, ArCH(CHaHb)2), 1.84 – 1.79 
(m, 2H, ArCH(CHaHb)2), 1.73 – 1.64 (m, 5H, 2× CH2, CH
aHb), 1.35 – 0.92 (m, 6H, 2× CH2, 
CH, CHaHb), 1.30 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 157.7 (ArCOCH3), 
139.0 (ArC), 127.5 (ArCH), 113.7 (ArCH), 83.2 (OC(CH3)2), 55.4 (OCH3), 49.2 (CH), 37.9 
(ArCCH(CH2)2), 35.3 (ArCCH), 29.2 (CH2), 27.0 (CH2), 26.9 (CH2), 25.0 (OC(CH3)2) ppm. 
HRMS (m/z): (ESI) calc’d for C23H25BNaO3 [M+Na]
+: 393.2576, found: 393.2576. IR (solid 
state) νmax: 2981, 2926, 2850, 1610, 1514, 1381, 1296, 1252, 1141, 1034, 861, 819 and 
687 cm−1. 
 





According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 3-(dimethyl)aminophenyl triflate (77 mg, 0.29 mmol, 1.2 equiv) were coupled 
to give a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column 
chromatography (SiO2; 48:50:2 pentane:DCM:Et2O) to afford the corresponding cyclobutane 
242 (81 mg, 89 %, >98:2 d.r.) as a colorless oil. TLC: Rf = 0.26 (48:50:2 pentane:DCM:Et2O). 
1H NMR (400 MHz, CDCl3) δ 7.19 – 7.15 (m, 1H, ArH), 6.62 – 6.55 (m, 3H, 3× ArH), 3.30 – 
3.21 (m, 1H, ArCCH), 6.22 (s, 6H, N(CH3)2), 2.57 – 2.52 (m, 2H, ArCH(CH
aHb)2), 1.90 – 1.85 
(m, 2H, ArCH(CHaHb)2), 1.73 – 1.64 (m, 5H, 2× CH2, CH
aHb), 1.31 (s, 12H, Bpin), 1.26 – 0.92 
(m, 6H, 2× CH2, CH, CH
aHb) ppm. 13C NMR (101 MHz, CDCl3) δ 150.8 (ArC), 147.7 (ArC), 
128.9 (ArCH), 115.0 (ArCH), 111.1 (ArCH), 110.4 (ArCH), 83.2 (OC(CH3)2), 49.1 (CH), 40.9 
(N(CH3)2), 37.5 (ArCCH(CH2)2), 36.3 (ArCCH), 29.3 (CH2), 27.0 (CH2), 26.9 (CH2), 25.0 
(OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C24H39BNO2 [M+H]
+: 384.3073, found: 




According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 2,6-dimethylphenyl triflate (73 mg, 0.29 mmol, 1.2 equiv) were coupled to give 
a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 70:20:10 pentane:PhMe:DCM) to afford the corresponding cyclobutane 243 (58 mg, 
66 %, >98:2 d.r.) as a white solid. m.p.: 124 – 126 °C (pentane). TLC: Rf = 0.30 (70:20:10 
pentane:PhMe:DCM). 1H NMR (400 MHz, CDCl3) δ 6.97 – 6.90 (m, 3H, 3× ArH), 3.58 – 3.49 
(m, 1H, ArCCH), 2.72 – 2.67 (m, 2H, ArCH(CHaHb)2), 2.32 (s, 6H, 2× ArCCH3), 2.10 – 2.04 
(m, 2H, ArCH(CHaHb)2), 1.71 – 1.63 (m, 5H, 2× CH2, CH
aHb), 1.37 – 0.90 (m, 6H, 2× CH2, 
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CH, CHaHb), 1.32 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 142.0 (ArC), 136.6 
(ArCCH3), 129.1 (ArCH), 125.4 (ArCH), 83.2 (OC(CH3)2), 49.4 (CH), 39.1 (ArCCH(CH2)2), 
36.0 (ArCCH), 29.5 (CH2), 27.0 (CH2), 26.9 (CH2), 24.9 (OC(CH3)2), 22.1 (2× ArCCH3) ppm. 
HRMS (m/z): (ESI) calc’d for C24H37BNaO2 [M+Na]
+: 391.2783, found: 391.2785. IR (solid 
state) νmax: 2974, 2914, 2842, 1461, 1378, 1296, 1141, 969, 867, 767 and 668 cm−1. 
Table 13. Crystal data and structure refinement for 243. 
Empirical formula  C24H37BO2  
Formula weight  368.34  
Temperature/K  100(2)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  11.6847(3)  
b/Å  13.8857(3)  
c/Å  13.3626(3)  
α/°  90  
β/°  90.8710(10)  
γ/°  90  
Volume/Å3  2167.83(9)  
Z  4  
ρcalcg/cm3  1.129  
μ/mm-1  0.068  
F(000)  808.0  
Crystal size/mm3  0.456 × 0.352 × 0.29  
Radiation  MoKα (λ = 0.71073)  
2θ range for data collection/°  3.486 to 55.932  
Index ranges  
-15 ≤ h ≤ 15, 
-18 ≤ k ≤ 18,  
-17 ≤ l ≤ 17  
Reflections collected  39263  
Rint / Rsigma 0.0398 / 0.0229  
Data/restraints/parameters  5209/178/272  
Goodness-of-fit on F2  1.028  
Final R indexes [I>=2σ (I)]  
R1 = 0.0469,  
wR2 = 0.1192  
Final R indexes [all data]  
R1 = 0.0596,  
wR2 = 0.1290  
Largest diff. peak/hole / e Å-3  0.71/-0.29 
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Figure 29. Illustration of the structure of 243 with the anisotropic displacement parameters depicted at the 50% 




According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 4-pinacol boronic ester phenyl triflate (101 mg, 0.29 mmol, 1.2 equiv) were 
coupled to give a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column 
chromatography (SiO2; 94:6 pentane:Et2O) to afford the corresponding cyclobutane 244 
(64 mg, 58 %, >98:2 d.r.) as a white solid. m.p.: 147 – 150 °C (pentane). TLC: Rf = 0.27 (94:6 
pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 7.9 Hz, 2H, ArH), 7.20 (d, J = 7.9 Hz, 
2H, ArH), 3.34 – 3.25 (m, 1H, ArCCH), 2.57 – 2.52 (m, 2H, ArCH(CHaHb)2), 1.88 – 1.83 (m, 
2H, ArCH(CHaHb)2), 1.73 – 1.63 (m, 5H, 2× CH2, CH
aHb), 1.37 – 0.92 (m, 6H, 2× CH2, CH, 
CHaHb), 1.33 (s, 12H, Bpin), 1.30 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 150.2 
(ArC), 134.8 (ArCH), 126.0 (ArCH), 83.7 (OC(CH3)2), 83.2 (OC(CH3)2), 49.2 (CH), 37.5 
(ArCCH(CH2)2), 36.1 (ArCCH), 29.2 (CH2), 26.9 (CH2), 26.9 (CH2), 25.0 (OC(CH3)2), 25.0 
(OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C28H44B2NaO4 [M+Na]
+: 489.3328, found: 
489.3308. IR (solid state) νmax: 2978, 2922, 2850, 1610, 1358, 1139, 1090, 1018, 964, 858 and 
658 cm−1. 





According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 2-pyridyl triflate (0.04 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude 
residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography (SiO2; 
85:15 DCM:EtOAc) to afford the corresponding cyclobutane 245 (60 mg, 74 %, >98:2 d.r.) as 
a colorless oil. TLC: Rf = 0.29 (85:15 DCM:EtOAc). 1H NMR (400 MHz, CDCl3) δ 8.53 (ddd, 
J = 4.9, 1.0, 0.9 Hz, 1H, ArH), 7.57 (app td, J = 7.7, 1.8 Hz, 1H, ArH), 7.16 (d, J = 7.7 Hz, 1H, 
ArH), 7.05 (ddd, J = 7.7, 4.9, 0.9 Hz, 1H, ArH), 4.48 – 3.39 (m, 1H, ArCCH), 2.59 – 2.54 (m, 
2H, ArCH(CHaHb)2), 2.03 – 1.98 (m, 2H, ArCH(CH
aHb)2), 1.71 – 1.62 (m, 5H, 2× CH2, 
CHaHb), 1.37 – 0.92 (m, 6H, 2× CH2, CH, CH
aHb), 1.30 (s, 12H, Bpin) ppm. 13C NMR 
(101 MHz, CDCl3) δ 165.2 (ArC), 149.2 (ArCH), 136.2 (ArCH), 121.1 (ArCH), 120.9 (ArCH), 
83.2 (OC(CH3)2), 49.2 (CH), 38.0 (ArCCH), 36.5 (ArCCH(CH2)2), 29.1 (CH2), 26.9 (CH2), 
26.9 (CH2), 25.0 (OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C21H32BNNaO2 [M+Na]
+: 
364.2422, found: 364.2417. IR (thin film) νmax: 2976, 2923, 2851, 1591, 1385, 1308, 1142, 




According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and quinolin-8-yl triflate (79 mg, 0.29 mmol, 1.2 equiv) were coupled to give a crude 
residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography (SiO2; 
97:3 DCM:EtOAc) to afford the corresponding cyclobutane 246 (80 mg, 86 %, >98:2 d.r.) as a 
white solid. m.p.: 120 – 124 °C (Et2O). TLC: Rf = 0.24 (97:3 DCM:EtOAc). 1H NMR 
(400 MHz, CDCl3) δ 8.90 (dd, J = 4.1, 1.8 Hz, 1H, ArH), 8.09 (dd, J = 8.2, 1.8 Hz, 1H, ArH), 
7.63 – 7.61 (m, 2H, 2× ArH), 7.50 (app t, J = 7.6 Hz, 1H, ArH), 4.42 – 4.33 (m, 1H, ArCCH), 
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2.85 – 2.80 (m, 2H, ArCH(CHaHb)2), 2.02 – 1.96 (m, 2H, ArCH(CH
aHb)2), 1.76 – 1.64 (m, 5H, 
2× CH2, CH
aHb), 1.40 – 0.96 (m, 6H, 2× CH2, CH, CH
aHb), 1.35 (s, 12H, Bpin) ppm. 13C NMR 
(101 MHz, CDCl3) δ 149.2 (ArCH), 146.8 (ArC), 145.4 (ArC), 136.1 (ArCH), 128.3 (ArC), 
126.3 (ArCH), 126.3 (ArCH), 125.6 (ArCH), 120.8 (ArCH), 83.2 (OC(CH3)2), 49.6 (CH), 37.8 
(ArCCH(CH2)2), 31.8 (ArCCH), 29.3 (CH2), 27.0 (CH2), 27.0 (CH2), 25.0 (OC(CH3)2) ppm. 
HRMS (m/z): (ESI) calc’d for C25H35BNO2 [M+H]
+: 392.2760, found: 392.2756. IR (solid 




According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and cyclohex-1-en-1-yl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to 
give a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column 
chromatography (SiO2; 98:2 pentane:Et2O) to afford the corresponding cyclobutane 247 
(64 mg, 78 %, >98:2 d.r.) as a white solid. m.p.: 98 – 101 °C (pentane). TLC: Rf = 0.28 (98:2 
pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 5.33 – 5.30 (m, 1H, =CH), 2.55 – 2.46 (m, 1H, 
=CCH), 2.25 – 2.20 (m, 2H, =CCH(CHaHb)2), 2.00 – 1.96 (m, 2H, =CHCH2), 1.85 – 1.84 (m, 
2H, =CCH2), 1.71 – 1.51 (m, 11H, =CCH(CH
aHb)2, CH
aHb, 4× CH2), 1.26 (s, 12H, Bpin), 1.21 
– 0.86 (m, 6H, CH, CHaHb, 2× CH2) ppm. 13C NMR (101 MHz, CDCl3) δ 141.8 (=C), 118.3 
(=CCH), 83.1 (OC(CH3)2), 49.3 (CH), 37.5 (=CCH), 35.0 (=CCH(CH2)2), 29.3 (CH2), 27.0 
(CH2), 27.0 (CH2), 26.1 (=CCH2), 25.2 (=CCHCH2), 24.9 (OC(CH3)2), 23.1 (CH2), 22.9 (CH2) 
ppm. HRMS (m/z): (ESI) calc’d for C22H37BNaO2 [M+Na]
+: 367.2783, found: 367.2787. IR 
(solid state) νmax: 2921, 2852, 1447, 1387, 1308, 1196, 1144, 967, 865, 803 and 679 cm−1. 
2-((1s,3s)-1-Cyclohexyl-3-vinylcyclobutyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (248) 
 
According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and vinyl triflate (14.8 % w/w solution in THF/hexane, 340 mg, 0.29 mmol, 
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1.2 equiv) were coupled to give a crude residue (>98:2 d.r. by crude NMR) that was purified 
by flash column chromatography (SiO2; 98:2 pentane:Et2O) to afford the corresponding 
cyclobutane 248 (38 mg, 55 %, >98:2 d.r.) as a colorless oil. TLC: Rf = 0.24 (98:2 
pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 5.85 (ddd, J = 16.9, 10.3, 6.4 Hz, 1H, =CH), 
4.92 – 4.84 (m, 2H, =CH2), 2.73 – 2.63 (m, 1H, ArCCH), 2.30 – 2.25 (m, 2H, ArCH(CH
aHb)2), 
1.72 – 1.55 (m, 8H, 3× CH2, ArCH(CH
aHb)2), 1.27 (s, 12H, Bpin), 1.23 – 0.87 (m, 5H, 2× CH2, 
CH) ppm. 13C NMR (101 MHz, CDCl3) δ 143.9 (=CH), 111.9 (=CH2), 83.1 (OC(CH3)2), 49.2 
(CH), 36.1 (ArCCH(CH2)2), 34.8 (ArCCH), 29.2 (CH2), 27.0 (CH2), 26.9 (CH2), 24.9 
(OC(CH3)2) ppm. HRMS (m/z): (MALDI) calc’d for C18H31BNaO2 [M+Na]
+: 313.2313, 




According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and benzo[d][1,3]dioxol-5-yl triflate (77 mg, 0.29 mmol, 1.2 equiv) were coupled to 
give a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column 
chromatography (SiO2; 70:30 pentane:DCM) to afford the corresponding cyclobutane 268 
(75 mg, 82 %, >98:2 d.r.) as a white solid. m.p.: 129 – 132 °C (pentane). TLC: Rf = 0.19 (70:30 
pentane:DCM). 1H NMR (400 MHz, CDCl3) δ 6.73 – 6.71 (m, 2H, 2× ArH), 6.64 – 6.61 (m, 
1H, ArH), 5.90 (s, 2H, OCH2O), 3.24 – 3.15 (m, 1H, ArCCH), 2.54 – 2.49 (m, 2H, 
ArCH(CHaHb)2), 1.81 – 1.76 (m, 2H, ArCH(CH
aHb)2), 1.76 – 1.63 (m, 5H, 2× CH2, CH
aHb), 
1.30 (s, 12H, Bpin), 1.22 – 0.91 (m, 6H, 2× CH2, CH, CH
aHb) ppm. 13C NMR (101 MHz, 
CDCl3) δ 147.6 (ArCO), 145.5 (ArCO), 141.0 (ArC), 119.3 (ArCH), 108.0 (ArCH), 107.2 
(ArCH), 100.8 (OCH2O), 83.2 (OC(CH3)2), 49.2 (CH), 37.9 (ArCCH(CH2)2), 35.8 (ArCCH), 
29.2 (CH2), 27.0 (CH2), 26.9 (CH2), 25.0 (OC(CH3)2) ppm. HRMS (m/z): (MALDI) calc’d for 
C23H33BNaO4 [M+Na]
+: 407.2368, found: 407.2377. IR (solid state) νmax: 2923, 2851, 1487, 
1379, 1297, 1230, 1187, 1141, 1036, 938, 858, 799, 697 and 627 cm−1. 
 





According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and eugenol-derived triflate (85 mg, 0.29 mmol, 1.2 equiv) were coupled to give a 
crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 60:40 pentane:DCM) to afford the corresponding cyclobutane 269 (70 mg, 71 %, 
>98:2 d.r.) as a white solid. m.p.: 85 – 88 °C (pentane). TLC: Rf = 0.24 (60:40 pentane:DCM). 
1H NMR (400 MHz, CDCl3) δ 7.12 – 7.05 (m, 1H, ArH), 6.75 (dd, J = 7.6, 1.3 Hz, 1H, ArH), 
6.62 (d, J = 1.5 Hz, 1H, ArH), 5.97 (ddt, J = 16.8, 10.0, 6.7 Hz, 1H, =CH), 5.12 – 5.04 (m, 2H, 
=CH2), 3.77 (s, 3H, OCH3), 3.47 – 3.36 (m, 1H, ArCCH), 3.36 (d, J = 6.7 Hz, 2H, =CHCH2), 
2.57 – 2.52 (m, 2H, ArCH(CHaHb)2), 1.84 – 1.78 (m, 2H, ArCH(CH
aHb)2), 1.71 – 1.63 (m, 5H, 
2× CH2, CH
aHb), 1.34 – 0.90 (m, 6H, 2× CH2, CH, CH
aHb), 1.31 (s, 12H, Bpin) ppm. 13C NMR 
(101 MHz, CDCl3) δ 157.5 (ArCOCH3), 138.7 (ArC), 137.8 (=CH), 132.6 (ArC), 127.0 
(ArCH), 120.4 (ArCH), 115.7 (=CH2), 110.7 (ArCH), 83.1 (OC(CH3)2), 55.4 (OCH3), 49.4 
(CH), 40.4 (=CHCH2), 37.0 (ArCCH(CH2)2), 30.8 (ArCCH), 29.3 (CH2), 27.0 (CH2), 27.0 
(CH2), 24.9 (OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C26H40BO3 [M+H]
+: 411.3070, 
found: 411.3076. IR (solid state) νmax: 2978, 2923, 2850, 1382, 1309, 1253, 1188, 1140, 1042, 





According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and estrone-derived triflate (114 mg, 0.29 mmol, 1.2 equiv) were coupled to give a 
crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
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(SiO2; 80:20 pentane:Et2O) to afford the corresponding cyclobutane 270 (94 mg, 76 %, 
>98:2 d.r.) as a white solid. m.p.: 162 – 165 °C (pentane). TLC: Rf = 0.17 (80:20 
pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.23 – 7.21 (d, J = 8.0 Hz, 1H, ArH), 7.03 – 7.00 
(m, 1H, ArH), 6.94 (s, 1H, ArH), 3,26 – 3.17 (m, 1H, ArCCH), 2.92 – 2.89 (m, 2H, C=OCH2), 
2.55 – 2.51 (m, 2H, ArCH(CHaHb)2), 2.51 – 2.40 (m, 2H), 2.32 – 2.25 (m, 1H), 2.19 – 1.94 (m, 
4H), 1.87 – 1.74 (m, 2H, ArCH(CHaHb)2), 1.74 – 1.41 (m, 12H), 1.30 (s, 12H, Bpin), 1.21 – 
0.92 (m, 6H), 0.90 (s, 3H, CH3) ppm. 13C NMR (101 MHz, CDCl3) δ 221.1 (C=O), 144.3 
(ArC), 137.1 (ArC), 136.2 (ArC), 127.2 (ArCH), 125.3 (ArCH), 124.1 (ArCH), 83.2 
(OC(CH3)2), 50.7 (CH), 49.2 (CH), 48.2 (C), 44.5 (CH), 38.4 (CH), 37.8 (ArCCH(CH2)2), 36.0 
(CH2), 35.6 (ArCCH), 31.8 (CH2), 29.6 (C=OCH2), 29.2 (CH2), 27.0 (CH2), 26.9 (CH2), 26.8 
(CH2), 25.9 (CH2), 24.9 (OC(CH3)2), 21.7 (CH2), 14.0 (CH3) ppm. HRMS (m/z): (ESI) calc’d 
for C34H49BNaO3 [M+Na]
+: 539.3673, found: 539.3653. IR (solid state) νmax: 2923, 2851, 
1741, 1385 and 1143 cm−1. [𝜶]𝐃




According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and 4-methyl-2-oxo-2H-chromen-7-yl triflate (87 mg, 0.29 mmol, 1.2 equiv) were 
coupled to give a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column 
chromatography (SiO2; DCM) to afford the corresponding cyclobutane 271 (23 mg, 23 %, 
>98:2 d.r.) as a colorless oil. TLC: Rf = 0.12 (DCM). 1H NMR (400 MHz, CDCl3) δ 7.49 (d, 
J = 8.1 Hz, 1H, ArH), 7.15 – 7.11 (m, 2H, 2× ArH), 6.22 – 6.21 (m, 1H, C=OCH=), 3.41 – 3.32 
(m, 1H, ArCCH), 2.61 – 2.56 (m, 2H, ArCH(CHaHb)2), 2.41 (d, J = 1.2 Hz, 3H, CH3), 1.89 – 
1.83 (m, 2H, ArCH(CHaHb)2), 1.74 – 1.60 (m, 5H, 2× CH2, CH
aHb), 1.31 (s, 12H, Bpin), 1.29 
– 0.93 (m, 6H, 2× CH2, CH, CH
aHb) ppm. 13C NMR (101 MHz, CDCl3) δ 161.3 (C), 153.8 (C), 
152.5 (C), 151.9 (C), 124.3 (ArCH), 122.8 (ArCH), 117.8 (ArC), 114.8 (ArCH), 114.1 (ArCH), 
83.4 (OC(CH3)2), 49.1 (CH), 37.3 (ArCCH(CH2)2), 35.7 (ArCCH), 29.1 (CH2), 26.9 (CH2), 
26.9 (CH2), 25.0 (OC(CH3)2), 18.8 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C26H36BO4 
[M+H]+: 423.2706, found: 423.2697. IR (thin film) νmax: 2923, 2851, 1731, 1617, 1386, 1143 
and 858 cm−1. 





According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and tyrosine-derived triflate (151 mg, 0.29 mmol, 1.2 equiv) were coupled to give a 
crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 18:2:80 pentane:Et2O:DCM) to afford the corresponding cyclobutane 272 (70 mg, 46 %, 
>98:2 d.r.) as a colorless oil. TLC: Rf = 0.27 (18:2:80 pentane:Et2O:DCM). 1H NMR 
(400 MHz, CDCl3) δ 7.11 – 7.06 (m, 4H, 4× ArH), 5.11 (dd, J = 10.4, 4.9 Hz, 1H, CHNBoc2), 
3.74 (s, 3H, OCH3), 3.38 (dd, J = 14.0, 4.9 Hz, 1H, CH
aHb), 3.26 – 3.14 (m, 2H, ArCCH, 
CHaHb), 2.52 – 2.48 (2H, ArCH(CHaHb)2), 1.82 – 1.77 (m, 2H, ArCH(CH
aHb)2), 1.73 – 1.66 
(m, 5H, 5× Cy-H), 1.48 – 0.91 (m, 6H, 6× Cy-H), 1.37 (s, 1f8H, C(CH3)3), 1.30 (s, 12H, Bpin) 
ppm. 13C NMR (101 MHz, CDCl3) δ 171.1 (C=O), 151.7 (C=O), 145.0 (ArC), 134.8 (ArC), 
129.4 (ArCH), 126.7 (ArCH), 83.2 (OC(CH3)2), 83.0 (C(CH3)3), 59.7 (CHNBoc2), 52.3 
(OCH3), 49.2 (CH), 37.7 (ArCCH(CH2)2), 36.0 (CH2), 35.6 (ArCCH), 29.2 (CH2), 28.0 
(C(CH3)3), 27.0 (CH2), 26.9 (CH2), 24.9 (OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for 
C36H56BNNaO8 [M+Na]
+: 664.3998, found: 664.4017. IR (thin film) νmax: 2980, 2927, 2852, 
1742, 1369, 1139, 906 and 727 cm−1. [𝜶]𝐃






According to General Procedure C, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) and pregnenolone-derived triflate (161 mg, 0.29 mmol, 1.2 equiv) were coupled to 
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give a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column 
chromatography (SiO2; 3× 89:10:1 pentane:DCM:Et2O) to afford the corresponding 
cyclobutane 273 (118 mg, 73 %, >98:2 d.r.) as a white solid. m.p.: 136 – 140 °C (Et2O). TLC: 
Rf = 0.23 (89:10:1 pentane:DCM:Et2O). 1H NMR (400 MHz, CDCl3) δ 5.32 – 5.31 (m, 1H, 
=CH), 4.78 (s, 2H, =CH2), 3.52 – 3.44 (m, 1H, CHOTBS), 2.67 – 2.58 (m, 1H, ArCCH), 2.36 
– 2.14 (m, 4H), 2.04 – 1.95 (m, 2H), 1.86 – 0.85 (m, 29H), 1.26 (s, 12H, Bpin), 0.99 (s, 3H, 
CH3), 0.89 (s, 9H, C(CH3)3), 0.53 (s, 3H, CH3), 0.06 (s, 6H, Si(CH3)2) ppm. 13C NMR 
(101 MHz, CDCl3) δ 154.0 (C), 141.7 (C), 121.3 (=CH), 107.1 (=CH2), 83.1 (OC(CH3)2), 72.8 
(CHOTBS), 56.9 (CH), 53.5 (CH), 50.5 (CH), 49.1 (CH), 43.0 (CH2), 42.9 (C), 38.6 (CH2), 
37.8 (CH), 37.6 (CH2), 37.4 (CH2), 36.8 (C), 36.1 (CH2), 32.5 (CH), 32.2 (CH2), 32.0 (CH2), 
29.4 (CH2), 29.4 (CH2), 28.1 (CH2), 27.3 (CH2), 27.0 (CH2), 26.1 (SiC(CH3)3), 25.9 (CH2), 25.0 
(OC(CH3)2), 24.9 (CH3), 24.8 (OC(CH3)2), 24.4 (CH2), 21.3 (CH2), 19.6 (CH3), 18.4 (C), 12.8 
(CH), −4.4 (Si(CH3)2) ppm. HRMS (m/z): (MALDI) calc’d for C43H73BNaO3Si [M+Na]
+: 
699.5322, found: 699.5335. IR (solid state) νmax: 2929, 2849, 1382, 1141, 1097, 883, 835 and 
770 cm−1. [𝜶]𝐃
𝟐𝟐: −35 (c = 1.0, CHCl3). 
4,4,5,5-Tetramethyl-2-((1s,3s)-1-methyl-3-phenylcyclobutyl)-1,3,2-dioxaborolane (249) 
 
According to General Procedure C, methyl pinacol boronic ester (34 mg, 0.24 mmol, 
1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude 
residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography (SiO2; 
97:3 pentane:Et2O) to afford the corresponding cyclobutane 249 (40 mg, 62 %, >98:2 d.r.) as a 
colorless oil. 
Gram-scale procedure: According to General Procedure C, but on 29× scale, tert-butyl 
lithium (in pentane, 9.15 mmol, 1.30 equiv) was added dropwise to a solution of BCB-sulfoxide 
224 (1.76 g, 9.15 mmol, 1.30 equiv) and methyl pinacol boronic ester (1.00 g, 7.04 mmol, 
1.0 equiv) in anhydrous 2-methyl tetrahydrofuran (30 mL) at ‒78 °C (dry ice/acetone) and 
allowed to stir for 5 min. After removing the cooling bath a solution of Pd(dba)2 (122 mg, 
0.21 mmol, 3.0 mol%) and dippf (106 mg, 0.25 mmol, 3.6 mol%) in 2-methyl tetrahydrofuran 
(7 mL) (pre-mixed under argon for 20 min) was then added followed by phenyl triflate 
(1.37 mL, 8.45 mmol, 1.20 equiv). The flask was sealed and heated at 40 °C (oil bath) for 14 h. 
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After cooling to ambient temperature, the solution was transferred to a separating funnel with 
pentane (20 mL). H2O (20 mL) and NH4Cl (saturated aqueous solution, 20 mL) were then 
added, and the organic phase collected. The aqueous phase was extracted with pentane (3× 
20 mL) and then the combined organic phases were dried (MgSO4), filtered, and concentrated 
under reduced pressure to give a crude residue (>98:2 d.r. by crude NMR) that was purified by 
flash column chromatography (SiO2; 97:3 pentane:Et2O) to yield the desired cyclobutane 249 
(1.12 g, 58 %, >98:2 d.r.) as a colorless oil. TLC: Rf = 0.32 (95:5 pentane:Et2O). 1H NMR 
(400 MHz, CDCl3) δ 7.31 – 7.27 (m, 2H, 2× ArH), 7.23 – 7.20 (m, 2H, 2× ArH), 7.18 – 7.14 
(m, 1H, ArH), 3.49 – 3.40 (m, 1H, ArCCH), 2.64 – 2.60 (m, 2H, ArCH(CHaHb)2), 1.85 – 1.80 
(m, 2H, ArCH(CHaHb)2), 1.31 (s, 12H, Bpin), 1.19 (s, 3H, CH3) ppm. 13C NMR (101 MHz, 
CDCl3) δ 146.7 (ArC), 128.2 (ArCH), 126.5 (ArCH), 125.7 (ArCH), 83.3 (OC(CH3)2), 40.2 
(ArCCH(CH2)2), 35.7 (ArCCH), 25.6 (CH3), 24.9 (OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d 
for C17H25BNaO2 [M+Na]
+: 295.1843, found: 295.1832. IR (thin film) νmax: 2977, 2939, 2858, 




According to General Procedure C, phenethyl pinacol boronic ester (55 mg, 0.24 mmol, 
1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude 
residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography (SiO2; 
60:40 pentane:DCM) to afford the corresponding cyclobutane 250 (67 mg, 76 %, >98:2 d.r.) as 
a colorless oil. TLC: Rf = 0.30 (60:40 pentane:DCM). 1H NMR (400 MHz, CDCl3) δ 7.22 – 
7.06 (m, 10H, 10× ArH), 3.44 – 3.35 (m, 1H, ArCCH), 2.56 – 2.51 (m, 2H, ArCH(CHaHb)2), 
2.46 – 2.42 (m, 2H, ArCH2), 1.82 – 1.76 (m, 4H, CH2, ArCH(CH
aHb)2), 1.25 (s, 3H, CH3) ppm. 
13C NMR (101 MHz, CDCl3) δ 146.6 (ArC), 143.2 (ArC), 128.5 (ArCH), 128.4 (ArCH), 128.3 
(ArCH), 126.5 (ArCH), 125.7 (ArCH), 125.7 (ArCH), 83.4 (OC(CH3)2), 43.0 (CH2), 38.6 
(ArCCH(CH2)2), 36.1 (ArCCH), 33.4 (ArCH2), 24.9 (OC(CH3)2) ppm. HRMS (m/z): (ESI) 
calc’d for C24H31BNaO2 [M+Na]
+: 385.2314, found: 385.2322. IR (thin film) νmax: 2976, 2925, 
1385, 1307, 1196, 1141, 965, 859, 750 and 696 cm−1. 





According to General Procedure C, 2-(3-azidopropyl) pinacol boronic ester (51 mg, 
0.24 mmol, 1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give 
a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 68:30:2 pentane:DCM:Et2O) to afford the corresponding cyclobutane 251 (16 mg, 20 %, 
>98:2 d.r.) as a colorless oil. TLC: Rf = 0.26 (pentane:DCM:PhMe 60:20:20). 1H NMR 
(400 MHz, CDCl3) δ 7.30 – 7.27 (m, 2H, 2× ArH), 7.21 – 7.14 (m, 3H, 3× ArH), 3.51 – 3.42 
(m, 1H, ArCCH), 3.23 (t, J = 6.7 Hz, 2H, CH2N3), 2.61 – 2.56 (m, 2H, ArCH(CH
aHb)2), 1.86 – 
1.80 (m, 2H, ArCH(CHaHb)2), 1.63 – 1.51 (m, 4H, 2× CH2), 1.30 (s, 12H, Bpin) ppm. 13C NMR 
(101 MHz, CDCl3) δ 146.4 (ArC), 128.3 (ArCH), 126.5 (ArCH), 125.8 (ArCH), 83.5 
(OC(CH3)2), 52.0 (CH2N3), 38.6 (ArCCH(CH2)2), 37.8 (CH2), 35.9 (ArCCH), 26.3 (CH2), 24.9 
(OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C19H28BN3NaO2 [M+Na]
+: 364.2170, found: 




According to General Procedure C, (S)-2-(4-(4-methoxyphenyl)butan-2-yl)-pinacol boronic 
ester (95:5 e.r., 69 mg, 0.24 mmol, 1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 
1.2 equiv) were coupled to give a crude residue (>98:2 d.r. by crude NMR) that was purified 
by flash column chromatography (SiO2; 50:50 pentane:DCM) to afford the corresponding 
cyclobutane 252 (77 mg, 77 %, >98:2 d.r., 95:5 e.r., 100 % e.s.) as a colorless oil. TLC: Rf = 
0.32 (50:50 pentane:DCM). 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.26 (m, 2H, 2× ArH), 7.18 
– 7.15 (m, 3H, 3× ArH), 7.12 – 7.08 (m, 2H, 2× ArH), 6.84 – 6.81 (m, 2H, 2× ArH), 3.79 (s, 
3H, OCH3), 3.35 – 3.26 (m, 1H, ArCCH), 2.70 – 2.56 (m, 3H, ArCH
aHb, ArCH(CHaHb)2), 2.49 
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– 2.41 (m, 1H, ArCHaHb), 1.84 – 1.77 (m, 2H, ArCH(CHaHb)2), 1.75 – 1.66 (m, 1H, CHCH
aHb), 
1.54 – 1.46 (m, 1H, CHCH3), 1.43 – 1.33 (m, 1H, CHCH
aHb), 1.30 (s, 12H, Bpin), 0.94 (d, J = 
6.7 Hz, 3H, CH3) ppm. 13C NMR (101 MHz, CDCl3) δ 157.7 (ArCOCH3), 146.7 (ArC), 135.4 
(ArC), 129.3 (ArCH), 128.2 (ArCH), 126.5 (ArCH), 125.6 (ArCH), 113.8 (ArCH), 83.2 





b), 35.9 (CHCH2), 35.6 (ArCCH), 33.6 (ArCH2), 25.0 (OC(CH3)2), 24.9 
(OC(CH3)2), 15.7 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C27H37BNaO3 [M+Na]
+: 
443.2733, found: 443.2722. IR (thin film) νmax: 2933, 1511, 1386, 1300, 1245, 1142, 907, 729 
and 698 cm−1. [𝜶]𝐃
𝟐𝟓: −43 (c = 1.0, CHCl3). Chiral HPLC: Daicel Chiralpak-IB column (25 
cm) with guard, 5.0 % isopropanol in hexane, 1.0 mL/min, ambient temperature, 210 nm: tR = 
3.83 min (major), tR = 4.12 min (minor), 95:5 e.r. 



































According to General Procedure C, cyclopropyl pinacol boronic ester (0.045 mL, 0.24 mmol, 
1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude 
residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography (SiO2; 
96:4 pentane:Et2O) to afford the corresponding cyclobutane 253 (63 mg, 85 %, >98:2 d.r.) as a 
colorless oil. TLC: Rf = 0.30 (95:5 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.26 
(m, 2H, 2× ArH), 7.21 – 7.13 (m, 3H, 3× ArH), 3.37 – 3.28 (m, 1H, ArCCH), 2.43 – 2.38 (m, 
2H, ArCH(CHaHb)2), 1.82 – 1.76 (m, 2H, ArCH(CH
aHb)2), 1.31 (s, 12H, Bpin), 0.98 – 0.91 (m, 
1H, CH), 0.36 – 0.22 (m, 4H, 2× CH2) ppm. 13C NMR (101 MHz, CDCl3) δ 146.5 (ArC), 128.2 
(ArCH), 126.5 (ArCH), 125.7 (ArCH), 83.4 (OC(CH3)2), 35.6 (ArCCH, ArCCH(CH2)2), 24.9 
(OC(CH3)2), 16.9 (CH), 1.2 (CH2) ppm. HRMS (m/z): (ESI) calc’d for C19H28BO2 [M+H]
+: 




































According to General Procedure C, 1-(phenylpropyl) pinacol boronic ester (59 mg, 
0.24 mmol, 1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give 
a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 70:30 pentane:DCM) to afford the corresponding cyclobutane 254 (70 mg, 78 %, 
>98:2 d.r.) as a colorless oil. TLC: Rf = 0.28 (70:30 pentane:DCM). 1H NMR (400 MHz, 
CDCl3) δ 7.28 – 7.11 (m, 10H, 10× ArH), 3.37 – 3.28 (m, 1H, ArCCH), 2.58 – 2.52 (m, 2H, 
CH, ArCH(CHa1Hb1)(CHa2Hb2)), 2.40 – 2.34 (m, 1H, ArCH(CHa1Hb1)(CHa2Hb2), 2.07 (app t, 
J = 10.6 Hz, 1H, ArCH(CHa1Hb1)(CHa2Hb2)), 2.01 (app t, J = 10.4 Hz, 1H, 
ArCH(CHa1Hb1)(CHa2Hb2)), 1.83 – 1.77 (m, 2H, CH2), 1.24 (s, 12H, Bpin), 0.76 (t, J = 7.3 Hz, 
3H, CH3) ppm. 13C NMR (101 MHz, CDCl3) δ 146.6 (ArC), 143.6 (ArC), 129.0 (ArCH), 128.2 





b), 35.7 (ArCCH), 25.0 (OC(CH3)2), 
24.8 (OC(CH3)2), 24.2 (CH2), 13.0 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C25H33BNaO2 
[M+Na]+: 399.2470, found: 399.2475. IR (thin film) νmax: 2974, 2931, 1378, 1305, 1143, 966, 




According to General Procedure C, tert-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)piperidine-1-carboxylate (75 mg, 0.24 mmol, 1.0 equiv) and phenyl triflate (0.05 mL, 
0.29 mmol, 1.2 equiv) were coupled to give a crude residue (>98:2 d.r. by crude NMR) that 
was purified by flash column chromatography (SiO2; pentane:Et2O:PhMe 70:10:20) to afford 
the corresponding cyclobutane 255 (54 mg, 51 %, >98:2 d.r.) as a colorless oil. TLC: Rf = 0.29 
(pentane:Et2O:PhMe 70:10:20). 1H NMR (400 MHz, CDCl3) δ 7.29 – 7.25 (m, 2H, 2× ArH), 
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7.20 – 7.13 (m, 3H, 3× ArH),  4.04 – 3.66 (br m, 1H), 3.37 – 3.15 (br m, 1H), 3.37 – 3.28 (m, 
1H, ArCCH), 2.61 – 2.55 (m, 1H, ArCH(CHa1Hb1)(CHa2Hb2)), 2.49 – 2.43 (m, 1H, 
ArCH(CHa1Hb1)(CHa2Hb2)), 2.12 – 1.98 (m, 2H, ArCH(CHa1Hb1)(CHa2Hb2) and 
ArCH(CHa1Hb1)(CHa2Hb2)), 1.71 – 1.46 (m, 7H), 1.46 (s, 9H, C(CH3)3), 1.31 (s, 12H, Bpin) 
ppm. Due to the presence of rotamers, further assignments were not made. 13C NMR 
(101 MHz, CDCl3) δ 155.9 (C=O), 146.5 (ArC), 128.2 (ArCH), 126.5 (ArCH), 125.7 (ArCH), 





36.0 (ArCCH), 28.6 (C(CH3)3), 26.1 (CH2), 25.1 (OC(CH3)2), 25.0 (CH2) ppm. NCH, NCH2 
and CH2 were not observed. HRMS (m/z): (ESI) calc’d for C26H41BNO4 [M+H]
+: 442.3128, 





According to General Procedure C, tert-butyldimethyl((1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)heptyl)oxy)silane (86 mg, 0.24 mmol, 1.0 equiv) and phenyl triflate 
(0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude residue (>98:2 d.r. by crude 
NMR) that was purified by flash column chromatography (SiO2; pentane:DCM 85:15) to afford 
the corresponding cyclobutane 256 (76 mg, 65 %, >98:2 d.r.) as a colorless oil. TLC: Rf = 0.19 
(pentane:DCM 85:15). 1H NMR (400 MHz, CDCl3) δ 7.28 – 7.21 (m, 4H, 4× ArH), 7.16 – 7.12 
(m, 1H, ArH), 3.66 – 3.64 (m, 1H, CHOTBS), 3.33 – 3.24 (m, 1H, ArCCH), 2.54 – 2.48 (m, 
1H, ArCH(CHa1Hb1)(CHa2Hb2)), 2.26 – 2.20 (m, 1H, ArCH(CHa1Hb1)(CHa2Hb2)), 2.17 – 2.08 
(m, 2H, ArCH(CHa1Hb1)(CHa2Hb2) and ArCH(CHa1Hb1)(CHa2Hb2)), 1.48 – 1.24 (m, 10H, 5× 
CH2), 1.30 (s, 12H, Bpin), 0.89 (s, 9H, C(CH3)3), 0.88 (t, J = 7.0 Hz, 3H, CH3), 0.05 (s, 3H, 
SiCH3), 0.05 (s, 3H, SiCH3) ppm. 13C NMR (101 MHz, CDCl3) δ 146.6 (ArC), 128.1 (ArCH), 





b), 32.0 (CH2), 29.9 (CH2), 26.2 (CH2), 
26.0 (C(CH3)3), 25.1 (OC(CH3)2), 24.6 (OC(CH3)2), 22.8 (CH2), 18.4 (SiC(CH3)3), 14.3 (CH3), 
−3.7 (SiCH3), −4.0 (SiCH3) ppm. HRMS (m/z): (ESI) calc’d for C29H51BNaO3Si [M+Na]
+: 
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509.3598, found: 509.3598. IR (thin film) νmax: 2928, 2856, 1461, 1379, 1308, 1254, 1142, 




According to General Procedure C, adamantyl pinacol boronic ester (63 mg, 0.24 mmol, 
1.0 equiv) and 4-methoxyphenyl triflate (74 mg, 0.29 mmol, 1.2 equiv) were coupled to give a 
crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 70:30 pentane:DCM) to afford the corresponding cyclobutane 257 (58 mg, 57 %, 
>98:2 d.r.) as a colorless oil that crystallised slowly to a white solid. m.p.: 113 – 116 °C 
(pentane). TLC: Rf = 0.14 (70:30 pentane:DCM). 1H NMR (400 MHz, CDCl3) δ 7.13 – 7.10 
(m, 2H, 2× ArH), 6.84 – 6.80 (m, 2H, 2× ArH), 3.78 (s, 3H, OCH3), 3.10 – 3.01 (m, 1H, 
ArCCH), 2.29 – 2.24 (m, 2H, ArCH(CHaHb)2), 2.12 – 2.07 (m, 2H, ArCH(CH
aHb)2), 1.96 (br 
s, 3H, 3× CH), 1.73 – 1.58 (m, 12H, 6× CH2), 1.32 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, 
CDCl3) δ 157.7 (ArCOCH3), 139.0 (ArC), 127.5 (ArCH), 113.7 (ArCH), 83.3 (OC(CH3)2), 55.4 
(OCH3), 39.0 (CH2), 37.5 (CH2), 34.7 (ArCCH), 32.0 (ArCCH(CH2)2), 28.9 (CH), 25.0 
(OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C27H39BNaO3 [M+Na]
+: 445.2889, found: 
445.2890. IR (solid state) νmax: 2972, 2900, 2848, 1611, 1513, 1369, 1351, 1298, 1245, 1177, 




According to General Procedure C, tert-butyl pinacol boronic ester (44 mg, 0.24 mmol, 
1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude 
residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography (SiO2; 
98:2 pentane:Et2O) to afford the corresponding cyclobutane 258 (52 mg, 69 %, >98:2 d.r.) as a 
colorless oil. TLC: Rf = 0.17 (98:2 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.26 
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(m, 2H, 2× ArH), 7.22 – 7.13 (m, 3H, 3× ArH), 3.20 – 3.10 (m, 1H, ArCCH), 2.40 – 2.36 (m, 
2H, ArCH(CHaHb)2), 2.08 – 2.03 (m, 2H, ArCH(CH
aHb)2), 1.32 (s, 12H, Bpin), 0.91 (s, 9H, 
C(CH3)3) ppm. 13C NMR (101 MHz, CDCl3) δ 146.6 (ArC), 128.2 (ArCH), 126.6 (ArCH), 
125.7 (ArCH), 83.3 (OC(CH3)2), 34.7 (ArCCH), 33.5 (ArCCH(CH2)2), 33.1 (C(CH3)3), 26.9 
(C(CH3)3), 25.0 (OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C20H31BNaO2 [M+Na]
+: 
337.2313, found: 337.2315. IR (thin film) νmax: 2957, 2867, 1359, 1349, 1298, 1142, 1108, 




According to General Procedure C, tert-butyl (2r,3R,4s,5S)-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)cubane-1-carboxylate (79 mg, 0.24 mmol, 1.0 equiv) and phenyl triflate 
(0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude residue (>98:2 d.r. by crude 
NMR) that was purified by flash column chromatography (SiO2; 90:10 pentane:Et2O) to afford 
the corresponding cyclobutane 259 (44 mg, 40 %, >98:2 d.r.) as a colorless oil. TLC: Rf = 0.23 
(90:10 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.26 (m, 2H, 2× ArH), 7.21 – 7.14 
(m, 3H, 3× ArH), 3.98 – 3.95 (m, 3H, 3× CH), 3.82 – 3.38 (m, 3H, 3× CH), 3.47 – 3.38 (m, 1H, 
ArCCH), 2.41 – 2.36 (m, 2H, ArCH(CHaHb)2), 1.98 – 1.92 (m, 2H, ArCH(CH
aHb)2), 1.46 (s, 
9H, C(CH3)3), 1.28 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 172.5 (C=O), 146.3 
(ArC), 128.3 (ArCH), 126.5 (ArCH), 125.8 (ArCH), 83.3 (OC(CH3)2), 79.9 (OC(CH3)3), 63.2 
(C), 58.0 (C), 45.7 (CH), 44.8 (CH), 35.6 (ArCCH), 31.9 (ArCCH(CH2)2), 28.3 (C(CH3)3), 24.9 
(OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C29H37BNaO2 [M+Na]
+: 483.2682, found: 
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According to General Procedure C, tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)-3,6-dihydropyridine-1(2H)-carboxylate (74 mg, 0.24 mmol, 1.0 equiv) and phenyl triflate 
(0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude residue (>98:2 d.r. by crude 
NMR) that was purified by flash column chromatography (SiO2; 98:2 DCM:Et2O) to afford the 
corresponding cyclobutane 260 (55 mg, 52 %, >98:2 d.r.) as a colorless oil. TLC: Rf = 0.15 
(98:2 DCM:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.24 (m, 2H, 2× ArH), 7.20 – 7.14 
(m, 3H, 3× ArH), 5.25 (br s, 1H, =CH), 3.89 (br s, 2H, NCH2CH=), 3.45 – 3.38 (m, 3H, ArCCH, 
=CCH2), 2.70 – 2.65 (m, 2H, ArCH(CH
aHb)2), 2.11 – 2.06 (m, 2H, ArCH(CH
aHb)2), 2.03 (br s, 
CH2N), 1.46 (s, 9H, C(CH3)3), 1.28 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 146.0 
(ArC), 128.3 (ArCH), 126.5 (ArCH), 125.9 (ArCH), 83.7 (OC(CH3)2), 79.4 (C(CH3)3), 37.3 
(ArCCH(CH2)2), 35.6 (ArCCH), 28.7 (C(CH3)3), 26.1 (CH2N), 24.8 (OC(CH3)2) ppm, peaks 
for =CH (114.6), NCH2CH= (43.5), and =CCH2 (39.9) were not observed, but correlations by 
HSQC were (approx. values given in brackets). HRMS (m/z): (ESI) calc’d for C26H38BNNaO4 
[M+Na]+: 462.2791, found: 462.2785. IR (thin film) νmax: 2975, 2929, 1694, 1364, 1314, 1238, 
1161, 1140, 1109, 965, 862, 837, 752 and 698 cm−1. 
4,4,5,5-Tetramethyl-2-((1s,3s)-3-phenyl-1-vinylcyclobutyl)-1,3,2-dioxaborolane (261) 
 
According to General Procedure C, vinyl pinacol boronic ester (0.04 mL, 0.24 mmol, 
1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude 
residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography (SiO2; 
97:3 pentane:Et2O) to afford the corresponding cyclobutane 261 (41 mg, 61 %, >98:2 d.r.) as a 
colorless oil. TLC: Rf = 0.17 (97:3 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.27 
(m, 2H, 2× ArH), 7.22 – 7.14 (m, 3H, 3× ArH), 6.07 (dd, J = 17.2, 10.5 Hz, 1H, CH=), 4.98 – 
4.91 (m, 2H, =CH2), 3.55 – 3.46 (m, 1H, ArCCH), 2.69 – 2.64 (m, 2H, ArCH(CH
aHb)2), 2.15 
– 2.10 (m, 2H, ArCH(CHaHb)2), 1.31 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 146.1 
(ArC), 144.4 (CH=), 128.3 (ArCH), 126.6 (ArCH), 125.9 (ArCH), 111.0 (=CH2), 83.7 
(OC(CH3)2), 37.9 (ArCCH(CH2)2), 36.0 (ArCCH), 24.8 (OC(CH3)2) ppm. HRMS (m/z): (ESI) 
calc’d for C18H25BNaO2 [M+Na]
+: 307.1843, found: 307.1844. IR (thin film) νmax: 2976, 2931, 
1628, 1460, 1353, 1311, 1138, 966, 898, 858, 756 and 697 cm−1. 
 




According to General Procedure C, phenyl pinacol boronic ester (49 mg, 0.24 mmol, 
1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude 
residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography (SiO2; 
97:3 pentane:Et2O) to afford the corresponding cyclobutane 262 (56 mg, 70 %, >98:2 d.r.) as a 
colorless oil that crystallised slowly to a white solid. m.p.: 80 – 84 °C (pentane). TLC: Rf = 
0.14 (97:3 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 7.34 – 7.29 (m, 4H, 4× ArH), 7.26 – 
7.24 (m, 2H, 2× ArH), 7.22 – 7.14 (m, 4H, 4× ArH), 3.64 – 3.55 (m, 1H, ArCCH), 3.10 – 3.05 
(m, 2H, ArCH(CHaHb)2), 2.46 – 2.40 (m, 2H, ArCH(CH
aHb)2), 1.28 (s, 12H, Bpin) ppm. 13C 
NMR (101 MHz, CDCl3) δ 148.6 (ArC), 145.7 (ArC), 128.3 (ArCH), 128.2 (ArCH), 126.6 
(ArCH), 125.9 (ArCH), 125.7 (ArCH), 124.8 (ArCH), 83.3 (OC(CH3)2), 39.4 (ArCCH(CH2)2), 
36.8 (ArCCH), 24.7 (OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C22H27BNaO2 [M+Na]
+: 
357.2000, found: 357.1994. IR (thin film) νmax: 2974, 1352, 1312, 1140, 1107, 965, 859, 836, 




According to General Procedure C, 4-chlorophenyl pinacol boronic ester (57 mg, 0.24 mmol, 
1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give a crude 
residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography (SiO2; 
95:5 pentane:Et2O) to afford the corresponding cyclobutane 263 (59 mg, 67 %, >98:2 d.r.) as a 
white solid. m.p.: 123 – 127 °C (Et2O). TLC: Rf = 0.21 (95:5 pentane:Et2O). 1H NMR 
(400 MHz, CDCl3) δ 7.28 – 7.14 (m, 7H, 7× ArH), 7.09 – 7.05 (m, 2H, 2× ArH), 3.59 – 3.50 
(m, 1H, ArCCH), 3.02 – 2.98 (m, 2H, ArCH(CHaHb)2), 2.35 – 2.30 (m, 2H, ArCH(CH
aHb)2), 
1.23 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 147.3 (ArC), 145.5 (ArC), 130.4 
(ArC), 128.3 (ArCH), 128.3 (ArCH), 127.1 (ArCH), 126.5 (ArCH), 126.0 (ArCH), 83.9 
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(OC(CH3)2), 39.4 (ArCCH(CH2)2), 36.6 (ArCCH), 24.7 (OC(CH3)2) ppm. HRMS (m/z): (ESI) 
calc’d for C22H26BClNaO2 [M+Na]
+: 391.1611, found: 391.1609. IR (solid state) νmax: 2971, 
1491, 1354, 1317, 1139, 1106, 1090, 841, 758, 699 and 523 cm−1. 
Table 14. Crystal data and structure refinement for 263. 
Empirical formula  C22H26BClO2  
Formula weight  368.69  
Temperature/K  100(2)  
Crystal system  monoclinic  
Space group  P21/n  
a/Å  12.0760(1)  
b/Å  11.3002(1)  
c/Å  15.1469(2)  
α/°  90  
β/°  105.940(1)  
γ/°  90  
Volume/Å3  1987.49(4)  
Z  4  
ρcalcg/cm3  1.232  
μ/mm-1  0.205  
F(000)  784.0  
Crystal size/mm3  0.38 × 0.34 × 0.26 
Radiation  
MoKα  
(λ = 0.71073)  
2θ range for data collection/°  3.838 to 55.866  
Index ranges  
-15 ≤ h ≤ 15,  
-14 ≤ k ≤ 14,  
-19 ≤ l ≤ 19  
Reflections collected  35924  
Rint / Rsigma  0.0296 / 0.0173  
Data/restraints/parameters  4755/0/239  
Goodness-of-fit on F2  1.041  
Final R indexes [I>=2σ (I)]  
R1 = 0.0333,  
wR2 = 0.0821  
Final R indexes [all data]  
R1 = 0.0389,  
wR2 = 0.0858  
Largest diff. peak/hole / e Å-3  0.41/-0.19  
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Figure 30. Illustration of the structure of 263 with the anisotropic displacement parameters depicted at the 50% 




According to General Procedure C, 2-methoxy-5-methylphenyl pinacol boronic ester (59 mg, 
0.24 mmol, 1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give 
a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 90:10 pentane:Et2O) to afford the corresponding cyclobutane 264 (58 mg, 64 %, 
>98:2 d.r.) as a colorless oil. TLC: Rf = 0.24 (90:10 pentane:Et2O). 1H NMR (400 MHz, 
CDCl3) δ 7.29 – 7.12 (m, 5H, 5× ArH), 6.97 (d, J = 2.1 Hz, 1H, ArH), 6.93 – 6.91 (m, 1H, 
ArH), 6.68 (d, J = 8.1 Hz, 1H, ArH), 3.77 – 3.68 (m, 1H, ArCCH), 3.75 (s, 3H, OCH3), 2.91 – 
2.86 (m, 2H, ArCH(CHaHb)2), 2.32 – 2.27 (m, 2H, ArCH(CH
aHb)2), 2.29 (s, 3H, CH3), 1.27 (s, 
12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 154.8 (ArC), 146.6 (ArC), 136.7 (ArC), 129.5 
(ArC), 128.2 (ArCH), 126.8 (ArCH), 126.7 (ArCH), 126.3 (ArCH), 125.7 (ArCH), 109.6 
(ArCH), 83.2 (OC(CH3)2), 55.2 (OCH3), 37.9 (ArCCH(CH2)2), 36.0 (ArCCH), 24.7 
(OC(CH3)2), 21.0 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C24H31BNaO3 [M+Na]
+: 
401.2263, found: 401.2266. IR (thin film) νmax: 2976, 1494, 1353, 1306, 1236, 1142, 908, 729 
and 698 cm−1. 
 
 





According to General Procedure C, 3-fluoro-4-methoxyphenyl pinacol boronic ester (60 mg, 
0.24 mmol, 1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give 
a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 90:10 pentane:Et2O) to afford the corresponding cyclobutane 265 (54 mg, 59 %, 
>98:2 d.r.) as a colorless oil. TLC: Rf = 0.17 (90:10 pentane:Et2O). 1H NMR (400 MHz, 
CDCl3) δ 7.29 – 7.14 (m, 5H, 5× ArH), 6.91 – 6.82 (m, 3H, 3× ArH), 3.86 (s, 3H, OCH3), 3.57 
– 3.48 (m, 1H, ArCCH), 2.99 – 2.94 (m, 2H, ArCH(CHaHb)2), 2.33 – 2.28 (m, 2H, 
ArCH(CHaHb)2), 1.24 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 152.4 (d, J = 
244.8 Hz, ArCF), 145.6 (ArC), 144.9 (d, J = 10.9 Hz, ArC), 142.0 (d, J = 5.7 Hz, ArC), 128.3 
(ArCH), 126.5 (ArCH), 126.0 (ArCH), 121.1 (d, J = 3.4 Hz, ArCH), 113.8 (d, J = 18.1 Hz, 
ArCH), 113.5 (d, J = 2.1 Hz, ArCH), 83.9 (OC(CH3)2), 56.5 (OCH3), 39.4 (ArCCH(CH2)2), 
36.4 (ArCCH), 24.7 (OC(CH3)2) ppm. 19F NMR (377 MHz, CDCl3) δ −135.8 ppm. HRMS 
(m/z): (ESI) calc’d for C23H28BFNaO3 [M+Na]
+: 405.2012, found: 405.2020. IR (thin film) 




According to General Procedure C, but without the aqueous work-up, 2-(benzofuran-2-yl) 
pinacol boronic ester (58 mg, 0.24 mmol, 1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 
1.2 equiv) were coupled to give a crude residue (>98:2 d.r. by crude NMR) that was purified 
by flash column chromatography (SiO2; 70:30 pentane:DCM) to afford the corresponding 
cyclobutane 266 (31 mg, 35 %, >98:2 d.r.) as a colorless oil. Note: The product is prone to 
protodeboronation! TLC: Rf = 0.21 (70:30 pentane:DCM). 1H NMR (400 MHz, CDCl3) δ 7.49 
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– 7.41 (m, 2H, 2× ArH), 7.34 – 7.28 (m, 4H, 4× ArH), 7.22 – 7.14 (m, 3H, 3× ArH), 6.47 (d, 
J = 0.9 Hz, 1H, ArH), 3.69 – 3.59 (m, 1H, ArCCH), 2.94 – 2.89 (m, 2H, ArCH(CHaHb)2), 2.68 
– 2.63 (m, 2H, ArCH(CHaHb)2), 1.36 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 163.3 
(ArC), 154.9 (ArC), 145.6 (ArC), 129.4 (ArC), 128.4 (ArCH), 126.7 (ArCH), 126.2 (ArCH), 
123.0 (ArCH), 122.4 (ArCH), 120.4 (ArCH), 110.9 (ArCH), 100.8 (ArCH), 84.2 (OC(CH3)2), 
37.9 (ArCCH(CH2)2), 36.2 (ArCCH), 24.8 (OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for 
C24H28BO3 [M+H]
+: 375.2130, found: 375.2131. IR (thin film) νmax: 2977, 1455, 1371, 1323, 




According to General Procedure C, tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)-1H-indole-1-carboxylate (82 mg, 0.24 mmol, 1.0 equiv) and 4-methoxyphenyl triflate 
(73 mg, 0.29 mmol, 1.2 equiv) were coupled to give a crude residue (>98:2 d.r. by crude NMR) 
that was purified by flash column chromatography (SiO2; 85:15 pentane:Et2O) to afford the 
corresponding cyclobutane 267 (32 mg, 26 %, >98:2 d.r.) as a colorless oil. TLC: Rf = 0.21 
(85:15 pentane:Et2O). 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 8.3 Hz, 1H, ArCH), 7.55 (d, 
J = 3.6 Hz, 1H, ArCH), 7.32 (d, J = 1.4 Hz, 1H, ArCH), 7.15 – 7.10 (m, 3H, 3× ArCH), 6.82 – 
6.78 (m, 2H, 2× ArCH), 6.51 – 6.50 (m, 1H, ArCH), 3.77 (s, 3H, OCH3), 3.53 – 3.44 (m, 1H, 
ArCCH), 3.06 – 3.01 (m, 2H, ArCH(CHaHb)2), 2.38 – 2.33 (m, 2H, ArCH(CH
aHb)2), 1.66 (s, 
9H, C(CH3)3), 1.22 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) δ 157.9 (C=O), 150.0 
(ArC), 143.2 (ArC), 138.0 (ArC), 130.8 (ArC), 133.1 (ArC), 127.6 (ArCH), 125.9 (ArCH), 
122.6 (ArCH), 117.5 (ArCH), 114.9 (ArCH), 113.7 (ArCH), 107.5 (ArCH), 83.7 (OC(CH3)2), 
83.5 (C(CH3)3), 55.4 (OCH3), 40.1 (ArCCH(CH2)2), 36.3 (ArCCH), 28.4 (C(CH3)3), 24.7 
(OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C30H38BNNaO5 [M+Na]
+: 526.2741, found: 
526.2730. IR (thin film) νmax: 2976, 1732, 1513, 1467, 1370, 1247, 1135, 1084 and 1023 cm−1. 
 
 







According to General Procedure C, TBS protected cholesteryl pinacol boronic ester (153 mg, 
0.24 mmol, 1.0 equiv) and phenyl triflate (0.05 mL, 0.29 mmol, 1.2 equiv) were coupled to give 
a crude residue (>98:2 d.r. by crude NMR) that was purified by flash column chromatography 
(SiO2; 80:20 pentane:DCM) to afford the corresponding cyclobutane 274 (116 mg, 63 %, 
>98:2 d.r.) as a colorless oil that crystallised slowly to a white solid. m.p.: 190 – 194 °C (Et2O). 
TLC: Rf = 0.19 (80:20 pentane:DCM). 1H NMR (400 MHz, CDCl3) δ 7.29 – 7.26 (m, 2H, 2× 
ArH), 7.19 – 7.13 (m, 3H, 3× ArH), 3.50 – 3.42 (m, 1H, CHOTBS), 3.31 – 3.22 (m, 1H, 
ArCCH), 2.70 – 2.56 (br m, 2H, CHaHb, CHaHb), 1.97 – 0.50 (m, 30H),  1.30 (s, 6H, Bpin), 
1.29 (s, 6H, Bpin), 0.89 (s, 9H, SiC(CH3)3), 0.87 (d, J = 6.6 Hz, 3H, CH(CH3)
a(CH3)
b), 0.86 (d, 
J = 6.6 Hz, 3H, CH(CH3)
a(CH3)
b), 0.80 (s, 3H, CH3), 0.64 (s, 3H, CH3), 0.08 (s, 6H, Si(CH3)2) 
ppm. 13C NMR (101 MHz, CDCl3) δ 146.7 (ArC), 128.2 (ArCH), 126.5 (ArCH), 125.6 (ArCH), 
83.1 (OC(CH3)2), 72.6 (CHOTBS), 56.6 (CH), 56.5 (CH), 54.8 (CH), 42.8 (C), 40.2 (CH2), 
39.7 (CH2), 37.6 (CH2), 36.4 (CH2), 35.9 (CH), 35.9 (CH), 35.7 (CH2), 35.5 (CH), 34.6 (CH2), 
31.7 (CH2), 28.4 (CH2), 28.2 (CH), 26.2 (C(CH3)3), 25.1 (OC(CH3)2), 24.9 (OC(CH3)2), 24.4 
(CH2), 24.0 (CH2), 23.0 (C), 22.7 (CH(CH3)
a(CH3)
b), 21.5 (CH2), 18.9 (CH(CH3)
a(CH3)
b), 18.4 
(SiC(CH3)3), 13.6 (CH3), 12.2 (CH3), −4.1 (SiCH3), −4.4 (SiCH3) ppm. HRMS (m/z): (ESI) 
calc’d for C49H83BNaSiO3 [M+Na]
+: 781.6102, found: 781.6106. IR (thin film) νmax: 2929, 
2854, 1379, 1143, 1083, 835, 775 and 697 cm−1. 
[𝜶]𝐃
𝟐𝟒: +8 (c = 1.0, CHCl3) 
4.2.3 Unsuccessful Substrates 
Several other triflates and boronic esters were tested which only yielded trace amounts or none 
of the desired products. These are shown in Figure 31. These triflates and boronic esters were 
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prepared according to published procedures231,232,233,234,235 or purchased from commercial 
vendors: please see Figure 31 for details. 
 
Figure 31. Unsuccessful substrates. 
For the paracetamol-derived triflate, the only observed product was the protonated boronate 
complex (93 % ‘H+ product’), and 5 % cyclohexyl pinacol boronic ester, by calibrated GC), 
which suggests that the NH of the amide is acting as a proton source. 
4.2.4 Boronic Ester Functionalisations 
 (1r,3r)-1-Methyl-3-phenylcyclobutan-1-ol (278) 
 
Boronic ester 249 (80 mg, 0.29 mmol, 1.0 equiv) was dissolved in THF (3 mL) and cooled to 
0 °C (ice/water). A 2:1 v:v mixture of NaOH (3 M aqueous solution, 2 mL) and H2O2 (30% 
aqueous solution, 1 mL) was prepared at 0 °C (ice/water) and degassed by gently bubbling N2 
through the solution for 1 min. This aqueous solution was then added dropwise to the vigorously 
stirring reaction mixture, which was subsequently warmed to ambient temperature and allowed 
to react for 1 hr. NH4Cl (saturated aqueous solution, 5 mL) was carefully added and the reaction 
mixture was extracted with EtOAc (3× 10 mL). The combined organic fractions were dried 
(MgSO4), filtered, and concentrated under reduced pressure. The crude residue was purified by 
flash column chromatography (SiO2; 70:30 pentane:EtOAc) to yield the alcohol 278 (45 mg, 
94 %, >98:2 d.r.) as a colorless oil. TLC: Rf = 0.30 (70:30 pentane:EtOAc). 1H NMR 
(400 MHz, CDCl3) δ 7.33 – 7.30 (m, 2H, 2× ArH), 7.23 – 7.17 (m, 3H, 3× ArH), 3.78 – 3.69 
(m, 1H, ArCCH), 2.54 – 2.49 (m, 2H, ArCH(CHaHb)2), 2.27 – 2.22 (m, 2H, ArCH(CH
aHb)2), 
1.80 (br s, 1H, OH), 1.37 (s, 3H, CH3) ppm. 13C NMR (101 MHz, CDCl3) δ 145.5 (ArC), 128.4 
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(ArCH), 126.6 (ArCH), 125.9 (ArCH), 72.4 (COH), 43.5 (ArCCH(CH2)2), 32.0 (ArCCH), 29.7 
(CH3) ppm. HRMS (m/z): HRMS could not be obtained, but a weak molecular ion, alongside 
expected fragments, was observed by GC−MS. IR (thin film) νmax: 3339, 2970, 2929, 1237, 
911, 750 and 697 cm−1. 
2-((1r,3r)-1-Methyl-3-phenylcyclobutyl)furan (279) 
 
According to a literature procedure,36 n-butyl lithium (in hexane, 0.35 mmol, 1.2 equiv) was 
added dropwise to a solution of furan (0.03 mL, 0.35 mmol, 1.2 equiv) in THF (1.2 mL) 
at −78 °C (dry ice/acetone) before warming to ambient temperature and stirring for 1 h. The 
reaction was cooled to ‒78 °C (dry ice/acetone) before adding boronic ester 249 (80 mg, 
0.29 mmol, 1.0 equiv) in THF (1 mL) dropwise and stirring for a further 1 h. 
N-Bromosuccinimide (63 mg, 0.35 mmol, 1.2 equiv) was quickly dissolved in THF (1.2 mL) 
and added, before stirring for a final 1 h. Na2S2O3 (saturated aqueous solution, 5 mL) was then 
added and the mixture was allowed to warm to ambient temperature. The reaction mixture was 
extracted with Et2O (3× 10 mL), and the combined organic phases were combined, dried 
(MgSO4), and concentrated under reduced pressure. The crude residue was purified by flash 
column chromatography (SiO2; pentane) to afford the corresponding arylated cyclobutane 279 
(53 mg, 85 %, >98:2 d.r.) as a colorless oil. TLC: Rf = 0.24 (pentane). 1H NMR (500 MHz, 
CDCl3) δ 7.43 (br s, 1H, ArH), 7.36 – 7.33 (m, 2H, 2× ArH), 7.28 – 7.26 (m, 2H, 2× ArH), 7.24 
– 7.21 (m, 1H, ArH), 6.38 – 6.37 (m, 1H, ArH), 6.19 – 6.18 (m, 1H, ArH), 3.70 – 3.63 (m, 1H, 
ArCCH), 2.83 – 2.79 (m, 2H, ArCH(CHaHb)2), 2.28 – 2.24 (m, 2H, ArCH(CH
aHb)2), 1.50 (s, 
3H, CH3) ppm. 13C NMR (126MHz, CDCl3) δ 162.6 (ArC), 146.0 (ArC), 141.3 (ArCH), 128.4 
(ArCH), 126.6 (ArCH), 126.0 (ArCH), 110.1 (ArCH), 103.2 (ArCH), 41.5 (ArCCH(CH2)2), 
35.4 (CCH3), 34.1 (ArCCH), 28.2 (CH3) ppm. HRMS (m/z): HRMS could not be obtained, but 
a weak molecular ion, alongside expected fragments, was observed by GC−MS. IR (thin film) 
νmax: 2965, 1506, 1495, 1290, 1157, 1011, 920, 797, 728 and 696 cm−1. 
3-Fluoro-4-((1r,3r)-1-methyl-3-phenylcyclobutyl)pyridine (280) 
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According to a literature procedure,37 n-butyl lithium (in hexane, 0.59 mmol, 2.0 equiv) was 
added dropwise to a solution of N,N-diisopropyl amine (0.08 mL, 0.59 mmol, 2.0 equiv) in 
anhydrous THF (1 mL) at ‒78 °C (dry ice/acetone) and allowed to react for 1 h. The solution 
was warmed to ‒60 °C (dry ice/CHCl3) and a solution of 3-fluoropyridine (57 mg, 0.59 mmol, 
2.0 equiv) in anhydrous THF (0.5 mL) was added dropwise before stirring for 30 min. The 
solution was cooled back to ‒78 °C (dry ice/acetone) and a solution of boronic ester 249 (80 mg, 
0.29 mmol, 1.0 equiv) in THF (1 mL) was added dropwise and stirred for 30 min, before 
warming to 0 °C (ice/water) and stirring for a further 30 min. The solution was cooled back to 
‒78 °C (dry ice/acetone) and 2,2,2-trichloroethyl chloroformate (0.16 mL, 1.18 mmol, 
4.0 equiv) was added dropwise, before allowing the reaction mixture to warm slowly to ambient 
temperature overnight (the dry ice/acetone bath was not removed). The mixture was transferred 
to a separating funnel and diluted with Et2O (10 mL) and NaHCO3 (saturated aqueous solution, 
10 mL). The layers were separated and the aqueous phase was extracted with Et2O (2× 10 mL). 
The combined organic phases were dried (MgSO4) and concentrated under reduced pressure. 
The residue was dissolved in THF (3 mL) and cooled to 0 °C. NaOH (3 M aqueous solution, 
1.5 mL) and H2O2 (30 % aqueous solution, 1.5 mL) were slowly added before warming to 
ambient temperature and stirring for 14 h. The solution was transferred to a separating funnel 
with Et2O (5 mL) and then HCl (1 M aqueous solution) was added to acidify the aqueous phase, 
which was then extracted with Et2O (2× 5 mL) which was discarded. The aqueous phase was 
then neutralised with NaHCO3 (saturated aqueous solution) and extracted with Et2O (3× 
10 mL). The combined organic phases were dried (MgSO4) and concentrated under reduced 
pressure. The crude residue was purified by flash column chromatography (SiO2; 95:5 
DCM:EtOAc) to yield the desired pyridine 280 (50 mg, 70 %, >98:2 d.r.) as a colorless oil. 
TLC: Rf = 0.19 (95:5 DCM:EtOAc). 1H NMR (400 MHz, CDCl3) δ 8.41 – 8.40 (m, 2H, 2× 
ArH), 7.35 – 7.31 (m, 3H, 3× ArH), 7.26 – 7.19 (m, 3H, 3× ArH), 3.40 – 3.31 (m, 1H, ArCCH), 
3.02 – 2.96 (m, 2H, ArCH(CHaHb)2), 2.43 – 2.38 (m, 2H, ArCH(CH
aHb)2), 1.46 (s, 3H, CH3) 
ppm. 13C NMR (101 MHz, CDCl3) δ 159.0 (d, J = 256.8 Hz, ArCF), 145.9 (d, J = 5.0 Hz, 
ArCH), 145.1 (ArC), 144.8 (d, J = 10.4 Hz, ArC), 138.7 (d, J = 25.4 Hz, ArCH), 128.5 (ArCH), 
126.5 (ArCH), 126.1 (ArCH), 122.0 (ArCH), 40.9 (ArCCH(CH2)2), 38.1 (CCH3), 33.6 
(ArCCH), 29.8 (CH3) ppm. 19F NMR (377 MHz, CDCl3) δ −128.1 ppm. HRMS (m/z): (ESI) 
calc’d for C16H17FN [M+H]
+: 242.1340, found: 242.1345. IR (thin film) νmax: 2969, 1602, 
1486, 1411, 1214, 834, 747 and 697 cm−1. 
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tert-Butyl ((1r,3r)-1-methyl-3-phenylcyclobutyl)carbamate (281) 
 
According to a procedure outlined by Morken,236 boronic ester 249 (80 mg, 0.29 mmol, 
1.0 equiv), potassium tert-butoxide (181 mg, 1.62 mmol, 5.50 equiv) and 
O-methylhydroxylamine (83 mg, 1.76 mmol, 6 equiv) in anhydrous toluene (1.2  mL) and 
anhydrous THF (0.65 mL) were heated at 80 °C (oil bath) for 14 hr in a tightly sealed vial. After 
cooling to ambient temperature, NaOH (3 M aqueous solution, 5 mL) was added and the mixture 
stirred for 5 min. DCM was added and the mixture was extracted with DCM (3× 10 mL). The 
combined organic layers were combined, dried (MgSO4) and concentrated under reduced 
pressure. The crude residue was dissolved in DCM (2 mL) and then triethylamine (0.08 mL, 
0.58 mmol, 2 equiv) and di-tert-butyl dicarbonate (0.25 mL, 1.91 mmol, 4 equiv) were added. 
The solution was stirred for 16 h at ambient temperature. Water (10 mL) was added and the 
mixture was extracted with Et2O (3× 10 mL). The combined organic fractions were combined, 
dried (MgSO4) and concentrated under reduced pressure. The crude residue was purified by 
flash column chromatography (SiO2; 95:5 to 90:10 pentane:EtOAc) to yield the desired amine 
281 (64 mg, 83 %, >98:2 d.r.) as a white solid. m.p.: 56 – 59 °C (Et2O). TLC: Rf = 0.16 (95:5 
pentane:EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.33 – 7.29 (m, 2H, 2× ArH), 7.21 – 7.17 (m, 
3H, 3× ArH), 4.75 (br s, 1H, NH), 3.71 – 3.62 (m, 1H, ArCCH), 2.68 – 2.63 (br m, 2H, 
ArCH(CHaHb)2), 2.17 – 2.12 (m, 2H, ArCH(CH
aHb)2), 1.48 (s, 9H, C(CH3)3), 1.41 (s, 3H, CH3) 
ppm. 13C NMR (126 MHz, CDCl3) δ 154.8 (C=O), 145.3 (ArC), 128.3 (ArCH), 126.4 (ArCH), 
125.8 (ArCH), 79.1 (OC(CH3)3), 51.8 (CNH), 41.1 (ArCCH(CH2)2), 33.0 (ArCCH), 28.5 
(C(CH3)3), 27.6 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C16H23NNaO2 [M+Na]
+: 284.1621, 
found: 284.1622. IR (thin film) νmax: 3348, 2976, 1693, 1493, 1365, 1170, 1155, 1058, 909, 
730 and 697 cm−1. 
 ((1r,3r)-3-Methyl-3-vinylcyclobutyl)benzene (282) 
 
According to a literature procedure,31 vinyl magnesium chloride (in THF, 1.18 mmol, 4.0 equiv) 
was added dropwise to a solution of boronic ester 249 (80 mg, 0.29 mmol, 1.0 equiv) in 
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anhydrous THF (1.5 mL) at 0 °C and the resulting solution was stirred at ambient temperature 
for 30 min. The solution was cooled to ‒78 °C (dry ice/acetone) and then a solution of iodine 
(298 mg, 1.18 mmol, 4.0 equiv) in anhydrous THF (2.4 mL) was added dropwise before stirring 
for 20 min. A suspension of NaOMe (127 mg, 2.35 mmol, 8.0 equiv) in methanol (1.5 mL) was 
added in a single portion before warming to 0 °C and stirring for a further 30 min. Na2S2O3 
(saturated aqueous solution, 10 mL) was added, followed by DCM (15 mL). The phases were 
separated and the aqueous phase was extracted with DCM (2× 10 mL). The combined organic 
phases were dried (MgSO4) and concentrated under reduced pressure. The crude residue was 
purified by flash column chromatography (SiO2; pentane) to yield the desired alkene 282 
(25 mg, 49 %, >98:2 d.r.) as a colorless oil Note: the product is volatile! (this likely explains 
the lower than expected yield). TLC: Rf = 0.38 (pentane). 1H NMR (400 MHz, CDCl3) δ 7.34 
– 7.30 (m, 2H, 2× ArH), 7.25 – 7.18 (m, 3H, 3× ArH), 6.18 (dd, J = 17.3, 10.5 Hz, 1H, =CH), 
5.16 (dd, J = 17.3, 1.3 Hz, =CHaHb), 5.07 (dd, J = 10.5, 1.3 Hz, =CHaHb), 3.51 – 3.42 (m, 1H, 
ArCCH), 2.50 – 2.44 (m, 2H, ArCH(CHaHb)2), 2.08 – 2.02 (m, 2H, ArCH(CH
aHb)2), 1.23 (s, 
3H, CH3) ppm. 13C NMR (101 MHz, CDCl3) δ 146.6 (=CH), 146.1 (ArC), 128.4 (ArCH), 126.6 
(ArCH), 125.8 (ArCH), 110.1 (=CH2), 40.8 (ArCCH(CH2)2), 37.5 (CCH=), 33.4 (ArCCH), 
28.5 (CH3) ppm. HRMS (m/z): HRMS could not be obtained, but a weak molecular ion, 
alongside expected fragments, was observed by GC−MS. IR (thin film) νmax: 2958, 1143, 908, 
749 and 697 cm−1. 
2-Methyl-4-((1r,3r)-1-methyl-3-phenylcyclobutyl)but-3-yn-2-ol (283) 
 
According to a literature procedure,34 freshly prepared LDA (0.86 M in THF, 0.51 mL, 
0.44 mmol, 1.5 equiv) was added dropwise to a solution of boronic ester 249 (80 mg, 
0.29 mmol, 1.0 equiv) and vinyl carbamate (76 mg, 0.44 mmol, 1.5 equiv) in anhydrous THF 
(1.5 mL) at ‒78 °C (dry ice/acetone) and then allowed to stir for 1 h, before warming to ‒40 °C 
(dry ice/acetone) for 30 min. The reaction was cooled to ‒78 °C (dry ice/acetone) and a solution 
of iodine (112 mg, 0.44 mmol, 1.5 equiv) in methanol (2.5 mL) was added dropwise before 
stirring for 10 min at this temperature, and then warming to ambient temperature for 1 h. 
Na2S2O3 (saturated aqueous solution, 10 mL) was added, and the mixture was transferred to a 
separating funnel with Et2O (5 mL). The layers were separated and the aqueous phase was 
extracted with Et2O (2× 10 mL). The combined organic layers were dried (MgSO4) and then 
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passed through a short plug of silica gel, before concentrating under reduced pressure. The 
residue was dissolved in anhydrous THF (3 mL) and cooled to ‒78 °C (dry ice/acetone) before 
adding LDA (0.86 M in THF, 2.05 mL, 1.76 mmol, 6.0 equiv) dropwise. The solution was 
warmed to ambient temperature and stirred for 30 min, before adding acetone (0.22 mL, 
2.90 mmol, 10 equiv) and stirring for a further 30 min. NH4Cl (saturated aqueous solution, 
10 mL) was added and the mixture was transferred to a separating funnel with Et2O (10 mL). 
The layers were separated and the aqueous phase was extracted with Et2O (2× 10 mL). The 
combined organic phases were dried (MgSO4) and concentrated under reduced pressure. The 
crude residue was purified by flash column chromatography (SiO2; 90:10 pentane:EtOAc) to 
yield the desired alkyne 283 (37 mg, 55 %, >98:2 d.r.) as a colorless oil. TLC: Rf = 0.15 (90:10 
pentane:EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H, 2× ArH), 7.20 – 7.17 (m, 
3H, 3× ArH), 3.77 – 3.68 (m, 1H, ArCCH), 2.67 – 2.60 (m, 2H, ArCH(CHaHb)2), 2.12 – 2.06 
(m, 2H, ArCH(CHaHb)2), 1.93 (s, 1H, OH), 1.56 (s, 6H, C(CH3)2), 1.36 (s, 3H, CH3) ppm. 13C 
NMR (101 MHz, CDCl3) δ 145.4 (ArC), 128.4 (ArCH), 126.5 (ArCH), 126.0 (ArCH), 90.1 
(C), 84.7 (C), 65.5 (C), 43.7 (ArCCH(CH2)2), 34.6 (ArCCH), 32.0 (C(CH3)2), 29.5 (C), 29.2 
(CH3) ppm. HRMS (m/z): (ESI) calc’d for C16H20NaO [M+Na]
+: 251.1406, found: 251.1402. 
IR (thin film) νmax: 3345, 2975, 2931, 2233, 1495, 1163, 937, 752 and 697 cm−1. 
Trifluoro((1s,3s)-1-methyl-3-phenylcyclobutyl)-λ4-borane, potassium salt (284) 
 
According to a literature procedure,237 KHF2 (4.5 M aqueous solution, 0.38 mL) was added 
dropwise to a solution of boronic ester 249 (80 mg, 0.29 mmol, 1.0 equiv) in methanol (5 mL) 
and the resulting mixture was stirred for 30 min. All volatiles were removed under reduced 
pressure and the residue was re-dissolved in methanol (6 mL) and water (4 mL), before 
removing all volatiles again. This cycle was repeated 10× to remove all pinacol. The residue 
was triturated with Et2O (3× 5 mL) and the combined liquid phases were concentrated under 
reduced pressure to yield the desired trifluoroborate salt 284 (128 mg, >95 %, >98:2 d.r.) as a 
white solid. 1H NMR (400 MHz, CD3CN) δ 7.26 – 7.23 (m, 4H, 4× ArH), 7.11 – 7.07 (m, 1H, 
ArH), 3.44 – 3.35 (m, 1H, ArCCH), 2.39 – 2.34 (m, 2H, ArCH(CHaHb)2), 1.46 – 1.41 (m, 2H, 
ArCH(CHaHb)2), 0.93 (s, 3H, CH3) ppm. 13C NMR (101 MHz, CD3CN) δ 149.9 (ArC), 128.9 
(ArCH), 127.4 (ArCH), 125.8 (ArCH), 41.0 (ArCCH(CH2)2), 35.8 (ArCCH), 30.9 (C), 27.6 
(CH3) ppm. 19F NMR (377 MHz, CDCl3) δ −146.8 ppm. HRMS (m/z): (ESI) calc’d for 
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C11H13BF3 [M‒K
+]‒: 213.1071, found: 213.1074. IR (solid state) νmax: 2937, 2854, 1304, 1027, 
989, 920, 743 and 696 cm−1. 
4.3.1 Other experiments 
Use of BCB-Li generated from BCB-Br 
 
Methyl lithium (in Et2O, 0.24 mmol, 1.0 equiv) was added dropwise to a solution of 
1,1-dibromo-2-(chloromethyl)cyclopropane 212 (59 mg, 0.24 mmol, 1.0 equiv) in Et2O (2 mL) 
at ‒78 °C (dry ice/acetone) and allowed to stir for 30 min, followed by 1 h at ‒50 °C (dry 
ice/acetone). The solution was then cooled back to –78 °C (dry ice/acetone) and a high vacuum 
was applied for 2 min in order to remove the volatile MeBr. tert-Butyl lithium (in pentane, 
0.24 mmol, 1.0 equiv) was then added and stirred for a further 20 min. A solution of cyclohexyl 
pinacol boronic ester (50 mg, 0.24 mmol, 1.0 equiv) in 2-methyl tetrahydrofuran (0.5 mL) was 
added dropwise and the mixture was stirred for 30 min. After removing the cooling bath a 
solution of Pd(dba)2 (4.1 mg, 7.2  μmol, 3.0 mol%) and dippf (3.6 mg, 8.6 μmol, 3.6 mol%) in 
2-methyl tetrahydrofuran (0.5 mL) (pre-mixed under argon for 20 min) was then added 
followed by phenyl triflate (0.05 mL, 0.29 mmol, 1.20 equiv). The flask was sealed and heated 
at 40 °C (oil bath) for 14 h. After cooling to ambient temperature, the solution was transferred 
to a 28 mL vial and the flask was washed with pentane (15 mL). H2O (5 mL) and NH4Cl 
(saturated aqueous solution, 5 mL) were then added, and the flask was sealed and shaken 
vigorously. The layers were allowed to separate, and the top organic phase was carefully 
collected using a pipette. The aqueous phase was subsequently washed with pentane (2× 7 mL) 
and then the combined organic phases were dried (MgSO4), filtered, and concentrated under 
reduced pressure. Analysis by crude 1H NMR did not show any trace of the desired cyclobutane 
product 234. 
During formation of 1-lithio bicyclo[1.1.0]butane 209, 1.0 equiv of LiCl is formed. This has 
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Is a cyclopropyl ring able to undergo similar reactivity? 
 
sec-Butyl lithium (in 92:8 cyclohexane:hexane, 0.24 mmol, 1.0 equiv) was added dropwise to 
a solution of cyclopropyl boronic ester (0.04 mL, 0.24 mmol, 1.0 equiv) in anhydrous 2-methyl 
tetrahydrofuran (2 mL) at ‒78 °C (dry ice/acetone) and allowed to stir for 15 min. After 
warming to ambient temperature a solution of Pd(dba)2 (4.1 mg, 3.0 mol%, 7.2 μmol) and dippf 
(3.6 mg, 3.6 mol%, 8.6 μmol) in 2-methyl tetrahydrofuran (0.5 mL) (pre-mixed under argon for 
20 min) was added followed by phenyl triflate (0.05 mL, 0.29 mmol, 1.20 equiv). The flask 
was sealed and heated at 40 °C (oil bath) for 14 h. After cooling to ambient temperature, the 
solution was transferred to a 28 mL vial and the flask was washed with pentane (15 mL). H2O 
(5 mL) and NH4Cl (saturated aqueous solution, 5 mL) were then added, and the flask was sealed 
and shaken vigorously. The layers were allowed to separate and the top organic phase sampled 
for analysis by GC−MS and TLC. Both methods were conclusive and showed that none of the 
desired ring-opened product had formed, and that the boronate complex had decomposed to 
regenerate the cyclopropyl pinacol boronic ester. 
4.3 Deprotonation of bicyclobutyl sulfoxide 
 
LDA (0.60 mL, 0.86 M in THF, 0.52 mmol, 2 equiv) was diluted with THF (1 mL) and cooled 
to −78 °C (dry ice/acetone). BCB-sulfoxide 224 (50 mg, 0.26 mmol, 1 equiv) in THF (0.5 mL) 
was then added dropwise and the solution was stirred for 1 h at the same temperature. 
Iodomethane (0.05 mL, 0.78 mmol, 3 equiv) was then added dropwise and the resulting solution 
stirred at −78 °C for 10 min and then warmed to ambient temperature. The solution was 
transferred to a 28 mL vial and the flask was washed with Et2O (15 mL). H2O (10 mL) was 
then added, and the flask was sealed and shaken vigorously. The layers were allowed to separate 
and the top organic phase was carefully collected using a pipette. The aqueous phase was 
subsequently washed with Et2O (2× 7 mL) and then the combined organic phases were dried 
(MgSO4), filtered, and concentrated under reduced pressure. The crude residue was directly 
purified by flash column chromatography (SiO2; 70:30 pentane:EtOAc) to yield the alkylated 
- 262 - 
 
BCB-sulfoxide 285 (45 mg, 83 %) as a colorless oil. TLC: Rf = 0.32 (60:40 pentane:EtOAc). 
1H NMR (400 MHz, CDCl3) δ 7.58 – 7.55 (m, 2H, 2× ArH), 7.32 – 7.30 (m, 2H, 2× ArH), 2.41 
(s, 3H, ArCH3), 2.21 – 2.20 (m, 1H, CH
aHb), 1.94 – 1.92 (m, 1H, CHaHb), 1.70 (s, 3H, CH3), 
1.26 (s, 1H, CHaHb), 1.05 (s, 1H, CHaHb) ppm. 13C NMR (101 MHz, CDCl3) δ 142.7 (ArC), 
141.3 (ArC), 129.9 (ArCH), 124.7 (ArCH), 38.5 (CH2), 33.2 (CH2), 26.4 (C), 21.6 (ArCH3), 
20.1 (C), 11.5 (CH3) ppm. HRMS (m/z): (ESI) calc’d for C12H14NaOS [M+Na]
+: 229.0658, 
found: 229.0655. IR (thin film) νmax: 2928, 1492, 1084, 1042, 1016, 934, 809 and 683 cm−1. 
4.4 Azetidine homologation of boronic esters 
4.4.1 General Procedure D: Azetidine Homologation of Boronic Esters 
 
General Procedure D: tert-Butyl lithium (in pentane, 0.28 mmol, 1.20 equiv)A was added 
dropwiseB to a solution of ABB-sulfoxide 292 (55 mg, 0.28 mmol, 1.20 equiv) and the boronic 
ester (0.24 mmol, 1.0 equiv) in anhydrous tetrahydrofuran (2 mL) at ‒78 °C (dry ice/acetone) 
and allowed to stir for 2 h. Acetic acid (0.03 mL, 0.48 mmol, 2.00 equiv) is then added dropwise 
and the mixture is stirred for 1 h at ‒78 °C (dry ice/acetone) then warmed to ambient 
temperature and stirred for a further 1 h. The crude reaction mixture is then directly added onto 
the top of a silica gel plug (10 mL silica, 2.5 cm diameter) using a small amount of EtOAc to 
aid complete transfer. The solvent is eluted and the silica plug is washed repeatedly with EtOAc 
(approx. 30 mL total) and then dried. The top layer of the silica (approx. 0.5 cm) is carefully 
removed and added into a flask.C DCM (10 mL) is then added, followed by triethylamine 
(0.14 mL, 0.96 mmol, 4.0 equiv) and di-tert-butyl dicarbonate (0.1 mL, approx. 0.48 mmol, 
approx. 2 equiv), and the resulting mixture is stirred overnight. The reaction mixture is then 
filtered through a plug of cotton wool and sand and then concentrated under reduced pressure. 
The crude residue was purified by flash column chromatography (SiO2)
D to yield the desired 
azetidines. Notes: (A) tert-Butyl lithium should be carefully titrated prior to use. (B) On this 
scale, this dropwise addition takes approximately 1 min. (C) There is often a visible layer of 
solid on top of the dried silica gel. (D) Typically, the only impurities observed at this stage are 
excess triethylamine and di-tert-butyl decarbonate. 
 





According to General Procedure D, cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 
1.0 equiv) was homologated by an azetidine unit and tert-butyloxycarbonyl protected to give a 
crude reside, which was purified by flash column chromatography (SiO2; 90:10 
pentane:EtOAc) to afford the corresponding azetidine (66 mg, 76 %) as a white solid. m.p.: 
119 – 121 °C (pentane). TLC: Rf = 0.24 (90:10 pentane:EtOAc). 1H NMR (400 MHz, CDCl3) 
δ 3.92 (d, J = 8.2 Hz, 2H, N(CHaHb)2), 3.64 (d, J = 8.2 Hz, 2H, N(CH
aHb)2), 1.76 – 1.63 (m, 
6H, 3× CH2), 1.55 – 1.48 (m, 1H, CH), 1.43 (s, 9H, OC(CH3)3), 1.25 (s, 12H, Bpin), 1.22 – 
0.94 (m, 4H, 2× CH2) ppm. 13C NMR (101 MHz, CDCl3) δ 156.6 (C=O), 83.8 (OC(CH3)2), 
79.1 (OC(CH3)3), 45.4 (CH), 29.1 (CH2), 28.6 (OC(CH3)3), 26.7 (2× CH2), 24.9 (OC(CH3)2) 
ppm. N(CH2)2 was not observed. HRMS (m/z): (ESI) calc’d for C20H36BNNaO4 [M+Na]
+: 





According to General Procedure D, tert-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)piperidine-1-carboxylate (75 mg, 0.24 mmol, 1.0 equiv) was homologated by an azetidine 
unit and tert-butyloxycarbonyl protected to give a crude reside, which was purified by flash 
column chromatography (SiO2; 75:25 pentane:EtOAc) to afford the corresponding azetidine 
(60 mg, 54 %) as a colorless oil that solidified slowly upon standing. m.p.: 110 – 114 °C 
(DCM). TLC: Rf = 0.19 (75:25 pentane:EtOAc). 1H NMR (400 MHz, CDCl3) δ 3.99 (d, J = 
8.1 Hz, 1H, N(CHaHb)(CHaHb)), 3.88 (d, J = 8.1 Hz, 1H, N(CHaHb)(CHaHb)), 3.74 – 3.54 (br 
m, 3H, N(CHaHb)(CHaHb), N(CHaHb)(CHaHb), NCH), 1.79 – 1.65 (br m, 8H, 4× CH2), 1.44 (s, 
9H, OC(CH3)3), 1.42 (s, 9H, OC(CH3)3), 1.23 (s, 12H, Bpin) ppm. 13C NMR (101 MHz, CDCl3) 
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δ 155.7 (C=O), 80.7 (OC(CH3)2), 79.0 (OC(CH3)3), 28.6 (OC(CH3)3), 25.3 (OC(CH3)2) ppm. 
All other signals not observed. HRMS (m/z): (ESI) calc’d for C24H43BN2NaO6 [M+Na]
+: 




According to General Procedure D, benzyl pinacol boronic ester (51 mg, 0.24 mmol, 
1.0 equiv) was homologated by an azetidine unit and tert-butyloxycarbonyl protected to give a 
crude reside, which was purified by flash column chromatography (SiO2; 80:20 
pentane:EtOAc) to afford the corresponding azetidine (59 mg, 68 %) as a colorless oil. TLC: 
Rf = 0.31 (80:20 pentane:EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.27 – 7.22 (m, 2H, 2× ArH), 
7.19 – 7.15 (m, 3H, 3× ArH), 4.01 (d, J = 8.3 Hz, 2H, N(CHaHb)2), 3.73 (d, J = 8.3 Hz, 
N(CHaHb)2), 3.05 (s, 2H, CH2), 1.44 (s, 9H, OC(CH3)3), 1.17 (s, 12H, Bpin) ppm. 13C NMR 
(101 MHz, CDCl3) δ 156.7 (C=O), 139.6 (ArC), 129.0 (ArCH), 128.4 (ArCH), 126.4 (ArCH), 
84.1 (OC(CH3)2), 79.3 (OC(CH3)3), 42.6 (CH2), 28.6 (OC(CH3)3), 24.8 (OC(CH3)2) ppm. 
N(CH2)2 was not observed. HRMS (m/z): (ESI) calc’d for C21H32BNaNO4 [M+Na]
+: 396.2320, 




According to General Procedure D, (R)-2-(4-(4-methoxyphenyl)butan-2-yl) pinacol boronic 
ester (95:5 e.r., 69 mg, 0.24 mmol, 1.0 equiv) was homologated by an azetidine unit and tert-
butyloxycarbonyl protected to give a crude reside, which was purified by flash column 
chromatography (SiO2; 85:15 pentane:EtOAc) to afford the corresponding azetidine (95:5 e.r., 
100 % e.s., 84 mg, 79 %) as a colorless oil. The analogous reaction using racemic boronic ester 
provided 78 % of the racemic product. TLC: Rf = 0.24 (85:15 pentane:EtOAc). 1H NMR 
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(400 MHz, CDCl3) δ 7.10 – 7.06 (m, 2H, 2× ArH), 6.84 – 6.80 (m, 2H, 2× ArH), 3.95 – 3.92 
(m, 2H, N(CHaHb)2), 3.79 (s, 3H, OCH3), 3.61 – 3.55 (m, 2H, N(CH
aHb)2), 2.71 – 2.64 (m, 1H, 
CHaHb), 2.46 – 2.39 (m, 2H, CHaHb), 1.74 – 1.56 (m, 3H, CH2, CH), 1.42 (s, 9H, OC(CH3)3), 
1.24 (s, 12H, Bpin), 0.95 (d, J = 6.7 Hz, 3H, CH3) ppm. 13C NMR (101 MHz, CDCl3) δ 157.8 
(ArCOCH3), 156.6 (C=O), 134.7 (ArC), 129.3 (ArCH), 113.9 (ArCH), 83.8 (OC(CH3)2), 79.2 
(OC(CH3)3), 55.4 (OCH3), 40.1 (CH), 35.7 (CH2), 33.3 (CH2), 28.6 (OC(CH3)3), 24.9 
(OC(CH3)2), 15.6 (CH3) ppm. N(CH2)2 was not observed. HRMS (m/z): (ESI) calc’d for 
C25H41BNO5 [M+H]
+: 446.3077, found: 446.3077. IR (thin film) νmax: 2975, 2933, 2873, 1699, 
1512, 1372, 1245 and 1138 cm−1. [𝜶]𝐃
𝟐𝟒: +14 (c = 1.0, CHCl3). Chiral HPLC: Daicel 
Chiralpak-IA column (25 cm) with guard, 10.0 % isopropanol in hexane, 0.7 mL/min, ambient 
temperature, 210 nm: tR = 6.41 min (major, (R)), tR = 6.85 min (minor, (S)), 95:5 e.r. 

































According to General Procedure D, (R)-2-(1-(4-chlorophenyl)-1-phenylethyl pinacol boronic 
ester (98:2 e.r., 81 mg, 0.24 mmol, 1.0 equiv) was homologated by an azetidine unit and tert-
butyloxycarbonyl protected to give a crude reside, which was purified by flash column 
chromatography (SiO2; 85:15 pentane:EtOAc) to afford the corresponding azetidine (101 mg, 
86 %) as a colorless oil. The analogous reaction using racemic boronic ester provided 53 % of 
the racemic product. TLC: Rf = 0.26 (85:15 pentane:EtOAc). 1H NMR (500 MHz, CDCl3) δ 
7.27 – 7.17 (m, 5H, 5× ArH), 7.07 – 7.02 (m, 4H, 4× ArH), 4.13 – 3.82 (br m, N(CH2)2), 1.78 
(s, 3H, CH3), 1.28 (s, 9H, OC(CH3)3), 1.14 (s, 12H, Bpin) ppm. 13C NMR (126 MHz, CDCl3) 





b), 49.5 (C), 28.4 (OC(CH3)3), 25.6 
(CH3), 24.6 (OC(CH3)2) ppm. HRMS (m/z): (ESI) calc’d for C28H37BClNNaO4 [M+Na]
+: 
520.2401, found: 520.2383. IR (thin film) νmax: 2977, 1698, 1346, 1316, 1139, 1093, 1011, 
854, 735 and 704 cm−1. [𝜶]𝐃
𝟐𝟒: −10 (c = 1.0, CHCl3). Chiral HPLC: Daicel Chiralpak-IA 
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column (25 cm) with guard, 10.0 % isopropanol in hexane, 1.0 mL/min, ambient temperature, 






































































According to General Procedure D, 4,4,5,5-tetramethyl-2-((1s,3s)-1-methyl-3-
phenylcyclobutyl)-1,3,2-dioxaborolane (>98:2 d.r., 65 mg, 0.24 mmol, 1.0 equiv) was 
homologated by an azetidine unit and tert-butyloxycarbonyl protected to give a crude reside, 
which was purified by flash column chromatography (SiO2; 90:10 pentane:EtOAc) to afford 
the corresponding azetidine (>98:2 d.r., 100 % d.s., 79 mg, 77 %) as a colorless oil. TLC: Rf = 
0.22 (90:10 pentane:EtOAc). 1H NMR (400 MHz, CDCl3) δ 7.33 – 7.24 (m, 4H, 4× ArH), 7.19 
– 7.15 (m, 1H, ArH), 4.00 (d, J = 8.5 Hz, 2H, N(CHaHb)2), 3.86 – 3.77 (br m, 2H, N(CH
aHb)2), 
3.45 – 3.36 (m, 1H, ArCH), 2.72 – 2.67 (m, 2H, ArCH(CHaHb)2), 2.01 – 1.96 (m, 2H, 
ArCH(CHaHb)2), 1.46 (s, 9H, OC(CH3)3), 1.25 (s, 12H, Bpin), 1.07 (s, 3H, CH3) ppm. 13C NMR 
(101 MHz, CDCl3) δ 156.5 (C=O), 147.2 (ArC), 128.4 (ArCH), 126.6 (ArCH), 125.6 (ArCH), 
83.8 (OC(CH3)2), 79.3 (OC(CH3)3), 37.1 (ArCH(CH2)2), 36.9 (C), 32.5 (ArCH), 28.6 
(OC(CH3)3), 27.3 (CH3), 24.9 (OC(CH3)2) ppm. N(CH2)2 was not observed. HRMS (m/z): 
(ESI) calc’d for C25H38BNNaO4 [M+Na]
+: 450.2791, found: 450.2794. IR (thin film) νmax: 
2975, 2879, 1699, 1356, 1317, 1133, 1096, 854, 752 and 698 cm−1.
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